FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Di Azevedo, MIN
   Pires, BC
   Libonati, H
   Pinto, PS
   Barbosa, LFC
   Carvalho-Costa, FA
   Lilenbaum, W
AF Nogueira Di Azevedo, Maria Isabel
   Pires, Bruno C.
   Libonati, Hugo
   Pinto, Priscila S.
   Cardoso Barbosa, Lucas Figueiredo
   Carvalho-Costa, Filipe Anibal
   Lilenbaum, Walter
TI Extra-renal bovine leptospirosis: Molecular characterization of the
   Leptospira interrogans Sejroe serogroup on the uterus of non-pregnant
   cows
SO VETERINARY MICROBIOLOGY
LA English
DT Article
DE Uterine infection; Cattle; PCR; lipL32; secY; Bovine genital
   leptospirosis
ID TRACTS
AB Bovine genital leptospirosis is a chronic disease that causes reproductive disorders such as abortions, stillbirths, and estrus repetition, as well as economic losses. Despite clinical signs related to reproductive failure, the majority of studies have focused on the detection of Leptospira spp. in the urine, while few have considered the reproductive tract. Consequently, the aim of the present study was to investigate the uterus as an important extra-renal site of leptospiral infection in cows. A total of 42 non-pregnant cows were studied at a slaughterhouse. Blood samples and uterine fragments were collected for serology and molecular analysis, respectively. Concerning serologic results, 20.5 % presented as reactive, all of them against the Sejroe serogroup. Regarding lipL32 PCR, 26.2 % (11/42) of samples were positive for pathogenic Leptospira sp. Sequencing the secY gene short region enabled nine strains to be characterized, all of which were L. interrogans, with high identity (98.8 %99.8 %) with serovar Hardjo. The use of molecular tools substantially improved the sensitivity of Leptospira sp. detection at species level and demonstrated that the uterus is an important site of bovine leptospiral infection. The findings of the present study reinforce our understanding that leptospiral uterine infection are associated to members of the Sejroe serogroup.
C1 [Nogueira Di Azevedo, Maria Isabel; Pires, Bruno C.; Libonati, Hugo; Pinto, Priscila S.; Cardoso Barbosa, Lucas Figueiredo; Lilenbaum, Walter] Fluminense Fed Univ, Biomed Inst, Lab Vet Bacteriol, Niteroi, RJ, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Epidemiol & Mol Systemat, Rio De Janeiro, Brazil.
RP Lilenbaum, W (corresponding author), Fluminense Fed Univ, Biomed Inst, Lab Vet Bacteriol, Niteroi, RJ, Brazil.
EM wlilenbaum@id.uff.br
FU Coordenacao de Aperfeicoamento de Pessoal de Nfvel Superior Brasil
   (CAPES)CAPES [001]
FX We thank Coordenacao de Aperfeicoamento de Pessoal de Nfvel Superior
   Brasil (CAPES) for partially funding the study Finance Code 001. We also
   thank the Bom Pastor and Juiz de Fora slaughterhouses for allowing
   access to cows. We are also grateful to the Program for Technological
   Development in Tools for Health-PDTIS/FIOCRUZ for allowing us to use its
   facilities. MINDA and WL are FAPERJ fellows, BCP is a CAPES fellow, and
   LFCB and WL are CNPq fellows.
CR Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28
   Correia L, 2017, VET J, V220, P63, DOI 10.1016/j.tvjl.2016.12.016
   ELLIS WA, 1986, AM J VET RES, V47, P1694
   ELLIS WA, 1986, VET REC, V118, P11, DOI 10.1136/vr.118.1.11
   Ellis WA, 2015, CURR TOP MICROBIOL, V387, P99, DOI 10.1007/978-3-662-45059-8_6
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Hamond C, 2014, VET RES COMMUN, V38, P81, DOI 10.1007/s11259-013-9582-x
   Hamond C, 2015, VET MICROBIOL, V179, P264, DOI 10.1016/j.vetmic.2015.06.014
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   Libonati HA, 2018, TROP ANIM HEALTH PRO, V50, P1625, DOI 10.1007/s11250-018-1604-9
   Libonati H, 2017, MICROB PATHOGENESIS, V108, P101, DOI 10.1016/j.micpath.2017.05.001
   Loureiro AP, 2017, ANIM REPROD SCI, V178, P54, DOI 10.1016/j.anireprosci.2017.01.008
   Loureiro AP, 2020, THERIOGENOLOGY, V141, P41, DOI 10.1016/j.theriogenology.2019.09.011
   Nally JE, 2018, VET MICROBIOL, V218, P25, DOI 10.1016/j.vetmic.2018.03.023
   OIE, 2018, MANUAL DIAGNOSTIC TE
   Otaka DY, 2012, VET REC, V170, DOI 10.1136/vr.100490
   Pires BC, 2018, MICROB PATHOGENESIS, V114, P163, DOI 10.1016/j.micpath.2017.11.056
   Silva AF, 2019, TROP ANIM HEALTH PRO, V51, P43, DOI 10.1007/s11250-018-1657-9
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Wang W, 2014, MICROB PATHOGENESIS, V75, P1, DOI 10.1016/j.micpath.2014.07.011
NR 21
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1135
EI 1873-2542
J9 VET MICROBIOL
JI Vet. Microbiol.
PD NOV
PY 2020
VL 250
AR 108869
DI 10.1016/j.vetmic.2020.108869
PG 4
WC Microbiology; Veterinary Sciences
SC Microbiology; Veterinary Sciences
GA OE6JE
UT WOS:000580634100018
PM 33010572
DA 2020-12-08
ER

PT J
AU Tavares, MD
   Nicol, AF
   Yokobatake, ER
   Melo, MML
   Vitoriano, BF
   Carvalho-Costa, FA
   Martinelli, KG
   de Paula, VS
AF Tavares, Maria do Carmo
   Nicol, Alcina F.
   Yokobatake, Elizabeth Ribeiro
   Melo, Mayara Magna Lima
   Vitoriano, Bruna Ferreira
   Carvalho-Costa, Filipe Anibal
   Martinelli, Katrini Guidolini
   de Paula, Vanessa Salete
TI Evaluation of cytopathological screening results and risk factors of
   women who underwent Papanicolaou test in a maternity school in
   Fortaleza, Ceara, Brazil
SO CYTOPATHOLOGY
LA English
DT Article
DE cervical cancer; cytopathology; endocervix; Papanicolaou smear;
   screening; STIs; women
ID BENEFITS
AB Introduction Papanicolaou test (Pap smear) is the standard screening test of pre-neoplastic lesions and cervical cancer. This study aimed to investigate cervical cancer screening results and risk factors such as age, reason for the examination, the epithelia detected in the sample, microbiota and signs of sexually transmitted infection (STIs) of women in a maternity school in Fortaleza, Ceara, Brazil. Methods In this cross-sectional study, data were retrieved of 353 women who underwent Pap smear between April 2016 and January 2017 at the Federal University of Ceara. Results Of all Pap smear samples retrieved, 54.1% (191/353) had glandular epithelium and 40.2% (142/353) had metaplastic epithelium. After statistical analyses adjusted for the final model, age >= 51 years (odds ratio = 3.47) and signs of STIs (odds ratio = 4.95) remained as risk factors. Conclusions The diagnosis of high-grade lesions and carcinomas in patients older than 50 years indicates a deficiency in cervical screening. Women with signs and symptoms of STIs and candidiasis sought medical services more frequently than asymptomatic women, and presence of these signs and symptoms contributes to the diagnosis of cervical cancer. We highlight the importance of obtaining a correct smear sampling to allow prompt detection of all preneoplastic lesions; moreover, the implementation of human papillomavirus vaccination and an efficient routine Pap screening are necessary in low-resource settings.
C1 [Tavares, Maria do Carmo; de Paula, Vanessa Salete] Fiocruz MS, Oswaldo Cruz Fdn, Lab Mol Virol, Rio De Janeiro, Brazil.
   [Tavares, Maria do Carmo] Univ Hosp Walter Cantidio, Fortaleza, Ceara, Brazil.
   [Nicol, Alcina F.] INI Fiocruz, Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [Yokobatake, Elizabeth Ribeiro; Melo, Mayara Magna Lima; Vitoriano, Bruna Ferreira] Matern Sch Assis Chateaubriand, Fortaleza, Ceara, Brazil.
   [Carvalho-Costa, Filipe Anibal; Martinelli, Katrini Guidolini] Fundacao Oswaldo Cruz, Lab Epidemiol & Systemat Mol, Rio De Janeiro, Brazil.
   [Martinelli, Katrini Guidolini] Fed Univ Espirito Santo UFES, Postgrad Program Publ Hlth, Vitoria, ES, Brazil.
   [Martinelli, Katrini Guidolini] Lab Canc Cytogenet, Fortaleza, Ceara, Brazil.
RP de Paula, VS (corresponding author), Fundacao Oswaldo Cruz, Lab Mol Virol, Av Brasil 4365 Manguinhos, BR-21040360 Rio De Janeiro, Brazil.
EM vdepaula@ioc.fiocruz.br
OI de Paula, Vanessa/0000-0002-6314-754X
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -
   Brasil (CAPES)CAPES [001]
FX Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -
   Brasil (CAPES) -, Grant/Award Number: Finance Code 001
CR Akinfolarin AC, 2017, J CYTOL, V34, P208, DOI [10.4103/JOC.JOC_199_15, 10.4103/joc.joc_199_15]
   Amaral RG, 2008, REV BRAS GINECOL OBS, V30, P556, DOI 10.1590/S0100-72032008001100005
   Arcaro F., 2010, Revista do Instituto Adolfo Lutz, V69, P119
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492
   Fedrizzi EN, 2008, J BRAS DOENCAS SEX T, V20, P73
   Gasparin VA, 2016, COGITARE ENFERM, V21, P1
   Gillison ML, 2014, INT J CANCER, V134, P497, DOI 10.1002/ijc.28201
   Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107
   Goncalves S, 2007, ESTUD BIOL, V29, P137
   Gupta N, 2013, CYTOPATHOLOGY, V24, P39, DOI 10.1111/j.1365-2303.2012.00992.x
   Martins LFL, 2018, EUR J CANCER PREV, V27, P339, DOI 10.1097/CEJ.0000000000000327
   Ministry of Health. Instituto Nacional de cancer - INCA, DIR RASTR CANC COL U
   Moen KA, 2017, EUR J CANCER PREV, V26, P521, DOI 10.1097/CEJ.0000000000000311
   da Silva DSM, 2014, CIENC SAUDE COLETIVA, V19, P1163, DOI 10.1590/1413-81232014194.00372013
   Nicol AF, 2015, ANN DIAGN PATHOL, V19, P418, DOI 10.1016/j.anndiagpath.2015.07.008
   Peterson CE, 2016, TRANSL BEHAV MED, V6, P672, DOI 10.1007/s13142-016-0441-5
   Prigge ES, 2017, MUTAT RES-REV MUTAT, V772, P51, DOI 10.1016/j.mrrev.2016.06.005
   Ribeiro JF, 2015, REV GESTAO SAUDE, V6, P1367
   Rodrigues LLS, 2018, GYNECOL ONCOL, V151, P102, DOI 10.1016/j.ygyno.2018.08.004
   Thongsak Natthapat, 2016, Asian Pac J Cancer Prev, V17, P5011
   Vallely A, 2014, SEX HEALTH, V11, P58, DOI 10.1071/SH13197
   Weyna C, 2013, CANCER EPIDEMIOL, V37, P457, DOI 10.1016/j.canep.2013.03.016
NR 22
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0956-5507
EI 1365-2303
J9 CYTOPATHOLOGY
JI Cytopathology
PD NOV
PY 2020
VL 31
IS 6
BP 586
EP 592
DI 10.1111/cyt.12883
EA SEP 2020
PG 7
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA NZ9JH
UT WOS:000566267200001
PM 32632990
DA 2020-12-08
ER

PT J
AU Calegar, DA
   Monteiro, KJL
   Goncalves, AB
   Boia, MN
   Jaeger, LH
   Nunes, BC
   Carvalho-Costa, FA
AF Calegar, Deiviane A.
   Monteiro, Kerla J. L.
   Goncalves, Andressa B.
   Boia, Marcio N.
   Jaeger, Lauren H.
   Nunes, Beatriz C.
   Carvalho-Costa, Filipe A.
TI Infections with Giardia duodenalis and Entamoeba histolytica/Entamoeba
   dispar as Hidden and Prevalent Conditions in Periurban Communities in
   the State of Rio de Janeiro, Brazil
SO JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
ID SOIL-TRANSMITTED HELMINTH; INTESTINAL PROTOZOA; CHILDREN; LAMBLIA;
   HEALTH; WATER
AB This study aims to assess the prevalence, distribution, and etiological profile of intestinal parasitism in children living in periurban areas in Cachoeiras de Macacu, Rio de Janeiro, Brazil. A community-based cross-sectional survey (n = 479) was carried out. Prevalence of infection withG. duodenalisandE. histolytica/E. disparwas 8.6% (n = 41) and 13.4% (n = 64), respectively. Infection withG. duodenaliswas significantly more frequent among children living in poor families (24/187 (12.8%) vs. 16/272 (5.9%); prevalence ratio (PR) = 2.18; 95% confidence interval (CI) = 1.19-3.99;p=0.011). This difference was also significant for infection with any pathogenic parasite (43/187 (23%) vs. 40/272 (14/7%); PR = 1.56; 95% CI = 1.06-2.30;p=0.026). In addition, people residing in houses with more than four inhabitants showed significantly higher positivity for infections withG. duodenalisand withE. histolytica/E. dispar(22/138 (15.9%) vs. 16/311 (5.1%); PR = 3.09; 95% CI = 1.68-5.71;p<0.001forG. duodenalisand 32/138 (23.2%) vs. 30/311 (9.6%); PR = 2.40; 95% CI = 1.52-3.79;p<0.001forE. histolytica/E. dispar). Laboratory diagnosis of protozoan enteric infections and effective drugs for their treatment are unmet goals in the primary health care system. Therefore, giardiasis and amebiasis are neglected conditions.
C1 [Calegar, Deiviane A.; Monteiro, Kerla J. L.; Goncalves, Andressa B.; Jaeger, Lauren H.; Nunes, Beatriz C.; Carvalho-Costa, Filipe A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, RJ, Brazil.
   [Monteiro, Kerla J. L.; Carvalho-Costa, Filipe A.] Escritorio Tecn Reg Fundacao Oswaldo Cruz, Ctr Norte, Rua Magalhaes Filho 519, Teresina, Piaui, Brazil.
   [Boia, Marcio N.] Fundacao Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Jaeger, Lauren H.] Univ Fed Juiz de Fora, Fac Farm, Rua Jose Lourenco Kelmer S-N,Campus Univ, Juiz De Fora, MG, Brazil.
   [Nunes, Beatriz C.] Fac Arthur Sa Earp Neto FASE, Fac Med Petropolis FMP, Rua Machado Fagundes 326, Petropolis, RJ, Brazil.
RP Calegar, DA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, RJ, Brazil.
EM deivianecalegar@gmail.com
OI CALEGAR, DEIVIANE APARECIDA/0000-0002-9311-2401
FU CoordenacAo de Aperfeicoamento de Pessoal de Nivel Superior, Brasil
   (CAPES) [001]; Foundation Oswaldo Cruz (FIOCRUZ)
FX The authors thank all the professionals involved, in particular,
   communitarian health agents within the Family Health Strategy program.
   This study was financed in part by the CoordenacAo de Aperfeicoamento de
   Pessoal de Nivel Superior, Brasil (CAPES) (finance code 001) and
   Foundation Oswaldo Cruz (FIOCRUZ).
CR Ahmed SA, 2018, PATHOG GLOB HEALTH, V112, P281, DOI 10.1080/20477724.2018.1523778
   Barbosa CV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193860
   Berne Ana Cristina, 2014, Revista de Patologia Tropical, V43, P412, DOI 10.5216/rpt.v43i4.33602
   Calegar DA, 2016, MEM I OSWALDO CRUZ, V111, P114, DOI 10.1590/0074-02760150383
   Campbell SJ, 2016, INT J PARASITOL, V46, P771, DOI 10.1016/j.ijpara.2016.07.005
   Carvalho-Costa Filipe Anibal, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P147, DOI 10.1590/S0036-46652007000300003
   Chammartin F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-440
   Chifunda K, 2019, PAEDIATR INT CHILD H, V39, P65, DOI 10.1080/20469047.2018.1479055
   Coronato-Nunes B, 2017, J INFECT DEV COUNTR, V11, P563, DOI 10.3855/jidc.8410
   Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002
   Dias AP, 2018, J TROP MED-US, V2018, DOI 10.1155/2018/8159354
   Dunn JC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006591
   Escobedo AA, 2003, ANN TROP MED PARASIT, V97, P499, DOI 10.1179/000349803235002380
   Faria CP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005445
   Fletcher SM, 2012, CLIN MICROBIOL REV, V25, P420, DOI 10.1128/CMR.05038-11
   Galeh TM, 2016, ASIAN PAC J TROP MED, V9, P866, DOI 10.1016/j.apjtm.2016.07.013
   Ignacio CF, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759056, 10.1590/s1678-9946201759056]
   Iza Jose A, 2019, Infez Med, V27, P336
   Kantor M, 2018, CAN J GASTROENTEROL, V2018, DOI 10.1155/2018/4601420
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Leung AKC, 2019, RECENT PATENTS INFLA, V13, P2, DOI 10.2174/1872213X13666181228154940
   Monteiro KJL, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860024, 10.1590/s1678-9946201860024]
   Macchioni F, 2015, AM J TROP MED HYG, V92, P794, DOI 10.4269/ajtmh.14-0039
   Muhsen K, 2012, CLIN INFECT DIS, V55, pS271, DOI 10.1093/cid/cis762
   Nunes BC, 2018, INFECT GENET EVOL, V59, P107, DOI 10.1016/j.meegid.2018.02.001
   Reses HE, 2018, EPIDEMIOL INFECT, V146, P1071, DOI 10.1017/S0950268818001073
   Turkeltaub JA, 2015, CURR OPIN GASTROEN, V31, P38, DOI 10.1097/MOG.0000000000000135
   Valverde JG, 2011, ANN TROP MED PARASIT, V105, P413, DOI 10.1179/1364859411Y.0000000034
   Vivancos V, 2018, CURR TOP MED CHEM, V18, P1287, DOI 10.2174/1568026618666181002095314
   von Huth S, 2019, T ROY SOC TROP MED H, V113, P545, DOI 10.1093/trstmh/trz032
   YOUNG KH, 1979, J CLIN MICROBIOL, V10, P852, DOI 10.1128/JCM.10.6.852-853.1979
NR 31
TC 1
Z9 1
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-9686
EI 1687-9694
J9 J TROP MED-US
JI J. Trop. Med.
PD JUL 14
PY 2020
VL 2020
AR 3134849
DI 10.1155/2020/3134849
PG 6
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA MV4DV
UT WOS:000556311400001
PM 32733575
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Lima, KMS
   Fernandes, ACL
   Carvalho-Costa, FA
   Barroso, DE
AF Lima, Katia M. S.
   Fernandes, Andreia C. L.
   Carvalho-Costa, Filipe A.
   Barroso, David E.
TI Neisseria meningitidis carriage in indigenous peoples of Amazonas State,
   Brazil
SO JOURNAL OF INFECTION
LA English
DT Letter
ID MENINGOCOCCAL CARRIAGE
C1 [Lima, Katia M. S.] Fiocruz MS, Leonidas & Maria Deane Inst, Lab Microbial Divers Importance Hlth, Manaus, Amazonas, Brazil.
   [Fernandes, Andreia C. L.; Carvalho-Costa, Filipe A.; Barroso, David E.] Fiocruz MS, Inst Oswaldo Cruz, Lab Epidemiol & Mol Systemat, Rio De Janeiro, RJ, Brazil.
RP Barroso, DE (corresponding author), Inst Oswaldo Cruz, Lab Epidemiol & Mol Systemat, Av Brasil 4365,Bldg 26,Rm 308, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM barroso@ioc.fiocruz.br
CR Ambrosio L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217500
   Barroso DE, 2007, BRAZ J INFECT DIS, V11, P598, DOI 10.1590/S1413-86702007000600014
   Basta NE, 2018, J INFECTION, V76, P140, DOI 10.1016/j.jinf.2017.11.006
   Butler JC, 2001, EMERG INFECT DIS, V7, P554
   Caugant DA, 2007, FEMS MICROBIOL REV, V31, P52, DOI 10.1111/j.1574-6976.2006.00052.x
   Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590
   Contreras M, 2010, MICROBIOL-SGM, V156, P3282, DOI 10.1099/mic.0.043174-0
   Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140
   Silva LA, 2018, INFECT DIS-NOR, V50, P697, DOI 10.1080/23744235.2018.1459829
   Trotter CL, 2005, AM J EPIDEMIOL, V162, P89, DOI 10.1093/aje/kwi160
NR 10
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD JUN
PY 2020
VL 80
IS 6
BP 671
EP 674
DI 10.1016/j.jinf.2020.01.022
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA LO3CF
UT WOS:000533506000021
PM 32035938
DA 2020-12-08
ER

PT J
AU Brito-Santos, F
   Trilles, L
   Firacative, C
   Wanke, B
   Carvalho-Costa, FA
   Nishikawa, MM
   Campos, JP
   Junqueira, ACV
   de Souza, AC
   Lazera, MD
   Meyer, W
AF Brito-Santos, Fabio
   Trilles, Luciana
   Firacative, Carolina
   Wanke, Bodo
   Anibal Carvalho-Costa, Filipe
   Nishikawa, Marilia Martins
   Campos, Jonas Pereira
   Verissimo Junqueira, Angela Cristina
   de Souza, Amanda Coutinho
   Lazera, Marcia dos Santos
   Meyer, Wieland
TI Indoor Dust as a Source of Virulent Strains of the Agents of
   Cryptococcosis in the Rio Negro Micro-Region of the Brazilian Amazon
SO MICROORGANISMS
LA English
DT Article
DE Cryptococcus neoformans; Cryptococcus gattii; indoor dust; MLST;
   virulence; Brazilian Amazon
ID OUTDOOR AIR; NEOFORMANS; GATTII; PCR; ENVIRONMENTS; INFECTION; EXPOSURE;
   PATTERN; STATE
AB Cryptococcosis, a potentially fatal mycosis in humans, is acquired via exposure to exogenous environmental sources. This study aimed to investigate the frequency, genetic diversity, and virulence of cryptococcal strains isolated from indoor dust in the Rio Negro micro-region of the Brazilian Amazon. A total of 8.9% of the studied houses were positive, recovering nine Cryptococcus neoformans VNI and 16 C. gattii VGII isolates, revealing an endemic pattern in domestic microenvironments. The International Society for Human and Animal Mycology (ISHAM) consensus multilocus sequence typing (MLST) scheme for the C. neoformans/C. gattii species complexes identified two sequence types (STs), ST93 and ST5, amongst C. neoformans isolates and six STs amongst C. gattii isolates, including the Vancouver Island Outbreak ST7 (VGIIa) and ST20 (VGIIb), the Australian ST5, and ST264, ST268 and ST445, being unique to the studied region. Virulence studies in the Galleria mellonella model showed that five C.gattii strains and one C. neoformans strain showed a similar pathogenic potential to the highly virulent Vancouver Island outbreak strain CDR265 (VGIIa). The findings of this study indicate that humans can be exposed to the agents of cryptococcosis via house dust, forming the basis for future studies to analyze the impact of early and continuous exposure to indoor dust on the development of subclinical or clinical infections.
C1 [Brito-Santos, Fabio; Trilles, Luciana; Wanke, Bodo; Campos, Jonas Pereira; Lazera, Marcia dos Santos; Meyer, Wieland] Fiocruz MS, Mycol Lab, Evandro Chagas Natl Inst Infect Dis, BR-21040900 Rio De Janeiro, Brazil.
   [Brito-Santos, Fabio; Firacative, Carolina; Meyer, Wieland] Univ Sydney, Westmead Hosp Res & Educ Network,Westmead Inst Me, Fac Med & Hlth,Westmead Clin Sch,Marie Bashir Ins, Mol Mycol Res Lab,Ctr Infect Dis & Microbiol,Sydn, Sydney, NSW 2006, Australia.
   [Firacative, Carolina] Univ Rosario, Sch Med & Hlth Sci, Studies Translat Microbiol & Emerging Dis MICROS, Bogota 541038, Colombia.
   [Anibal Carvalho-Costa, Filipe] Fiocruz MS, Lab Mol Epidemiol & Systemat, Oswaldo Cruz Inst, BR-21040900 Rio De Janeiro, Brazil.
   [Nishikawa, Marilia Martins] INCQS FIOCRUZ, Natl Inst Qual Control Hlth, BR-21040900 Rio De Janeiro, Brazil.
   [Verissimo Junqueira, Angela Cristina; de Souza, Amanda Coutinho] Oswaldo Cruz Inst, Lab Parasitol, BR-21040900 Rio De Janeiro, Brazil.
RP Meyer, W (corresponding author), Fiocruz MS, Mycol Lab, Evandro Chagas Natl Inst Infect Dis, BR-21040900 Rio De Janeiro, Brazil.; Meyer, W (corresponding author), Univ Sydney, Westmead Hosp Res & Educ Network,Westmead Inst Me, Fac Med & Hlth,Westmead Clin Sch,Marie Bashir Ins, Mol Mycol Res Lab,Ctr Infect Dis & Microbiol,Sydn, Sydney, NSW 2006, Australia.
EM fabio.santos@ini.fiocruz.br; luciana.trilles@ini.fiocruz.br;
   cfiracative@gmail.com; bodo.wanke@ini.fiocruz.br;
   carvalhocosta70@hotmail.com; marilia.martins@incqs.fiocruz.br;
   jonasc.rj@hotmail.com; junqueir.rlk@terra.com.br;
   amandacout@yahoo.com.br; marcia.lazera@ini.fiocruz.br;
   wieland.meyer@sydney.edu.au
RI Firacative, Carolina/C-8539-2018
OI Firacative, Carolina/0000-0001-7547-5172
FU "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior"
   (CAPES)CAPES [098/2012]; National Health and Medical Research Council
   (NH&MRC) of AustraliaNational Health and Medical Research Council of
   Australia [APP1031943]
FX This work was partially supported by the "Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior" (CAPES) grant 098/2012 to WM and by a
   National Health and Medical Research Council (NH&MRC) of Australia grant
   APP1031943 to WM.
CR Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28
   Brito-Santos F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115866
   Chaturvedi S, 2000, J CLIN MICROBIOL, V38, P2007, DOI 10.1128/JCM.38.5.2007-2009.2000
   Dannemiller KC, 2016, J ALLERGY CLIN IMMUN, V138, P76, DOI 10.1016/j.jaci.2015.11.027
   DOCORREA MP, 1999, REV SOC BRAS MED TRO, V32, P505
   dos Santos WRA, 2008, MEM I OSWALDO CRUZ, V103, P813, DOI 10.1590/S0074-02762008000800012
   Engelthaler DM, 2014, MBIO, V5, DOI 10.1128/mBio.01464-14
   Ferreira-Paim K, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005223
   Ferrer C, 2001, J CLIN MICROBIOL, V39, P2873, DOI 10.1128/JCM.39.8.2873-2879.2001
   Firacative C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105076
   Fyfe M, 2008, Can Commun Dis Rep, V34, P1
   Galanis E, 2010, EMERG INFECT DIS, V16, P251, DOI [10.3201/eid1602.090900, 10.3201/eid1601.090900]
   Hanson B, 2016, ENVIRON SCI-PROC IMP, V18, P713, DOI [10.1039/c5em00639b, 10.1039/C5EM00639B]
   Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165
   Kwon-Chung KJ, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00357-16
   Kwon-Chung KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019760
   Lazera MS, 2000, MED MYCOL, V38, P379, DOI 10.1080/714030957
   Lazera MS, 1996, J MED VET MYCOL, V34, P127
   Lemons AR, 2017, ENVIRON SCI-PROC IMP, V19, P101, DOI [10.1039/c6em00413j, 10.1039/C6EM00413J]
   Freire AKL, 2012, MYCOSES, V55, pe145, DOI 10.1111/j.1439-0507.2012.02173.x
   Litvintseva AP, 2005, J CLIN MICROBIOL, V43, P556, DOI 10.1128/JCM.43.2.556-564.2005
   Malliari E, 2017, ENVIRON INT, V108, P146, DOI 10.1016/j.envint.2017.08.011
   Martins DB, 2011, VET DERMATOL, V22, P232, DOI 10.1111/j.1365-3164.2010.00948.x
   Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886
   Passoni LFC, 1998, MED MYCOL, V36, P305, DOI 10.1080/02681219880000481
   Phillips P, 2015, CLIN INFECT DIS, V60, P1368, DOI 10.1093/cid/civ041
   Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/s1473-3099(17)30243-8, 10.1016/S1473-3099(17)30243-8]
   Rocha DFS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197841
   Sorrell TC, 1996, J CLIN MICROBIOL, V34, P1253, DOI 10.1128/JCM.34.5.1253-1260.1996
   Souto ACP, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004885
   Swinne D, 1994, Med Trop (Mars), V54, P53
   SWINNE D, 1989, AIDS, V3, P389, DOI 10.1097/00002030-198906000-00009
   Trilles L, 2008, MEM I OSWALDO CRUZ, V103, P455, DOI 10.1590/S0074-02762008000500008
NR 33
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-2607
J9 MICROORGANISMS
JI Microorganisms
PD MAY
PY 2020
VL 8
IS 5
AR 682
DI 10.3390/microorganisms8050682
PG 10
WC Microbiology
SC Microbiology
GA LY0NZ
UT WOS:000540222300063
PM 32392852
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Almeida, MM
   Monteiro, KJL
   Bacelar, PAA
   dos Santos, JP
   de Freitas, SPC
   Evangelista, BBC
   Leal, DN
   Silva, DDE
   Cardoso, AB
   do Nascimento, EF
   Neto, AHAD
   Carvalho-Costa, FA
AF Almeida, Mayron Morais
   Lima Monteiro, Kerla Joeline
   Alves Bacelar, Polyanna Araujo
   dos Santos, Jessica Pereira
   Carneiro de Freitas, Simone Patricia
   Costa Evangelista, Brenda Bulsara
   Leal, Daniella Nobre
   de Araujo e Silva, Denilson
   Cardoso, Aline Borges
   do Nascimento, Elaine Ferreira
   de Moraes Neto, Antonio Henrique Almeida
   Carvalho-Costa, Filipe Anibal
TI Interactions between malnutrition, soil-transmitted helminthiasis and
   poverty among children living in periurban communities in Maranhao
   State, Northeastern Brazil
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Malnutrition; Soil-transmitted helminthiases; Poverty; Northeastern
   Brazil; Childhood infections
ID NUTRITIONAL-STATUS; UNDERNUTRITION; INFECTIONS; SCHISTOSOMIASIS;
   SCHOOLCHILDREN; ASSOCIATION
AB Poverty, malnutrition and neglected tropical diseases such as soil-transmitted helminthiases (STHs) interact in a multi-causal feedback network. This study aimed to assess the relationships between STHs, income and nutritional status of children in impoverished communities in the city of Caxias, Maranhao State, Northeastern Brazil. A cross-sectional survey (n=259 children) was carried out with the collection of fecal samples and assessment of sociodemographic, anthropometric, dietary and sanitation data. Hookworm infection and ascariasis presented prevalence rates of 14.3% and 9.3%, respectively. The logistic regression analysis showed that hookworm infection was more frequent in males (odds ratio [OR]=3.43; 95% confidence interval [CI]=1.45-8.08), children aged 11-15 years old (OR=3.72; 95% CI=1.19-11.62), children living in poor families (OR=2.44; 95% CI=1.04-5.68) and those living in rented houses (OR=5.74; 95%CI=1.91-17.25). Concerning ascariasis, living in the Caldeiroes community (OR=0.01; 95%CI=0-0.17) and belonging to the 11-15 years age group (OR=0.21; 95%CI=0.04-1.02) were protection factors. Poor children have a significantly lower frequency of consumption of meat, milk, vegetables, tubers and fruits than not poor children. The frequent consumption of meat, milk and tubers was associated with significant higher values in the parameter height-for-age, whereas the consumption of meat and milk positively influenced the weight-for-age. The frequencies of stunting, underweight and wasting were 8.1%, 4.9% and 2.9%, respectively. The multivariate model demonstrated that stunting was significantly associated with economic poverty (OR=2.82; 95%CI=1.03-7.70) and low weight was associated with male sex (OR=6.43; 95% CI=1.35-30.68). In conclusion, the study describes the interactions between the dimensions of development represented by income, STHs and nutritional status revealing the importance of raising income levels to improve the living conditions of families in impoverished communities in Northeastern Brazil.
C1 [Almeida, Mayron Morais; Alves Bacelar, Polyanna Araujo; dos Santos, Jessica Pereira; Carvalho-Costa, Filipe Anibal] Fundacao Oswald Cruz, Lab Epidemiol & Sistemat Mol, Inst Oswaldo Cruz, Av Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Almeida, Mayron Morais; Lima Monteiro, Kerla Joeline; Alves Bacelar, Polyanna Araujo; dos Santos, Jessica Pereira; Carneiro de Freitas, Simone Patricia; Costa Evangelista, Brenda Bulsara; Leal, Daniella Nobre; de Araujo e Silva, Denilson; Cardoso, Aline Borges; do Nascimento, Elaine Ferreira; Carvalho-Costa, Filipe Anibal] Escritorio Tecn Reg Fiocruz Piaui, Teresina, Piaui, Brazil.
   [de Moraes Neto, Antonio Henrique Almeida] Fundacao Oswaldo Cruz, Lab Inovacoes Terapias Ensino & Bioprod, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [do Nascimento, Elaine Ferreira] Univ Fed Piaui, Coordenacao Programa Posgrad Polit Publ, Teresina, Piaui, Brazil.
RP Carvalho-Costa, FA (corresponding author), Fundacao Oswald Cruz, Lab Epidemiol & Sistemat Mol, Inst Oswaldo Cruz, Av Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
EM carvalhocosta70@hotmail.com
OI Costa Evangelista, Brenda Bulsara/0000-0002-0304-9884; Morais Almeida,
   Mayron/0000-0002-1819-0178; SANTOS, JESSICA/0000-0002-1639-517X;
   Freitas, Simone/0000-0001-9016-644X; , aline/0000-0003-3882-5190
FU Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e
   Tecnologico do Maranhao (FAPEMA) [BM-01949/19]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Instituto
   Oswaldo Cruz (FIOCRUZ)
FX This study was supported by grants from Fundacao de Amparo a Pesquisa e
   ao Desenvolvimento Cientifico e Tecnologico do Maranhao (FAPEMA:
   BM-01949/19), Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), and Instituto Oswaldo Cruz (FIOCRUZ).
CR Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X
   Blouin B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006688
   Brasil. Instituto Brasileiro de Geografia e Estatistica, 2011, CENS DEM 2010 CAR PO
   Brasil. Ministerio da Saude. Secretaria de Atencao a Saude. Departamento de Atencao Basica, 2011, OR COL AN DAD ANTR S
   Carvalho-Costa Filipe Anibal, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P147, DOI 10.1590/S0036-46652007000300003
   Casmo V, 2014, REV INST MED TROP SP, V56, P219, DOI 10.1590/S0036-46652014000300007
   Chammartin F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-440
   Coronato-Nunes B, 2017, J INFECT DEV COUNTR, V11, P563, DOI 10.3855/jidc.8410
   Echazu A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004111
   Casavechia MTG, 2016, PARASITOL RES, V115, P2321, DOI 10.1007/s00436-016-4980-y
   HARADA YOSHIMICHI, 1955, YONAGO ACTA MED, V1, P177
   Hurlimann E, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2642-x
   Husseini M, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1179-3
   INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA, 2012, CENS DEM 2010 CAR GE
   Instituto Brasileiro de Geografia e Estatistica, 2010, PESQ ORC FAM 2008 20
   Kajjura RB, 2019, FOOD NUTR BULL, V40, P221, DOI 10.1177/0379572119840214
   Katz N, 2016, COORDENADORES INQUER
   Monteiro KJL, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860024, 10.1590/s1678-9946201860024]
   Lo NC, 2017, LANCET INFECT DIS, V17, pE64, DOI 10.1016/S1473-3099(16)30535-7
   Lopes AF, 2019, WATER RESOUR ECON, V28, DOI 10.1016/j.wre.2018.06.002
   LUTZ Adolpho, 1919, Memorias do Instituto Oswaldo Cruz, V11, P121, DOI 10.1590/S0074-02761919000100006
   Marquis GS, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12677
   Martins-Melo FR, 2017, PARASITOLOGY, V144, P669, DOI 10.1017/S0031182016002341
   Mogre V, 2017, CURATIONIS, V40, P1618
   Mohsena M, 2010, PUBLIC HEALTH NUTR, V13, P1498, DOI 10.1017/S1368980010001758
   Molla Eshetu, 2018, BMC Res Notes, V11, P585, DOI 10.1186/s13104-018-3679-9
   Moncayo AL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021319
   Oduor FO, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12633
   Owada K, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3107-y
   Pan American Health Organization, BRAZ INN FIGHT NIDS
   RUGAI E., 1954, REV INST ADOLFO LUTZ, V14, P5
   Sreeramareddy CT, 2015, PUBLIC HEALTH NUTR, V18, P2906, DOI 10.1017/S1368980014002729
   Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620
   United Nations, TRANSF OUR WORLD 203
   Weatherhead JE, 2017, PEDIATR CLIN N AM, V64, P867, DOI 10.1016/j.pcl.2017.03.005
   Willis HH, 1921, MED J AUSTRALIA, V2, P375
NR 36
TC 0
Z9 0
U1 0
U2 0
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2020
VL 62
AR e73
DI 10.1590/S1678-9946202062073
PG 9
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA OE4AD
UT WOS:000580474300008
PM 33027397
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU dos Santos, JP
   Guimaraes, LM
   Lima, IP
   Batista, FMD
   Carvalho-Costa, FA
   dos Santos-Mallet, JR
AF dos Santos, Jessica Pereira
   Guimaraes, Lucas Melo
   Lima, Inacio Pereira
   de Araujo Batista, Francisca Miriane
   Carvalho-Costa, Filipe Anibal
   dos Santos-Mallet, Jacenir Reis
TI Spatial distribution of synanthropic triatomines in Piaui State,
   Northeastern Brazil
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Chagas disease; Spatial distribution; Triatomines; Piaui State
ID CHAGAS-DISEASE; RHODNIUS-NASUTUS; TRANSMISSION; INTERRUPTION;
   ELIMINATION; INFECTION; INFESTANS; AREA
AB This study aimed to describe the spatial distribution and assess entomological indicators of synanthropic triatomines in Piaui State, Northeastern Brazil. We used surveillance data on the detection, identification and assessment of natural infection with trypanosomatids from triatomines in the State from 2014 to 2017. The State was divided into four macroregions. In relation to the dispersion rates of triatomines, they were much lower in the North, when compared to Southwest, Southeast and Central North macroregions. Infestation rates were higher in the Southwest and Southeast and intradomicile infestation rates varied during the study period, reaching high values in all regions. Insects belonging to the species Triatoma brasiliensis complex. Triatoma pseudomaculata, Triatoma sordida, and to the genus Panstrongylus spp. and Rhodnius spp. were collected during this period. T. brasiliensis was collected from all four regions of the State, but more frequently in those located in the Southeast. A similar pattern was observed for T. pseudomaculata. T. sordida was detected in the municipalities in the Southeast and Southwest regions, and less frequently in the Central North municipalities. Rhodnius spp. was detected in the Central North and North regions, and Panstrongylus spp. in the Central North and Southeast regions. The highest trypanosomatid-positivity rate of T. brasiliensis and Panstrongylus spp. was in the Southeast region. A significant proportion of the municipalities of Piaui State presents entomological parameters that indicate a risk of Chagas disease by vector transmission.
C1 [dos Santos, Jessica Pereira; Carvalho-Costa, Filipe Anibal; dos Santos-Mallet, Jacenir Reis] Fundacao Oswaldo Cruz, Escritorio Tecn Reg, Teresina, Piaui, Brazil.
   [Guimaraes, Lucas Melo] Fundacao Oswaldo Cruz, Dept Epidemiol Saude Publ, Escola Nacl Saude Publ, Rio De Janeiro, RJ, Brazil.
   [Lima, Inacio Pereira; de Araujo Batista, Francisca Miriane] Secretaria Saude Estado Piaui, Teresina, Piaui, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [dos Santos-Mallet, Jacenir Reis] Fundacao Oswaldo Cruz, Lab Interdisciplinar Vigilancia Entomol Diptera &, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [dos Santos-Mallet, Jacenir Reis] Univ Iguacu, Rio De Janeiro, RJ, Brazil.
RP dos Santos, JP (corresponding author), Fundacao Oswaldo Cruz, Escritorio Tecn Reg, Rua Magalhaes Filho 519, BR-64000128 Teresina, PI, Brazil.
EM jessik_ssantos@hotmail.com
OI SANTOS, JESSICA/0000-0002-1639-517X; araujo, miriane/0000-0002-0351-8994
FU Oswaldo Cruz Foundation (Fiocruz)
FX This study was supported by the Oswaldo Cruz Foundation (Fiocruz).
   Entomological surveillance data were generated by the Health Secretariat
   of the Piaui State, Brazil.
CR Abad-Franch F, 2015, ACTA TROP, V151, P126, DOI 10.1016/j.actatropica.2015.07.005
   Araujo EL, 2017, FUNCTIONAL ECOSYS CO, V1, P15
   Bento D.N.C., 1989, Revista da Sociedade Brasileira de Medicina Tropical, V22, P73
   Bento D.N.C., 1992, BRASIL REV SOC BRAS, V25, P51, DOI DOI 10.1590/S0037-86821992000100008
   Bezerra CM, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3235-4
   Borges-Pereira J, 2006, REV SOC BRAS MED TRO, V39, P530, DOI 10.1590/S0037-86822006000600004
   Borges-Pereira José, 2002, Rev. Soc. Bras. Med. Trop., V35, P315, DOI 10.1590/S0037-86822002000400007
   CAMARGO ME, 1984, REV I MED TROP, V26, P192, DOI 10.1590/S0036-46651984000400003
   Sangenis LHC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0732-8
   COURA J R, 1984, Memorias do Instituto Oswaldo Cruz, V79, P101, DOI 10.1590/S0074-02761984000100012
   Dias J C, 2000, Cad Saude Publica, V16 Suppl 2, P13, DOI 10.1590/S0102-311X2000000800003
   Dias J C, 1993, Cad Saude Publica, V9, P201, DOI 10.1590/S0102-311X1993000200012
   Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092
   Dumonteil E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22455-x
   Escandon-Vargas K, 2017, BIOMEDICA, V37, P299, DOI 10.7705/biomedica.v37i3.3304
   Fe NF, 2009, MEM I OSWALDO CRUZ, V104, P121, DOI 10.1590/S0074-02762009000100019
   Figueiredo PZ, 1975, REV SOC BRAS MED TRO, V9, P105
   Freitas Simone Patrícia Carneiro, 2004, Cad. Saúde Pública, V20, P333, DOI 10.1590/S0102-311X2004000100052
   Gurgel-Goncalves Rodrigo, 2010, Revista Pan-Amazonica de Saude, V1, P57
   Herrera L, 2005, T ROY SOC TROP MED H, V99, P379, DOI 10.1016/j.trstmh.2004.07.006
   Justi SA, 2017, TRENDS PARASITOL, V33, P42, DOI 10.1016/j.pt.2016.11.002
   Lima MM, 2008, AM J TROP MED HYG, V79, P750, DOI 10.4269/ajtmh.2008.79.750
   Lopez PM, 2018, CHRONOBIOL INT, V35, P1402, DOI 10.1080/07420528.2018.1486851
   Ferreira IDM, 2006, REV SOC BRAS MED TRO, V39, P507, DOI 10.1590/S0037-86822006000500018
   Massaro Débora Cristina, 2008, Rev. bras. epidemiol., V11, P228, DOI 10.1590/S1415-790X2008000200005
   NEIVA Arthur, 1916, Memorias do Instituto Oswaldo Cruz, V8, P74, DOI 10.1590/S0074-02761916000300001
   Parente CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170278
   Pinto A. da S., 1986, Revista da Sociedade Brasileira de Medicina Tropical, V19, P243
   Dias JC, 2008, REV SOC BRAS MED TRO, V41, P193, DOI 10.1590/S0037-86822008000200012
   Salvatella R, 2014, MEM I OSWALDO CRUZ, V109, P122, DOI 10.1590/0074-0276140338
   Santos Silvia Menezes Dos, 2017, Rev Inst Med Trop Sao Paulo, V59, pe27, DOI 10.1590/S1678-9946201759027
   Santos-Filho F. S., 2013, REV EQUADOR UFPI, V1, P2
   Sarquis O, 2012, PARASITOL RES, V110, P1481, DOI 10.1007/s00436-011-2651-6
   Schofield CJ, 1999, ADV PARASIT, V42, P1, DOI 10.1016/S0065-308X(08)60147-5
   Silveira A C, 1998, Rev Soc Bras Med Trop, V31 Suppl 2, P15
   Silveira AC, 2011, REV SOC BRAS MED TRO, V44, P52, DOI 10.1590/S0037-86822011000800009
   Sant'Anna MRV, 2017, J INSECT PHYSIOL, V97, P20, DOI [10.1016/flinsphys.2016.08.004, 10.1016/j.jinsphys.2016.08.004]
   Vinhaes MC, 2014, ACTA TROP, V137, P105, DOI 10.1016/j.actatropica.2014.05.007
   World Health Organization Expert Committee on the Control of Chagas Disease, 2002, CONTR CHAG DIS 2 REP
NR 39
TC 0
Z9 0
U1 0
U2 0
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2020
VL 62
AR e57
DI 10.1590/S1678-9946202062057
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA NJ8WH
UT WOS:000566325600002
PM 32844905
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Monteiro, KJL
   Calegar, DA
   Carvalho-Costa, FA
   Jaeger, LH
AF Monteiro, K. J. L.
   Calegar, D. A.
   Carvalho-Costa, F. A.
   Jaeger, L. H.
CA Amazonas Res Grp
TI Kato-Katz thick smears as a DNA source of soil-transmitted helminths
SO JOURNAL OF HELMINTHOLOGY
LA English
DT Article
DE DNA; helminth; Kato-Katz; PCR; phylogeny; soil-transmitted helminths
ID PCR
AB Despite the reduction in the prevalence of soil-transmitted helminthiases in many regions of the world, morbidity rates remain high in some rural regions. The Kato-Katz technique is a simple, inexpensive and field-applicable tool commonly used for the diagnosis and worm-burden characterization of these infections. Molecular studies have revolutionized our understanding of the epidemiology and evolutionary genetics of parasites. In this study we recovered helminthic DNA from Kato-Katz slides (n = 93) prepared in 2011 in the Brazilian Amazon. We achieved DNA recovery by polymerase chain reaction (PCR) in 84% of cases for Ascaris sp. and 75% of cases for hookworms. The sequencing confirmed the specific species of the amplicons. The slides stored for a few years could be analysed using this methodology, allowing access to DNA from a large collection of samples. We must consider the Kato-Katz thick smears as a source of helminth DNA. This can significantly reduce logistical difficulties in the field in terms of obtaining, preserving, transporting and initial processing of samples.
C1 [Monteiro, K. J. L.; Calegar, D. A.; Carvalho-Costa, F. A.; Jaeger, L. H.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Pavilhao Leonidas Deane,Sala 308,Ave Brasil 4365, Manguinho, RJ, Brazil.
   [Amazonas Res Grp] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Programa Posgrad Med Trop, Pavilhao Arthur Neiva,Ave Brasil 4365, Manguinho, RJ, Brazil.
   [Carvalho-Costa, F. A.] Fundacao Oswaldo Cruz, Escritorio Tecn Reg, Ave Odilon Araujo 372, Teresina, PE, Brazil.
RP Jaeger, LH (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Pavilhao Leonidas Deane,Sala 308,Ave Brasil 4365, Manguinho, RJ, Brazil.
EM laurenhj@hotmail.com
OI Jaeger, Lauren H./0000-0001-8031-7742
FU Oswaldo Cruz Foundation (Fiocruz); Brazilian National Council for
   Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq); Federal Agency for
   Support and Evaluation of Graduate Education (CAPES)
FX This work was supported by the Oswaldo Cruz Foundation (Fiocruz),
   Brazilian National Council for Scientific and Technological Development
   (CNPq), and the Federal Agency for Support and Evaluation of Graduate
   Education (CAPES).
CR Barenbold O, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005953
   Demeler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061285
   Diawara A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002247
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Hasegawa H, 2017, PARASITOL INT, V66, P12, DOI 10.1016/j.parint.2016.11.003
   Kato K., 1954, JAPAN J PARASITOL, V3, P35
   Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397
   Lindholz CG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006274
   Monti JR, 1998, MOL CELL PROBE, V12, P71, DOI 10.1006/mcpr.1997.0151
   Montresor A, 1998, GUIDELINES EVALUATIO
   O'Connell EM, 2016, AM J TROP MED HYG, V95, P508, DOI 10.4269/ajtmh.16-0266
   Odongo-Aginya Emmanuel I, 2007, Afr Health Sci, V7, P33
   Peng WD, 2005, ELECTROPHORESIS, V26, P4317, DOI 10.1002/elps.200500276
   Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37
   Stutzer C, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00067
   van Mens SP, 2013, T ROY SOC TROP MED H, V107, P269, DOI 10.1093/trstmh/trs094
   WHO, 2015, ASS EP SOIL TRANSM H
   WHO, 2018, SCHISTOSOMIASIS
   World Health Organization, 2017, GUID PREV CHEM CONTR
NR 19
TC 2
Z9 2
U1 1
U2 1
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0022-149X
EI 1475-2697
J9 J HELMINTHOL
JI J. Helminthol.
PY 2020
VL 94
AR e10
DI 10.1017/S0022149X18001013
PG 4
WC Parasitology; Zoology
SC Parasitology; Zoology
GA LW0BG
UT WOS:000538811300010
PM 30428936
DA 2020-12-08
ER

PT J
AU Loureiro, AP
   Jaeger, LH
   Di Azevedo, MIN
   Miraglia, F
   Moreno, LZ
   Moreno, AM
   Pestana, CP
   Carvalho-Costa, FA
   Medeiros, MA
   Lilenbaum, W
AF Loureiro, Ana P.
   Jaeger, Lauren H.
   Di Azevedo, Maria Isabel N.
   Miraglia, Fabiana
   Moreno, Luisa Z.
   Moreno, Andrea M.
   Pestana, Cristiane P.
   Carvalho-Costa, Filipe A.
   Medeiros, Marco A.
   Lilenbaum, Walter
TI Molecular epidemiology of Leptospira noguchii reveals important insights
   into a One Health context
SO TRANSBOUNDARY AND EMERGING DISEASES
LA English
DT Article
DE bovine leptospirosis; genotyping; Leptospira noguchii; MLST; PFGE
ID STRAINS
AB Leptospirosis presents a complex and dynamic epidemiology. Bovine leptospirosis has been described as a major infectious disease impairing reproductive efficiency. Although infections by Leptospira interrogans, L. santarosai and L. borgpetersenii are frequently reported in cattle, the presence of L. noguchii in these animals should not be neglected. In this study, we describe serological (MAT) and molecular characterization (rrs and secY gene sequencing, multilocus sequence typing [MLST] and pulsed-field gel electrophoresis [PFGE]) of eight L. noguchii strains obtained from slaughtered cows. Intraspecific genetic diversity was evaluated, and haplotype networks were constructed based on hosts and geographical localizations. Strains were characterized as belonging to serogroups Australis, Autumnalis and Panama, and molecular characterization showed a high heterogeneity of these strains. Ten different STs were found (including nine new STs and 39 novel alleles) as well as nine different pulsotypes. Two clonal complexes were found. Phylogenetic trees based on secY locus and concatenated MLST loci showed two main clusters, with sequences from the present study included in the first. In general, there was no relationship between the geographical origin and the secY phylogenetic clusters, as well as between secY phylogenetic clusters and serogroups. Molecular diversity indexes confirmed a high variability (H > 0.8). This high intraspecific variation observed may be related to differences in virulence, pathogenicity and antigenicity or even adaptability of the strains. In addition, haplotype networks clearly demonstrated the circulation of genotypes between humans and animals, confirming the zoonotic potential. The present study provides relevant data for the study of leptospirosis in the One Health context, where human, animal and environmental health is closely connected.
C1 [Loureiro, Ana P.; Jaeger, Lauren H.; Di Azevedo, Maria Isabel N.; Miraglia, Fabiana; Lilenbaum, Walter] Univ Fed Fluminense, Dept Microbiol & Parasitol, Lab Bacteriol Vet, Niteroi, RJ, Brazil.
   [Jaeger, Lauren H.; Carvalho-Costa, Filipe A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, Brazil.
   [Miraglia, Fabiana; Moreno, Luisa Z.; Moreno, Andrea M.] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Med Vet Prevent & Saude Anim, Sao Paulo, Brazil.
   [Pestana, Cristiane P.; Medeiros, Marco A.] Fiocruz MS, Lab Tecnol Recombinante Biomanguinh, Rio De Janeiro, Brazil.
RP Lilenbaum, W (corresponding author), Univ Fed Fluminense, Dept Microbiol & Parasitol, Lab Bacteriol Vet, Niteroi, RJ, Brazil.
EM wlilenbaum@id.uff.br
RI Moreno, Luisa Z/K-5800-2012
OI Moreno, Luisa Z/0000-0003-0134-9741; Lilenbaum,
   Walter/0000-0002-2434-8728
FU Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ) [2011/18290-0, E-26/202.766/2016, E-26/202.370/2018];
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/17136-2]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro (APL FAPERJ, 2011/18290-0, LHJ E-26/202.766/2016 and
   MINDA E-26/202.370/2018) and Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (LZM FAPESP, 2013/17136-2). WL, MAM and AMM are a CNPq and
   FAPERJ fellow.
CR Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28
   Ballados-Gonzalez GG, 2018, TRANSBOUND EMERG DIS, V65, P773, DOI 10.1111/tbed.12802
   Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036
   Barragan V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004990
   Boonsilp S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001954
   Cameron CE, 2015, CURR TOP MICROBIOL, V387, P21, DOI 10.1007/978-3-662-45059-8_3
   Ellis WA, 2015, CURR TOP MICROBIOL, V387, P99, DOI 10.1007/978-3-662-45059-8_6
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x
   Faine S., 1999, LEPTOSPIRA LEPTOSPIR
   Fenner JS, 2010, RES VET SCI, V89, P48, DOI 10.1016/j.rvsc.2009.12.014
   Flores BJ, 2017, ACTA TROP, V170, P79, DOI 10.1016/j.actatropica.2017.02.031
   Fouts DE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004403
   Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152
   Galloway RL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000824
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Hamond C, 2016, EPIDEMIOL INFECT, V144, P72, DOI 10.1017/S0950268815001363
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Leigh JW, 2015, SYST BIOL, V64, P741, DOI 10.1093/sysbio/syv030
   Loureiro AP, 2015, LETT APPL MICROBIOL, V61, P603, DOI 10.1111/lam.12501
   Martins G, 2015, EPIDEMIOL INFECT, V143, P1538, DOI 10.1017/S0950268814002416
   Pellizzaro M, 2017, REV SOC BRAS MED TRO, V50, P857, DOI 10.1590/0037-8682-0138-2017
   Pinto PS, 2017, ACTA TROP, V172, P156, DOI 10.1016/j.actatropica.2017.04.032
   Ribeiro-Goncalves B, 2016, NUCLEIC ACIDS RES, V44, pW246, DOI 10.1093/nar/gkw359
   Silva EF, 2007, VET MICROBIOL, V121, P144, DOI 10.1016/j.vetmic.2006.11.010
   Silva EF, 2009, EMERG INFECT DIS, V15, P621, DOI 10.3201/eid1504.071669
   van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x
   Vieira AS, 2019, TRANSBOUND EMERG DIS, V66, P1195, DOI 10.1111/tbed.13135
   Xu YH, 2015, HUM VACC IMMUNOTHER, V11, P1272, DOI 10.1080/21645515.2015.1020266
   Zarantonelli L, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006694
NR 29
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1865-1674
EI 1865-1682
J9 TRANSBOUND EMERG DIS
JI Transbound. Emerg. Dis.
PD JAN
PY 2020
VL 67
IS 1
BP 276
EP 283
DI 10.1111/tbed.13349
EA SEP 2019
PG 8
WC Infectious Diseases; Veterinary Sciences
SC Infectious Diseases; Veterinary Sciences
GA KD4ND
UT WOS:000486898000001
PM 31484225
OA Bronze
DA 2020-12-08
ER

PT J
AU Jaeger, LH
   Pestana, CP
   Correia, LFL
   Carvalho-Costa, FA
   Medeiros, MA
   Lilenbaum, W
AF Jaeger, L. H.
   Pestana, C. P.
   Correia, L. F. L.
   Carvalho-Costa, F. A.
   Medeiros, M. A.
   Lilenbaum, W.
TI Novel MLST sequence types of pathogenic Leptospira spp.: Opening the
   black Chock for box of animal leptospirosis in Brazil
SO ACTA TROPICA
LA English
DT Article
DE Leptospira; Genotyping; secY; MLST; Animal leptospirosis
ID TYPING MLST; STRAINS; HYDROCHAERIS; MAINTENANCE; CAPYBARAS; VIRULENCE;
   GENOTYPES; REVEALS; GENOME; CATTLE
AB In the current context of the emergence of certain infectious diseases and discussion of the One Health concept for many of these, the study of leptospirosis both in domestic and wild hosts cannot be neglected. The study of animal leptospirosis has evolved in recent years. It has been demonstrated that the human-animal-environment interface is more important than previously thought. In the present study, 35 strains of five pathogenic Leptospira species were isolated from different animal species in Brazil and characterized by rrs, secY, and Multilocus Sequence Typing (MLST) sequencing. Phylogenetic inferences were performed and the molecular diversity of the populations (intra- and inter-population levels) was evaluated. Among the five studied species, 18 different sequence types (STs) were found (22 new alleles and 11 new STs). eBURST analysis revealed two clonal complexes (CCs) and seven singletons. A high genetic diversity was demonstrated (H = 0.954 +/- 0.017), mainly for the L. santarosai population (H = 0.942 +/- 0.034, n = 20). The same strain was identified in different host species, as well as strains with zoonotic potential circulating in the country. Although the difficulty of culturing Leptospira strains is well known, the high variability of the strains found in Brazil highlights the importance of animals in maintaining the biological cycle of the bacterium in nature. Moreover, the selection of autochthonous strains for the development of vaccines becomes a challenge.
C1 [Jaeger, L. H.; Correia, L. F. L.; Lilenbaum, W.] Univ Fed Fluminense, Dept Microbiol & Parasitol, Lab Vet Bacteriol, Niteroi, RJ, Brazil.
   [Jaeger, L. H.; Carvalho-Costa, F. A.] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Epidemiol & Mol Systemat, Rio De Janeiro, RJ, Brazil.
   [Pestana, C. P.; Medeiros, M. A.] Fundacao Oswaldo Cruz, Lab Recombinant Technol, Biomanguinhos, Rio De Janeiro, RJ, Brazil.
RP Lilenbaum, W (corresponding author), Rua Prof Hemani Melo 101, BR-24210130 Niteroi, RJ, Brazil.
EM laurenhj@hotmail.com; cristiane.pinheiro@bio.fiocruz.br;
   lucascorreia@id.uff.br; carvalhocosta70@hotmail.com;
   medeiros@bio.fiocruz.br; wfilenbaum@id.uff.br
FU Fundacao Carlos Chagas de Ampar a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Conselho Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX This work was supported by the Fundacao Carlos Chagas de Ampar a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ, fellows: LHJ and WL) and
   Conselho Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq, fellows: FACC, MAM, and WL). The authors thank the Program for
   Technological Development in Tools for Health-PDTIS/FIOCRUZ for use of
   its facilities. We are grateful to Janjira Thaipadungpanit (Mahidol
   University, Bangkok, Thailand) for assigning novel alleles and sequence
   types (STs).
CR Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28
   Azhari NN, 2018, ACTA TROP, V188, P68, DOI 10.1016/j.actatropica.2018.08.020
   Barbosa C, 2019, MICROB PATHOGENESIS, V126, P134, DOI 10.1016/j.micpath.2018.10.032
   Barragan V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004990
   Biscornet L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005831
   Boonsilp S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001954
   Chiani Y, 2016, INFECT GENET EVOL, V37, P245, DOI 10.1016/j.meegid.2015.11.033
   Chideroli RT, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15018473
   COSATE MRV, 2015, GENOME ANNOUNC, V3, DOI DOI 10.1128/GENOMEA.01302-15
   de Albuquerque NF, 2017, ACTA TROP, V169, P57, DOI 10.1016/j.actatropica.2017.01.018
   Delooz L, 2018, TRANSBOUND EMERG DIS, V65, P158, DOI 10.1111/tbed.12643
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x
   Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004
   Fouts DE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004403
   Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Hamond C, 2016, EPIDEMIOL INFECT, V144, P72, DOI 10.1017/S0950268815001363
   Hamond C, 2019, TRANSBOUND EMERG DIS, V66, P1186, DOI 10.1111/tbed.13133
   Hamond C, 2015, J MED MICROBIOL, V64, P507, DOI 10.1099/jmm.0.000045
   Jaeger LH, 2018, LETT APPL MICROBIOL, V67, P183, DOI 10.1111/lam.13008
   Jaeger LH, 2018, J MED MICROBIOL, V67, P1361, DOI 10.1099/jmm.0.000806
   Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595
   Jorge S, 2012, CURR MICROBIOL, V65, P461, DOI 10.1007/s00284-012-0169-5
   Kanagavel M, 2016, INFECT GENET EVOL, V37, P123, DOI 10.1016/j.meegid.2015.11.008
   Kremer FS, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.00910-15
   Kremer FS, 2016, MEM I OSWALDO CRUZ, V111, P280, DOI 10.1590/0074-02760160010
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11
   Levett Paul N, 2018, Int J Syst Evol Microbiol, V68, P3362, DOI 10.1099/ijsem.0.002961
   Loureiro AP, 2016, RES VET SCI, V105, P249, DOI 10.1016/j.rvsc.2016.02.012
   Martins G, 2015, CURR MICROBIOL, V71, P624, DOI 10.1007/s00284-015-0894-7
   Martins G, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-237
   Miotto BA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200384
   Miotto BA, 2016, ACTA TROP, V162, P1, DOI 10.1016/j.actatropica.2016.06.007
   Moreno LZ, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx119
   Moreno LZ, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.16
   Moreno LZ, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.01179-15
   Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004
   Sanchez RGP, 2016, MEM I OSWALDO CRUZ, V111, P737, DOI 10.1590/0074-02760160245
   Pereira MM, 2000, J CLIN MICROBIOL, V38, P450
   Picardeau M, 2017, TOOLBOX OF MOLECULAR
   da Cunha CEP, 2016, AM J TROP MED HYG, V94, P519, DOI 10.4269/ajtmh.15-0505
   Ribeiro-Goncalves B, 2016, NUCLEIC ACIDS RES, V44, pW246, DOI 10.1093/nar/gkw359
   Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248
   Silva EF, 2009, EMERG INFECT DIS, V15, P621, DOI 10.3201/eid1504.071669
   Szonyi B, 2011, VET J, V188, P237, DOI 10.1016/j.tvjl.2010.05.002
   Thibeaux R, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000144
   Wang HK, 2020, J MICROBIOL IMMUNOL, V53, P307, DOI 10.1016/j.jmii.2018.05.005
   WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991
   Weiss S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004996
   Xu YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20020
   Zhang CC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003762
NR 52
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD AUG
PY 2019
VL 196
BP 135
EP 141
DI 10.1016/j.actatropica.2019.05.025
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA IN9UM
UT WOS:000479023900019
PM 31121146
DA 2020-12-08
ER

PT J
AU de Almeida, IMLM
   Ramos, CV
   Rodrigues, DC
   de Sousa, AC
   do Nascimento, MDCAPC
   da Silva, MVB
   Batista, FMA
   dos Santos, JP
   de Oliveira, RS
   Soares, FAD
   Xavier, SCD
   Carvalho-Costa, FA
AF Lopes Moreira de Almeida, Isabel Marlucia
   Ramos, Carmen Viana
   Rodrigues, Danielle Carvalho
   de Sousa, Amanda Carvalho
   Paz Carvalho do Nascimento, Maria de Lourdes Cristina Alcantara
   Bittencourt da Silva, Marcos Vilhena
   Araujo Batista, Francisca Miriane
   dos Santos, Jessica Pereira
   de Oliveira, Roselane Sampaio
   de Freitas Soares, Filipe Augusto
   das Chagas Xavier, Samanta Cristina
   Carvalho-Costa, Filipe Anibal
TI Clinical and epidemiological aspects of microcephaly in the state of
   Piaui, northeastern Brazil, 2015-2016
SO JORNAL DE PEDIATRIA
LA English
DT Article
DE Microcephaly; Infants; Zika; Stage of Piaui
ID ZIKA VIRUS-INFECTION; INFANTS
AB Objectives: To describe aspects of the microcephaly epidemic in the state of Piaui.
   Methods: All cases of congenital microcephaly confirmed in the state between 2015 and 2016 were included (n=100). Investigation forms of the Regional Reference Center for Microcephaly were reviewed. Discarded cases (n=63) were used as a comparison group.
   Results: In October, November, and December 2015 incidence rates reached 4.46, 6.33 and 3.86/1000 live births, respectively; 44 cases were reported in the state capital. Among the mothers of confirmed and discarded cases, the frequency of skin rash during pregnancy was 50/97 (51.5%) and 8/51 (15.7%), respectively (p< 0.001); 33 confirmed cases (35.9%) had a head circumference z-score between -2 and -3, 23 (25%) between -3 and -4, and 8 (8.7%) had a z-score of less than -4. Head computer tomography scans revealed calcifications in 78/95 (82.1%) cases. Lissencephaly, hydrocephalus and agenesis of the corpus callosum were also frequently observed. Ophthalmic findings included retinal pigment epithelium rarefaction and atrophy. Absence of otoacoustic emissions was observed in 21/70 cases. One newborn also presented lower limb muscle atrophy. There were no significant differences in vaccination rates for influenza, diphtheria-tetanus-acellular pertussis, and hepatitis B in either group.
   Conclusions: The state of Piaui, like others in the northeastern region, faced an epidemic of congenital microcephaly between 2015 and 2016, presumably related to congenital Zika virus infection, more intense in the capital. Current challenges include the improvement of vector control, basic research, scaling-up of diagnostic tools for pre-natal screening of Zika virus, vaccines, and health care for affected children. (C) 2018 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Pediatria.
C1 [Lopes Moreira de Almeida, Isabel Marlucia; Ramos, Carmen Viana; de Sousa, Amanda Carvalho; Paz Carvalho do Nascimento, Maria de Lourdes Cristina Alcantara; Bittencourt da Silva, Marcos Vilhena; Araujo Batista, Francisca Miriane] Ctr Reg Referencia Reg Microcefalia Governo Estad, Teresina, PI, Brazil.
   [Rodrigues, Danielle Carvalho; dos Santos, Jessica Pereira; de Freitas Soares, Filipe Augusto; das Chagas Xavier, Samanta Cristina; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [dos Santos, Jessica Pereira; Carvalho-Costa, Filipe Anibal] Escritorio Reg Fiocruz Piaui, Teresina, PI, Brazil.
   [de Oliveira, Roselane Sampaio] Univ Fed Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
RP Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.; Carvalho-Costa, FA (corresponding author), Escritorio Reg Fiocruz Piaui, Teresina, PI, Brazil.
EM guaratiba@ioc.fiocruz.br
RI Ramos, Carmem/AAG-3666-2020; Ramos, Carmen Viana/AAK-9415-2020
OI Xavier, Samanta Cristina/0000-0002-3475-0075; araujo,
   miriane/0000-0002-0351-8994; Viana Ramos, Carmen/0000-0003-3378-0149;
   SANTOS, JESSICA/0000-0002-1639-517X; de Freitas Soares, Filipe
   Augusto/0000-0003-0510-3968
FU Fundacao Oswaldo Cruz (Fiocruz)
FX This research was supported by funds from the Fundacao Oswaldo Cruz
   (Fiocruz).
CR Aleman TS, 2017, JAMA OPHTHALMOL, V135, P1069, DOI 10.1001/jamaophthalmol.2017.3292
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Centers for Disease Control and Prevention (CDC), 2017, ZIKA AND PREGNANCY C
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   Devakumar D, 2018, LANCET INFECT DIS, V18, pE1, DOI [10.1016/s1473-3099(17)30398-5, 10.1016/S1473-3099(17)30398-5]
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Mazzu-Nascimento T, 2017, GENET MOL BIOL, V40, P387, DOI [10.1590/1678-4685-gmb-2016-0179, 10.1590/1678-4685-GMB-2016-0179]
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moura AA, 2016, VACCINE, V34, P445, DOI 10.1016/j.vaccine.2015.12.019
   Serafim AS, 2014, REV SOC BRAS MED TRO, V47, P170, DOI 10.1590/0037-8682-0045-2014
   Trujillano D, 2017, EUR J HUM GENET, V25, P176, DOI 10.1038/ejhg.2016.146
   World Health Organization (WHO), 2016, SCREEN ASS MAN NEON
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zorrilla CD, 2017, J INFECT DIS, V216, pS891, DOI 10.1093/infdis/jix448
NR 24
TC 0
Z9 0
U1 0
U2 1
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD JUL-AUG
PY 2019
VL 95
IS 4
BP 466
EP 474
DI 10.1016/j.jped.2018.04.013
PG 9
WC Pediatrics
SC Pediatrics
GA IX6KR
UT WOS:000485792700012
PM 29963988
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Monteiro, KJL
   Calegar, DA
   Santos, JP
   Bacelar, PAA
   Coronato-Nunes, B
   Reis, ERC
   Boia, MN
   Carvalho-Costa, FA
   Jaeger, LH
AF Monteiro, Kerla J. L.
   Calegar, Deiviane A.
   Santos, Jessica P.
   Bacelar, Polyanna A. A.
   Coronato-Nunes, Beatriz
   Reis, Elis Regina C.
   Boia, Marcio N.
   Carvalho-Costa, Filipe A.
   Jaeger, Lauren H.
TI Genetic diversity of Ascaris spp. infecting humans and pigs in distinct
   Brazilian regions, as revealed by mitochondrial DNA
SO PLOS ONE
LA English
DT Article
ID MOLECULAR EPIDEMIOLOGY; SUUM; LUMBRICOIDES; TRANSMISSION; VARIABILITY
AB In this study, we assessed the genetic diversity of Ascaris lumbricoides / Ascaris suum circulating in humans and pigs, exploring potential zoonotic cycles in endemic areas in Brazil. We carried out cross-sectional surveys in four municipalities: Santa Isabel do Rio Negro (SIRN-AM) (n = 328); Nossa Senhora de Nazare (NSN-PI) and Teresina (TER-PI) (n = 605 and n = 297, respectively); and Cachoeiras de Macacu (CAM-RJ) (n = 543). We also studied 61 fecal samples/adult worms obtained from pigs (n = 53 in NSN-PI and n = 8 in TER-PI). A similar to 450 bp fragment of the Ascaris cytochrome c oxidase subunit 1 (cox1) and similar to 400 bp of the NADH dehydrogenase subunit 1 (nad1) were amplified and sequenced. Maximum-likeli-hood (ML) tree and Median-joining (MJ) haplotype network analyses were performed. We also performed scanning electron micrographs of adult specimens. Positivity rates were 93/328 (28.4%) in SIRN-AM, 6/297 (2.0%) in TER-PI, 0/605 (0%) in NSN-PI, and 6/543 (1.1%) in CAM-RJ. In NSN-PI it reached 11/53 (20.7%) in pigs. The MJ network based on cox1 locus (383 bp) revealed three main clusters, one centered around haplotypes H01/H28/H32 and the other around H07/H11. The cox1 haplotypes had a heterogeneous distribution, showing no pattern by geographic region, and high haplotype diversity. The ML trees based on cox1 and nad1 loci showed a similar topology with each other, and with the haplotype networks. Three distinct clusters were observed. Sequences of cox1 and nad1 from humans and animals were distributed throughout the tree and it was not possible to differentiate specimens of human and swine origin. Ascaris populations obtained from humans and swine in different Brazilian regions are not discriminable through the genetic markers used, which indicates the potential for zoonotic transmission and the need for better control of these infections in swine herds, mainly when created in a peridomestic environment.
C1 [Monteiro, Kerla J. L.; Calegar, Deiviane A.; Santos, Jessica P.; Bacelar, Polyanna A. A.; Coronato-Nunes, Beatriz; Reis, Elis Regina C.; Carvalho-Costa, Filipe A.; Jaeger, Lauren H.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, RJ, Brazil.
   [Monteiro, Kerla J. L.; Santos, Jessica P.; Bacelar, Polyanna A. A.; Carvalho-Costa, Filipe A.] Fundacao Oswaldo Cruz Piaui, Escritorio Tecn Reg, Teresina, Piaui, Brazil.
   [Boia, Marcio N.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, Rio De Janeiro, RJ, Brazil.
   [Jaeger, Lauren H.] Univ Fed Juiz de Fora, Dept Ciencias Farmaceut, Juiz De Fora, MG, Brazil.
RP Jaeger, LH (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, RJ, Brazil.; Jaeger, LH (corresponding author), Univ Fed Juiz de Fora, Dept Ciencias Farmaceut, Juiz De Fora, MG, Brazil.
EM laurenhj@hotmail.com
OI Jaeger, Lauren H./0000-0001-8031-7742; SANTOS,
   JESSICA/0000-0002-1639-517X
FU Oswaldo Cruz Foundation (Fiocruz); Brazilian Federal Agency for Support
   and Evaluation of Graduate Education (CAPES)CAPES
FX This work was supported by the Oswaldo Cruz Foundation (Fiocruz) and the
   Brazilian Federal Agency for Support and Evaluation of Graduate
   Education (CAPES) to KJLM. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004
   [Anonymous], 2016, GUIA PRATICO OPERACI
   ANSEL M, 1973, International Journal for Parasitology, V3, P317, DOI 10.1016/0020-7519(73)90109-4
   Ascunce MS, 2013, AM J PHYS ANTHROPOL, V152, P118, DOI 10.1002/ajpa.22336
   Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036
   Belew S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004057
   Bendall RP, 2011, EMERG INFECT DIS, V17, P1964, DOI 10.3201/eid1710.101826
   Betson M, 2014, J INFECT DIS, V210, P932, DOI 10.1093/infdis/jiu193
   Betson M, 2012, T ROY SOC TROP MED H, V106, P75, DOI 10.1016/j.trstmh.2011.10.011
   Betson M, 2011, T ROY SOC TROP MED H, V105, P370, DOI 10.1016/j.trstmh.2011.04.009
   Blouin B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006688
   Boes J, 1998, VET PARASITOL, V75, P181, DOI 10.1016/S0304-4017(97)00197-0
   Bronzan RN, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006551
   Brooker SJ, 2015, LANCET INFECT DIS, V15, P941, DOI 10.1016/S1473-3099(15)70042-3
   Carvalho-Costa Filipe Anibal, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P147, DOI 10.1590/S0036-46652007000300003
   Chelladurai JJ, 2017, J INFECT DIS, V215, P131, DOI 10.1093/infdis/jiw507
   Criscione CD, 2007, P ROY SOC B-BIOL SCI, V274, P2669, DOI 10.1098/rspb.2007.0877
   Alves EBD, 2016, J INFECT DIS, V213, P1355, DOI 10.1093/infdis/jiw027
   Dutto M, 2013, CENT EUR J PUBL HEAL, V21, P224, DOI 10.21101/cejph.a3798
   Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x
   Farrell SH, 2018, CLIN INFECT DIS, V66, pS253, DOI 10.1093/cid/ciy002
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Iniguez AM, 2012, T ROY SOC TROP MED H, V106, P604, DOI 10.1016/j.trstmh.2012.06.009
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Leles D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-42
   Leles D, 2010, PARASITOL INT, V59, P93, DOI 10.1016/j.parint.2009.10.001
   Leles D, 2009, VET PARASITOL, V163, P167, DOI 10.1016/j.vetpar.2009.03.050
   Monteiro KJL, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860024, 10.1590/s1678-9946201860024]
   Liu GH, 2012, GENE, V492, P110, DOI 10.1016/j.gene.2011.10.043
   Andrade AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000655
   Miller LA, 2015, EMERG INFECT DIS, V21, P332, DOI 10.3201/eid2102.140048
   Moncayo AL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021319
   Monteiro KJL, 2020, J HELMINTHOL, V94, DOI 10.1017/S0022149X18001013
   Nejsum P, 2012, J HELMINTHOL, V86, P148, DOI 10.1017/S0022149X12000193
   Nejsuma P, 2017, INFECT GENET EVOL, V48, P4, DOI 10.1016/j.meegid.2016.12.003
   Peng WD, 2005, ELECTROPHORESIS, V26, P4317, DOI 10.1002/elps.200500276
   Roepstorff A, 2011, VET PARASITOL, V180, P72, DOI 10.1016/j.vetpar.2011.05.029
   Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248
   Sadaow L, 2018, PARASITOL RES, V117, P2427, DOI 10.1007/s00436-018-5931-6
   Soe MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004855
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Umetsu S, 2014, WORLD J GASTROENTERO, V20, P14058, DOI 10.3748/wjg.v20.i38.14058
NR 42
TC 2
Z9 2
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 24
PY 2019
VL 14
IS 6
AR e0218867
DI 10.1371/journal.pone.0218867
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW3QN
UT WOS:000484896700047
PM 31233550
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Vieira, AS
   D'Andrea, PS
   Vilela, RD
   Loretto, D
   Jaeger, LH
   Carvalho-Costa, FA
   Lilenbaum, W
AF Vieira, Anahi S.
   D'Andrea, Paulo Sergio
   Vilela, Roberto do Val
   Loretto, Diogo
   Jaeger, Lauren H.
   Carvalho-Costa, Filipe A.
   Lilenbaum, Walter
TI Pathogenic Leptospira species are widely disseminated among small
   mammals in Atlantic Forest biome
SO TRANSBOUNDARY AND EMERGING DISEASES
LA English
DT Article
DE Leptospirosis; marsupials; rodents
ID TRYPANOSOMA-CRUZI; WILD RODENTS; RAIN-FOREST; BRAZIL; SPP.; INFECTIONS;
   ANIMALS; PCR; IDENTIFICATION; POPULATIONS
AB Leptospirosis is a common worldwide bacterial zoonosis and has been studied in One Health approaches. Small mammals are described as the most important maintenance reservoirs of several pathogens in nature, including leptospires. The aim of this study was to identify infection by leptospires among small mammals on the Atlantic forest biome and evaluate their potential as carriers of these spirochetes. A total of 153 small mammals belonging to orders Rodentia and Didelphimorphia (distributed on 17 genera and 22 species) were captured. Blood and kidney samples were collected from animals and a conventional PCR targeted on lipL32 gene was conducted on renal tissues. Species identification was performed in eight samples by sequencing of rrs gene. A total of 28% of the animals presented lipL32 PCR-positive, and four pathogenic Leptospira species (L. interrogans, L. borgpetersenii, L. santarosai and L. noguchii) were identified. This study highlights the role of small mammals as carriers of leptospires on the Atlantic Forest representing a potential source of pathogenic Leptospira spp infection for both humans and domestic animals.
C1 [Vieira, Anahi S.; Jaeger, Lauren H.; Lilenbaum, Walter] Univ Fed Fluminense, Inst Biomed, Lab Bacteriol Vet, Niteroi, RJ, Brazil.
   [D'Andrea, Paulo Sergio; Vilela, Roberto do Val; Loretto, Diogo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, Rio De Janeiro, RJ, Brazil.
   [Jaeger, Lauren H.; Carvalho-Costa, Filipe A.] Fundacao Oswaldo Cruz, Inst Oswaldo, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, RJ, Brazil.
RP Lilenbaum, W (corresponding author), Univ Fed Fluminense, Inst Biomed, Lab Bacteriol Vet, Niteroi, RJ, Brazil.
EM wlilenbaum@id.uff.br
RI Vilela, Roberto V/D-1525-2015; Loretto, Diogo/ABE-1192-2020; D'Andrea,
   Paulo S./G-6820-2011
OI Vilela, Roberto V/0000-0003-3275-2648; Loretto,
   Diogo/0000-0002-9464-6712; Lilenbaum, Walter/0000-0002-2434-8728;
   D'Andrea, Paulo Sergio/0000-0001-7880-8761
CR Ahmed A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007093
   Andersen-Ranberg EU, 2016, J WILDLIFE DIS, V52, P468, DOI 10.7589/2014-10-245
   Arent ZJ, 2017, ECOHEALTH, V14, P48, DOI 10.1007/s10393-017-1210-8
   Ayral F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162549
   Bunnell JE, 2000, AM J TROP MED HYG, V63, P255, DOI 10.4269/ajtmh.2000.63.255
   Colombo AF, 2010, BRAZ J BIOL, V70, P697, DOI 10.1590/S1519-69842010000400002
   Conselho Federal de Medicina Veterinaria-CFMV, 2012, GUIA BRAS BOAS PRAT
   CORDEIRO F, 1981, PESQUISA VET BRASIL, V1, P19
   Correa JP, 2017, ACTA TROP, V176, P105, DOI 10.1016/j.actatropica.2017.07.032
   Correia L, 2017, VET J, V220, P63, DOI 10.1016/j.tvjl.2016.12.016
   de Oliveira RC, 2017, AM J TROP MED HYG, V97, P125, DOI 10.4269/ajtmh.16-0845
   Dietrich M, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0059-4
   Ellis WA, 2015, CURR TOP MICROBIOL, V387, P99, DOI 10.1007/978-3-662-45059-8_6
   Fischer S, 2018, VECTOR-BORNE ZOONOT, V18, P188, DOI 10.1089/vbz.2017.2140
   Fornazari F, 2018, ACTA TROP, V178, P205, DOI 10.1016/j.actatropica.2017.11.019
   Gennari SM, 2015, REV BRAS PARASITOL V, V24, P379, DOI 10.1590/S1984-29612015045
   Haake DA, 2015, CURR TOP MICROBIOL, V387, P65, DOI 10.1007/978-3-662-45059-8_5
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Hamond C, 2014, VET RES COMMUN, V38, P81, DOI 10.1007/s11259-013-9582-x
   Kudo Y, 2018, VECTOR-BORNE ZOONOT, V18, P144, DOI 10.1089/vbz.2017.2198
   Latifah I, 2017, MALAYS J PATHOL, V39, P161
   Libonati H, 2017, MICROB PATHOGENESIS, V108, P101, DOI 10.1016/j.micpath.2017.05.001
   Lovera R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005722
   Mayer FQ, 2017, COMP IMMUNOL MICROB, V52, P14, DOI 10.1016/j.cimid.2017.05.003
   Medici EP, 2014, J WILDLIFE DIS, V50, P817, DOI 10.7589/2014-02-029
   MERIEN F, 1992, J CLIN MICROBIOL, V30, P2219
   Ministerio do Meio Ambiente, 2017, BIOM MAT ATL
   Mwachui MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003843
   Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501
   Obiegala A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004501
   OIE, 2014, LEPT MAN DIAGN TESTS
   Pardini R, 2005, BIOL CONSERV, V124, P253, DOI 10.1016/j.biocon.2005.01.033
   Picardeau M, 2017, NAT REV MICROBIOL, V15, P297, DOI 10.1038/nrmicro.2017.5
   Pinto PS, 2015, ACTA TROP, V149, P163, DOI 10.1016/j.actatropica.2015.05.008
   Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021
   Rood EJJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186987
   SANTAROSA CA, 1975, AM J VET RES, V36, P1363
   Schneider MC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004095
   Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Lopes CMT, 2018, MEM I OSWALDO CRUZ, V113, P45, DOI 10.1590/0074-02760170297
   Thibeaux R, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00816
   Trueb I, 2018, J WILDLIFE DIS, V54, P76, DOI 10.7589/2017-01-017
   Vieira AS, 2018, TROP ANIM HEALTH PRO, V50, P229, DOI 10.1007/s11250-017-1429-y
   Vieira AS, 2016, ACTA TROP, V163, P87, DOI 10.1016/j.actatropica.2016.08.001
   Vieira Anahi Souto, 2013, Ciênc. anim. bras., V14, P373, DOI 10.5216/cab.v14i3.17147
NR 46
TC 6
Z9 6
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1865-1674
EI 1865-1682
J9 TRANSBOUND EMERG DIS
JI Transbound. Emerg. Dis.
PD MAY
PY 2019
VL 66
IS 3
BP 1195
EP 1201
DI 10.1111/tbed.13135
PG 7
WC Infectious Diseases; Veterinary Sciences
SC Infectious Diseases; Veterinary Sciences
GA HY7MJ
UT WOS:000468319700014
PM 30703279
DA 2020-12-08
ER

PT J
AU Monteiro, KJL
   Jaeger, LH
   Nunes, BC
   Calegar, DA
   dos Reis, ERC
   Bacelar, PAA
   dos Santos, JP
   Boia, MN
   Carvalho-Costa, FA
AF Lima Monteiro, Kerla Joeline
   Jaeger, Lauren Hubert
   Nunes, Beatriz Coronato
   Calegar, Deiviane Aparecida
   Chaves dos Reis, Elis Regina
   Alves Bacelar, Polyanna Araujo
   dos Santos, Jessica Pereira
   Boia, Marcio Neves
   Carvalho-Costa, Filipe Anibal
TI Mitochondrial DNA reveals species composition and phylogenetic
   relationships of hookworms in northeastern Brazil
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Hookworm; cox1; Northeastern; Brazil
ID NECATOR-AMERICANUS NEMATODA; C-OXIDASE SUBUNIT-1;
   OESOPHAGOSTOMUM-BIFURCUM; ANCYLOSTOMA-CEYLANICUM; HUMAN INFECTION;
   ENDEMIC AREA; SPP.; IDENTIFICATION; PARASITES; PRIMATES
AB Hookworm infection persists focally in rural communities in Brazil. In this study, we analyze the mitochondrial nucleotide sequences obtained from hookworms infecting humans in order to characterize species composition and assess their genetic diversity and phylogenetic relationships. Field expeditions and cross-sectional surveys were carried out in three Brazilian municipalities from 2013 to 2017: Nossa Senhora de Nazare (n = 605) and Teresina (n = 297), in the state of Piaui., and Russas (n = 213) in the State of Ceara. Parasitological methods were used to evaluate fecal samples. Hookworm-positive samples had a partial mtDNA cox1 amplified and sequenced. Maximum-likelihood and Bayesian analysis demonstrated two strongly-supported clades, including Group A, corresponding to Necator americanus, and Groups B and C, corresponding to Necator sp. Group A was divided into three main clusters: A1 grouped with Asian sequences, A2 grouped with African sequences, and A3 had only Asian sequences. Group B was closely related to Necator sp., showing a sequence similarity of 98%-99% with African samples circulating zoonotically among humans and non-human primates. Twenty three N. americanus haplotypes were identified. N. americanus Median-Joining network revealed three distinct groups, designated again as A1, A2, and A3. Group A1 presented a star-like shape, with one dominant haplotype. The molecular dating suggested that the two clades dividing N. americanus and Necator sp. began to diverge during the middle Pleistocene. The most recent common ancestor among N. americanus groups was dated to the late Pleistocene. Hookworms circulating in the studied communities are structured in well-defined subpopulations presenting both Asian and African genetic backgrounds. This reveals a double origin for hookworms in northeastern Brazil and opens up new possibilities in phylogeographic, evolutionary, and molecular epidemiological studies in regions where hookworms persists focally, despite control efforts. The presence of potentially zoonotic species and the specific identification of Necator sp. should be further investigated.
C1 [Lima Monteiro, Kerla Joeline; Jaeger, Lauren Hubert; Nunes, Beatriz Coronato; Calegar, Deiviane Aparecida; Chaves dos Reis, Elis Regina; Alves Bacelar, Polyanna Araujo; dos Santos, Jessica Pereira; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Epidemiol & Mol Systemat, Ave Brasil 4365, Rio De Janeiro, Brazil.
   [Lima Monteiro, Kerla Joeline; Alves Bacelar, Polyanna Araujo; dos Santos, Jessica Pereira; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Teresina, Piaui, Brazil.
   [Boia, Marcio Neves] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Biol & Parasitol Wild Reservoir Mammals, Rio De Janeiro, Brazil.
RP Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Epidemiol & Mol Systemat, Ave Brasil 4365, Rio De Janeiro, Brazil.
EM guaratiba@ioc.fiocruz.br
OI SANTOS, JESSICA/0000-0002-1639-517X; CALEGAR, DEIVIANE
   APARECIDA/0000-0002-9311-2401
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior - Brasil (CAPES) Finance Code 001. We thank to
   Dr. Arnaldo Maldonado for contributed reagents/materials and Dr. Roberto
   Vilela for the suggestion of the protocol (cox1 primers). The authors
   thank the Program for Technological Development in Tools for
   Health-PDTIS/FIOCRUZ for use of its facilities.
CR Araujo A, 2011, CHUNGARA, V43, P303, DOI 10.4067/S0717-73562011000200011
   Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036
   Bartsch SM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004922
   BLOTKAMP J, 1993, J HELMINTHOL, V67, P49, DOI 10.1017/S0022149X00012840
   Bóia Márcio Neves, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P189, DOI 10.1590/S0036-46652006000400003
   Buonfrate D, 2017, INFECTION, V45, P233, DOI 10.1007/s15010-016-0957-0
   Carvalho-Costa Filipe Anibal, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P147, DOI 10.1590/S0036-46652007000300003
   Casmo V, 2014, REV INST MED TROP SP, V56, P219, DOI 10.1590/S0036-46652014000300007
   Chammartin F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-440
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Gasser RB, 2006, PARASITOLOGY, V132, P453, DOI 10.1017/S0031182005009406
   Gasser RB, 1998, MOL BIOCHEM PARASIT, V92, P303, DOI 10.1016/S0166-6851(98)00008-5
   George S, 2016, T ROY SOC TROP MED H, V110, P657, DOI 10.1093/trstmh/trw078
   Gholami S, 2015, IRAN J PARASITOL, V10, P110
   GOLDSMID JM, 1968, T ROY SOC TROP MED H, V62, P109, DOI 10.1016/0035-9203(68)90038-2
   GRABER M, 1981, REV ELEVAGE MED VET, V34, P27
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Hasegawa H, 2017, PARASITOL INT, V66, P12, DOI 10.1016/j.parint.2016.11.003
   Hasegawa H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002715
   Hawdon JM, 2001, MOL ECOL, V10, P1433, DOI 10.1046/j.1365-294X.2001.01296.x
   Hu M, 2003, INT J PARASITOL, V33, P955, DOI 10.1016/S0020-7519(03)00129-2
   Hu M, 2002, INT J PARASITOL, V32, P145, DOI 10.1016/S0020-7519(01)00316-2
   Hu M, 2002, ELECTROPHORESIS, V23, P27, DOI 10.1002/1522-2683(200201)23:1&lt;27::AID-ELPS27&gt;3.0.CO;2-7
   Hu M, 2008, MOL CELL PROBE, V22, P234, DOI 10.1016/j.mcp.2008.04.001
   Kalousova B, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1357-0
   Kobayashi Jun, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P13, DOI 10.1590/S0036-46651995000100003
   Lattes S, 2011, EMERG INFECT DIS, V17, P1301, DOI 10.3201/eid1707.101519
   Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187
   Monteiro KJL, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860024, 10.1590/s1678-9946201860024]
   Loukas A, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.88
   Marzochi M.C. de A., 1978, Revista do Instituto de Medicina Tropical de Sao Paulo, V20, P36
   Messing J, 1993, Methods Mol Biol, V23, P9
   POLDERMAN AM, 1995, PARASITOL TODAY, V11, P451, DOI 10.1016/0169-4758(95)80058-1
   Prosser SWJ, 2013, MOL ECOL RESOUR, V13, P1108, DOI 10.1111/1755-0998.12082
   Rambaut A, 2009, TRACER VERSION 1 5
   Rambaut A, 2014, FIGTREE V1 4 2 TREE
   Rambaut A, 2015, TREEANNOTATOR V2 0 3
   Romstad A, 1998, INT J PARASITOL, V28, P611, DOI 10.1016/S0020-7519(97)00213-0
   Sato M, 2011, AM J TROP MED HYG, V84, P52, DOI 10.4269/ajtmh.2011.10-0385
   Sharifdini M, 2017, ACTA TROP, V176, P293, DOI 10.1016/j.actatropica.2017.07.001
   Shi XL, 2018, INFECT GENET EVOL, V62, P40, DOI 10.1016/j.meegid.2018.04.012
   Souza RP, 2013, BIOMEDICA, V33, P439, DOI 10.7705/biomedica.v33i3.770
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Traub RJ, 2013, INT J PARASITOL, V43, P1009, DOI 10.1016/j.ijpara.2013.07.006
   Verweij JJ, 2001, TROP MED INT HEALTH, V6, P726, DOI 10.1046/j.1365-3156.2001.00770.x
   Yong Tai-Soon, 2007, Korean Journal of Parasitology, V45, P69, DOI 10.3347/kjp.2007.45.1.69
   Zarlenga DS, 2006, P NATL ACAD SCI USA, V103, P7354, DOI 10.1073/pnas.0602466103
NR 48
TC 2
Z9 2
U1 0
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD MAR
PY 2019
VL 68
BP 105
EP 112
DI 10.1016/j.meegid.2018.11.018
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA HK1AS
UT WOS:000457637700016
PM 30508686
DA 2020-12-08
ER

PT J
AU Carvalho-Costa, FA
   de Assis, RMS
   Fialho, AM
   Araujo, IT
   Silva, MF
   Gomez, MM
   Andrade, JS
   Rose, TL
   Fumian, TM
   Volotao, EM
   Miagostovich, MP
   Leite, JPG
AF Carvalho-Costa, Filipe A.
   de Assis, Rosane M. S.
   Fialho, Alexandre M.
   Araujo, Irene T.
   Silva, Marcelle F.
   Gomez, Mariela M.
   Andrade, Juliana S.
   Rose, Tatiana L.
   Fumian, Tulio M.
   Volotao, Eduardo M.
   Miagostovich, Marize P.
   Leite, Jose Paulo G.
TI The evolving epidemiology of rotavirus A infection in Brazil a decade
   after the introduction of universal vaccination with Rotarix (R)
SO BMC PEDIATRICS
LA English
DT Article
DE Rotavirus; Monovalent vaccine; Genotypes; Epidemiology
ID 1ST 2 YEARS; GROUP-A ROTAVIRUS; YOUNG-CHILDREN; LATIN-AMERICAN;
   DEVELOPING-COUNTRIES; DIARRHEAL DISEASE; NATIONAL CAUSES; DOUBLE-BLIND;
   STRAINS; GENOTYPE
AB BackgroundBrazil introduced the monovalent rotavirus vaccine (Rotarix (R)) in 2006. This study aimed to assess the epidemiology and genotype distribution of species-A rotavirus (RVA) in Brazil, comparing the pre- and post-vaccination periods.MethodsLaboratory-based RVA surveillance included 866 municipalities in 22 Brazilian states, over a 21-year period. A total of 16,185 children with diarrheal diseases (DD) aged up to 12years between 1996 and 2005 (pre-vaccination period, n=7030) and from 2006 to 2017 (post-vaccination period, n=9155) were enrolled. RVA was detected using ELISA immune assay and/or polyacrylamide gel electrophoresis and genotyped using nested PCR and/or nucleotide sequencing. RVA-positivity and genotypes detection rates were compared in distinct periods and age groups and Rotarix vaccination status.ResultsRVA-positivity in pre- and post-vaccination periods was, respectively: 4-11months bracket, 33.3% (668/2006) and 16.3% (415/2547) (p<0.001); 12-24months, 28.2% (607/2154) and 22.2% (680/3068) (p<0.001); 25-48months, 17.4% (215/1235) and 29.4% (505/1720) (p<0.001). Genotypes distribution in the pre- and post-vaccination periods was, respectively: G1P [8]/G1P[Not Typed], 417/855 (48.8%) and 118/1835 (6.4%) (p<0.001); G2P [4]/G2P[NT], 47/855 (5.5%) and 838/1835 (45.7%) (p<0.001); G3P [8]/G3P[NT], 55/855 (6.4%) and 253/1835 (13.8%) (p<0.001); G9P [8]/G9P[NT], 238/855 (27.8%) and 152/1835 (8.3%) (p<0.001); G12P [8]/G129P[NT], 0/871 (0%) and 249/1835(13.6%) (p<0.001). Concerning infants aged 4-11months, RVA frequency in fully vaccinated and non-vaccinated individuals was 11.9% (125/1052) and 24.5% (58/237) (p<0.001), respectively. In children aged 12-24months, RVA detection rate was 18.1% (253/1395) and 29.6% (77/260) (p<0.001), for the vaccinated and non-vaccinated individuals, respectively (p<0.001).ConclusionsRVA infection was significantly less frequent in children aged 2years with DD after implementing vaccination, mainly among vaccinated children. It was also observed a decrease of P [8] circulation and emergence of G2P[4] in 2005, and afterwards in the post-vaccine era, with spreading of G12P[8] in 2014-2015 and of G3P[8] in 2017. Continuous RVA surveillance must be carried out in this scenario.
C1 [Carvalho-Costa, Filipe A.; de Assis, Rosane M. S.; Fialho, Alexandre M.; Araujo, Irene T.; Silva, Marcelle F.; Gomez, Mariela M.; Andrade, Juliana S.; Rose, Tatiana L.; Fumian, Tulio M.; Volotao, Eduardo M.; Miagostovich, Marize P.; Leite, Jose Paulo G.] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Comparat & Environm Virol, Av Brasil 4365 Pavilhao Helio & Peggy Pereira, Rio De Janeiro, RJ, Brazil.
   [Carvalho-Costa, Filipe A.] Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Epidemiol & Mol Systemat, Av Brasil 4365 Pavilhao Leonidas Deane, Rio De Janeiro, RJ, Brazil.
   [Carvalho-Costa, Filipe A.] Fiocruz Piaui, Reg Off, Rua Magalhaes Filho 519, Teresina, Piaui, Brazil.
RP Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Comparat & Environm Virol, Av Brasil 4365 Pavilhao Helio & Peggy Pereira, Rio De Janeiro, RJ, Brazil.; Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz, Oswaldo Cruz Inst, Lab Epidemiol & Mol Systemat, Av Brasil 4365 Pavilhao Leonidas Deane, Rio De Janeiro, RJ, Brazil.; Carvalho-Costa, FA (corresponding author), Fiocruz Piaui, Reg Off, Rua Magalhaes Filho 519, Teresina, Piaui, Brazil.
EM carvalhocosta70@hotmail.com
RI Silva-Sales, Marcelle/D-9809-2015; LEITE, JOSE PAULO
   GAGLIARDI/AAY-1230-2020
OI Silva-Sales, Marcelle/0000-0002-4275-9627; 
FU Oswaldo Cruz Institute; National Council for Scientific and
   Technological DevelopmentNational Council for Scientific and
   Technological Development (CNPq); Program of Excellence in Research;
   PAPES VI/Fiocruz - CNPq; Brazilian Federal Agency for Support and
   Evaluation of Graduate Education [CAPES-MERCOSUL PPCP 023/2011]; General
   Coordination of Public Health Laboratories - Secretary of Health
   Surveillance; Carlos Chagas Filho Foundation for Research Support of Rio
   de Janeiro State
FX This research was supported by funds from the Oswaldo Cruz Institute
   (laboratory infrastructure); the National Council for Scientific and
   Technological Development (research grants for researchers and
   postgraduate students); the Program of Excellence in Research (reagents
   for molecular biology); PAPES VI/Fiocruz - CNPq (reagents for molecular
   biology); Brazilian Federal Agency for Support and Evaluation of
   Graduate Education - project CAPES-MERCOSUL PPCP 023/2011 (scholarships
   for foreign researchers), the General Coordination of Public Health
   Laboratories - Secretary of Health Surveillance (material for the
   laboratory diagnosis of RVA infections), and the Carlos Chagas Filho
   Foundation for Research Support of Rio de Janeiro State (equipment and
   reagents).
CR Amarilla A, 2007, MED SCI MONITOR, V13, pCR333
   [Anonymous], 2013, VACCINE, V31, P6170, DOI 10.1016/j.vaccine.2013.05.037
   Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1
   de Oliveira LH, 2015, VACCINE, V33, pA248, DOI 10.1016/j.vaccine.2014.11.060
   Delogu R, 2015, J MED VIROL, V87, P1292, DOI 10.1002/jmv.24180
   Desai R, 2011, MEM I OSWALDO CRUZ, V106, P907, DOI 10.1590/S0074-02762011000800002
   Fernandes EG, 2014, VACCINE, V32, P3402, DOI 10.1016/j.vaccine.2014.04.015
   Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499
   Gomez MM, 2014, INFECT GENET EVOL, V28, P486, DOI 10.1016/j.meegid.2014.09.012
   Gomez MM, 2011, J MED VIROL, V83, P1093, DOI 10.1002/jmv.22071
   Hull JJ, 2011, PEDIATR INFECT DIS J, V30, pS42, DOI 10.1097/INF.0b013e3181fefd78
   Ichihara MYT, 2014, VACCINE, V32, P2740, DOI 10.1016/j.vaccine.2014.01.007
   Degiuseppe JI, 2013, ARCH ARGENT PEDIATR, V111, P148, DOI [10.5546/aap.2013.148, 10.1590/S0325-00752013000200010]
   do Carmo GMI, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001024
   Justino MCA, 2012, MEM I OSWALDO CRUZ, V107, P846, DOI 10.1590/S0074-02762012000700002
   Justino MCA, 2011, PEDIATR INFECT DIS J, V30, P396, DOI 10.1097/INF.0b013e3182055cc2
   Kirkwood CD, 2011, PEDIATR INFECT DIS J, V30, pS48, DOI 10.1097/INF.0b013e3181fefd90
   Kotloff KL, 2017, PEDIATR CLIN N AM, V64, P799, DOI 10.1016/j.pcl.2017.03.006
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Kyu HH, 2016, JAMA PEDIATR, V170, P267, DOI 10.1001/jamapediatrics.2015.4276
   Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788
   Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3
   Linhares AC, 2014, EXPERT REV VACCINES, V13, P43, DOI 10.1586/14760584.2014.861746
   Linhares AC, 2011, REV MED VIROL, V21, P89, DOI 10.1002/rmv.682
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   Luchs A, 2016, ACTA TROP, V156, P87, DOI 10.1016/j.actatropica.2015.12.008
   Mandile MG, 2014, J CLIN VIROL, V60, P282, DOI 10.1016/j.jcv.2014.04.022
   Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07
   Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007
   Operario DJ, 2017, J INFECT DIS, V216, P220, DOI 10.1093/infdis/jix294
   Patel MM, 2008, EMERG INFECT DIS, V14, P863, DOI 10.3201/eid1405.071440
   Paternina-Caicedo A, 2015, VACCINE, V33, P3923, DOI 10.1016/j.vaccine.2015.06.058
   Pitzer VE, 2011, P NATL ACAD SCI USA, V108, P19353, DOI 10.1073/pnas.1110507108
   Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5
   Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434
   Siqueira AA, 2010, INT J INFECT DIS, V14, pE898, DOI 10.1016/j.ijid.2010.03.024
   Soares LD, 2014, J MED VIROL, V86, P1065, DOI 10.1002/jmv.23797
   Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013
   Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9
   Wazny K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001446
   World Health Organization, 2009, MAN ROT DET CHAR MET
   Yu JX, 2019, J INFECTION, V78, P66, DOI 10.1016/j.jinf.2018.07.004
NR 42
TC 10
Z9 10
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2431
J9 BMC PEDIATR
JI BMC Pediatr.
PD JAN 31
PY 2019
VL 19
AR 42
DI 10.1186/s12887-019-1415-9
PG 10
WC Pediatrics
SC Pediatrics
GA HJ8RZ
UT WOS:000457468700004
PM 30704518
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Daflon-Teixeira, NF
   Coutinho, C
   Gomes, TF
   Toma, HK
   Duarte, R
   Boia, MN
   Carvalho-Costa, FA
   Almeida, CE
   Lima, MM
AF Daflon-Teixeira, Natalia Faria
   Coutinho, Carolina
   Gomes, Tais Ferreira
   Toma, Helena Keiko
   Duarte, Rosemere
   Boia, Marcio Neves
   Carvalho-Costa, Filipe Anibal
   Almeida, Carlos Eduardo
   Lima, Marli Maria
TI Multiple Approaches to Address Potential Risk Factors of Chagas Disease
   Transmission in Northeastern Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID TRIATOMA-BRASILIENSIS; TRYPANOSOMA-CRUZI; REDUVIIDAE; HEMIPTERA;
   IDENTIFICATION; INFESTANS; VECTORS; STATE; PSEUDOMACULATA; DOMICILIARY
AB Chagas disease is one of the most significant systemic parasitosis in Latin America, caused by Trypanosoma cruzi, which is mainly transmitted by hematophagous insects, the triatomines. This research was carried out in both domestic and wild environments throughout a Northeastern rural locality. Triatomines were captured in both peridomicile and wild environments, obtaining 508 specimens of triatomines, of which 99.6% were Triatoma brasiliensis. Insects were captured in 10 (18.5%) peridomiciles with an average of 8.3 triatomines per residence. Triatoma brasiliensis nymphs and adults were found in six peridomiciles, generating a 11.1% colonization. No T. cruzi infection was detected in the 447 peridomestic insects analyzed. On the other hand, of the 55 sylvatic T. brasiliensis molecularly examined for T. cruzi, 12 (21%) were positive, all harboring T. cruzi I. The blood meal analysis by enzyme-linked immunosorbent assay from gut content revealed that both peridomestic and wild triatomine populations fed mainly on birds, refractory to the parasite, which may explain the null rate of natural infection prevalence in the domestic environment. However, infected triatomines for potential home infestation within the radius of insect dispersion capacity were registered in rock outcrops around the dwellings. Anthropogenic environmental influences are able to rapidly alter these scenarios. Therefore, to avoid disease transmission to humans, we recommend constant vector control combined with periodic serological surveillance. The associated methodology presented herein may serve as a model for early detections of risk factors for Chagas disease transmission in the Brazilian Northeast.
C1 [Daflon-Teixeira, Natalia Faria; Gomes, Tais Ferreira; Lima, Marli Maria] IOC Fiocruz, Inst Oswaldo Cruz, Lab Ecoepidemiol Doenca Chagas, Rio De Janeiro, Brazil.
   [Coutinho, Carolina] Inst Comunicacao & Informacao Cient & Tecnol Saud, Rio De Janeiro, Brazil.
   [Toma, Helena Keiko] Univ Fed Rio de Janeiro UFRJ, Lab Diagnost Mol & Hematol, Rio De Janeiro, Brazil.
   [Duarte, Rosemere] Escola Nacl Saude Publ ENSP Fiocruz, Dept Ciencias Biol, Rio De Janeiro, Brazil.
   [Boia, Marcio Neves] IOC Fiocruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe Anibal] IOC Fiocruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Escritorio Reg Fiocruz Piaui, Teresina, Brazil.
   [Almeida, Carlos Eduardo] Univ Estadual Campinas, Unicamp, Inst Biol, Campinas, SP, Brazil.
   [Daflon-Teixeira, Natalia Faria; Gomes, Tais Ferreira; Lima, Marli Maria] Inst Oswaldo Cruz Fiocruz, Lab Ecoepidemiol Doenca Chagas, Av Brazil 4365, BR-21045900 Rio De Janeiro, Brazil.
   [Toma, Helena Keiko] Univ Fed Rio de Janeiro, Lab Diagnost Mol & Hematol, Rio De Janeiro, Brazil.
   [Duarte, Rosemere] Escola Nacl Saude Publ Fiocruz, Escola Nacl Saude Publ, Dept Ciencias Biol, Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, Brazil.
RP Almeida, CE (corresponding author), Rua Monteiro Lobato 255, BR-13083862 Campinas, SP, Brazil.; Lima, MM (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Ecoepidemiol Doenca Chagas, Av Brazil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM nataliadaflon@gmail.com; carolina.coutinho@icict.fiocruz.br;
   taisferreiragomes@gmail.com; hktoma@globo.com; rduarte@ensp.fiocruz.br;
   mboia@ioc.fiocruz.br; carvalhocosta70@hotmail.com;
   almeida_ce@hotmail.com; mmlima@ioc.fiocruz.br
RI DE ALMEIDA, CARLOS CAETANO/K-4265-2016; de Souza Coutinho, Carolina
   Fausto/AAR-6069-2020; Almeida, Carlos Eduardo C E/E-7983-2014
OI DE ALMEIDA, CARLOS CAETANO/0000-0002-3215-5731; de Souza Coutinho,
   Carolina Fausto/0000-0002-9005-8171; Almeida, Carlos Eduardo C
   E/0000-0003-4605-2618
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPESCAPES;
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [306897/2014-8]; Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2016/08176-9]
FX Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES,
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq
   process number 306897/2014-8), Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP, process number and 2016/08176-9). Opinions,
   hypotheses, conclusions, and recommendations expressed in this material
   are the responsibility of the corresponding authors and do not
   necessarily reflect the views of the funding agencies.
CR Abad-Franch F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003187
   Alencar JE, 1987, HIST NATURAL DOENCA
   Almeida CE, 2009, MED VET ENTOMOL, V23, P410, DOI 10.1111/j.1365-2915.2009.00822.x
   Almeida CE, 2008, AM J TROP MED HYG, V78, P791, DOI 10.4269/ajtmh.2008.78.791
   Almeida CE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004447
   Almeida CE, 2000, MEM I OSWALDO CRUZ, V95, P761, DOI 10.1590/S0074-02762000000600003
   BRONFEN E, 1989, MEM I OSWALDO CRUZ, V84, P237, DOI 10.1590/S0074-02761989000200012
   BURKOT TR, 1981, AM J TROP MED HYG, V30, P1336, DOI 10.4269/ajtmh.1981.30.1336
   de la Fuente ALC, 2007, ACTA TROP, V101, P115, DOI 10.1016/j.actatropica.2006.12.007
   Cecere MC, 2004, AM J TROP MED HYG, V71, P803, DOI 10.4269/ajtmh.2004.71.803
   Costa J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-238
   Costa J, 2013, MEM I OSWALDO CRUZ, V108, P785, DOI 10.1590/0074-0276108062013016
   Coura JR, 2013, MEM I OSWALDO CRUZ, V108, P1009, DOI 10.1590/0074-0276130425
   Coutinho CFS, 2012, ACTA TROP, V121, P30, DOI 10.1016/j.actatropica.2011.10.005
   Ramirez JD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002041
   Coutinho CFD, 2014, CAD SAUDE PUBLICA, V30, P785, DOI 10.1590/0102-311X00176512
   Dias JCP, 2000, CAD SAUDE PUBLICA S2, V16, pS13, DOI [10.1590/S0102-311X2000000800003, DOI 10.1590/S0102-311X2000000800003]
   Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092
   Diotaiuti L, 2000, Cad Saude Publica, V16 Suppl 2, P61, DOI 10.1590/S0102-311X2000000800006
   Dumonteil E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22455-x
   Fernandes O, 2001, T ROY SOC TROP MED H, V95, P97, DOI 10.1016/S0035-9203(01)90350-5
   Forattini OP, 2006, REV SAUDE PUBL, V40, P964, DOI 10.1590/s0034-89102006000700004
   Galvao C, 2014, VETORES DOENCA CHAGA, P289
   Gomes Tais F, 2013, World Health Popul, V14, P14
   Guhl F, 2011, ACTA TROP, V119, P1, DOI 10.1016/j.actatropica.2011.04.002
   LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123
   Lilioso M, 2017, AM J TROP MED HYG, V96, P1456, DOI 10.4269/ajtmh.16-0823
   Lima MM, 2015, PARASITOL RES, V114, P1687, DOI 10.1007/s00436-015-4350-1
   Lima MM, 2012, T ROY SOC TROP MED H, V106, P143, DOI 10.1016/j.trstmh.2011.10.013
   Lorenzo M G, 2000, Cad Saude Publica, V16 Suppl 2, P69
   Ferreira IDM, 2006, REV SOC BRAS MED TRO, V39, P507, DOI 10.1590/S0037-86822006000500018
   Oliveira J, 2017, ACTA TROP, V170, P140, DOI 10.1016/j.actatropica.2017.02.020
   OPAS, 2009, GUIA SIG PREV CONTR
   Ostermayer AL, 2011, REV SOC BRAS MED TRO, V44, P108, DOI 10.1590/S0037-86822011000800015
   Sandoval CM, 2004, MEM I OSWALDO CRUZ, V99, P137, DOI 10.1590/S0074-02762004000200004
   Sarquis O, 2006, MEM I OSWALDO CRUZ, V101, P143, DOI 10.1590/S0074-02762006000200005
   Sarquis O, 2012, PARASITOL RES, V110, P1481, DOI 10.1007/s00436-011-2651-6
   Sarquis O, 2010, J VECTOR ECOL, V35, P385, DOI 10.1111/j.1948-7134.2010.00097.x
   Silveira A C, 2000, Cad Saude Publica, V16 Suppl 2, P35, DOI 10.1590/S0102-311X2000000800004
   Silveira AC, 2011, REV SOC BRAS MED TRO, V44, P52, DOI 10.1590/S0037-86822011000800009
   Silveira CA, 2003, GUIA MUESTREO ACTIVI, P46
   Valenca-Barbosa C, 2015, AM J TROP MED HYG, V93, P994, DOI 10.4269/ajtmh.15-0156
   Valenca-Barbosa C, 2014, AM J TROP MED HYG, V90, P1059, DOI 10.4269/ajtmh.13-0204
   Valenca-Barbosa C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002861
   Walter Annie, 2005, Cad. Saúde Pública, V21, P974, DOI 10.1590/S0102-311X2005000300034
   Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021
   Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009
NR 47
TC 0
Z9 0
U1 0
U2 5
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2019
VL 100
IS 2
BP 296
EP 302
DI 10.4269/ajtmh.18-0480
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HN7YU
UT WOS:000460410600015
PM 30734691
OA Bronze, Green Published
DA 2020-12-08
ER

PT J
AU Cruz, HM
   Barbosa, JR
   Colares, JKB
   Neto, AHAD
   Alencar, MDL
   Bastos, FI
   da Mota, JC
   Carvalho-Costa, FA
   Ivantes, CAP
   Lewis-Ximenez, LL
   Villar, LM
AF Cruz, Helena Medina
   Barbosa, Jakeline Ribeiro
   Baima Colares, Jeova Keny
   Almeida de Moraes Neto, Antonio Henrique
   Leal Alencar, Maria de Fatima
   Bastos, Francisco Inacio
   da Mota, Jurema Correa
   Carvalho-Costa, Filipe Anibal
   Pontes Ivantes, Claudia Alexandra
   Lewis-Ximenez, Lia Laura
   Villar, Livia Melo
TI Cross-sectional study to determine viral hepatitis knowledge in
   different urban populations in Brazil
SO WORLD JOURNAL OF HEPATOLOGY
LA English
DT Article
DE Viral hepatitis; Knowledge; Perception; Urban population; Brazil
ID VIRUS-INFECTION; HBV INFECTION; PREVALENCE; ATTITUDES; MARKERS
AB AIM
   To evaluate viral hepatitis knowledge among individuals from different resource areas and health conditions to identify possible gaps.
   METHODS
   A cross-sectional, descriptive study was carried out among 447 individuals from five distinct populations in Brazil: Southeast Viral Hepatitis Ambulatory (n = 100), South (n = 89) and Northeast (n = 114) Health Center, Southeast (n = 77) and Northeast (n = 67) low resource areas. All individuals answered a questionnaire assessing sociodemographic characteristics and viral hepatitis awareness. The perception was scored based on the average number of correct answers of all participants and categorized as "low" (0-28 correct answers) or "desirable" (29-46 correct answers). Associations between sociodemographic characteristics and perception were also evaluated.
   RESULTS
   A low level of knowledge was observed in individuals from Northeast Health Center, Northeast and Southeast low resource areas while desirable knowledge was observed in individuals from Viral Hepatitis Ambulatory and South Health Center. According to sociodemographic characteristics, desirable scores were more common among those with secondary education (47.1%), those who declared themselves as white (46.3%), and those who lived in houses with three individuals (25.5%). Multivariate analysis showed an association between viral hepatitis perception and type of population.
   CONCLUSION
   The results demonstrated high level of knowledge among study participants from health clinics from the Southeast region of Brazil and the importance of education programs in increasing the level of knowledge in low resource areas.
C1 [Cruz, Helena Medina; Barbosa, Jakeline Ribeiro; Lewis-Ximenez, Lia Laura; Villar, Livia Melo] Fiocruz MS, Lab Viral Hepatitis, Oswaldo Cruz Inst, BR-21040360 Rio De Janeiro, Brazil.
   [Barbosa, Jakeline Ribeiro; Baima Colares, Jeova Keny] Univ Fed Ceara, Postgrad Program Pathol, BR-60020181 Fortaleza, Ceara, Brazil.
   [Baima Colares, Jeova Keny] Univ Fortaleza, Postgrad Program Med Sci, BR-60430160 Fortaleza, Ceara, Brazil.
   [Almeida de Moraes Neto, Antonio Henrique; Leal Alencar, Maria de Fatima] Fiocruz MS, Oswaldo Cruz Inst, Lab Innovat Therapies Teaching & Bioprod, BR-21040360 Rio De Janeiro, Brazil.
   [Bastos, Francisco Inacio; da Mota, Jurema Correa] Fundacao Oswaldo Cruz, Inst Commun & Sci Informat & Technol Hlth, BR-21040900 Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fiocruz MS, Oswaldo Cruz Inst, Lab Epidemiol & Mol Systemat, BR-21040900 Rio De Janeiro, Brazil.
   [Pontes Ivantes, Claudia Alexandra] Orientat & Counselling Ctr, BR-80810070 Curitiba, Parana, Brazil.
RP Villar, LM (corresponding author), Oswaldo Cruz Inst, Viral Hepatitis Lab, Helio & Peggy Pereira Pavill,Ground Floor, BR-21036004 Manguinho, RJ, Brazil.
EM lvillar@ioc.fiocruz.br
RI Colares, Jeova Keny Baima/C-5257-2014; Cruz, Helena Medina/U-4780-2019;
   Barbosa, Jakeline/AAC-9805-2020; MELO VILLAR, LIVIA/F-7811-2012
OI Colares, Jeova Keny Baima/0000-0003-1367-6272; Cruz, Helena
   Medina/0000-0003-2088-7705; Barbosa, Jakeline/0000-0001-6238-7173; Mota,
   Jurema/0000-0002-5007-1590; MELO VILLAR, LIVIA/0000-0001-7644-8969
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX The authors would like to acknowledge the financial support of CAPES,
   CNPq and FAPERJ, and the volunteers who agreed to participate in this
   study.
CR Abdela Abdnur, 2016, BMC Res Notes, V9, P410, DOI 10.1186/s13104-016-2216-y
   Ataei B, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.6215
   Brouard C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-576
   Centers for Disease Control and Prevention (CDC), 2012, EPIDEMIOLOGY PREVENT
   Chemaitelly H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069803
   Cruz HM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020189
   Cui WH, 2016, INT J INFECT DIS, V49, P62, DOI 10.1016/j.ijid.2016.05.028
   Debing Y, 2016, J HEPATOL, V65, P200, DOI 10.1016/j.jhep.2016.02.045
   dos Santos DCM, 2002, MEM I OSWALDO CRUZ, V97, P637, DOI 10.1590/S0074-02762002000500007
   Focaccia R, 2013, TRATADO HEPATITES VI
   Ganczak M, 2016, J COMMUN HEALTH, V41, P635, DOI 10.1007/s10900-015-0139-5
   Ghahramani F., 2006, Hepatitis Monthly, V6, P59
   Instituto Brasileiro de Geografia e Etatistica, PORT IBGE
   Joukar F, 2012, WORLD J GASTROENTERO, V18, P2238, DOI 10.3748/wjg.v18.i18.2238
   Komatsu H, 2012, J INFECT DIS, V206, P478, DOI 10.1093/infdis/jis293
   Lyra AC, 2005, BRAZ J MED BIOL RES, V38, P767, DOI 10.1590/S0100-879X2005000500015
   Maniero VC, 2012, J NURS UFPE LINE, V6, P831
   Ogholikhan S, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4010006
   PANG L, 1995, AM J TROP MED HYG, V52, P347, DOI 10.4269/ajtmh.1995.52.347
   Parana R, 1999, HEPATOLOGY, V30, P289, DOI 10.1002/hep.510300143
   Pereira LMMB, 2009, AM J TROP MED HYG, V81, P240
   Polo D, 2015, INT J FOOD MICROBIOL, V193, P43, DOI 10.1016/j.ijfoodmicro.2014.10.007
   Sood A, 2002, Trop Gastroenterol, V23, P198
   Trinta KS, 2001, MEM I OSWALDO CRUZ, V96, P25, DOI 10.1590/S0074-02762001000100004
   ul Haq N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-448
   ul Haq N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-692
   Villar Livia Melo, 2015, World J Virol, V4, P323, DOI 10.5501/wjv.v4.i4.323
   Villar LM, 2014, J MED VIROL, V86, P1515, DOI 10.1002/jmv.23993
   World Health Organization, 2017, HLTH TOP HEP
   Wu E, 2015, HEPATOL INT, V9, P58, DOI 10.1007/s12072-014-9559-z
   Zhang XS, 2016, HUM VACC IMMUNOTHER, V12, P2322, DOI 10.1080/21645515.2015.1134069
NR 31
TC 2
Z9 3
U1 0
U2 0
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 1948-5182
J9 WORLD J HEPATOL
JI World J. Hepatol.
PD NOV 27
PY 2018
VL 10
IS 11
BP 867
EP 876
DI 10.4254/wjh.v10.i11.867
PG 10
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA HD0XO
UT WOS:000452232900010
PM 30533187
OA Green Published, Other Gold
DA 2020-12-08
ER

PT J
AU Villar, LM
   Bezerra, CS
   Portilho, MM
   Mendonca, ACF
   Frota, CC
   Carvalho-Costa, FA
   Da Cruz, JNM
   Lewis-Ximenez, LL
   Lago, BV
   Lampe, E
AF Villar, Livia Melo
   Bezerra, Cristianne Sousa
   Portilho, Moyra Machado
   Fonseca Mendonca, Ana Carolina
   Frota, Cristiane Cunha
   Carvalho-Costa, Filipe Anibal
   Monte Da Cruz, Jose Napoleao
   Lewis-Ximenez, Lia Laura
   Lago, Barbara Vieira
   Lampe, Elisabeth
TI Dried Blood Spot Samples As Alternative to Serum for Hepatitis B Virus
   Molecular Detection.
SO HEPATOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the
   American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver
   Meeting
CY NOV 09-13, 2018
CL San Francisco, CA
SP Amer Assoc Study Liver Dis
C1 [Villar, Livia Melo; Bezerra, Cristianne Sousa; Portilho, Moyra Machado; Fonseca Mendonca, Ana Carolina; Lewis-Ximenez, Lia Laura; Lago, Barbara Vieira; Lampe, Elisabeth] Fiocruz MS, Oswaldo Cruz Inst, Viral Hepatitis Lab, Rio De Janeiro, Brazil.
   [Bezerra, Cristianne Sousa] Inst Fed Ciencia Tecnol Ceara, Fortaleza, Ceara, Brazil.
   [Frota, Cristiane Cunha] Univ Fed Ceara, Fortaleza, Ceara, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fiocruz MS, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, Brazil.
   [Monte Da Cruz, Jose Napoleao] Lab Cent Saude Publ, Brasilia, DF, Brazil.
RI , Cristiane/M-7424-2018
OI , Cristiane/0000-0003-0018-7736
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD OCT
PY 2018
VL 68
SU 1
MA 2105
BP 1200A
EP 1200A
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA GV3TU
UT WOS:000446020503333
DA 2020-12-08
ER

PT J
AU Jaeger, LH
   Pestana, CP
   Carvalho-Costa, FA
   Medeiros, MA
   Lilenbaum, W
AF Jaeger, Lauren Hubert
   Pestana, Cristiane Pinheiro
   Carvalho-Costa, Filipe Anibal
   Medeiros, Marco Alberto
   Lilenbaum, Walter
TI Characterization of the clonal subpopulation Fiocruz L1-130 of
   Leptospira interrogans in rats and dogs from Brazil
SO JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Article
DE serogroup Icterohaemorrhagiae; genotyping; VNTR; MLST; MST
ID TANDEM-REPEAT ANALYSIS; MOLECULAR CHARACTERIZATION; DOMESTIC-ANIMALS;
   SENSU-STRICTO; 1ST ISOLATION; IDENTIFICATION; ARGENTINA; STRAINS;
   SEROVARS; RODENTS
AB Purpose. Leptospira interrogans serogroup Icterohaemorrhagiae strains have been described as causing disease in both humans and animals and as being present worldwide. Icterohaemorrhagiae and Copenhageni serovars are known to cause severe disease in their hosts, and zoonotic outbreaks have been described. The genetic similarity among the strains of these serovars is known. However, it has not yet been demonstrated whether major clonal subpopulation in humans, strain Fiocruz L1-130-like, can circulate among other hosts.
   Methodology. We performed genetic characterization of Brazilian serogroup Icterohaemorrhagiae strains of dog and rat origin by secY sequencing, variable-number tandem-repeat, multilocus sequence type and multi-spacer typing analysis.
   Results. The strains were found to be identical among themselves and to strain Fiocruz L1-130. We suggest that the major strain of L. interrogans serogroup Icterohaemorrhagiae, Fiocruz L1-130, is widely distributed in Brazil in different hosts with substantial zoonotic potential.
   Conclusion. Understanding the circulation of strain Fiocruz L1-130 is important for the implementation of appropriate control measures. Its circulation highlights the need to treat leptospirosis caused by L. interrogans serogroup Icterohaemorrhagiae as a zoonosis that acts in the human-animal-environment interface, as per the One Health approach.
C1 [Jaeger, Lauren Hubert; Lilenbaum, Walter] Univ Fed Fluminense, Dept Microbiol & Parasitol, Lab Vet Bacteriol, Niteroi, RJ, Brazil.
   [Jaeger, Lauren Hubert; Carvalho-Costa, Filipe Anibal] Fiocruz MS, Oswaldo Cruz Inst, Lab Epidemiol & Mol Systemat, BR-21040900 Rio De Janeiro, Brazil.
   [Pestana, Cristiane Pinheiro; Medeiros, Marco Alberto] Fundacao Oswaldo Cruz, Biomanguinhos, Rio De Janeiro, RJ, Brazil.
RP Lilenbaum, W (corresponding author), Univ Fed Fluminense, Dept Microbiol & Parasitol, Lab Vet Bacteriol, Niteroi, RJ, Brazil.
EM wlilenbaum@id.uff.br
FU Fundacao Carlos Chagas de Ampar a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Conselho Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX This work was supported by the Fundacao Carlos Chagas de Ampar a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ, fellows: L. H. J. and
   W.L.) and Conselho Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq, fellows: F. A. C. C., M. A. M. and W. L.).
CR Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28
   Andre-Fontaine G, 2016, REV SCI TECH OIE, V35, P913, DOI 10.20506/rst.35.3.2579
   Ayral F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162549
   Ayral F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139604
   Biscornet L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005831
   Boonsilp S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001954
   Bourhy P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002114
   Caimi K, 2012, MEM I OSWALDO CRUZ, V107, P644, DOI 10.1590/S0074-02762012000500011
   Jung LRC, 2015, BRAZ J MICROBIOL, V46, P465, DOI 10.1590/S1517-838246220120018
   Gozzi AC, 2013, WILDLIFE BIOL, V19, P483, DOI 10.2981/13-051
   Centers for Disease Control and Prevention, 2018, ZOON DIS
   Chappel RJ, 2012, MICROBIOL AUST, V33, P154
   Correa Sandra Helena Ramiro, 2004, Brazilian Journal of Veterinary Research and Animal Science, V41, P189, DOI 10.1590/S1413-95962004000300007
   Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898
   de la Pena-Moctezuma A, 2001, FEMS IMMUNOL MED MIC, V31, P73, DOI 10.1111/j.1574-695X.2001.tb01589.x
   Delaude A, 2017, PREV VET MED, V141, P48, DOI 10.1016/j.prevetmed.2017.04.008
   Fenner JS, 2010, RES VET SCI, V89, P48, DOI 10.1016/j.rvsc.2009.12.014
   Flores BJ, 2017, ACTA TROP, V170, P79, DOI 10.1016/j.actatropica.2017.02.031
   Forster KM, 2013, BRAZ J MICROBIOL, V44, P165, DOI 10.1590/S1517-83822013005000029
   Fouts DE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004403
   Loffler SG, 2014, REV ARGENT MICROBIOL, V46, P201, DOI 10.1016/S0325-7541(14)70073-2
   Guernier V, 2018, PARASITOLOGY, V145, P595, DOI 10.1017/S0031182017001147
   Habus J, 2017, ACTA TROP, V168, P1, DOI 10.1016/j.actatropica.2017.01.002
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Jaeger LH, 2018, LETT APPL MICROBIOL, V67, P183, DOI 10.1111/lam.13008
   Jorge S, 2015, CURR MICROBIOL, V71, P496, DOI 10.1007/s00284-015-0857-z
   Jorge S, 2012, CURR MICROBIOL, V65, P461, DOI 10.1007/s00284-012-0169-5
   Ko AI, 1999, LANCET, V354, P820, DOI 10.1016/S0140-6736(99)80012-9
   Koizumi N, 2015, J MED MICROBIOL, V64, P288, DOI 10.1099/jmm.0.000027
   Kremer FS, 2016, MEM I OSWALDO CRUZ, V111, P280, DOI 10.1590/0074-02760160010
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   La Scola B, 2006, FEMS MICROBIOL LETT, V263, P142, DOI 10.1111/j.1574-6968.2006.00377.x
   LARSON CR, 2017, JMM CASE REPORTS, V0004
   Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001
   Majed Z, 2005, J CLIN MICROBIOL, V43, P539, DOI 10.1128/JCM.43.2.539-545.2005
   Mason MR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004895
   Miraglia F, 2013, DIAGN MICR INFEC DIS, V77, P195, DOI 10.1016/j.diagmicrobio.2013.08.003
   Monte LG, 2013, ACTA TROP, V126, P164, DOI 10.1016/j.actatropica.2013.02.009
   Moreno LZ, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.16
   Mori M, 2017, EUROSURVEILLANCE, V22, P9, DOI 10.2807/1560-7917.ES.2017.22.43.16-00792
   Pereira MM, 2000, J CLIN MICROBIOL, V38, P450
   Picardeau M., 2017, CURRENT TOPICS MICRO
   Puche R, 2018, INT J SYST EVOL MICR, V68, P513, DOI 10.1099/ijsem.0.002528
   Salaun L, 2006, J CLIN MICROBIOL, V44, P3954, DOI 10.1128/JCM.00336-06
   Scialfa E, 2013, J WILDLIFE DIS, V49, P168, DOI 10.7589/2011-07-219
   Szonyi B, 2011, VET J, V188, P237, DOI 10.1016/j.tvjl.2010.05.002
   Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752
   Vieira AS, 2017, RES VET SCI, V115, P496, DOI 10.1016/j.rvsc.2017.08.001
   WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991
   Xu YH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00149
   YASUDA PH, 1987, INT J SYST BACTERIOL, V37, P407, DOI 10.1099/00207713-37-4-407
   Zhang CC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003762
   Zilber AL, 2014, J CLIN MICROBIOL, V52, P564, DOI 10.1128/JCM.02482-13
NR 53
TC 5
Z9 5
U1 0
U2 3
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-2615
EI 1473-5644
J9 J MED MICROBIOL
JI J. Med. Microbiol.
PD SEP
PY 2018
VL 67
IS 9
BP 1361
EP 1367
DI 10.1099/jmm.0.000806
PG 7
WC Microbiology
SC Microbiology
GA GT1AB
UT WOS:000444186500024
PM 30059000
OA Bronze
DA 2020-12-08
ER

PT J
AU Cardoso, DRF
   dos Reis, LMS
   de Sousa, RFV
   do Nascimento, EF
   dos Santos, JP
   Carvalho-Costa, FA
   dos Santos-Mallet, JR
AF Florencio Cardoso, Darwin Renne
   Saboia dos Reis, Leia Madeira
   Viana de Sousa, Ranieri Flavio
   do Nascimento, Elaine Ferreira
   Pereira dos Santos, Jessica
   Carvalho-Costa, Filipe Anibal
   dos Santos-Mallet, Jacenir Reis
TI Chagasic infection among blood donors in Brazil: an integrative review
SO HEMATOLOGY TRANSFUSION AND CELL THERAPY
LA English
DT Review
DE Chagas disease; Trypanosome cruzi; Blood donor; Blood transfusion;
   Brazil
AB Based on the literature, this work aimed to discuss infection by Chagas disease among blood donors in Brazil. Studies on the prevalence of Trypanosoma cruzi infection in donors or candidates for blood donation in Brazil are important. The prevalence of infection appears to be a sensitive indicator and can be a true marker of the risk of the transmission of Chagas disease by blood transfusion. Moreover, it serves as a marker of the level of transmission of the disease in a region, as well as a tool to characterize the epidemiological profile of individuals affected by the disease. The present study is an integrative review of the literature on chagasic infection among blood donors. An evaluation of the literature identified the epidemiological profile of blood donors infected by T. cruzi, which is characterized in general as men, over 30 years old, with a low level of schooling, low income and mainly coming from rural areas. (C) 2018 Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda.
C1 [Florencio Cardoso, Darwin Renne; Saboia dos Reis, Leia Madeira; do Nascimento, Elaine Ferreira; Pereira dos Santos, Jessica; Carvalho-Costa, Filipe Anibal; dos Santos-Mallet, Jacenir Reis] Escritorio Reg Fiocruz, Rua Magalhaes Filho 519, BR-64000128 Teresina, PI, Brazil.
   [Viana de Sousa, Ranieri Flavio] Univ Estadual Piaui UESPI, Teresina, PI, Brazil.
   [do Nascimento, Elaine Ferreira] Fac Ciencias & Tecnol Maranhao FACEMA, Caxias, MA, Brazil.
   [Carvalho-Costa, Filipe Anibal; dos Santos-Mallet, Jacenir Reis] Fiocruz MS, Inst Oswaldo Cruz, IOC, Rio De Janeiro, RJ, Brazil.
RP Cardoso, DRF (corresponding author), Escritorio Reg Fiocruz, Rua Magalhaes Filho 519, BR-64000128 Teresina, PI, Brazil.
EM darwin.cardoso@hotmail.com
OI SANTOS, JESSICA/0000-0002-1639-517X
CR Araujo AB, 2008, BRAZ J INFECT DIS, V12, P480, DOI 10.1590/S1413-86702008000600007
   Bonametti AM, 1998, REV SAUDE PUBL, V32, P566, DOI 10.1590/S0034-89101998000600010
   de Lima LM, 2012, REV SOC BRAS MED TRO, V45, P723, DOI 10.1590/S0037-86822012000600013
   Oliveira-Marques Divina Seila de, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P321, DOI 10.1590/S0036-46652005000600003
   Ferreira Filho Julio César Rente, 2011, Rev. Soc. Bras. Med. Trop., V44, P110, DOI 10.1590/S0037-86822011000100025
   Ferreira-Silva MM, 2010, MEM I OSWALDO CRUZ, V105, P800, DOI 10.1590/S0074-02762010000600012
   Hamerschlak N, 1997, Rev Soc Bras Med Trop, V30, P205, DOI 10.1590/S0037-86821997000300006
   Lopes PD, 2015, REV INST MED TROP SP, V57, P461, DOI 10.1590/S0036-46652015000600001
   Luitgards-Moura José Francisco, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P45, DOI 10.1590/S0036-46652005000100008
   Melo Adriene S., 2009, Rev. Bras. Hematol. Hemoter., V31, P69
   Moraes-Souza H, 2011, REV SOC BRAS MED TRO, V44, P64, DOI 10.1590/S0037-86822011000800010
   Nascimento IC, 2017, SANARE, V16, P90
   Sabino EC, 2013, TRANSFUSION, V53, P1257, DOI 10.1111/j.1537-2995.2012.03902.x
   Sabino EC, 2010, TRANSFUSION, V50, P2628, DOI 10.1111/j.1537-2995.2010.02756.x
   Salles Nanci A., 2003, Rev Panam Salud Publica, V13, P111, DOI 10.1590/S1020-49892003000200011
   Silva Sônia Mara Nunes da, 2016, Rev. Bras. Hematol. Hemoter., V38, P206, DOI 10.1016/j.bjhh.2016.05.005
   Silveira AC, 2011, REV SOC BRAS MED TRO, V44, P122, DOI 10.1590/S0037-86822011000800016
   Slavov SN, 2017, J INFECT DEV COUNTR, V11, P277, DOI 10.3855/jidc.8169
   Sobreira A C, 2001, Rev Soc Bras Med Trop, V34, P193
NR 19
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2531-1379
J9 HEMATOL TRANSF CELL
JI Hematol. Transf. Cell Ther.
PD JUL-SEP
PY 2018
VL 40
IS 3
BP 283
EP 291
DI 10.1016/j.htct.2018.01.010
PG 9
WC Oncology; Hematology
SC Oncology; Hematology
GA VJ3QT
UT WOS:000587465200016
PM 30128440
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Brito-Santos, F
   Trilles, L
   Firacative, C
   Nishikawa, MM
   Junqueira, AV
   de Souza, AC
   Carvalho-Costa, F
   Wanke, B
   Meyer, W
   Lazera, MS
AF Brito-Santos, Fabio
   Trilles, Luciana
   Firacative, Carolina
   Nishikawa, Marilia Martins
   Junqueira, Angela Verissimo
   de Souza, Amanda Coutinho
   Carvalho-Costa, Filipe
   Wanke, Bodo
   Meyer, Wieland
   Lazera, Marcia Santos
TI Multilocus sequence typing of the agents of cryptococcosis in the Rio
   Negro river basin, Brazilian Amazon region
SO MEDICAL MYCOLOGY
LA English
DT Meeting Abstract
C1 [Brito-Santos, Fabio; Trilles, Luciana; Wanke, Bodo; Lazera, Marcia Santos] Fiocruz MS, Evandro Chagas Clin Res Inst, Rio De Janeiro, Brazil.
   [Firacative, Carolina; Meyer, Wieland] Sydney Med Sch Westmead, Ctr Infect Dis & Microbiol, Sydney, NSW, Australia.
   [Nishikawa, Marilia Martins] Fiocruz MS, Natl Inst Qual Control Hlth, INCQS, Rio De Janeiro, Brazil.
   [Junqueira, Angela Verissimo; de Souza, Amanda Coutinho; Carvalho-Costa, Filipe] Fiocruz MS, IOC, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1369-3786
EI 1460-2709
J9 MED MYCOL
JI Med. Mycol.
PD JUN
PY 2018
VL 56
SU 2
MA P072
BP S84
EP S84
PG 1
WC Infectious Diseases; Mycology; Veterinary Sciences
SC Infectious Diseases; Mycology; Veterinary Sciences
GA GI9NU
UT WOS:000434852700471
DA 2020-12-08
ER

PT J
AU Nunes, BC
   Calegar, DA
   Pavan, MG
   Jaeger, LH
   Monteiro, KJL
   dos Reis, ERC
   Lima, MM
   Boia, MN
   Carvalho-Costa, FA
AF Nunes, Beatriz Coronato
   Calegar, Deiviane Aparecida
   Pavan, Marcio Galvao
   Jaeger, Lauren Hubert
   Lima Monteiro, Kerla Joeline
   Chaves dos Reis, Elis Regina
   Lima, Marli Maria
   Boia, Marcio Neves
   Carvalho-Costa, Filipe Anibal
TI Genetic diversity of Giardia duodenalis circulating in three Brazilian
   biomes
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Giardia duodenalis; Triosephosphate isomerase; Glutamate dehydrogenase;
   beta-Giardin; Genotypes; Brazil
ID MOLECULAR CHARACTERIZATION; PROTOZOAN PARASITES; UNITED-STATES;
   CHILDREN; EPIDEMIOLOGY; TRANSMISSION; INFECTIONS; PREVALENCE; OUTBREAKS;
   LAMBLIA
AB Giardia duodenalis has a wide genetic variety, and its characterization helps in the understanding of its transmission dynamics and in the development control strategies. This study aimed to assess the genetic diversity of G. duodenalis obtained in different Brazilian biomes and estimate their phylogenetic relationships. Three surveys including 944 participants were carried out in the municipalities of Russas (RSS, Caatinga semiarid biome), Santa Isabel do Rio Negro (SIRN, Amazon rainforest biome) and Nossa Senhora de Nazare (NSN, Cerrado-Caatinga transition biome). G. duodenalis-positive fecal samples were submitted to amplification of gene fragments encoding beta-giardin (beta G, N=71), glutamate dehydrogenase (GDH, N=42), and triosephosphate isomerase (TPI, N=27). Overall detection rates of assemblage A in G. duodenalis-positive samples through beta G, GDH and TPI were 22/71 (31%), 13/42 (31%), and 13/27 (48.1%), respectively. Concerning assemblage B, rates with distinct genetic markers were 49/71 (69%), 29/42 (69%), and 14/27 (51.9%), respectively. In the Amazon, assemblage B was more prevalent (77.8%, 71.8% and 65% through aG, GDH and TPI, respectively), while in the Cerrado biome assemblage A predominated (50%, 66.6%, and 85.7%, through beta G, GDH and TPI, respectively). In Caatinga biome assemblage A also predominated (71.4%, through beta G). Thirty new sub-assemblages are described for assemblage B (24 beta G and six TPI), as well as three new sub-assemblages are described for assemblage A (one GDH and 2 TPI). Higher genetic diversity of assemblage B in the Amazon may be related to demographic concentration leading to a more complex transmission network within a poorer sanitation background. The high genetic divergence between assemblages A and B (5.5-6.3%) support the proposal of taxon separation in distinct species.
C1 [Nunes, Beatriz Coronato; Calegar, Deiviane Aparecida; Pavan, Marcio Galvao; Jaeger, Lauren Hubert; Lima Monteiro, Kerla Joeline; Chaves dos Reis, Elis Regina; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Av Brasil 4365 Manguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Pavan, Marcio Galvao] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Av Brasil 4365 Manguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Lima, Marli Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Ecoepidemiol Doenca Chagas, Av Brasil 4365 Manguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Boia, Marcio Neves] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, Av Brasil 4365 Manguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Escritorio Reg Fiocruz Piaui, Rua Magalhaes Filho,519 Ctr Norte, BR-64000128 Teresina, PI, Brazil.
RP Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Av Brasil 4365 Manguinhos, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM guaratiba@ioc.fiocruz.br
RI Pavan, Marcio/AAW-5813-2020
OI Pavan, Marcio/0000-0002-5699-242X
FU Oswaldo Cruz Foundation (Fiocruz); Brazilian Federal Agency for Support
   and Evaluation of Graduate Education (CAPES)/Brazilian Ministry of
   Education; Ministry of Social Development
FX This work was supported by the Oswaldo Cruz Foundation (Fiocruz) and the
   Brazilian Federal Agency for Support and Evaluation of Graduate
   Education (CAPES)/Brazilian Ministry of Education and Ministry of Social
   Development, in the context of the CAPES-Fiocruz-Brazil without Poverty
   Plan.
CR Adam EA, 2016, EPIDEMIOL INFECT, V144, P2790, DOI 10.1017/S0950268815003040
   Bóia Márcio Neves, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P189, DOI 10.1590/S0036-46652006000400003
   Brown J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008215
   Caccio SA, 2002, INT J PARASITOL, V32, P1023, DOI 10.1016/S0020-7519(02)00068-1
   Caccio SM, 2008, MOL BIOCHEM PARASIT, V160, P75, DOI 10.1016/j.molbiopara.2008.04.006
   Basso RMC, 2008, REV SOC BRAS MED TRO, V41, P263, DOI 10.1590/S0037-86822008000300008
   Carvalho-Costa Filipe Anibal, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P147, DOI 10.1590/S0036-46652007000300003
   Carvalho-Costa FA, 2007, REV SOC BRAS MED TRO, V40, P346, DOI 10.1590/S0037-86822007000300020
   Cooper MA, 2010, J INFECT DIS, V202, P1713, DOI 10.1086/657142
   Coronato-Nunes B., 2016, PLOS ONE, V11
   Coronato-Nunes B, 2017, J INFECT DEV COUNTR, V11, P563, DOI 10.3855/jidc.8410
   Coutinho Leopoldo Magno, 2006, Acta Bot. Bras., V20, P13, DOI 10.1590/S0102-33062006000100002
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Davies AP, 2009, PEDIATR INFECT DIS J, V28, P838, DOI 10.1097/INF.0b013e31819d646d
   Durigan M, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.424
   Durigan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115489
   Efstratiou A, 2017, WATER RES, V114, P14, DOI 10.1016/j.watres.2017.01.036
   Einarsson E, 2016, CURR OPIN MICROBIOL, V34, P47, DOI 10.1016/j.mib.2016.07.019
   Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10
   Gelanew T, 2007, ACTA TROP, V102, P92, DOI 10.1016/j.actatropica.2007.04.003
   Genser L, 2015, SURG OBES RELAT DIS, V11, P1182, DOI 10.1016/j.soard.2015.06.002
   Golenberg EM, 1996, NUCLEIC ACIDS RES, V24, P5026, DOI 10.1093/nar/24.24.5026
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Heyworth MF, 2016, PARASITE, V23, DOI 10.1051/parasite/2016013
   Hummell BMD, 2016, INT J DISAST RISK SC, V7, P111, DOI 10.1007/s13753-016-0090-9
   Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683
   Kosuwin R, 2010, GENE, V449, P1, DOI 10.1016/j.gene.2009.09.010
   Kumar T, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0095-z
   Messing J, 1993, Methods Mol Biol, V23, P9
   Monis PT, 2009, TRENDS PARASITOL, V25, P93, DOI 10.1016/j.pt.2008.11.006
   Nunes B.C., 2011, THESIS
   Oliveira-Arbex AP, 2016, EPIDEMIOL INFECT, V144, P1418, DOI 10.1017/S0950268815002514
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   Painter JE, 2015, MMWR SURVEILL SUMM, V64, P1
   Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001
   Robertson LJ, 2007, J INFECTION, V55, P79, DOI 10.1016/j.jinf.2007.02.001
   Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001
   Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558
   Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Thompson RCA, 2000, PARASITOL TODAY, V16, P210, DOI 10.1016/S0169-4758(99)01624-5
   Valverde JG, 2011, ANN TROP MED PARASIT, V105, P413, DOI 10.1179/1364859411Y.0000000034
   Wielinga CM, 2007, PARASITOLOGY, V134, P1795, DOI 10.1017/S0031182007003071
NR 43
TC 2
Z9 2
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD APR
PY 2018
VL 59
BP 107
EP 112
DI 10.1016/j.meegid.2018.02.001
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA FZ2PL
UT WOS:000427422100015
PM 29410226
OA Bronze
DA 2020-12-08
ER

PT J
AU Fioretti, JM
   Fumian, TM
   Rocha, MS
   dos Santos, IDL
   Carvalho-Costa, FA
   de Assis, MR
   Rodrigues, JD
   Leite, JPG
   Miagostovich, MP
AF Fioretti, Julia Monassa
   Fumian, Tulio Machado
   Rocha, Monica Simoes
   Lucena dos Santos, Ingrid de Arruda
   Carvalho-Costa, Filipe Anibal
   de Assis, Matheus Ribeiro
   Rodrigues, Janaina de Souza
   Gagliardi Leite, Jose Paulo
   Miagostovich, Marize Pereira
TI Surveillance of Noroviruses in Rio De Janeiro, Brazil: Occurrence of New
   GIV Genotype in Clinical and Wastewater Samples
SO FOOD AND ENVIRONMENTAL VIROLOGY
LA English
DT Article
DE Norovirus; GIV; Clinical samples; Wastewater samples; Brazil
ID GENOGROUP IV; HOSPITALIZED CHILDREN; ACUTE GASTROENTERITIS; GENETIC
   DIVERSITY; PREVALENCE; VIRUSES; SEWAGE; BELEM; NOMENCLATURE; OUTBREAKS
AB Genogroup (G) IV norovirus (NoV) has been described in the literature as infectious agents in humans, although there are few reports regarding the frequency and spread of this virus, resulting in insufficient epidemiological data. The aim of this study was to investigate the occurrence of GIV norovirus in the State of Rio de Janeiro, Brazil in order to evaluate frequency, concentration, and genetic diversity using clinical and environmental approaches. For this purpose, 316 stool samples were collected from acute gastroenteritis cases reported over a period of three years. Wastewater samples were also obtained from the main wastewater treatment plant (WWTP) located in Rio de Janeiro throughout one year, totalizing 156 samples. All samples were submitted to quantitative analysis by TaqMan (TM) real-time PCR for GIV norovirus. Three out of 316 clinical samples were positive (0.9%) for GIV, with viral load ranging from 10(4) to 10(6) genome copies (CG) per gram. Regarding wastewater samples, GIV were detected in 52% of raw sewage, with viral load ranging from 10(4) to 10(6) CG per liter. Phylogenetic analysis revealed the circulation of a new GIV genotype in both clinical and environmental samples. To our knowledge, this is the first description of GIV norovirus in clinical samples in Brazil. These results demonstrate the importance of performing laboratory surveillance of clinical and environmental samples, assisting the comprehension of the epidemiology pattern of viruses with neglected diagnosis and indefinite impact in the population.
C1 [Fioretti, Julia Monassa; Fumian, Tulio Machado; Rocha, Monica Simoes; Lucena dos Santos, Ingrid de Arruda; de Assis, Matheus Ribeiro; Rodrigues, Janaina de Souza; Gagliardi Leite, Jose Paulo; Miagostovich, Marize Pereira] Fundacao Oswaldo Cruz, Lab Comparat & Environm Virol, Inst Oswaldo Cruz, Ave Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Lab Epidemiol & Mol Systemat, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Fioretti, JM (corresponding author), Fundacao Oswaldo Cruz, Lab Comparat & Environm Virol, Inst Oswaldo Cruz, Ave Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.
EM juliafior@ioc.fiocruz.br
RI LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020
FU Fundacao de Amparo a pesquisa do Rio de Janeiro (Faperj)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/102.845/2012]; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq)
FX We kindly thank Peter White, from the School of Biotechnology and
   Biomolecular Sciences, Faculty of Science, University of New South
   Wales, Sydney, Australia for the generous provision of plasmids that
   contained the GIV norovirus genome. The project was financially
   supported by Fundacao de Amparo a pesquisa do Rio de Janeiro (Faperj)
   (E-26/102.845/2012) and Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq). This research study is under the scope of the
   activities of Fiocruz as a Collaborating Center of Pan American Health
   Organization (PAHO) and World Health Organization (WHO) of Public and
   Environmental Health.
CR Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4
   Aragao GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056608
   Calgua B, 2013, J VIROL METHODS, V187, P215, DOI 10.1016/j.jviromet.2012.10.012
   Di Martino B, 2014, EMERG INFECT DIS, V20, P1828, DOI 10.3201/eid2011.131601
   Fioretti JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092988
   Fioretti JM, 2011, MEM I OSWALDO CRUZ, V106, P942, DOI 10.1590/S0074-02762011000800008
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Hardy ME, 2005, FEMS MICROBIOL LETT, V253, P1, DOI 10.1016/j.femsle.2005.08.031
   Kitajima M, 2009, LETT APPL MICROBIOL, V49, P655, DOI 10.1111/j.1472-765X.2009.02718.x
   Kitajima M, 2016, ARCH VIROL, V161, P3521, DOI 10.1007/s00705-016-3036-z
   Kitajima M, 2014, SCI TOTAL ENVIRON, V488, P290, DOI 10.1016/j.scitotenv.2014.04.087
   Kitajima M, 2010, ENVIRON SCI TECHNOL, V44, P7116, DOI 10.1021/es100346a
   Kroneman A, 2008, J CLIN MICROBIOL, V46, P2959, DOI 10.1128/JCM.00499-08
   Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   La Rosa G, 2008, ARCH VIROL, V153, P2077, DOI 10.1007/s00705-008-0241-4
   La Rosa G, 2010, ARCH VIROL, V155, P589, DOI 10.1007/s00705-010-0619-y
   Siqueira JAM, 2013, J MED VIROL, V85, P737, DOI 10.1002/jmv.23506
   Siqueira JAM, 2011, DIAGN MICR INFEC DIS, V71, P391, DOI 10.1016/j.diagmicrobio.2011.08.023
   Muscillo M, 2013, FOOD ENVIRON VIROL, V5, P194, DOI 10.1007/s12560-013-9121-5
   Portal TM, 2016, BRAZ J MICROBIOL, V47, P724, DOI 10.1016/j.bjm.2016.04.008
   Rahman M, 2016, J MED VIROL, V88, P1742, DOI 10.1002/jmv.24530
   de Andrade JDR, 2014, J CLIN VIROL, V61, P345, DOI 10.1016/j.jcv.2014.08.024
   Ferreira MSR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033754
   Teixeira DM, 2016, FOOD ENVIRON VIROL, V8, P101, DOI 10.1007/s12560-015-9220-6
   Trujillo AA, 2006, J CLIN MICROBIOL, V44, P1405, DOI 10.1128/JCM.44.4.1405-1412.2006
   Vicentini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069348
   Victoria M, 2007, PEDIATR INFECT DIS J, V26, P602, DOI 10.1097/INF.0b013e3180618bea
   Victoria M, 2010, J WATER HEALTH, V8, P158, DOI 10.2166/wh.2009.012
   Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14
   Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015
NR 31
TC 5
Z9 5
U1 1
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1867-0334
EI 1867-0342
J9 FOOD ENVIRON VIROL
JI Food Environ. Virol.
PD MAR
PY 2018
VL 10
IS 1
BP 1
EP 6
DI 10.1007/s12560-017-9308-2
PG 6
WC Environmental Sciences; Microbiology; Virology
SC Environmental Sciences & Ecology; Microbiology; Virology
GA FX3NW
UT WOS:000425979700001
PM 28639212
DA 2020-12-08
ER

PT J
AU Monteiro, KJL
   dos Reis, ERC
   Nunes, BC
   Jaeger, LH
   Calegar, DA
   dos Santos, JP
   Maia, AD
   Xavier, SCD
   Boia, MN
   Carvalho-Costa, FA
AF Lima Monteiro, Kerla Joeline
   Chaves dos Reis, Elis Regina
   Nunes, Beatriz Coronato
   Jaeger, Lauren Hubert
   Calegar, Deiviane Aparecida
   dos Santos, Jessica Pereira
   Maia, Alexander de Oliveira
   das Chagas Xavier, Samanta Cristina
   Boia, Marcio Neves
   Carvalho-Costa, Filipe Anibal
TI Focal persistence of soil-transmitted helminthiases in impoverished
   areas in the State of Piaui, Northeastern Brazil
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Soil-transmitted helminthiases; Hookworm; Prevalence; Epidemiology;
   Northeast Brazil
ID SYSTEMATIC ANALYSIS; INFECTIONS; BURDEN; RISK; DISEASES; CHILDREN
AB This study aims to describe the prevalence, distribution, and factors associated with soil-transmitted helminthiases (STHs) in rural localities in Piaui, Brazil. Two cross-sectional surveys (n=605 subjects; 172 families) were carried out in order to obtain socio-demographic, anthropometric, spatial and parasitological data. Parasites were evaluated using Kato-Katz and centrifugal sedimentation techniques. Eggs were measured to assess infection with zoonotic Strongylida parasites. Kernel maps were constructed with Q-GIS. The prevalence of hookworm infection was 12.4% (75/605). Other helminthes found were Trichuris trichiura (n=1; 0.2%) and Hymenolepis nana (n=1; 0.2%). The hookworm positivity rate was significantly lower among subjects who had used albendazole when compared with individuals who had not used anthelmintics or had used antiprotozoal drugs in the last 6 months (8/134 [6.0%] vs. 59/415 [14.2%]; p=0.009). A total of 39/172 (22.7%) families had at least one infected member. The association between the number of dwellers and hookworm positivity in the family was present in a logistic regression multivariate model. Assessment of worm burdens showed 92.2% light, 6.2% moderate, and 1.6% heavy infections. Hookworm eggs (n=34) measured 57.2 - 75.4 mu m in length and 36.4 - 44.2 mu m in width (mean +/- SD = 65.86 +/- 4.66 mu m L and 40.05 +/- 1.99 mu m W), commensurate with human hookworms. Hotspots suggest that transmission has a focal pattern. STHs persist in impoverished rural areas in Northeastern Brazil where currently available control strategies (mass drug administration) apparently do not allow the elimination of the infection.
C1 [Lima Monteiro, Kerla Joeline; Chaves dos Reis, Elis Regina; Nunes, Beatriz Coronato; Jaeger, Lauren Hubert; Calegar, Deiviane Aparecida; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Pavilhao Leonidas Deane,Sala 308,Ave Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [dos Santos, Jessica Pereira; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Escritorio Tecn Reg, Teresina, Piaui, Brazil.
   [Maia, Alexander de Oliveira; Boia, Marcio Neves] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, Rio De Janeiro, RJ, Brazil.
   [das Chagas Xavier, Samanta Cristina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Tripanosomatideos, Rio De Janeiro, RJ, Brazil.
RP Monteiro, KJL (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Pavilhao Leonidas Deane,Sala 308,Ave Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM kerla@ioc.fiocruz.br
OI Xavier, Samanta Cristina/0000-0002-3475-0075; SANTOS,
   JESSICA/0000-0002-1639-517X
CR Albonico M, 2003, B WORLD HEALTH ORGAN, V81, P343
   Alves Jair Rodrigues, 2003, Cad. Saúde Pública, V19, P667, DOI 10.1590/S0102-311X2003000200034
   Anderson R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0435
   Anderson RM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003897
   Anuar TS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04101
   Bartsch SM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004922
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia em Doencas Transmissiveis, 2012, PLAN INT AC ESTR EL
   Brooker SJ, 2015, LANCET INFECT DIS, V15, P941, DOI 10.1016/S1473-3099(15)70042-3
   Brumpt E., 1949, PRECIS PARASITOLOGIE
   Chammartin F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-440
   Confalonieri UEC, 2014, ACTA TROP, V129, P33, DOI 10.1016/j.actatropica.2013.09.013
   de Gier B, 2016, AM J TROP MED HYG, V95, P77, DOI 10.4269/ajtmh.15-0533
   Echazu A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004111
   FLEURY G C, 1970, Revista do Instituto de Medicina Tropical de Sao Paulo, V12, P288
   GOLDSMID JM, 1968, T ROY SOC TROP MED H, V62, P109, DOI 10.1016/0035-9203(68)90038-2
   Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325
   Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397
   Loukas A, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.88
   Magalhaes RJS, 2011, P NATL ACAD SCI USA, V108, P20084, DOI 10.1073/pnas.1106784108
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4
   Pan American Health Organization. World Health Organization, 2015, OP GUID IMPL INT DEW
   Prichard RK, 2007, PARASITOLOGY, V134, P1087, DOI 10.1017/S003118200700008X
   Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37
   Schmidlin T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065722
   Scholte RGC, 2013, GEOSPATIAL HEALTH, V8, P97, DOI 10.4081/gh.2013.58
   Souza RP, 2013, BIOMEDICA, V33, P439, DOI 10.7705/biomedica.v33i3.770
   Turner HC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1187-5
   Vercruysse J, 2011, INT J PARASITOL-DRUG, V1, P14, DOI 10.1016/j.ijpddr.2011.09.002
   Wall EC, 2011, J TRAVEL MED, V18, P59, DOI 10.1111/j.1708-8305.2010.00474.x
   WATERLOW JC, 1977, B WORLD HEALTH ORGAN, V55, P489
   Webster JP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0434
   WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1
   WHO, 2006, PREV CHEM HUM HELM C
   WHO, 1978, GROWTH CHART INT US
   World Health Organization, 2012, SOIL TRANSM HELM EL
   Worrell CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150744
   YOUNG KH, 1979, J CLIN MICROBIOL, V10, P852, DOI 10.1128/JCM.10.6.852-853.1979
NR 37
TC 5
Z9 5
U1 0
U2 0
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2018
VL 60
AR e24
DI 10.1590/S1678-9946201860024
PG 10
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GL8GU
UT WOS:000437456200001
PM 29972463
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Silva, LA
   Coronato, B
   Schlackman, J
   Marsh, JW
   Ezeonwuka, C
   Fernandes, ACL
   Souza, VC
   da Silva, LS
   de Amorim, EFQ
   Naveca, FG
   de Albuquerque, BC
   Amaral, A
   Souza, ALS
   Carvalho-Costa, FA
   Mustapha, MM
   Harrison, LH
   Barroso, DE
AF Silva, Luciete A.
   Coronato, Beatriz
   Schlackman, Jessica
   Marsh, Jane W.
   Ezeonwuka, Chinelo
   Fernandes, Andreia C. L.
   Souza, Victor C.
   da Silva, Lirna S.
   de Amorim, Elaine F. Q.
   Naveca, Felipe G.
   de Albuquerque, Bernardino C.
   Amaral, Alcirene
   Souza, Ana L. S.
   Carvalho-Costa, Filipe A.
   Mustapha, Mustapha M.
   Harrison, Lee H.
   Barroso, David E.
TI Neisseria meningitidis disease-associated clones in Amazonas State,
   Brazil
SO INFECTIOUS DISEASES
LA English
DT Article
DE Neisseria meningitidis; Meningococcal disease; Serogroup C conjugate
   vaccine; MLST clones; Amazonas
ID RIO-DE-JANEIRO; MENINGOCOCCAL DISEASE; STRAINS; SEROGROUP;
   SUSCEPTIBILITY; EPIDEMIC; VACCINE
AB Background: The aim of this study is to describe the molecular epidemiology of Neisseria meningitidis invasive disease before the introduction of serogroup C conjugate vaccine in Amazonas State in 2010.
   Methods: Meningococcal disease reported cases were investigated in Amazonas State during the period 2000-2010. N. meningitidis isolates (n = 196) recovered from patients were genotyped by multilocus sequence typing (MLST) and sequencing of porB, porA, fetA, fHbp and penA. Antimicrobial susceptibility was determined using E-test.
   Results: In the study period, 948 cases were reported; the incidence was 2.8 for the entire state and 4.8 per 100,000 in the capital of Manaus. Most meningococcal disease was caused by N. meningitidis belonging to ST-32 (72%; 141/196) or ST-103 (21%; 41/196) clonal complexes. Capsular switching (B -> C) was suggested within clonal complex (cc) 32. There were 6 (3%; 6/196) strains with intermediate susceptibility to penicillin and a single strain was resistant to rifampicin. Since 2007, serogroup C strains belonging to the cc103 have predominated and case-fatality has increased.
   Conclusion: We demonstrate a high rate of meningococcal disease in Amazonas State, where, like other parts of Brazil, serogroup C replaced serogroup B during 2000s. These data serve as a baseline to measure impact of serogroup C conjugate vaccine introduction in 2010. This study emphasizes the need for enhanced surveillance to monitor changes in meningococcal disease trends following the introduction of meningococcal vaccines.
C1 [Silva, Luciete A.; Fernandes, Andreia C. L.; Souza, Victor C.; da Silva, Lirna S.; de Amorim, Elaine F. Q.; Naveca, Felipe G.] Fiocruz MS, Leonidas & Maria Deane Inst, Lab Microbial Divers Importance Hlth, Manaus, Amazonas, Brazil.
   [Silva, Luciete A.; Fernandes, Andreia C. L.; Souza, Victor C.; da Silva, Lirna S.; de Amorim, Elaine F. Q.; Naveca, Felipe G.] Fiocruz MS, Leonidas & Maria Deane Inst, Lab Communicable Dis Ecol, Manaus, Amazonas, Brazil.
   [Coronato, Beatriz; Ezeonwuka, Chinelo; Carvalho-Costa, Filipe A.; Barroso, David E.] Fiocruz MS, Oswaldo Cruz Inst, Lab Epidemiol & Mol Systemat, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Schlackman, Jessica; Marsh, Jane W.; Mustapha, Mustapha M.; Harrison, Lee H.] Univ Pittsburgh, Sch Med, Infect Dis Epidemiol Res Unit, Pittsburgh, PA USA.
   [Schlackman, Jessica; Marsh, Jane W.; Mustapha, Mustapha M.; Harrison, Lee H.] Grad Sch Publ Hlth, Pittsburgh, PA USA.
   [de Albuquerque, Bernardino C.; Amaral, Alcirene; Souza, Ana L. S.] Fdn Hlth Surveillance Amazonas, Dept Epidemiol Surveillance, Manaus, Amazonas, Brazil.
   [de Albuquerque, Bernardino C.; Amaral, Alcirene; Souza, Ana L. S.] Fdn Hlth Surveillance Amazonas, Cent Lab, Manaus, Amazonas, Brazil.
   [Carvalho-Costa, Filipe A.] Fiocruz MS, Reg Tech Off, Teresina, Brazil.
RP Barroso, DE (corresponding author), Fiocruz MS, Oswaldo Cruz Inst, Lab Epidemiol & Mol Systemat, Av Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM barroso@ioc.fiocruz.br
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060; Souza, Victor Costa
   de/0000-0002-3869-1519
FU Fogarty International Center Global Infectious Diseases Research
   Training Program grant; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [D43TW006592]; Fundacao de Amparoa Pesquisa do Estado do Amazonas
   - FAPEAM [Foundation for Research Support of the State of Amazonas]
   [021/2011]; FOGARTY INTERNATIONAL CENTERUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Fogarty International Center (FIC) [D43TW006592, D43TW006592,
   D43TW006592, D43TW006592, D43TW006592, D43TW006592, D43TW006592,
   D43TW006592, D43TW006592, D43TW006592] Funding Source: NIH RePORTER
FX This work was supported in part by a Fogarty International Center Global
   Infectious Diseases Research Training Program grant, National Institutes
   of Health, to the University of Pittsburgh [D43TW006592], and by the
   Fundacao de Amparoa Pesquisa do Estado do Amazonas - FAPEAM [Foundation
   for Research Support of the State of Amazonas], to the Leonidas & Maria
   Deane Institute (021/2011).
CR Alcala B, 2002, EMERG INFECT DIS, V8, P1512, DOI 10.3201/eid0812.020081
   Almeida G., 1921, REV MED CIRURG BRASI, V29, P449
   [Anonymous], 2010, M100S20 CLSI
   Barroso DE, 2007, BRAZ J INFECT DIS, V11, P598, DOI 10.1590/S1413-86702007000600014
   Barroso DE, 2013, EMERG INFECT DIS, V19, P1847, DOI [10.3201/eid1911.130610, 10.3201/13-0610]
   Barroso DE, 2010, BRAZ J INFECT DIS, V14, P242, DOI 10.1590/S1413-86702010000300008
   Castineiras TMPP, 2012, EMERG INFECT DIS, V18, P1336, DOI 10.3201/eid1808.111344
   de Filippis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033016
   Harrison LH, 2010, J INFECT DIS, V201, P1208, DOI 10.1086/651505
   Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799
   Lucidarme J, 2011, CLIN VACCINE IMMUNOL, V18, P194, DOI 10.1128/CVI.00401-10
   Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140
   Ministry of Health of Brazil, 2015, MEN DIS SER
   Mustapha MM, 2016, GENOME BIOL EVOL, V8, P2065, DOI 10.1093/gbe/evw122
   NORONHA CP, 1995, INT J EPIDEMIOL, V24, P1050, DOI 10.1093/ije/24.5.1050
   Pajon R, 2010, VACCINE, V28, P2122, DOI 10.1016/j.vaccine.2009.12.027
   Pavan MG, 2016, ABSTRACTS OF 20TH IN, P214
   Pedro LGF, 2007, SCAND J INFECT DIS, V39, P28, DOI 10.1080/00365540600904761
   SACCHI CT, 1992, J CLIN MICROBIOL, V30, P1734, DOI 10.1128/JCM.30.7.1734-1738.1992
   Safadi MAP, 2013, EPIDEMIOL INFECT, V141, P447, DOI 10.1017/S0950268812001689
   Santos Magda Levantezi, 2005, Cad. Saúde Pública, V21, P823, DOI 10.1590/S0102-311X2005000300016
   Stefanelli P, 2003, J CLIN MICROBIOL, V41, P5783, DOI 10.1128/JCM.41.12.5783-5786.2003
   Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271
   Taha MK, 2007, ANTIMICROB AGENTS CH, V51, P2784, DOI 10.1128/AAC.00412-07
   Taha MK, 2010, ANTIMICROB AGENTS CH, V54, P3651, DOI 10.1128/AAC.00315-10
   Tsang Raymond Sw, 2005, Can J Infect Dis Med Microbiol, V16, P171
   Wang QA, 2010, INFECT IMMUN, V78, P3883, DOI 10.1128/IAI.00363-10
   Zhu BQ, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.01019-16
NR 28
TC 3
Z9 3
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2374-4235
EI 2374-4243
J9 INFECT DIS-NOR
JI Infect. Dis.
PY 2018
VL 50
IS 9
BP 697
EP 704
DI 10.1080/23744235.2018.1459829
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA GS7JH
UT WOS:000443876300007
PM 29623748
OA Green Accepted
DA 2020-12-08
ER

PT J
AU Dias, AP
   Calegar, D
   Carvalho-Costa, FA
   Alencar, MDL
   Ignacio, CF
   da Silva, MEC
   Neto, AHAD
AF Dias, Alexandre Pessoa
   Calegar, Deiviane
   Carvalho-Costa, Filipe Anibal
   Leal Alencar, Maria de Fatima
   Ignacio, Caroline Ferraz
   Chagas da Silva, Milena Enderson
   Almeida de Moraes Neto, Antonio Henrique
TI Assessing the Influence of Water Management and Rainfall Seasonality on
   Water Quality and Intestinal Parasitism in Rural Northeastern Brazil
SO JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
ID PREVALENCE; RAINWATER; HEALTH
AB Introduction. The drought in the Brazilian semiarid region has affected the quality of water. This study assessed the relationships between enteric parasitoses, water management, and water quality, correlating them with pluviometric seasonality. Methods. Cross-sectional surveys were carried out in four rural communities at the beginning of the dry season (n=151), at the end of the dry season (n=184), and in the rainy season (n=199), in order to collect sociodemographic data, human fecal samples, and samples of the water used for human consumption for physicochemical and microbiological analyses. In 2015, water filters were provided to 30 households under study. Results. There was an increasing trend in detection rates of commensal protozoa and the Entamoeba histolytica/Entamoeba dispar complex at the beginning of the rainy season, with detection rates of 6% in 2014 and 21.6% in 2016. Giardia intestinalis and Ascaris lumbricoides presented distinct temporal distributions, which peaked in 2015: 20.1% and 30%, respectively. The proportion of inhabitants drinking inadequate water was 55% at the beginning of the dry season and 28.8% at the end of the dry season, reaching 70.9% at the beginning of the rainy season. The presence of filters reduced this proportion among those who received the hollow ceramic candle filter. Conclusions. Data suggest that the strategies to increase water supply in the Brazilian semiarid region can be ameliorated in order to improve the quality of drinking water.
C1 [Dias, Alexandre Pessoa; Leal Alencar, Maria de Fatima; Ignacio, Caroline Ferraz; Chagas da Silva, Milena Enderson; Almeida de Moraes Neto, Antonio Henrique] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, LITEB, Rio De Janeiro, Brazil.
   [Dias, Alexandre Pessoa] Fundacao Oswaldo Cruz, Escola Politecn Saude Joaquim Venancio, Lab Educ Profiss Vigilancia Saude LAVSA, Rio De Janeiro, Brazil.
   [Calegar, Deiviane; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, LESM, Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe Anibal] Escritorio Tecn Reg Fiocruz Piaui, Rio De Janeiro, Brazil.
RP Dias, AP (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, LITEB, Rio De Janeiro, Brazil.; Dias, AP (corresponding author), Fundacao Oswaldo Cruz, Escola Politecn Saude Joaquim Venancio, Lab Educ Profiss Vigilancia Saude LAVSA, Rio De Janeiro, Brazil.
EM apessoadias@gmail.com
OI CALEGAR, DEIVIANE APARECIDA/0000-0002-9311-2401
CR Alpino TA, 2016, CIENC SAUDE COLETIVA, V21, P809, DOI 10.1590/1413-81232015213.21392015
   Alves F, 2014, J WATER HEALTH, V12, P513, DOI 10.2166/wh.2014.139
   APHA, 2012, STAND METH EX WAT WA
   Associacao Brasileira de Normas Tecnicas, 2012, 16098 NBR ABNT
   Brasil. Ministerio da Integracao Nacional, 2005, GRUP TRAB INT RED SE
   Brasil. Ministerio da Saude, 2012, TRAC COM CAUS CEG CO
   Brasil. Ministerio do Desenvolvimento Social e Combatea Fome, 2011, NOT MDS PERF EXTR PO
   Brasil. Ministerio doDesenvolvimento Social eAgr ario, 2016, DADOS
   Brasil. Secretaria de Vigil ancia em Sude, 2012, B EPIDEMIOLOGICO SEC, V2014, P1
   Brito L. T. L., 2007, CISTERNAS DOMICILIAR
   Calegar DA, 2016, MEM I OSWALDO CRUZ, V111, P114, DOI 10.1590/0074-02760150383
   Clasen TF, 2004, AM J TROP MED HYG, V70, P651, DOI 10.4269/ajtmh.2004.70.651
   Coelho C. F., 2012, 50 C SOC BRAS EC ADM
   Dobrowsky PH, 2014, APPL ENVIRON MICROB, V80, P1633, DOI 10.1128/AEM.03061-13
   Fonseca JE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002943
   IBGE, 2011, CAR POP DOM RES UN
   IBGE-Instituto Brasileiro de Geografia e Estatistica, 2014, PESQ NAC AM DOM PNAD
   Ignatius R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001677
   Instituto de Pesquisa e Estrat egia Economica do Cear a (Ipece), 2014, PERF BAS MUN MAD
   Instituto Nacional de Colonizac aoe Reforma Agraria (Incra), 1997, COOP CENTR AR REF AG
   Lutz A., 1919, SCHISTOSOMUM MANSONI, V11
   Malvezzi R., 2007, SEMIARIDO
   Marcynuk PB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-65
   Mwabi JK, 2013, WATER SA, V39, P445, DOI 10.4314/wsa.v39i4.2
   Nunes BC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158805
   Rey L., 2011, PARASITOLOGIA
   Sobsey M.D., 2002, MANAGING WATER HOME
   Turkeltaub JA, 2015, CURR OPIN GASTROEN, V31, P38, DOI 10.1097/MOG.0000000000000135
   World Health Organization, 2012, TOOLK MON EV HOUS WA
   Xavier RP, 2011, REV INST MED TROP SP, V53, P121, DOI 10.1590/S0036-46652011000300001
NR 30
TC 3
Z9 3
U1 0
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-9686
EI 1687-9694
J9 J TROP MED-US
JI J. Trop. Med.
PY 2018
VL 2018
AR 8159354
DI 10.1155/2018/8159354
PG 10
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GP0KV
UT WOS:000440499300001
PM 30105057
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Pires, BC
   Grapiglia, JB
   Moreira, L
   Jaeger, LH
   Carvalho-Costa, FA
   Lilenbaum, W
AF Pires, Bruno Cabral
   Grapiglia, Junia Berzin
   Moreira, Lio
   Jaeger, Lauren Hubert
   Carvalho-Costa, Filipe Anibal
   Lilenbaum, Walter
TI Occurrence of uterine carriers for Leptospira interrogans on slaughtered
   cows
SO MICROBIAL PATHOGENESIS
LA English
DT Article
DE Leptospirosis; Genital tract; Uterus; Sec Y; Sequencing
ID BOVINE LEPTOSPIROSIS; TISSUES; TRACTS; SPP.; PCR
AB Reproductive tract is an important site of infection for chronic leptospirosis and cooperate in pathogenesis of reproductive failure, leading to economic losses. Since serology techniques cannot detect chronic carriers, the molecular analysis of clinical samples is an alternative to detect these animals on livestock. The aim of the present study was to perform a retrospective study in order to detect leptospiral uterine carriers in slaughtered cows. Tissue samples were collected from 50 post-pubertal, nonpregnant cows. These samples were fixed in 10% buffered formalin, paraffin-embedded and stored. PCR targeting lipL32 gene and molecular characterization by secY sequence was performed. Leptospiral DNA was identified in 18% (9/50) examined blocks. Two sequences were characterized as L. interrogans. These findings suggest that the presence of infectious leptospires in uterus is associated with the physiopathogenesis of the reproductive failure.
C1 [Pires, Bruno Cabral; Grapiglia, Junia Berzin; Jaeger, Lauren Hubert; Lilenbaum, Walter] Univ Fed Fluminense, Lab Vet Bacteriol, Dept Microbiol & Parasitol, Prof Hernani Melo St 101, BR-24210130 Niteroi, RI, Brazil.
   [Moreira, Lio] Univ Fed Estado Rio de Janeiro, Dept Microbiol & Parasitol, Lab Pathol, Frei Caneca 94, BR-20211010 Rio De Janeiro, RJ, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Lab Epidemiol & Mol Sistemat, Ave Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
RP Lilenbaum, W (corresponding author), Univ Fed Fluminense, Lab Vet Bacteriol, Dept Microbiol & Parasitol, Prof Hernani Melo St 101, BR-24210130 Niteroi, RI, Brazil.
EM wlilenbaum@id.uff.br
CR Adler B., 2015, HIST LEPTOSPIROSIS L
   Ahmed N., 2006, ANN CLIN MICROB ANTI, V23, P5
   Arent Z, 2013, VET REC, V173, DOI 10.1136/vr.101969
   Azizi S, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i1.821
   D'Andrea A, 2012, MEM I OSWALDO CRUZ, V107, P85, DOI 10.1590/S0074-02762012000100012
   Director A, 2014, J MED MICROBIOL, V63, P1234, DOI 10.1099/jmm.0.065466-0
   ELLIS WA, 1982, VET REC, V110, P147, DOI 10.1136/vr.110.7.147
   ELLIS WA, 1986, AM J VET RES, V47, P1694
   ELLIS WA, 1986, VET REC, V118, P11, DOI 10.1136/vr.118.1.11
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Hamond C, 2014, VET RES COMMUN, V38, P81, DOI 10.1007/s11259-013-9582-x
   Hamond C, 2015, VET MICROBIOL, V179, P264, DOI 10.1016/j.vetmic.2015.06.014
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]
   Lilenbaum W, 2008, THERIOGENOLOGY, V69, P837, DOI 10.1016/j.theriogenology.2007.10.027
   Lilenbaum W, 2014, TRANSBOUND EMERG DIS, V61, P63, DOI 10.1111/tbed.12233
   Loureiro AP, 2017, ANIM REPROD SCI, V178, P54, DOI 10.1016/j.anireprosci.2017.01.008
   Manu V, 2009, INDIAN J MED RES, V129, P105
   Martins G, 2017, RES VET SCI, V112, P156, DOI 10.1016/j.rvsc.2017.03.021
   Moreira L, 2007, ARQ BRAS MED VET ZOO, V59, P1097, DOI 10.1590/S0102-09352007000500002
   Subharat S, 2010, NEW ZEAL VET J, V58, P281, DOI 10.1080/00480169.2010.69755
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Wang W, 2014, MICROB PATHOGENESIS, V75, P1, DOI 10.1016/j.micpath.2014.07.011
NR 22
TC 9
Z9 9
U1 0
U2 1
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0882-4010
J9 MICROB PATHOGENESIS
JI Microb. Pathog.
PD JAN
PY 2018
VL 114
BP 163
EP 165
DI 10.1016/j.micpath.2017.11.056
PG 3
WC Immunology; Microbiology
SC Immunology; Microbiology
GA FX6VZ
UT WOS:000426226700025
PM 29197523
DA 2020-12-08
ER

PT J
AU Jaeger, LH
   Carvalho-Costa, FA
AF Jaeger, Lauren Hubert
   Carvalho-Costa, Filipe Anibal
TI Status of benzimidazole resistance in intestinal nematode populations of
   livestock in Brazil: a systematic review
SO BMC VETERINARY RESEARCH
LA English
DT Review
DE Benzimidazole; Anthelmintic resistance; Nematodes; Livestock; Brazil
ID BETA-TUBULIN GENE; SAO-PAULO STATE; ANTHELMINTIC RESISTANCE;
   HAEMONCHUS-CONTORTUS; GASTROINTESTINAL NEMATODES; SOUTHERN BRAZIL;
   VETERINARY IMPORTANCE; MANAGEMENT-PRACTICES; SHEEP FLOCK; GOAT HERDS
AB Background: Benzimidazoles (BZ) are a class of drugs widely used in veterinary and human medicine, creating a great selection pressure and the emergence of BZ resistance. We conducted a systematic review to assess the status of resistance and/or effectiveness reduction of BZ drugs in animal nematodes in Brazil, and make information accessible to the scientific community, as many studies are published in Portuguese. PubMed, SciELO Brasil, LILACS/Bireme, GNTD database, and Google Scholar were searched with no language restrictions.
   Results: A total of 40 studies met our eligibility criteria (from the year 1989 forward). Sheep was the host most frequently analysed, and albendazole was the most frequently drug studied. The majority of studies (75.7%) showed that BZ drugs are insufficiently active (FECRT <80%) against nematode parasites of livestock. The mean FECRT for fenbendazole, thiabendazole, albendazole, mebendazole, oxfendazole, and ricobendazole were 71.8%, 71.8%, 58.6%, 53.9%, 46.9%, and 41.5%, respectively. It was observed through linear regression that FECRT is significantly reduced over time between 2007 and 2014 (R = -0.653 p = 0.021) for the treatment of cattle with BZ, suggesting progressive loss of effectiveness and increased resistance for these hosts.
   Conclusions: The scenario of BZ resistance in nematode populations in Brazil is not favourable. Given the high cost of drug discovery and development, it is urgent to implement control measures and to monitor the effectiveness/resistance to nematodes in livestock in Brazil.
C1 [Jaeger, Lauren Hubert; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Pavilhao Leonidas Deane,Sala 308,Ave Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Rua Magalhaes Filho 519, BR-64000128 Teresina, Piaui, Brazil.
RP Jaeger, LH (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Pavilhao Leonidas Deane,Sala 308,Ave Brasil 4365, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM laurenhj@hotmail.com
FU CNPq, BrazilNational Council for Scientific and Technological
   Development (CNPq)
FX FACC has a productivity research grant of CNPq, Brazil.
CR Ahid S. M. M., 2007, Acta Veterinaria Brasilica, V1, P56, DOI 10.21708/avb.2007.1.2.281
   Amarante A. F. T., 1992, Brazilian Journal of Veterinary Research and Animal Science, V29, P31
   Araujo N. K. S., 2008, Acta Veterinaria Brasilica, V2, P47
   Barda BD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002344
   Bennett A, 2000, PARASITOL TODAY, V16, P71, DOI 10.1016/S0169-4758(99)01544-6
   Borges FA, 2010, PARANA CI ANIM BRAS, V11, P618
   Borges SL, 2015, PESQUI VET BRASIL, V35, P643, DOI 10.1590/S0100-736X2015000700007
   Brasil BSAF, 2012, INT J PARASITOL, V42, P469, DOI 10.1016/j.ijpara.2012.03.003
   Bruhn FRP, 2012, ACTA TECNOL, V7, P25
   Cezar AS, 2010, VET PARASITOL, V173, P157, DOI 10.1016/j.vetpar.2010.06.013
   Coles GC, 2006, VET PARASITOL, V136, P167, DOI 10.1016/j.vetpar.2005.11.019
   COLES GC, 1992, VET PARASITOL, V44, P35, DOI 10.1016/0304-4017(92)90141-U
   Costa Coelho Wesley Adson, 2010, Ciencia Animal Brasileira, V11, P589, DOI 10.5216/cab.v11i3.5389
   Cringoli G, 2010, NAT PROTOC, V5, P503, DOI 10.1038/nprot.2009.235
   Cunha Filho LFC, 1998, BRASIL SEMINA CI AGR, V19, P31
   da Cruz DG, 2010, VET PARASITOL, V170, P340, DOI 10.1016/j.vetpar.2010.02.030
   das Neves JH, 2014, VET PARASITOL, V206, P216, DOI 10.1016/j.vetpar.2014.10.015
   de Souza AP, 2008, CIENC RURAL, V38, P1363, DOI 10.1590/S0103-84782008000500026
   de Souza LP, 2012, VET PARASITOL, V189, P387, DOI 10.1016/j.vetpar.2012.04.030
   Demeler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070212
   Diawara A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002247
   Diawara A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000397
   Duarte ER, 2012, PESQUI VET BRASIL, V32, P147, DOI 10.1590/S0100-736X2012000200010
   Echevarria F, 1996, VET PARASITOL, V62, P199, DOI 10.1016/0304-4017(95)00906-X
   Farias MT, 1997, VET PARASITOL, V72, P209, DOI 10.1016/S0304-4017(97)01111-4
   Fonseca Lindoso Melo Ana Carolina, 2005, Revista Portuguesa de Ciencias Veterinarias, V100, P141
   Fortes FS, 2013, PESQUI VET BRASIL, V33, P1391, DOI 10.1590/S0100-736X2013001200001
   Ghisi M, 2007, VET PARASITOL, V144, P313, DOI 10.1016/j.vetpar.2006.10.003
   de Soutello RVG, 2010, REV BRAS PARASITOL V, V19, P183, DOI 10.1590/S1984-29612010000300011
   Hammerschmidt J, 2012, ARQ BRAS MED VET ZOO, V64, P927, DOI 10.1590/S0102-09352012000400020
   Humbert JF, 2001, VET PARASITOL, V101, P405, DOI 10.1016/S0304-4017(01)00565-9
   IBGE, 2014, PROD PEC MUN 2013 RI
   Klauck V, 2014, AN ACAD BRAS CIENC, V86, P777, DOI 10.1590/0001-3765201420130061
   Knapp-Lawitzke F, 2015, VET PARASITOL, V209, P84, DOI 10.1016/j.vetpar.2015.02.005
   Krucken J, 2017, INT J PARASITOL-DRUG, V7, P262, DOI 10.1016/j.ijpddr.2017.06.001
   KWA MSG, 1994, MOL BIOCHEM PARASIT, V63, P299, DOI 10.1016/0166-6851(94)90066-3
   LACEY E, 1990, PARASITOL TODAY, V6, P112, DOI 10.1016/0169-4758(90)90227-U
   LACEY E, 1994, ACTA TROP, V56, P245, DOI 10.1016/0001-706X(94)90066-3
   Leathwick DM, 2015, INT J PARASITOL-DRUG, V5, P9, DOI 10.1016/j.ijpddr.2015.01.001
   dos Santos JML, 2014, VET PARASITOL, V199, P160, DOI 10.1016/j.vetpar.2013.11.006
   Lima WC, 2010, PESQUI VET BRASIL, V30, P1003, DOI 10.1590/S0100-736X2010001200001
   Melo Ana Carolina Fonseca Lindoso, 2003, Cienc. Rural, V33, P339, DOI 10.1590/S0103-84782003000200024
   MELO ACF, 1998, CIENC ANIM, V8, P7
   Niciura SCM, 2012, VET PARASITOL, V190, P608, DOI 10.1016/j.vetpar.2012.07.016
   Moher D, 2010, INT J SURG, V8, P658, DOI 10.1016/j.ijsu.2010.07.299
   Molento M. B., 2004, Revista Brasileira de Parasitologia Veterinaria, V13, P82
   Nunes RL, 2013, REV BRAS PARASITOL V, V22, P548, DOI 10.1590/S1984-29612013000400015
   Pereira Firmino Cardoso, 2010, Ciencia Animal Brasileira, V11, P947
   Pereira RHMA, 2008, ACTA VET BRASILICA, V2, P16
   Prichard R. K, 2008, P 15 C BRAS PAR VET, V15, P62
   PRICHARD RK, 1980, AUST VET J, V56, P239, DOI 10.1111/j.1751-0813.1980.tb15983.x
   Ramos César Itaqui, 2002, Cienc. Rural, V32, P473, DOI 10.1590/S0103-84782002000300017
   Rashwan N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005113
   Redman E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003494
   Rist CL, 2015, TRENDS PARASITOL, V31, P527, DOI 10.1016/j.pt.2015.09.005
   Rodrigues AB, 2007, PESQUI VET BRASIL, V27, P162, DOI 10.1590/S0100-736X2007000400006
   ROOS MH, 1990, MOL BIOCHEM PARASIT, V43, P77, DOI 10.1016/0166-6851(90)90132-6
   Santos Fernanda C. C., 2014, Revista Portuguesa de Ciencias Veterinarias, V109, P33
   Sczesny-Moraes EA, 2010, PESQUI VET BRASIL, V30, P229, DOI 10.1590/S0100-736X2010000300007
   Silvestre A, 2002, INT J PARASITOL, V32, P921, DOI 10.1016/S0020-7519(02)00032-2
   Silvestre A, 2002, MOL BIOCHEM PARASIT, V120, P297, DOI 10.1016/S0166-6851(01)00455-8
   Soccol VT, 1996, VET REC, V139, P421, DOI 10.1136/vr.139.17.421
   Soutello RGV, 2007, VET PARASITOL, V148, P360, DOI 10.1016/j.vetpar.2007.06.023
   Souza ALSO, 2013, BRASIL ACSA, V9, P33
   Thomaz-Soccol V, 2004, BRAZ ARCH BIOL TECHN, V47, P41, DOI 10.1590/S1516-89132004000100006
   Vercruysse J, 2011, INT J PARASITOL-DRUG, V1, P14, DOI 10.1016/j.ijpddr.2011.09.002
   Verissimo CJ, 2012, VET PARASITOL, V187, P209, DOI 10.1016/j.vetpar.2012.01.013
   Furtado LFV, 2014, VET PARASITOL, V206, P313, DOI 10.1016/j.vetpar.2014.10.021
   VIEIRA LD, 1989, PESQUI AGROPECU BRAS, V24, P1255
   Vieira LS, 1999, PESQUI VET BRASIL, V19, P99, DOI 10.1590/S0100-736X1999000300002
   Vieira LS, 2005, ENDOPARASITOSES GAST
   Vieira LS, 1989, B PES EMBRAPA, V11, P5
   WHO, 2015, ASS EP SOIL TRANSM H
NR 73
TC 8
Z9 8
U1 1
U2 18
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1746-6148
J9 BMC VET RES
JI BMC Vet. Res.
PD NOV 25
PY 2017
VL 13
AR 358
DI 10.1186/s12917-017-1282-2
PG 10
WC Veterinary Sciences
SC Veterinary Sciences
GA FN6LY
UT WOS:000416127200009
PM 29178952
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Portes, SAR
   Carvalho-Costa, FA
   Rocha, MS
   Fumian, TM
   Maranhao, AG
   de Assis, RM
   Xavier, MDTP
   Rocha, MS
   Miagostovich, MP
   Leite, JPG
   Volotao, ED
AF Rodrigues Portes, Silvana Augusta
   Carvalho-Costa, Filipe Anibal
   Rocha, Monica Simoes
   Fumian, Tulio Machado
   Maranhao, Adriana Goncalves
   de Assis, Rosane Maria
   Trindade Pinheiro Xavier, Maria da Penha
   Rocha, Myrna Santos
   Miagostovich, Marize Pereira
   Gagliardi Leite, Jose Paulo
   Volotao, Eduardo de Mello
TI Enteric viruses in HIV-1 seropositive and HIV-1 seronegative children
   with diarrheal diseases in Brazil
SO PLOS ONE
LA English
DT Article
ID MOLECULAR CHARACTERIZATION; ROTAVIRUS STRAINS; HUMAN ADENOVIRUS; HUMAN
   BOCAVIRUS; PCR; PREVALENCE; INFECTION; IDENTIFICATION; CALICIVIRUS;
   SEQUENCES
AB Diarrheal diseases (DD) have distinct etiological profiles in immune-deficient and immune-competent patients. This study compares detection rates, genotype distribution and viral loads of different enteric viral agents in HIV-1 seropositive (n = 200) and HIV-1 seronegative (n = 125) children hospitalized with DD in Rio de Janeiro, Brazil. Except for group A rotavirus (RVA), which were detected through enzyme immunoassay, the other enteric viruses (noro-virus [NoV], astrovirus [HAstV], adenovirus [HAdV] and bocavirus [HBoV]) were detected through PCR or RT-PCR. A quantitative PCR was performed for RVA, NoV, HAstV, HAdV and HBoV. Infections with NoV (19% vs. 9.6%; p<0.001), HBoV (14% vs. 7.2%; p = 0.042) and HAdV (30.5% vs. 14.4%; p<0.001) were significantly more frequent among HIV-1 seropositive children. RVA was significantly less frequent among HIV-1 seropositive patients (6.5% vs. 20%; p<0.001). Similarly, frequency of infection with HAstV was lower among HIV-1 seropositive children (5.5% vs. 12.8%; p = 0.018). Among HIV-1 seropositive children 33 (16.5%) had co-infections, including three enteric viruses, such as NoV, HBoV and HAdV (n = 2) and NoV, HAstV and HAdV (n = 2). The frequency of infection with more than one virus was 17 (13.6%) in the HIV-1 negative group, triple infection (NoV + HAstV + HBoV) being observed in only one patient. The median viral load of HAstV in feces was significantly higher among HIV-1 positive children compared to HIV-1 negative children. Concerning children infected with RVA, NoV, HBoV and HAdV, no statistically significant differences were observed in the medians of viral loads in feces, comparing HIV-1 seropositive and HIV-1 seronegative children. Similar detection rates were observed for RVA, HAstV and HAdV, whilst NoV and HBoV were significantly more prevalent among children with CD4(+) T lymphocyte count below 200 cells/mm(3). Enteric viruses should be considered an important cause of DD in HIV-1 seropositive children, along with pathogens more classically associated with intestinal infections in immunocompromised hosts.
C1 [Rodrigues Portes, Silvana Augusta; Carvalho-Costa, Filipe Anibal; Rocha, Monica Simoes; Fumian, Tulio Machado; Maranhao, Adriana Goncalves; de Assis, Rosane Maria; Trindade Pinheiro Xavier, Maria da Penha; Miagostovich, Marize Pereira; Gagliardi Leite, Jose Paulo; Volotao, Eduardo de Mello] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Rio De Janeiro, RJ, Brazil.
   [Carvalho-Costa, Filipe Anibal] Escritorio Reg Fiocruz Piaui, Teresina, Piaui, Brazil.
   [Rocha, Myrna Santos] Hosp Municipal Jesus, Rio De Janeiro, Brazil.
RP Portes, SAR (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Rio De Janeiro, RJ, Brazil.
EM sil@ioc.fiocruz.br
RI LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020
OI Xavier, Maria/0000-0001-9657-1980
FU Oswaldo Cruz Institute/Fiocruz; National Council for Scientific and
   Technological Development (PAPES) [VI/Fiocruz-CNPq-407566]; PAEF/Fiocruz
   [IOC008-FIO-15-71]; Coordination for Improvement of Higher Level
   Personnel (CAPES)CAPES; Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro [FAPERJ-E-26/202.968/2015]
FX This study was sponsored by Oswaldo Cruz Institute/Fiocruz, National
   Council for Scientific and Technological Development (PAPES
   VI/Fiocruz-CNPq-407566), PAEF/Fiocruz (IOC008-FIO-15-71), Coordination
   for Improvement of Higher Level Personnel (CAPES) and Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ-E-26/202.968/2015). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102
   Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001
   Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391
   Arvelo W, 2010, INT J INFECT DIS, V14, pE1002, DOI 10.1016/j.ijid.2010.06.014
   Rossit ARB, 2009, REV INST MED TROP SP, V51, P59, DOI 10.1590/S0036-46652009000200001
   Beuret C, 2002, APPL ENVIRON MICROB, V68, P1925, DOI 10.1128/AEM.68.4.1925-1931.2002
   Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1
   Bosch A, 2014, CLIN MICROBIOL REV, V27, P1048, DOI 10.1128/CMR.00013-14
   Campe H, 2008, J CLIN VIROL, V43, P340, DOI 10.1016/j.jcv.2008.07.014
   Clark B, 2004, CURR OPIN INFECT DIS, V17, P461, DOI 10.1097/00001432-200410000-00011
   Dai YC, 2010, ARCH VIROL, V155, P977, DOI 10.1007/s00705-010-0664-6
   DAS BK, 1994, J CLIN MICROBIOL, V32, P1820, DOI 10.1128/JCM.32.7.1820-1822.1994
   Drexler JF, 2011, EMERG INFECT DIS, V17, P1544, DOI 10.3201/eid1708.101556
   Fischer TK, 2000, J CLIN MICROBIOL, V38, P264
   Fumian TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145391
   Garbino J, 2008, AIDS, V22, P701, DOI 10.1097/QAD.0b013e3282f470ac
   GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992
   Ghebremedhin B, 2014, EUR J MICROBIOL IMMU, V4, P26, DOI 10.1556/EuJMI.4.2014.1.2
   Giordano MO, 1999, AIDS RES HUM RETROV, V15, P1427, DOI 10.1089/088922299309937
   Goncalves ACM, 2009, AM J TROP MED HYG, V81, P463, DOI 10.4269/ajtmh.2009.81.463
   Gonzalez GG, 1998, J MED VIROL, V55, P288, DOI 10.1002/(SICI)1096-9071(199808)55:4&lt;288::AID-JMV6&gt;3.0.CO;2-X
   GOUVEA V, 1994, J CLIN MICROBIOL, V32, P1338, DOI 10.1128/JCM.32.5.1338-1340.1994
   GROHMANN GS, 1993, NEW ENGL J MED, V329, P14, DOI 10.1056/NEJM199307013290103
   Groome MJ, 2012, VACCINE, V30, pA173, DOI 10.1016/j.vaccine.2011.08.004
   Hernroth BE, 2002, APPL ENVIRON MICROB, V68, P4523, DOI 10.1128/AEM.68.9.4523-4533.2002
   Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003
   Kantola K, 2010, J CLIN MICROBIOL, V48, P4044, DOI 10.1128/JCM.00686-10
   Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831
   Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416
   Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9
   Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006
   Kroneman A, 2013, ARCH VIROL, V158, P2059, DOI 10.1007/s00705-013-1708-5
   La Rosa G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/142912
   Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310
   Liste MB, 2000, J CLIN MICROBIOL, V38, P2873, DOI 10.1128/JCM.38.8.2873-2877.2000
   Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6
   Mans J, 2014, J MED VIROL, V86, P75, DOI 10.1002/jmv.23784
   Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861
   Morillo SG, 2010, T ROY SOC TROP MED H, V104, P165, DOI 10.1016/j.trstmh.2009.07.023
   Moyo S, 2014, INFECT GENET EVOL, V26, P340, DOI 10.1016/j.meegid.2014.06.013
   Moyo SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097562
   Moyo SJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0666-1
   NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995
   Nunes MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086448
   Page NA, 2017, EPIDEMIOL INFECT, V10, P1
   Pollok RCG, 2001, NOVART FDN SYMP, V238, P276
   Rodriguez-Guillen L, 2005, J CLIN VIROL, V33, P104, DOI 10.1016/j.jcv.2004.09.031
   Santos N, 2010, J CLIN VIROL, V48, P127, DOI 10.1016/j.jcv.2010.03.014
   Silva RC, 2010, BRAZ J INFECT DIS, V14, P549, DOI [10.1590/S1413-86702010000600012, 10.1590/S1413-86702010000600001]
   Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013
   Thomas P D, 1999, HIV Med, V1, P19, DOI 10.1046/j.1468-1293.1999.00004.x
   Tse H, 2012, J VIROL, V86, P9531, DOI 10.1128/JVI.01312-12
   Vinje J, 2004, J VIROL METHODS, V116, P109, DOI 10.1016/j.jviromet.2003.11.001
   Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14
   Vu DL, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9020033
   WHO (World Health Organization), 2011, GLOB ROT INF SURV B, V4
   World Health Organization, 2009, MAN ROT DET CHAR MET
   Yan ZQ, 1998, AM J SURG PATHOL, V22, P1101, DOI 10.1097/00000478-199809000-00009
   Zeng SQ, 2008, J VIROL METHODS, V153, P238, DOI 10.1016/j.jviromet.2008.08.004
NR 59
TC 9
Z9 9
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 30
PY 2017
VL 12
IS 8
AR e0183196
DI 10.1371/journal.pone.0183196
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FF1XX
UT WOS:000408693600033
PM 28854225
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Coronato-Nunes, B
   Calegar, DA
   Monteiro, KJL
   Jaeger, LH
   Reis, ERC
   Xavier, SCD
   Carpp, LN
   Lima, MM
   Boia, MN
   Carvalho-Costa, FA
AF Coronato-Nunes, Beatriz
   Calegar, Deiviane Aparecida
   Lima Monteiro, Kerla Joeline
   Jaeger, Lauren Hubert
   Chaves Reis, Elis Regina
   das Chagas Xavier, Samanta Cristina
   Carpp, Lindsay Nicole
   Lima, Marli Maria
   Boia, Marcio Neves
   Carvalho-Costa, Filipe Anibal
TI Giardia intestinalis infection associated with malnutrition in children
   living in northeastern Brazil
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Article
DE Giardia intestinalis; nutritional status; intestinal parasites;
   northeastern Brazil; Brazil; poverty
ID SOIL-TRANSMITTED HELMINTHS; NUTRITIONAL-STATUS; PARASITIC INFECTIONS;
   YOUNG-CHILDREN; DUODENALIS; LAMBLIA; PREVALENCE; COLOMBIA; SALVADOR;
   PROTOZOA
AB Introduction: The present study aimed to determine the prevalence and factors associated with Giardia intestinalis infection, verifying its impact on the nutritional status of children in northeastern Brazil.
   Methodology: A cross-sectional study was conducted to obtain parasitological, sociodemographic, and anthropometric data in two municipalities in the states of Piaui and Ceara, northeastern Brazil.
   Results: Prevalence of giardiasis was 55/511 (10.8%). G. intestinalis was more frequent in people living in poverty (30/209 [14.4%], p = 0.041), performing open evacuation (26/173 [15%], p = 0.034), and drinking rainwater stored in cisterns (9/56 [16.1%], p = 0.005). The proportion of stunting and being underweight in children infected with G. intestinalis was significantly higher than that in uninfected children (5/23 [21.7%] vs. 10/179 [5.6%], p = 0.017, OR = 4.69, 95% confidence interval [CI] = 1.44-15.25 and 5/23 [21.7%] vs. 13/179 [7.3%], p = 0.038, OR = 3.54, 95% CI = 1.13-11.09, respectively). Infection with G. intestinalis remained significantly associated with stunting and being underweight after adjustment for poverty, municipality, sex, and age in a logistic regression multivariate model.
   Conclusions: In rural areas in northeastern Brazil, giardiasis has acquired great public health importance in the soil-transmitted helminths control era, impacting the nutritional status of children and requiring new approaches to diagnosis and treatment and translational research that could generate applicable solutions at the community level.
C1 [Coronato-Nunes, Beatriz; Calegar, Deiviane Aparecida; Lima Monteiro, Kerla Joeline; Jaeger, Lauren Hubert; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Lab Epidemiol & Mol Systemat, Ave Brasil 4365,Pavilhao Leonidas Deane,Sala 308, BR-21040900 Rio De Janeiro, Brazil.
   [Chaves Reis, Elis Regina] Nossa Senhora de Nazare Municipal Hlth Off, Coordinat Primary Hlth Care, Nossa Senhora De Nazare, Brazil.
   [das Chagas Xavier, Samanta Cristina] Fundacao Oswaldo Cruz, Lab Trypanosomatid Biol, Rio De Janeiro, Brazil.
   [Carpp, Lindsay Nicole] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.
   [Lima, Marli Maria] Fundacao Oswaldo Cruz, Chagas Dis Ecoepidemiol Lab, Rio De Janeiro, Brazil.
   [Boia, Marcio Neves] Fundacao Oswaldo Cruz, Lab Biol & Parasitol Wild Reservoir Mammals, Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe Anibal] Reg Off Fiocruz Piaui, Teresina, Brazil.
RP Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz, Lab Epidemiol & Mol Systemat, Ave Brasil 4365,Pavilhao Leonidas Deane,Sala 308, BR-21040900 Rio De Janeiro, Brazil.
EM guaratiba@ioc.fiocruz.br
OI Xavier, Samanta Cristina/0000-0002-3475-0075
FU Oswaldo Cruz Foundation (Fiocruz); Brazilian Federal Agency for Support
   and Evaluation of Graduate Education (Capes)/Brazil's Ministry of
   Education; Ministry of Social Development
FX This work was supported by Oswaldo Cruz Foundation (Fiocruz) and
   Brazilian Federal Agency for Support and Evaluation of Graduate
   Education (Capes)/Brazil's Ministry of Education and Ministry of Social
   Development, in the context of the agreement Capes-Fiocruz-Brazil
   Without Poverty Plan.
CR Abou-Shady O, 2011, BIOL TRACE ELEM RES, V140, P1, DOI 10.1007/s12011-010-8673-6
   Matos SMA, 2008, CAD SAUDE PUBLICA, V24, P1527, DOI 10.1590/S0102-311X2008000700007
   [Anonymous], 2013, TECHN REP NAT CAMP L
   Astiazaran-Garcia H, 2000, EXP PARASITOL, V95, P128, DOI 10.1006/expr.2000.4514
   Bartelt Luther A, 2015, F1000Prime Rep, V7, P62, DOI 10.12703/P7-62
   Botero-Garces JH, 2009, REV INST MED TROP SP, V51, P155, DOI 10.1590/S0036-46652009000300006
   Caccio SM, 2010, EXP PARASITOL, V124, P107, DOI 10.1016/j.exppara.2009.02.007
   Campello Tereza, 2014, BRAZIL POVERTY
   Carvalho-Costa Filipe Anibal, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P147, DOI 10.1590/S0036-46652007000300003
   Ramirez JD, 2015, INFECT GENET EVOL, V32, P208, DOI 10.1016/j.meegid.2015.03.015
   Ehsan AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118239
   Faust E. C., 1938, American Journal of Tropical Medicine, V18, P169
   Ferreira FS, 2015, J TROP PEDIATRICS, V61, P106, DOI 10.1093/tropej/fmu078
   Gil FF, 2013, PATHOG GLOB HEALTH, V107, P320, DOI 10.1179/2047773213Y.0000000107
   Ignatius R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001677
   Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130
   Leitsch David, 2015, Curr Trop Med Rep, V2, P128
   Lustigman S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001582
   Macchioni F, 2015, AM J TROP MED HYG, V92, P794, DOI 10.4269/ajtmh.14-0039
   Mateo M, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000075
   Mbae CK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-243
   Moraes RG, 1948, REV SERV ESP SAUDE P, V1, P507
   Nematian J, 2008, ANN TROP MED PARASIT, V102, P209, DOI 10.1179/136485908X267876
   Prado MS, 2005, PARASITOLOGY, V131, P51, DOI 10.1017/S0031182005007353
   Quihui L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-85
   Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001
   Silva RR, 2009, T ROY SOC TROP MED H, V103, P512, DOI 10.1016/j.trstmh.2008.10.019
   Turkeltaub JA, 2015, CURR OPIN GASTROEN, V31, P38, DOI 10.1097/MOG.0000000000000135
   Verhagen LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077581
   WATERLOW JC, 1977, B WORLD HEALTH ORGAN, V55, P489
   WHO, 1978, GROWTH CHART INT US
   YOUNG KH, 1979, J CLIN MICROBIOL, V10, P852, DOI 10.1128/JCM.10.6.852-853.1979
NR 34
TC 4
Z9 4
U1 0
U2 1
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD JUL
PY 2017
VL 11
IS 7
BP 563
EP 570
DI 10.3855/jidc.8410
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA FH2HE
UT WOS:000410959000007
PM 31071066
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Barbosa, JR
   Bezerra, CS
   Carvalho-Costa, FA
   de Azevedo, CP
   Flores, GL
   Colares, JKB
   Lima, DM
   Lampe, E
   Villar, LM
AF Barbosa, Jakeline Ribeiro
   Bezerra, Cristianne Sousa
   Carvalho-Costa, Filipe Anibal
   de Azevedo, Carolina Pimentel
   Flores, Geane Lopes
   Baima Colares, Jeova Keny
   Lima, Danielle Malta
   Lampe, Elisabeth
   Villar, Livia Melo
TI Cross-Sectional Study to Determine the Prevalence of Hepatitis B and C
   Virus Infection in High Risk Groups in the Northeast Region of Brazil
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE prevalence; hepatitis B virus; hepatitis C virus; human immunodeficiency
   virus 1; haemodialysis; coagulopathy
ID HEMODIALYSIS-PATIENTS; MULTICENTRIC SURVEY; NATURAL-HISTORY; HIV; STATE;
   SEROPREVALENCE; EPIDEMIOLOGY; HEMOPHILIACS; COINFECTION; HBV
AB Background: HBV (Hepatitis B Virus) and HCV (Hepatitis C Virus) infections are more prevalent in vulnerable populations than the general population. The objective of this study was to investigate the prevalence of HBV and HCV infection in HIV-positive patients (GI), chronic renal failure (CRF) patients (GII) and coagulation disorder individuals (GIII). Methods: A cross-sectional study was conducted from June 2014 to March 2015. Serum samples were tested for markers of hepatitis B and C by enzyme-linked immunosorbent assay (ELISA). Sociodemographic, epidemiological, clinical and laboratory data and accompanying statistical analyses were performed using Epi Info (TM) 7. Results: A total of 348 individuals were recruited, i.e., 154 HIV-positive, 143 CRF and 51 coagulopathy patients. Among them, more than 66% were men, and the predominant age group was 26-35 years in GI and 56-65 years in GIII. Most patients had more than 8 years of education (66.2% in GI, 60.6% in GIII and 46.1% in GII), with a family income between 100-400 dollars in more than 48% of patients. The prevalence of the HBsAg marker was 3.9%, 7% and 3.9%, total anti-HBc was 28.6%, 55.9% and 31.4%, and anti-HCV was 1.3%, 12.6% and 47% for GI, GII and GIII, respectively. However, the prevalence of anti-HBs was greater than 70% in all groups. Conclusions: This study shows a high prevalence of HBV and HCV among specific groups compared to the general population. Factors such as age, income, number of sexual partners, sexually transmitted disease burden, blood transfusion history or blood products and blood transfusions before 1994 were associated with a higher prevalence for these infections.
C1 [Barbosa, Jakeline Ribeiro; Bezerra, Cristianne Sousa; de Azevedo, Carolina Pimentel; Flores, Geane Lopes; Lampe, Elisabeth; Villar, Livia Melo] Fiocruz MS, Oswaldo Cruz Fdn, Oswaldo Cruz Inst, Viral Hepatitis Lab, BR-21040900 Rio De Janeiro, Brazil.
   [Barbosa, Jakeline Ribeiro; Bezerra, Cristianne Sousa; Baima Colares, Jeova Keny; Lima, Danielle Malta] Fed Univ Ceara State, Postgrad Programme Pathol, BR-60430160 Fortaleza, CE, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fiocruz MS, Oswaldo Cruz Inst, Lab Epidemiol & Mol Systemat, BR-21040900 Rio De Janeiro, Brazil.
   [Baima Colares, Jeova Keny; Lima, Danielle Malta] Univ Fortaleza, Postgrad Programme Med Sci, BR-60811905 Fortaleza, CE, Brazil.
RP Villar, LM (corresponding author), Fiocruz MS, Oswaldo Cruz Fdn, Oswaldo Cruz Inst, Viral Hepatitis Lab, BR-21040900 Rio De Janeiro, Brazil.
EM jakelinebarbosa@gmail.com; tiannebezerra@gmail.com;
   guaratiba@ioc.fiocruz.br; carolazevedo09@msn.com; geane@ioc.fiocruz.br;
   kenycolares@unifor.br; danimalta37@gmail.com; elampe@ioc.fiocruz.br;
   lvillar@ioc.fiocruz.br
RI VILLAR, LIVIA M/F-7811-2012; Barbosa, Jakeline/AAC-9805-2020; Colares,
   Jeova Keny Baima/C-5257-2014; Lima, Danielle/A-6108-2013
OI VILLAR, LIVIA M/0000-0001-7644-8969; Barbosa,
   Jakeline/0000-0001-6238-7173; Colares, Jeova Keny
   Baima/0000-0003-1367-6272; Sousa Bezerra,
   Cristianne/0000-0002-9389-5186; Lima, Danielle/0000-0003-2734-6768
FU Brazilian Ministry of Health; Coordination of Improvement of Higher
   Education Personnel (CAPES)CAPES; Brazilian National Council of
   Technological and Scientific Development (CNPq)National Council for
   Scientific and Technological Development (CNPq); Oswaldo Cruz Foundation
   (FIOCRUZ)
FX The authors would like to thank the health authorities from the
   recruitment centres health authorities from the recruitment centers for
   technical support, the Center for Integrated Medical Care of the
   University of Fortaleza, the PRONEFRON Group, the Outpatient clinic of
   Hereditary Coagulopathies of the Hematology and Hemotherapy Center of
   Ceara-Hemoce and, Juliana Custodio Miguel and Elisangela Ferreira da
   Silva from the Laboratory of Viral Hepatitis (LAHEP/FIOCRUZ) for
   technical assistance in laboratory testing. This research was supported
   by the Brazilian Ministry of Health, the Coordination of Improvement of
   Higher Education Personnel (CAPES), Brazilian National Council of
   Technological and Scientific Development (CNPq), and Oswaldo Cruz
   Foundation (FIOCRUZ).
CR Brandao NAA, 2015, BRAZ J INFECT DIS, V19, P426, DOI 10.1016/j.bjid.2015.02.001
   Brazilian Health Ministry, 2015, PROF HER COAG BRAZ, P62
   Carmo RA, 2002, BRAZ J MED BIOL RES, V35, P589, DOI 10.1590/S0100-879X2002000500012
   Carneiro MAS, 2001, MEM I OSWALDO CRUZ, V96, P765, DOI 10.1590/S0074-02762001000600003
   Carrilho FJ, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-13
   Chang JM, 2014, INT J MED SCI, V11, P436, DOI 10.7150/ijms.8265
   de Medeiros MTG, 2004, REV SAUDE PUBL, V38, P187, DOI 10.1590/S0034-89102004000200006
   de Oliveira SB, 2014, CAD SAUDE PUBLICA, V30, P433, DOI 10.1590/0102-311X00010413
   Edey M, 2010, NEPHROLOGY, V15, P137, DOI 10.1111/j.1440-1797.2009.01268.x
   Farias N, 2012, EPIDEMIOL SERV SAUDE, V21, P475, DOI 10.5123/S1679-49742012000300013
   Federici AB, 2006, HAEMATOLOGICA, V91, P503
   TÁVORA Lara Gurgel Fernandes, 2013, Arq. Gastroenterol., V50, P277, DOI 10.1590/S0004-28032013000400007
   Ferreira AA, 2014, J BLOOD MED, V5, P175, DOI 10.2147/JBM.S68234
   Flores GL, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13030314
   Fontes Eva M. A., 2003, Rev Panam Salud Publica, V13, P124, DOI 10.1590/S1020-49892003000200013
   Franchini M, 2010, BRIT J HAEMATOL, V148, P522, DOI 10.1111/j.1365-2141.2009.08005.x
   Halle MP, 2016, IRAN J KIDNEY DIS, V10, P304
   Hoepers Andréa T. C., 2008, Rev. Bras. Hematol. Hemoter., V30, P172, DOI 10.1590/S1516-84842008000200020
   Joukar F, 2011, HEPAT MON, V11, P178
   Kapembwa KC, 2011, J GLOB INFECT DIS, V3, P269, DOI 10.4103/0974-777X.83534
   Kretzer IF, 2014, SCI WORLD J, DOI 10.1155/2014/827849
   Kucharska M, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.35658
   Lacombe K, 2012, GUT, V61, P47, DOI 10.1136/gutjnl-2012-302062
   Leão José Rafael, 2010, Arq. Gastroenterol., V47, P28, DOI 10.1590/S0004-28032010000100006
   Mannucci PM, 2001, NEW ENGL J MED, V344, P1773, DOI 10.1056/NEJM200106073442307
   Marquesini G., 2008, REV PAN INFECTOL, V10, P23
   McMahon BJ, 2004, SEMIN LIVER DIS, V24, P17, DOI 10.1055/s-2004-828674
   Moreira RC, 2010, MEM I OSWALDO CRUZ, V105, P107, DOI 10.1590/S0074-02762010000100017
   Pereira LMMB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-60
   Pereira LMMB, 2009, AM J TROP MED HYG, V81, P240
   Rezende SM, 2009, HAEMOPHILIA, V15, P142, DOI 10.1111/j.1365-2516.2008.01907.x
   Santos MAM, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-32
   Sassaki L., 2006, ARQ MUDI, V10, P5
   Seeff LB, 2009, LIVER INT, V29, P89, DOI 10.1111/j.1478-3231.2008.01927.x
   Sesso Ricardo Cintra, 2014, J. Bras. Nefrol., V36, P476, DOI 10.5935/0101-2800.20140068
   Silva LK, 2005, REV SOC BRAS MED TRO, V38, P496, DOI 10.1590/S0037-86822005000600010
   World Health Organization-WHO, HEP B HEP C
   Ximenes RAA, 2015, AM J TROP MED HYG, V93, P1341, DOI 10.4269/ajtmh.15-0216
   Zambonato TK, 2008, J BRAS NEFROL, V30, P192
   Ziaee M, 2015, PAK J MED SCI, V31, P1246, DOI 10.12669/pjms.315.7888
NR 40
TC 3
Z9 3
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1661-7827
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUL
PY 2017
VL 14
IS 7
AR 793
DI 10.3390/ijerph14070793
PG 12
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA FD2ND
UT WOS:000407370700125
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Brito-Santos, F
   Ferreira, MD
   Trilles, L
   Muniz, MD
   dos Santos, VGV
   Carvalho-Costa, FA
   Meyer, W
   Wanke, B
   Lazera, MD
AF Brito-Santos, Fabio
   Ferreira, Marcela de Faria
   Trilles, Luciana
   Muniz, Mauro de Medeiros
   Veloso dos Santos, Valdilea Goncalves
   Carvalho-Costa, Filipe Anibal
   Meyer, Wieland
   Wanke, Bodo
   Lazera, Marcia dos Santos
TI Preheating of urine improves the specificity of urinary cryptococcal
   antigen testing using the lateral flow assay
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Editorial Material
ID MENINGITIS; PREVALENCE; SERUM
C1 [Brito-Santos, Fabio; Ferreira, Marcela de Faria; Trilles, Luciana; Muniz, Mauro de Medeiros; Veloso dos Santos, Valdilea Goncalves; Meyer, Wieland; Wanke, Bodo; Lazera, Marcia dos Santos] Fiocruz MS, Natl Inst Infect Dis Evandro Chagas INI, Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fiocruz MS, Oswaldo Cruz Inst, Rio De Janeiro, Brazil.
   [Meyer, Wieland] Univ Sydney, Ctr Infect Dis & Microbiol, Sydney Med Sch,Westmead Inst Med Res, Westmead Hosp,Marie Bashir Inst Infect Dis & Bios, Sydney, NSW, Australia.
RP Lazera, MD (corresponding author), Fiocruz MS, Natl Inst Infect Dis Evandro Chagas INI, Rio De Janeiro, Brazil.
EM marcia.lazera@ini.fiocruz.br
FU "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior"
   (CAPES)CAPES [098/2012]; CNPq-PAPES/Fiocruz grant [407565/2012 4];
   program science without borders (CAPES), Brazil [AUXPE-PVE 0251/2013]
FX The study was partially supported by the "Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior" (CAPES) grant # 098/2012 to BW,
   CNPq-PAPES/Fiocruz grant # 407565/2012 4 to MdSL, the program science
   without borders (CAPES), Brazil, grant # AUXPE-PVE 0251/2013 to WM. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Drain PK, 2015, HIV MED, V16, P640, DOI 10.1111/hiv.12263
   Huang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114910
   Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613
   Longley N, 2016, CLIN INFECT DIS, V62, P581, DOI 10.1093/cid/civ936
   Magambo KA, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19040
   Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac
   Tenforde MW, 2015, HIV MED
   Trilles L, 2008, MEM I OSWALDO CRUZ, V103, P455, DOI 10.1590/S0074-02762008000500008
   Williams DA, 2015, CLIN INFECT DIS, V61, P464, DOI 10.1093/cid/civ263
NR 9
TC 2
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2017
VL 11
IS 5
AR e0005304
DI 10.1371/journal.pntd.0005304
PG 4
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EX0RA
UT WOS:000402927300004
PM 28493865
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Parente, CC
   Bezerra, FSM
   Parente, PI
   Neto, RVD
   Xavier, SCC
   Ramos, AN
   Carvalho-Costa, FA
   Lima, MM
AF Parente, Cynara Carvalho
   Bezerra, Fernando S. M.
   Parente, Plutarco I.
   Dias-Neto, Raimundo V.
   Xavier, Samanta C. C.
   Ramos, Alberto N., Jr.
   Carvalho-Costa, Filipe A.
   Lima, Marli M.
TI Community-Based Entomological Surveillance Reveals Urban Foci of Chagas
   Disease Vectors in Sobral, State of Ceara, Northeastern Brazil
SO PLOS ONE
LA English
DT Article
ID RHODNIUS-NASUTUS; TRIATOMA-BRASILIENSIS; REDUVIIDAE; HEMIPTERA;
   PSEUDOMACULATA; EPIDEMIOLOGY; TRANSMISSION; POPULATIONS; AREAS
AB Background
   The aim of this work was to explore the potential risk of vector-borne Chagas disease in urban districts in northeastern Brazil, by analyzing the spatiotemporal distributions and natural infection rates with Trypanosoma cruzi of triatomine species captured in recent years. The main motivation of this work was an acute human case of Chagas disease reported in 2008 in the municipality of Sobral.
   Methodology/principal findings
   We analyzed data from community-based entomological surveillance carried out from 2010 to 2014. Triatomine natural T. cruzi infection was assessed by examination of insect feces by optical microscopy. Sites of triatomine capture were georeferenced through Google Earth and analyzed with ArcGIS. A total of 191 triatomines were collected, consisting of 82.2% Triatoma pseudomaculata, 7.9% Rhodnius nasutus, 5.8% T. brasiliensis, 3.7% Panstrongylus lutzi, and 0.5% P. megistus, with an overall natural infection index of 17.8%. Most infestations were reported in the districts of Dom Jose (36.2%), Padre Palhano (24.7%), and Alto do Cristo (10.6%). The overwhelming majority of insects (185/96.9%) were captured inside houses, and most insects tended to be collected in intermittent peaks. Moreover, captured triatomines tended to constitute colonies. The acute case reported in 2008 was found to be situated within a T. pseudomaculata hotspot.
   Conclusion
   The triatomine collection events carried out by dwellers were aggregated in time and space into distinct foci, suggesting that insects are intermittently and artificially introduced into the city, possibly via accidental migration from their natural reservoirs. The relatively high T. cruzi infection rate indicates considerable circulation of the parasite in these areas, increasing the risk of vector-borne Chagas disease infection. These data suggest a need to strengthen epidemiological surveillance and integrate appropriate control actions targeting triatomines, T. cruzi reservoirs, and human populations. Our data also identify Chagas disease transmission as a hazard in urban areas of Sobral.
C1 [Parente, Cynara Carvalho; Parente, Plutarco I.] Univ Fed Ceara Sobral, Fac Med, Sobral, Ceara, Brazil.
   [Bezerra, Fernando S. M.] Univ Fed Ceara, Fac Farm Odontol & Enfermagem, Fortaleza, Ceara, Brazil.
   [Dias-Neto, Raimundo V.] Secretaria Municipal Saude Sobral, Ctr Controle Zoonoses, Sobral, Ceara, Brazil.
   [Xavier, Samanta C. C.] Fiocruz MS, Fundacao Oswaldo Cruz, Lab Biol Tripanossomatideos, Rio De Janeiro, RJ, Brazil.
   [Ramos, Alberto N., Jr.] Univ Fed Ceara, Fac Med, Fortaleza, Ceara, Brazil.
   [Carvalho-Costa, Filipe A.] Fiocruz MS, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe A.] Escritorio Tecn Reg Fiocruz, Teresina, Piaui, Brazil.
   [Lima, Marli M.] Fiocruz MS, Inst Oswaldo Cruz, Lab Ecoepidemiol Doenca de Chagas, Rio De Janeiro, Brazil.
RP Lima, MM (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Ecoepidemiol Doenca de Chagas, Rio De Janeiro, Brazil.
EM marlilima@uol.com.br
RI Junior, Alberto Novaes Ramos/A-4276-2013
OI Junior, Alberto Novaes Ramos/0000-0001-7982-1757; Bezerra,
   Fernando/0000-0003-4920-7718
FU Oswaldo Cruz Foundation; CAPESCAPES
FX The authors received funding from Oswaldo Cruz Foundation and CAPES.
CR Abad-Franch F, 2015, ACTA TROP, V15, P52
   Abad-Franch F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003187
   Andrade DV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003010
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33
   ASSIS GFM, 2007, REV SOC BRAS MED TRO, V40, P391
   Bezerra CM, 2008, REV SOC BRAS MED TRO, V42, P308
   Borges-Pereira J, 2008, REV SOC BRAS MED TRO, V41, P345, DOI 10.1590/S0037-86822008000400005
   de la Fuente ALC, 2007, ACTA TROP, V101, P115, DOI 10.1016/j.actatropica.2006.12.007
   Chagas C., 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008
   Coura JR, 2015, ACTA TROP, V15, P134
   de la Fuente ALC, 2008, J MED ENTOMOL, V45, P14, DOI 10.1603/0022-2585(2008)45[14:BPOTRT]2.0.CO;2
   Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092
   Forattini O P, 1979, Rev Saude Publica, V13, P220, DOI 10.1590/S0034-89101979000300007
   Freitas Simone Patrícia Carneiro, 2004, Cad. Saúde Pública, V20, P333, DOI 10.1590/S0102-311X2004000100052
   Freitas SPC, 2005, REV SAUDE PUBL, V39, P27, DOI 10.1590/s0034-89102005000100004
   Gumiel M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0836-z
   Lima MM, 2008, PARASITOL RES, V102, P797, DOI 10.1007/s00436-007-0823-1
   Lima MM, 2008, AM J TROP MED HYG, V79, P750, DOI 10.4269/ajtmh.2008.79.750
   Lima MM, 2015, PARASITOL RES, V114, P1687, DOI 10.1007/s00436-015-4350-1
   Lima MM, 2012, T ROY SOC TROP MED H, V106, P143, DOI 10.1016/j.trstmh.2011.10.013
   Martins-Melo FR, 2014, TROP MED INT HEALTH, V19, P943, DOI 10.1111/tmi.12328
   Nobrega AA, 2009, EMERG INFECT DIS, V15, P653, DOI 10.3201/eid1504.081450
   Ramos JR, 2001, CAD SAUDE PUBLICA, V17, P1403
   Sarquis O, 2006, MEM I OSWALDO CRUZ, V101, P143, DOI 10.1590/S0074-02762006000200005
   Sarquis O, 2012, PARASITOL RES, V110, P1481, DOI 10.1007/s00436-011-2651-6
   Sonoda IV, 2010, MEM I OSWALDO CRUZ, V105, P348, DOI 10.1590/S0074-02762010000300019
   Dias FBS, 2011, INFECT GENET EVOL, V11, P869, DOI 10.1016/j.meegid.2011.02.008
   Valenca-Barbosa C, 2014, AM J TROP MED HYG, V90, P1059, DOI 10.4269/ajtmh.13-0204
NR 28
TC 3
Z9 3
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 19
PY 2017
VL 12
IS 1
AR e0170278
DI 10.1371/journal.pone.0170278
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EI3HP
UT WOS:000392381100049
PM 28103294
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU dos Santos, SM
   de Sousa, DM
   dos Santos, JP
   Vieira, JFPD
   Goncalves, TCM
   dos Santos-Mallet, JR
   Carvalho-Costa, FA
AF dos Santos, Silvia Menezes
   de Sousa, Danielle Misael
   dos Santos, Jessica Pereira
   Pinheiro do Nascimento Vieira, Jose Felipe
   Monte Goncalves, Teresa Cristina
   dos Santos-Mallet, Jacenir Reis
   Carvalho-Costa, Filipe Anibal
TI Entomological survey in the state of Piaui, Northeastern Brazil, reveals
   intradomiciliary colonization of Triatoma brasiliensis macromelasoma
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Chagas disease; Triatoma brasiliensis macromelasoma; State of Piaui
ID TRYPANOSOMA-CRUZI INFECTION; CHAGAS-DISEASE VECTOR; SPECIES COMPLEX;
   REDUVIIDAE; HEMIPTERA; AREAS
AB This survey aimed to assess the presence of triatomine vectors of Chagas disease within the rural communities of Sao Joao do Piaui, Northeast Brazil. Intradomiciliary and peridomiciliary collection strategies were implemented wherein 279 specimens of Triatoma brasiliensis macromelasoma, both nymph and adult were found in 15 (50%) of the studied homes. Of the intradomiciliary insects, 73 (67.6%) were identified as nymph instars (1(st) instar [N1]= 6, N2= 14, N3= 28, N4= 7 and N5= 18). In the studied communities, a continuous interaction between triatomine bugs and humans could be shown. It is therefore urgent that suitable strategies for the control of the triatomine vector are implemented in this area.
C1 [dos Santos, Silvia Menezes; de Sousa, Danielle Misael; Monte Goncalves, Teresa Cristina; dos Santos-Mallet, Jacenir Reis] Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Vigilancia Entomol Diptera &, Av Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [dos Santos, Silvia Menezes; dos Santos, Jessica Pereira; Pinheiro do Nascimento Vieira, Jose Felipe; Carvalho-Costa, Filipe Anibal] Fiocruz MS, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, RJ, Brazil.
   [dos Santos, Jessica Pereira; Carvalho-Costa, Filipe Anibal] Fiocruz MS, Escritirio Tecn Reg Piaui, Teresina, Piaui, Brazil.
RP dos Santos, SM (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Interdisciplinar Vigilancia Entomol Diptera &, Av Brasil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
EM smenezes5@yahoo.com.br
RI Goncalves, Teresa/AAT-3566-2020
OI SANTOS, JESSICA/0000-0002-1639-517X
CR Borges-Pereira J, 2007, REV SOC BRAS MED TRO, V40, P521, DOI 10.1590/S0037-86822007000500006
   Borges-Pereira J, 2006, REV SOC BRAS MED TRO, V39, P530, DOI 10.1590/S0037-86822006000600004
   Breniere SF, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004792
   Costa J, 2003, MEM I OSWALDO CRUZ, V98, P443, DOI 10.1590/S0074-02762003000400002
   Costa J, 2002, AM J TROP MED HYG, V67, P516, DOI 10.4269/ajtmh.2002.67.516
   Costa J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-238
   Coura J R, 1996, Rev Soc Bras Med Trop, V29, P197, DOI 10.1590/S0037-86821996000200012
   Dias J C, 2000, Cad Saude Publica, V16 Suppl 2, P13, DOI 10.1590/S0102-311X2000000800003
   Diotaiuti L, 2000, Cad Saude Publica, V16 Suppl 2, P61, DOI 10.1590/S0102-311X2000000800006
   Justi SA, 2017, TRENDS PARASITOL, V33, P42, DOI 10.1016/j.pt.2016.11.002
   Mendonca VJ, 2016, ZOOTAXA, V4107, P239, DOI 10.11646/zootaxa.4107.2.6
   Mendonca VJ, 2016, 52 C SOC BRAS MED TR
   Oliveira J, 2017, ACTA TROP, V170, P140, DOI 10.1016/j.actatropica.2017.02.020
   Perez TD, 2016, REV INST MED TROP SP, V58, DOI 10.1590/S1678-9946201658079
   Rassi A, 2003, MINAS GERAIS REV SOC, V36, P719
   Sarquis O, 2006, MEM I OSWALDO CRUZ, V101, P143, DOI 10.1590/S0074-02762006000200005
   Sarquis O, 2012, PARASITOL RES, V110, P1481, DOI 10.1007/s00436-011-2651-6
   Sarquis O, 2010, J VECTOR ECOL, V35, P385, DOI 10.1111/j.1948-7134.2010.00097.x
   Schofield CJ, 1999, ADV PARASIT, V42, P1, DOI 10.1016/S0065-308X(08)60147-5
   Xavier SCC, 2007, PARASITOL INT, V56, P119, DOI 10.1016/j.parint.2007.01.003
NR 20
TC 1
Z9 1
U1 0
U2 2
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PY 2017
VL 59
AR e27
DI 10.1590/S1678-9946201759027
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EX5IO
UT WOS:000403274300003
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU da Silva, MFM
   Fumian, TM
   de Assis, RMS
   Fialho, AM
   Carvalho-Costa, FA
   de Andrade, JDR
   Leite, JPG
AF Marques da Silva, Marcelle Figueira
   Fumian, Tulio Machado
   Santos de Assis, Rosane Maria
   Fialho, Alexandre Madi
   Carvalho-Costa, Filipe Anibal
   Ribeiro de Andrade, Juliana da Silva
   Gagliardi Leite, Jose Paulo
TI VP7 and VP8*genetic characterization of group A rotavirus genotype
   G12P[8]: Emergence and spreading in the Eastern Brazilian coast in 2014
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE diarrhea disease; group A rotavirus; genotype G12P[8]; adults infection
ID SEROTYPE G12 ROTAVIRUSES; ACUTE GASTROENTERITIS; RT-PCR; MOLECULAR
   EPIDEMIOLOGY; 1ST DETECTION; STRAINS; VACCINE; CHILDREN; ADULTS;
   DIARRHEA
AB Group A rotavirus (RVA) genotype G12 is habitually associated with diarrhea disease (DD) in African children and recently its detection has increased worldwide. A total of 970 stool samples collected from individuals with DD in the Northeastern, Southeastern, and Southern Brazilian regions, Eastern coast, were analyzed and 321 (33%) were positive for RVA and of these, 241 (75%) genotyped as G12P[8]. The rate of RVA positivity was higher among children aged 5-10 years old (60%). All RVA infections observed in adults aged >21 years were G12P[8] (n=27) showing that this genotype affected older age groups during the year of 2014 in Brazil. Phylogenetic analysis of VP7 and VP8* G12P[8] strains demonstrated an elevated similarity among Brazilian and G12-III prototypes strains circulating worldwide recently, suggesting that this lineage is associated with the global spread of the G12 genotype, considered as the 6th most prevalent human RVA genotype nowadays; while other G12 lineages remain sporadically detected and usually detected in association with other P genotypes. VP8* analysis revealed that Brazilian strains belong to P[8]-3 lineage, the single P[8] lineage presently detected in the country. No major nucleotide/amino acid disparities were observed among strains recovered from children and adults for VP7 and VP8* genes. These data are essential to support the surveillance studies, particularly in countries where the RVA vaccine was introduced in their National Immunization Program enabling identification of potential alterations in the epidemiological profile that can impact its efficacy in vaccination programs. J. Med. Virol. 89:64-70, 2017. (c) 2016 Wiley Periodicals, Inc.
C1 [Marques da Silva, Marcelle Figueira; Fumian, Tulio Machado; Santos de Assis, Rosane Maria; Fialho, Alexandre Madi; Carvalho-Costa, Filipe Anibal; Ribeiro de Andrade, Juliana da Silva; Gagliardi Leite, Jose Paulo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Minist Hlth, Rio De Janeiro, RJ, Brazil.
RP da Silva, MFM (corresponding author), Univ Barcelona, Dept Microbiol, Lab Virus Contaminants Water & Food, Fac Biol, Diagonal Ave 643, E-08028 Barcelona, Spain.
EM marcelle.figueira@gmail.com
RI Silva-Sales, Marcelle/D-9809-2015; LEITE, JOSE PAULO
   GAGLIARDI/AAY-1230-2020
OI Silva-Sales, Marcelle/0000-0002-4275-9627; Fialho, Alexandre
   Madi/0000-0002-5412-3896
FU Oswaldo Cruz Institute (IOC-Fiocruz); National Council for Scientific
   and Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq); Program of Excellence in Research
   (PROEP-IOC/Fiocruz/CNPq); PAPES VI/Fiocruz-CNPqNational Council for
   Scientific and Technological Development (CNPq); Brazilian Federal
   Agency for Support and Evaluation of Graduate Education (CAPES)CAPES
   [CAPES-MERCOSUL PPCP 023/2011]; General Coordination of Public Health
   Laboratories-Secretary of Health Surveillance (CGLAB/SVS/M of H); Carlos
   Chagas Filho Foundation for Research Support of Rio de Janeiro State
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ)
FX Grant sponsor: Oswaldo Cruz Institute (IOC-Fiocruz); Grant sponsor:
   National Council for Scientific and Technological Development (CNPq);
   Grant sponsor: Program of Excellence in Research
   (PROEP-IOC/Fiocruz/CNPq); Grant sponsor: PAPES VI/Fiocruz-CNPq; Grant
   sponsor: Brazilian Federal Agency for Support and Evaluation of Graduate
   Education (CAPES); Grant number: CAPES-MERCOSUL PPCP 023/2011; Grant
   sponsor: General Coordination of Public Health Laboratories-Secretary of
   Health Surveillance (CGLAB/SVS/M of H); Grant sponsor: Carlos Chagas
   Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ)
CR Anandan S, 2014, VACCINE, V32, pA33, DOI 10.1016/j.vaccine.2014.03.008
   Anderson EJ, 2004, LANCET INFECT DIS, V4, P91, DOI 10.1016/S1473-3099(04)00928-4
   Anderson EJ, 2015, J INFECTION, V70, P683, DOI 10.1016/j.jinf.2014.11.012
   [Anonymous], 2013, Wkly Epidemiol Rec, V88, P49
   Ategbo S, 2015, ARCH PEDIATRIE, V22, P323, DOI 10.1016/j.arcped.2014.11.006
   Banyai K, 2007, EMERG INFECT DIS, V13, P916, DOI 10.3201/eid1306.061181
   Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Caillere N, 2013, EUROSURVEILLANCE, V18, P8
   Carvalho-Costa FA, 2015, COMMUNICATION
   Castello AA, 2006, J CLIN MICROBIOL, V44, P2046, DOI 10.1128/JCM.02436-05
   Cotes-Cantillo K, 2014, VACCINE, V32, P3035, DOI 10.1016/j.vaccine.2014.03.064
   Cunliffe NA, 2009, EMERG INFECT DIS, V15, P87, DOI 10.3201/eid1501.080427
   de Oliveira LH, 2015, VACCINE, V33, pA248, DOI 10.1016/j.vaccine.2014.11.060
   Delogu R, 2015, J MED VIROL, V87, P1292, DOI 10.1002/jmv.24180
   Enweronu-Laryea CC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-287
   Fumian TM, 2016, J VIROL METHODS, V228, P123, DOI 10.1016/j.jviromet.2015.11.008
   Gomez MM, 2014, INFECT GENET EVOL, V28, P385, DOI 10.1016/j.meegid.2014.04.007
   Gunn L, 2012, J MED VIROL, V84, P2008, DOI 10.1002/jmv.23416
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Kirkwood CD, 2014, COMMUN DIS INTELL, V38, pE334
   Kittigul L, 2014, SE ASIAN J TROP MED, V45, P816
   Komoto S, 2014, INFECT GENET EVOL, V27, P277, DOI 10.1016/j.meegid.2014.08.002
   Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788
   Langa JS, 2016, J MED VIROL
   Leite JPG, 1996, ARCH VIROL, V141, P2365, DOI 10.1007/BF01718637
   Linhares AC, 2011, REV MED VIROL, V21, P89, DOI 10.1002/rmv.682
   Tort LFL, 2015, J MED VIROL, V87, P754, DOI 10.1002/jmv.24123
   Luchs A, 2016, ACTA TROP, V156, P87, DOI 10.1016/j.actatropica.2015.12.008
   Luchs A, 2014, BRAZ J INFECT DIS, V18, P53, DOI 10.1016/j.bjid.2013.05.010
   da Silva MFM, 2015, INFECT GENET EVOL, V30, P206, DOI 10.1016/j.meegid.2014.12.030
   da Silva MFM, 2013, INFECT GENET EVOL, V16, P200, DOI 10.1016/j.meegid.2013.01.004
   Marshall J, 2003, J CLIN VIROL, V28, P331, DOI 10.1016/S1386-6532(03)00081-7
   Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007
   Matthijnssens J, 2009, FUTURE MICROBIOL, V4, P1303, DOI 10.2217/FMB.09.96
   McDonald SM, 2012, J VIROL, V86, P9148, DOI 10.1128/JVI.01105-12
   Mijatovic-Rustempasic S, 2014, INFECT GENET EVOL, V21, P214, DOI 10.1016/j.meegid.2013.11.004
   Morillo SG, 2010, T ROY SOC TROP MED H, V104, P165, DOI 10.1016/j.trstmh.2009.07.023
   Nakajima H, 2001, LANCET, V357, P1950, DOI 10.1016/S0140-6736(00)05086-8
   Ndze VN, 2014, INFECT GENET EVOL, V28, P537, DOI 10.1016/j.meegid.2014.10.009
   Neves MAO, 2016, J MED VIROL, V88, P782, DOI 10.1002/jmv.24404
   O'Ryan M, 2015, HUM VACC IMMUNOTHER, V11, P584, DOI 10.1080/21645515.2015.1011019
   Pacilli M, 2015, CLIN INFECT DIS, V61, pE20, DOI 10.1093/cid/civ294
   Patel MM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3726
   Patton JT, 2012, DISCOV MED, V13, P85
   Pietruchinski E, 2006, J MED VIROL, V78, P1241, DOI 10.1002/jmv.20686
   Pietsch C, 2009, EMERG INFECT DIS, V15, P1512, DOI 10.3201/eid1509.090497
   Rahman M, 2007, J VIROL, V81, P2382, DOI 10.1128/JVI.01622-06
   Ray P, 2007, J CLIN MICROBIOL, V45, P3824, DOI 10.1128/JCM.01288-07
   Soares LD, 2012, ARCH VIROL, V157, P135, DOI 10.1007/s00705-011-1111-z
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Tatte VS, 2014, VACCINE, V32, pA68, DOI 10.1016/j.vaccine.2014.03.009
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0
   Wangchuk S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110795
   Zeng SQ, 2008, J VIROL METHODS, V153, P238, DOI 10.1016/j.jviromet.2008.08.004
NR 56
TC 10
Z9 10
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JAN
PY 2017
VL 89
IS 1
BP 64
EP 70
DI 10.1002/jmv.24605
PG 7
WC Virology
SC Virology
GA EB2CR
UT WOS:000387165200010
PM 27322509
DA 2020-12-08
ER

PT J
AU Ganime, AC
   Leite, JPG
   Figueiredo, CED
   Carvalho-Costa, FA
   Melgaco, FG
   Malta, FC
   Fumian, TM
   Miagostovich, MP
AF Ganime, Ana Carolina
   Leite, Jose Paulo G.
   da Silva Figueiredo, Carlos Eduardo
   Carvalho-Costa, Filipe A.
   Melgaco, Fabiana Gil
   Malta, Fabio Correia
   Fumian, Tulio M.
   Miagostovich, Marize P.
TI Dissemination of human adenoviruses and rotavirus species A on fomites
   of hospital pediatric units
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
DE Hospital infection; Neonatal intensive care unit; Hospital surfaces
ID PATHOGENS; SURFACES
AB Rotavirus A and human adenovirus dissemination were demonstrated both in a pediatric ward and in a neonatal intensive care unit (NICU) of the same pediatric hospital. Virus detection from fomites samples were higher in the pediatric ward (42.3% [137 out of 324]) than in the NICU (4.5% [7 out of 156]), revealing that cleaning processes used in our NICU are effective in reducing viral contamination, suggesting human adenovirus as a potential biomarker of contamination of hospital fomites. (C) 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
C1 [Ganime, Ana Carolina; Leite, Jose Paulo G.; Carvalho-Costa, Filipe A.; Melgaco, Fabiana Gil; Malta, Fabio Correia; Fumian, Tulio M.; Miagostovich, Marize P.] Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Rio De Janeiro, Brazil.
   [da Silva Figueiredo, Carlos Eduardo] Fundacao Oswaldo Cruz, Fernandes Figueira Natl Inst Hlth Women Children, Rio De Janeiro, Brazil.
RP Miagostovich, MP (corresponding author), Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Ave Brasil,4365 Pav Helio & Peggy Pereira, BR-21040360 Manguinho, RJ, Brazil.
EM acganime@ioc.fiocruz.br
RI LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020
FU Oswaldo Cruz Institute (IOC); National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq); Program of Excellence in Research
   (PROEP - IOC/FIOCRUZ/CNPq); PAPES VI/FIOCRUZ-CNPq; Carlos Chagas Filho
   Foundation for Research Support of Rio de Janeiro State (FAPERJ)Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ)
FX This work is within the scope of the activities of FIOCRUZ because it is
   a collaborating center of the Pan American Health Organization/World
   Health Organization Department of Public and Environmental Health. This
   research was supported by funds from the Oswaldo Cruz Institute (IOC);
   the National Council for Scientific and Technological Development
   (CNPq); the Program of Excellence in Research (PROEP -
   IOC/FIOCRUZ/CNPq); PAPES VI/FIOCRUZ-CNPq; and the Carlos Chagas Filho
   Foundation for Research Support of Rio de Janeiro State (FAPERJ).
CR Ayliffe G., 2000, CONTROL HOSP INFECT
   Gallimore CI, 2006, J CLIN MICROBIOL, V44, P395, DOI 10.1128/JCM.44.2.395-399.2006
   Ganime AC, 2014, J MED VIROL, V86, P2065, DOI 10.1002/jmv.23907
   Ganime AC, 2012, AM J INFECT CONTROL, V40, P544, DOI 10.1016/j.ajic.2011.07.017
   Hernroth BE, 2002, APPL ENVIRON MICROB, V68, P4523, DOI 10.1128/AEM.68.9.4523-4533.2002
   Ichihara MYT, 2015, T ROY SOC TROP MED H, V109, P454, DOI 10.1093/trstmh/trv041
   Kelley CJ, 2010, NEONATAL NETW, V29, P297, DOI 10.1891/0730-0832.29.5.297
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130
   Zeng SQ, 2008, J VIROL METHODS, V153, P238, DOI 10.1016/j.jviromet.2008.08.004
NR 9
TC 6
Z9 6
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD NOV 1
PY 2016
VL 44
IS 11
BP 1411
EP 1413
DI 10.1016/j.ajic.2016.04.207
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EE3QQ
UT WOS:000389510700061
PM 27217348
DA 2020-12-08
ER

PT J
AU Fioretti, JM
   Rocha, MS
   Fumian, TM
   Ginuino, A
   da Silva, TP
   de Assis, MR
   Rodrigues, JD
   Carvalho-Costa, FA
   Miagostovich, MP
AF Fioretti, J. M.
   Rocha, M. S.
   Fumian, T. M.
   Ginuino, A.
   da Silva, T. P.
   de Assis, M. R.
   Rodrigues, J. de S.
   Carvalho-Costa, F. A.
   Miagostovich, M. P.
TI Occurrence of human sapoviruses in wastewater and stool samples in Rio
   De Janeiro, Brazil
SO JOURNAL OF APPLIED MICROBIOLOGY
LA English
DT Article
DE Brazil; diarrheal disease; genotypes; sapovirus; wastewater
ID ACUTE GASTROENTERITIS; MOLECULAR-DETECTION; CHILDREN; CALICIVIRUS;
   INFECTIONS; OUTBREAKS; EPIDEMIOLOGY; PREVALENCE; ASTROVIRUS; NOROVIRUS
AB AimTo determine the prevalence and molecular epidemiology of human sapovirus (SaV) in both wastewater and stool samples in a 3-year (2012-2014) surveillance study performed in Rio de Janeiro State, Brazil.
   Methods and ResultsA total of 156 wastewater and 341 stool samples were analysed using quantitative real-time PCR. SaV was detected in 35% (12/341) in stool samples with virus load concentrations ranging from 10(4) to 10(9) genome copies per gram (gcg(-1)), and in 330% (51/156) wastewater samples, with range concentration varying from 10(4) to 10(6)gcl(-1). Partial genome sequencing of wastewater and stool samples revealed the circulation of genotypes GI.1, GI.2, GI.6, GII.1 and GV.1.
   ConclusionThis study demonstrated the prevalence of human SaV in acute gastroenteritis (AGE) cases and revealed, for the first time, the environmental dissemination of those viruses in Brazil.
   Significance and Impact of the StudySaV diagnosis should be considered in hospitalized children with AGE and the higher positive rate detection in environmental samples suggests that SaV infection could be underestimated or associated with asymptomatic cases.
C1 [Fioretti, J. M.; Rocha, M. S.; Fumian, T. M.; Ginuino, A.; da Silva, T. P.; de Assis, M. R.; Rodrigues, J. de S.; Miagostovich, M. P.] Fundacao Oswaldo Cruz, Lab Comparat & Environm Virol, Inst Oswaldo Cruz, Ave Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.
   [Carvalho-Costa, F. A.] Fundacao Oswaldo Cruz, Lab Epidemiol & Mol Systemat, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Fioretti, JM (corresponding author), Fundacao Oswaldo Cruz, Lab Comparat & Environm Virol, Inst Oswaldo Cruz, Ave Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.
EM juliafior@ioc.fiocruz.br
FU FaperjCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/102.845/2012]; CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX We are most grateful to Tatsuya Nagata from the Departamento de Biologia
   Celular, Universidade de Brasilia, DF, Brazil for the kind provision of
   plasmids that contained the SaV genome. The project was financially
   supported by Faperj (E-26/102.845/2012) and CNPq. This research study is
   under the scope of the activities of Fiocruz as a Collaborating Center
   of PAHO/WHO of Public and Environmental Health.
CR Aragao GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056608
   Bucardo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098201
   Bucardo F, 2012, EMERG INFECT DIS, V18, P1875, DOI 10.3201/eid1811.111581
   Calgua B, 2013, J VIROL METHODS, V187, P215, DOI 10.1016/j.jviromet.2012.10.012
   CHIBA S, 1979, J MED VIROL, V4, P249, DOI 10.1002/jmv.1890040402
   de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666
   Di Bartolo I, 2013, FOOD ENVIRON VIROL, V5, P236, DOI 10.1007/s12560-013-9124-2
   Farkas T, 2006, J CLIN MICROBIOL, V44, P3674, DOI 10.1128/JCM.01087-06
   Green KY, 2013, FIELDS VIROLOGY, P582
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Hansman GS, 2007, EMERG INFECT DIS, V13, P133, DOI 10.3201/eid1301.061047
   Haramoto E, 2007, J APPL MICROBIOL, V103, P2153, DOI 10.1111/j.1365-2672.2007.03453.x
   Iizuka S, 2013, FOOD ENVIRON VIROL, V5, P119, DOI 10.1007/s12560-013-9109-1
   Iritani N, 2016, J MED VIROL, V88, P1187, DOI 10.1002/jmv.24451
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Kitajima M., 2014, SCI TOTAL ENVIRON, V1, P488
   Kitajima M, 2011, APPL ENVIRON MICROB, V77, P4226, DOI 10.1128/AEM.00088-11
   Kitajima M, 2010, APPL ENVIRON MICROB, V76, P2461, DOI 10.1128/AEM.02739-09
   Kobayashi S, 2012, ARCH VIROL, V157, P1995, DOI 10.1007/s00705-012-1394-8
   Lee LE, 2012, EMERG INFECT DIS, V18, P873, DOI 10.3201/eid1805.111843
   Liu XF, 2015, J CLIN VIROL, V68, P83, DOI 10.1016/j.jcv.2015.05.001
   Malasao R, 2008, J MED VIROL, V80, P1749, DOI 10.1002/jmv.21244
   MATSON DO, 1990, PEDIATR INFECT DIS J, V9, P190, DOI 10.1097/00006454-199003000-00009
   Medici MC, 2012, J MED VIROL, V84, P643, DOI 10.1002/jmv.23231
   de Oliveira DMM, 2014, J MED VIROL, V86, P1569, DOI 10.1002/jmv.23791
   Murray TY, 2016, J CLIN VIROL, V76, P24, DOI 10.1016/j.jcv.2016.01.003
   Nakata S, 1998, J CLIN MICROBIOL, V36, P3160, DOI 10.1128/JCM.36.11.3160-3163.1998
   NAKATA S, 1988, J CLIN MICROBIOL, V26, P2001, DOI 10.1128/JCM.26.10.2001-2005.1988
   Nakata S, 2000, J INFECT DIS, V181, P2029, DOI 10.1086/315500
   Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699
   Oka T, 2012, ARCH VIROL, V157, P349, DOI 10.1007/s00705-011-1161-2
   Page N, 2016, J CLIN VIROL, V78, P82, DOI 10.1016/j.jcv.2016.03.013
   Pang XL, 2000, J INFECT DIS, V181, pS288, DOI 10.1086/315590
   Prado T, 2012, T ROY SOC TROP MED H, V106, P104, DOI 10.1016/j.trstmh.2011.10.005
   Rajal VB, 2007, WATER RES, V41, P1411, DOI 10.1016/j.watres.2006.12.034
   Sano D, 2011, APPL ENVIRON MICROB, V77, P1111, DOI 10.1128/AEM.01721-10
   Scheuer KA, 2013, J CLIN MICROBIOL, V51, P2344, DOI 10.1128/JCM.00865-13
   Svraka S, 2010, J CLIN MICROBIOL, V48, P2191, DOI 10.1128/JCM.02427-09
   Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Usuku S, 2014, JPN J INFECT DIS, V67, P411, DOI 10.7883/yoken.67.411
   Xavier MPTP, 2009, BRAZ J MED BIOL RES, V42, P438, DOI 10.1590/S0100-879X2009000500007
   Yoneda M, 2017, JPN J INFECT DIS, V70, P87, DOI 10.7883/yoken.JJID.2015.529
   Yoshida T, 2009, J CLIN VIROL, V45, P67, DOI 10.1016/j.jcv.2009.03.003
NR 44
TC 14
Z9 14
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1364-5072
EI 1365-2672
J9 J APPL MICROBIOL
JI J. Appl. Microbiol.
PD SEP
PY 2016
VL 121
IS 3
BP 855
EP 862
DI 10.1111/jam.13205
PG 8
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA DW1LO
UT WOS:000383404900024
PM 27306455
OA Bronze
DA 2020-12-08
ER

PT J
AU Nunes, BC
   Pavan, MG
   Jaeger, LH
   Monteiro, KJL
   Xavier, SCC
   Monteiro, FA
   Boia, MN
   Carvalho-Costa, FA
AF Nunes, Beatriz Coronato
   Pavan, Marcio G.
   Jaeger, Lauren H.
   Monteiro, Kerla J. L.
   Xavier, Samanta C. C.
   Monteiro, Fernando A.
   Boia, Marcio N.
   Carvalho-Costa, Filipe A.
TI Spatial and Molecular Epidemiology of Giardia intestinalis Deep in the
   Amazon, Brazil
SO PLOS ONE
LA English
DT Article
ID SOIL-TRANSMITTED HELMINTHS; PARASITIC INFECTIONS; CHILDREN; PROTOZOA;
   DUODENALIS; HEALTH; SCHOOLCHILDREN; PREVALENCE; LAMBLIA; SAMPLES
AB Background
   Current control policies for intestinal parasitosis focuses on soil-transmitted helminths, being ineffective against Giardia intestinalis, a highly prevalent protozoon that impacts children's nutritional status in developing countries. The objective of this study was to explore spatial and molecular epidemiology of Giardia intestinalis in children of Amerindian descent in the Brazilian Amazon.
   Methodology/Principal Findings
   A cross sectional survey was performed in the Brazilian Amazon with 433 children aged 1 to 14 years. Fecal samples were processed through parasitological techniques and molecular characterization. Prevalence of G. intestinalis infection was 16.9%(73/433), reaching 22.2% (35/158) among children aged 2-5 years, and a wide distribution throughout the city with some hot spots. Positivity-rate was similar among children living in distinct socio-economic strata (48/280 [17.1%] and 19/116 [16.4%] below and above the poverty line, respectively). Sequencing of the beta-giardin gene revealed 52.2% (n = 12) of assemblage A and 47.8% (n = 11) of assemblage B with high haplotype diversity for the latter. The isolates clustered into two well-supported G. intestinalis clades. A total of 38 haplotypes were obtained, with the following subassemblages distribution: 5.3% (n = 2) AII, 26.3% (n = 10) AIII, 7.9% (n = 3) BIII, and 60.5%(n = 23) new B genotypes not previously described.
   Conclusions/Significance
   Giardia intestinalis infection presents a high prevalence rate among Amerindian descended children living in Santa Isabel do Rio Negro/Amazon. The wide distribution observed in a small city suggests the presence of multiple sources of infection, which could be related to environmental contamination with feces, possibly of human and animal origin, highlighting the need of improving sanitation, safe water supply and access to diagnosis and adequate treatment of infections.
C1 [Nunes, Beatriz Coronato; Pavan, Marcio G.; Jaeger, Lauren H.; Monteiro, Kerla J. L.; Xavier, Samanta C. C.; Monteiro, Fernando A.; Boia, Marcio N.; Carvalho-Costa, Filipe A.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe A.] Fundacao Oswaldo Cruz, Teresina, Piaui, Brazil.
RP Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.; Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz, Teresina, Piaui, Brazil.
EM guaratiba@ioc.fiocruz.br
RI Pavan, Marcio G/F-3270-2015; Pavan, Marcio/AAW-5813-2020
OI Pavan, Marcio G/0000-0002-5699-242X; Pavan, Marcio/0000-0002-5699-242X;
   Xavier, Samanta Cristina/0000-0002-3475-0075
FU Oswaldo Cruz Foundation (Fiocruz); Brazilian Federal Agency for Support
   and Evaluation of Graduate Education (CAPES)/Brazilian Ministry of
   Education; Ministry of Social Development, in the context of the
   CAPES-Fiocruz-Brazil
FX This work was supported by the Oswaldo Cruz Foundation (Fiocruz) and the
   Brazilian Federal Agency for Support and Evaluation of Graduate
   Education (CAPES)/Brazilian Ministry of Education and Ministry of Social
   Development, in the context of the CAPES-Fiocruz-Brazil without Poverty
   Plan.
CR Adam RD, 2013, GENOME BIOL EVOL, V5, P2498, DOI 10.1093/gbe/evt197
   Barry MA, 2013, PEDIATR CLIN N AM, V60, P471, DOI 10.1016/j.pcl.2012.12.011
   Caccio SA, 2002, INT J PARASITOL, V32, P1023, DOI 10.1016/S0020-7519(02)00068-1
   Caccio SM, 2010, EXP PARASITOL, V124, P107, DOI 10.1016/j.exppara.2009.02.007
   Carvalho-Costa Filipe Anibal, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P147, DOI 10.1590/S0036-46652007000300003
   David EB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0714-8
   Durigan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115489
   Ehsan AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118239
   Feng YY, 2011, CLIN MICROBIOL REV, V24, P110, DOI 10.1128/CMR.00033-10
   Ferreira FS, 2015, J TROP PEDIATRICS, V61, P106, DOI 10.1093/tropej/fmu078
   Fletcher SM, 2012, CLIN MICROBIOL REV, V25, P420, DOI 10.1128/CMR.05038-11
   Garbossa G, 2013, PATHOG GLOB HEALTH, V107, P141, DOI 10.1179/2047773213Y.0000000087
   Ignatius R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001677
   Jenkins EJ, 2013, ADV PARASIT, V82, P33, DOI 10.1016/B978-0-12-407706-5.00002-2
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Luther A, 2015, F1000PRIME REP, V7, P62, DOI 10.12703/P7-62
   Macchioni F, 2015, AM J TROP MED HYG, V92, P794, DOI 10.4269/ajtmh.14-0039
   Messing J, 1993, Methods Mol Biol, V23, P9
   Monis PT, 2009, TRENDS PARASITOL, V25, P93, DOI 10.1016/j.pt.2008.11.006
   Nematian J, 2008, ANN TROP MED PARASIT, V102, P209, DOI 10.1179/136485908X267876
   Nygard K, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-141
   Quihui L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-85
   RITCHIE LAWRENCE S., 1948, BULL U S ARMY MED DEPT, V8, P326
   Robertson LJ, 2011, GIARDIA: A MODEL ORGANISM, P29
   Trivino-Valencia J, 2016, PARASITOL RES, V115, P1789, DOI 10.1007/s00436-016-4917-5
   Turkeltaub JA, 2015, CURR OPIN GASTROEN, V31, P38, DOI 10.1097/MOG.0000000000000135
   Verhagen LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077581
NR 27
TC 10
Z9 11
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 8
PY 2016
VL 11
IS 7
AR e0158805
DI 10.1371/journal.pone.0158805
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DR6IK
UT WOS:000380005400128
PM 27392098
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Mota, AD
   Carvalho-Costa, FA
AF Mota, Alessandra de Martino
   Carvalho-Costa, Filipe Anibal
TI Varicella zoster virus related deaths and hospitalizations before the
   introduction of universal vaccination with the tetraviral vaccine
SO JORNAL DE PEDIATRIA
LA English
DT Article
DE Varicella-zoster virus; Varicella; Tetraviral vaccine; Deaths;
   Hospitalizations
ID HERPES-ZOSTER; ROUTINE VACCINATION; COST-EFFECTIVENESS; UNITED-STATES;
   EPIDEMIOLOGY; COMPLICATIONS; PROGRAM; IMPACT; RUBELLA; MEASLES
AB Objective: To characterize varicella zoster virus-related deaths and hospitalizations in Brazil before universal vaccination with the tetravalent (measles, mumps, rubella, and varicella) vaccine, attempting to collect baseline data on varicella morbidity and mortality in order to evaluate the impact of the varicella vaccination program.
   Methods: Varicella-associated mortality data were evaluated between 1996 and 2011 and varicella zoster virus-associated hospitalizations between 1998 and 2013. Data were gathered from the Informatics Department of the Unified Health System, considering the International Classification of Diseases, 10th Revision, code B01. All age groups were assessed. Varicella-specific mortality rates were calculated and seasonality of varicella-zoster virus-associated hospitalizations was described.
   Results: There were 2334 varicella deaths between 1996 and 2011, 19.3% in infants aged less than 1 year and 36% in children from 1 to 4 years. In infants under 1 year, varicella mortality rates reached 3.2/100,000/year. In children aged 1-4 years, varicella mortality rates reach 1.64/100,000/year. Average annual mortality rates for varicella in Brazil are 0.88/100,000 in infants under 1 year and 0.40/100,000 in children aged 1-4 years. The total number of hospitalizations associated with varicella zoster virus was 62,246 from 2008 to 2013. Varicella-associated hospitalizations have a seasonal distribution in children, peaking in November. In the elderly, monthly averages of herpes zoster-associated hospitalizations present no significant seasonal variation.
   Conclusions: Varicella is associated, in the pre-vaccine period, to significant morbidity and mortality in Brazil. The universal vaccination program is expected to decrease the disease burden from varicella. (C) 2016 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license.
C1 [Mota, Alessandra de Martino; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz Fiocruz, IOC, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, RJ, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz Fiocruz, Escritorio Reg Fiocruz Piaui, Teresina, PI, Brazil.
RP Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz Fiocruz, IOC, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, RJ, Brazil.; Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Escritorio Reg Fiocruz Piaui, Teresina, PI, Brazil.
EM guaratiba@ioc.fiocruz.br
FU Fiocruz
FX This study was supported with funds from Fiocruz.
CR Arvin A, 2012, PRINCIPLES PRACTICE, P1035
   Baxter R, 2014, PEDIATRICS, V134, P24, DOI 10.1542/peds.2013-4251
   Bozzola E, 2012, VACCINE, V30, P5785, DOI 10.1016/j.vaccine.2012.05.057
   Breuer J, 2011, BMJ CLIN EVID, V2011
   Brisson M, 2002, VACCINE, V20, P2500, DOI 10.1016/S0264-410X(02)00180-9
   Ferreira RA, 2013, DINAMICADAS DOENCAS, V2, P1951
   Gershon AA, 2008, J INFECT DIS, V197, pS242, DOI 10.1086/522151
   Goldman GS, 2013, VACCINE, V31, P1680, DOI 10.1016/j.vaccine.2012.05.050
   Heininger U, 2006, LANCET, V368, P1365, DOI 10.1016/S0140-6736(06)69561-5
   Lu L, 2013, PEDIATR INFECT DIS J, V32, pE314, DOI 10.1097/INF.0b013e31828d948b
   Marin Mona, 2010, Morbidity and Mortality Weekly Report, V59, P1
   Ozaki T, 2013, J INFECT CHEMOTHER, V19, P188, DOI 10.1007/s10156-013-0577-x
   Pena-Rey I, 2009, REV ESP SALUD PUBLIC, V83, P711, DOI 10.1590/s1135-57272009000500012
   PREBLUD SR, 1981, PEDIATRICS, V68, P14
   Prymula R, 2014, LANCET, V383, P1313, DOI 10.1016/S0140-6736(12)61461-5
   Quian J, 2008, ARCH DIS CHILD, V93, P845, DOI 10.1136/adc.2007.126243
   Reynolds MA, 2008, J INFECT DIS, V197, pS224, DOI 10.1086/522162
   Russell ML, 2014, VACCINE, V32, P6319, DOI 10.1016/j.vaccine.2013.09.018
   Science M, 2014, J PEDIATR-US, V165, P779, DOI 10.1016/j.jpeds.2014.06.014
   Streng A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-303
   TAKAHASH.M, 1974, LANCET, V2, P1288, DOI 10.1016/S0140-6736(74)90144-5
   Valentim J, 2008, VACCINE, V26, P6281, DOI 10.1016/j.vaccine.2008.07.021
NR 22
TC 11
Z9 11
U1 1
U2 7
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD JUL-AUG
PY 2016
VL 92
IS 4
BP 361
EP 366
DI 10.1016/j.jped.2015.10.003
PG 6
WC Pediatrics
SC Pediatrics
GA DY3VW
UT WOS:000385025000006
PM 26969400
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Portes, SAR
   Volotao, ED
   Rocha, MS
   Rebelo, MC
   Xavier, MDTP
   de Assis, RM
   Rose, TL
   Miagostovich, MP
   Leite, JPG
   Carvalho-Costa, FA
AF Rodrigues Portes, Silvana Augusta
   Volotao, Eduardo de Mello
   Rocha, Monica Simoes
   Rebelo, Maria Cristina
   Trindade Pinheiro Xavier, Maria da Penha
   de Assis, Rosane Maria
   Rose, Tatiana Lundgren
   Miagostovich, Marize Pereira
   Gagliardi Leite, Jose Paulo
   Carvalho-Costa, Filipe Anibal
TI A non-enteric adenovirus A12 gastroenteritis outbreak in Rio de Janeiro,
   Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE gastroenteritis; adenovirus; quantitative polymerase chain reaction
ID ENTERIC VIRUSES; MOLECULAR CHARACTERIZATION; VIRAL GASTROENTERITIS;
   AICHI VIRUS; CHILDREN; PCR; PREVALENCE; ASTROVIRUS; ROTAVIRUS; DIVERSITY
AB A gastroenteritis outbreak that occurred in 2013 in a low-income community in Rio de Janeiro was investigated for the presence of enteric viruses, including species A rotavirus (RVA), norovirus (NoV), astrovirus (HAstV), bocavirus (HBoV), aichivirus (AiV), and adenovirus (HAdV). Five of nine stool samples (83%) from patients were positive for HAdV, and no other enteric viruses were detected. Polymerase chain reaction products were sequenced and subjected to phylogenetic analysis, which revealed four strains and one strain of non-enteric HAdV-A12 and HAdV-F41, respectively. The HAdV-A12 nucleotide sequences shared 100% nucleotide similarity. Viral load was assessed using a TaqMan real-time PCR assay. Stool samples that were positive for HAdV-A12 had high viral loads (mean 1.9 x 10(7) DNA copies/g stool). All four patients with HAdV-A12 were <25 months of age and had symptoms of fever and diarrhoea. Evaluation of enteric virus outbreaks allows the characterisation of novel or unique diarrhoea-associated viruses in regions where RVA vaccination is routinely performed.
C1 [Rodrigues Portes, Silvana Augusta; Volotao, Eduardo de Mello; Rocha, Monica Simoes; Trindade Pinheiro Xavier, Maria da Penha; de Assis, Rosane Maria; Rose, Tatiana Lundgren; Miagostovich, Marize Pereira; Gagliardi Leite, Jose Paulo; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Virol Comparada & Ambiental, Rio De Janeiro, RJ, Brazil.
   [Rebelo, Maria Cristina] Lab Cent Saude Publ, Rio De Janeiro, RJ, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Escritorio Tecn Reg Fiocruz Piaui, Teresina, PI, Brazil.
RP Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Virol Comparada & Ambiental, Rio De Janeiro, RJ, Brazil.; Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz, Escritorio Tecn Reg Fiocruz Piaui, Teresina, PI, Brazil.
EM guaratiba@ioc.fiocruz.br
RI LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020
OI Xavier, Maria/0000-0001-9657-1980
CR Akihara S, 2005, ARCH VIROL, V150, P2061, DOI 10.1007/s00705-005-0540-y
   Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001
   Carvalho-Costa FA, 2011, PEDIATR INFECT DIS J, V30, pS35, DOI 10.1097/INF.0b013e3181fefd5f
   Chitambar S, 2012, INT J ENV RES PUB HE, V9, P895, DOI 10.3390/ijerph9030895
   Corcoran MS, 2014, EUR J CLIN MICROBIOL, V33, P1663, DOI 10.1007/s10096-014-2135-6
   Elhag WI, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-209
   Hernroth BE, 2002, APPL ENVIRON MICROB, V68, P4523, DOI 10.1128/AEM.68.9.4523-4533.2002
   Ishiko H, 2008, J CLIN MICROBIOL, V46, P2002, DOI 10.1128/JCM.01835-07
   Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416
   Lee JI, 2012, MICROBIOL IMMUNOL, V56, P523, DOI 10.1111/j.1348-0421.2012.00469.x
   Lekana-Douki SE, 2015, INT J INFECT DIS, V34, P90, DOI 10.1016/j.ijid.2015.03.009
   Moyo SJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0666-1
   Ren ZZ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-412
   de Andrade JDR, 2014, J CLIN VIROL, V61, P345, DOI 10.1016/j.jcv.2014.08.024
   Ferreira MSR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033754
   Portes SAR, 2015, CURR HIV RES, V13, P325, DOI 10.2174/1570162X13666150511145950
   Yamashita T, 2000, J CLIN MICROBIOL, V38, P2955, DOI 10.1128/JCM.38.8.2955-2961.2000
NR 17
TC 14
Z9 14
U1 0
U2 2
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD JUN
PY 2016
VL 111
IS 6
BP 403
EP 406
DI 10.1590/0074-02760160030
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DQ0LC
UT WOS:000378889800008
PM 27223654
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Calegar, DA
   Nunes, BC
   Monteiro, KJL
   dos Santos, JP
   Toma, HK
   Gomes, TF
   Lima, MM
   Boia, MN
   Carvalho-Costa, FA
AF Calegar, Deiviane Aparecida
   Nunes, Beatriz Coronato
   Lima Monteiro, Kerla Joeline
   dos Santos, Jessica Pereira
   Toma, Helena Keiko
   Gomes, Tais Ferreira
   Lima, Marli Maria
   Boia, Marcio Neves
   Carvalho-Costa, Filipe Anibal
TI Frequency and molecular characterisation of Entamoeba histolytica,
   Entamoeba dispar, Entamoeba moshkovskii, and Entamoeba hartmanni in the
   context of water scarcity in northeastern Brazil
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE parasites; protozoa; entamoebiasis; epidemiology; Brazil
ID INTESTINAL PROTOZOA; INFECTIONS; PCR; HEALTH; IMPACT
AB This study aimed to estimate the frequency, associated factors, and molecular characterisation of Entamoeba histolytica, Entamoeba dispar, Entamoeba moshkovskii, and Entamoeba hartmanni infections. We performed a survey (n = 213 subjects) to obtain parasitological, sanitation, and sociodemographic data. Faecal samples were processed through flotation and centrifugation methods. E. histolytica, E. dispar, E. moshkovskii, and E. hartmanni were identified by nested-polymerase chain reaction (PCR). The overall prevalence of infection was 22/213 (10.3%). The infection rate among subjects who drink rainwater collected from roofs in tanks was higher than the rate in subjects who drink desalinated water pumped from wells; similarly, the infection rate among subjects who practice open defecation was significantly higher than that of subjects with latrines. Out of the 22 samples positive for morphologically indistinguishable Entamoeba species, the differentiation by PCR was successful for 21. The species distribution was as follows: 57.1% to E. dispar, 23.8% to E. histolytica, 14.3% to E. histolytica and E. dispar, and 4.8% E. dispar and E. hartmanni. These data suggest a high prevalence of asymptomatic infection by the group of morphologically indistinguishable Entamoeba histolytica/dispar/moshkovskii complex and E. hartmanni species. In this context of water scarcity, the sanitary and socioenvironmental characteristics of the region appear to favour transmission.
C1 [Calegar, Deiviane Aparecida; Boia, Marcio Neves] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, Rio De Janeiro, RJ, Brazil.
   [Nunes, Beatriz Coronato; Lima Monteiro, Kerla Joeline; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, RJ, Brazil.
   [dos Santos, Jessica Pereira; Carvalho-Costa, Filipe Anibal] Escritorio Tecn Reg Fiocruz Piaui, Fundacao Oswaldo Cruz, Sao Paulo, Brazil.
   [Toma, Helena Keiko] Univ Fed Rio de Janeiro, Lab Diagnost Mol & Hematol, Rio De Janeiro, RJ, Brazil.
   [Gomes, Tais Ferreira; Lima, Marli Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Ecoepidemiol Doenca Chagas, Rio De Janeiro, RJ, Brazil.
RP Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, RJ, Brazil.; Carvalho-Costa, FA (corresponding author), Escritorio Tecn Reg Fiocruz Piaui, Fundacao Oswaldo Cruz, Sao Paulo, Brazil.
EM guaratiba@ioc.fiocruz.br
OI SANTOS, JESSICA/0000-0002-1639-517X
CR Bosch DE, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.30
   Braga LL, 1998, J CLIN MICROBIOL, V36, P3044, DOI 10.1128/JCM.36.10.3044-3045.1998
   BRUMPT E., 1926, Bulletin de la Societe de Pathologie Exotique, V19, P399
   Brumpt E., 1949, PRECIS PARASITOLOGIE
   Chacin-Bonilla L, 2013, REV MED CHILE, V141, P609, DOI 10.4067/S0034-98872013000500009
   Costa CAX, 2010, EUR J HISTOCHEM, V54, P170, DOI 10.4081/ejh.2010.e39
   Efunshile MA, 2015, AM J TROP MED HYG, V93, P257, DOI 10.4269/ajtmh.14-0781
   Faust E. C., 1938, American Journal of Tropical Medicine, V18, P169
   Fonseca JE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002943
   GOLDMAN M, 1969, B WORLD HEALTH ORGAN, V40, P355
   Gomes TD, 2014, SCI WORLD J, DOI 10.1155/2014/645084
   Jackson TFHG, 1998, INT J PARASITOL, V28, P181, DOI 10.1016/S0020-7519(97)00177-X
   Lau YL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-250
   Lin Chung-Cheng, 2013, Case Rep Gastroenterol, V7, P438, DOI 10.1159/000355880
   Nair GV, 2014, CURR OPIN INFECT DIS, V27, P465, DOI 10.1097/QCO.0000000000000095
   Nath J, 2015, PARASITOLOGY, V142, P1318, DOI 10.1017/S0031182015000669
   Ngui R, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-187
   Ojha SC, 2014, J INFECT DEV COUNTR, V8, P5, DOI 10.3855/jidc.3183
   Oliveira FMS, 2015, TROP PARASITOL, V10
   Paglia MG, 2004, ACTA TROP, V92, P273, DOI 10.1016/j.actatropica.2004.09.003
   Parija SC, 2005, J HEALTH POPUL NUTR, V23, P292
   Pimenta PEP, 2002, J EUKARYOT MICROBIOL, V49, P209, DOI 10.1111/j.1550-7408.2002.tb00525.x
   Ralston KS, 2011, TRENDS PARASITOL, V27, P253, DOI 10.1016/j.pt.2011.02.006
   Ramos F, 2005, AM J TROP MED HYG, V73, P87, DOI 10.4269/ajtmh.2005.73.87
   Rasella D, 2013, CAD SAUDE PUBLICA, V29, P40, DOI 10.1590/S0102-311X2013000100006
   RITCHIE LAWRENCE S., 1948, BULL U S ARMY MED DEPT, V8, P326
   Skappak C, 2014, CAN J GASTROENTEROL, V28, P355, DOI 10.1155/2014/745130
   Thibeaux R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003824
   Tshalaia L. E., 1941, Medical Parasitology and Parasitic Diseases Moscow, V10, P244
   Turkeltaub JA, 2015, CURR OPIN GASTROEN, V31, P38, DOI 10.1097/MOG.0000000000000135
   WHO, 1997, EPIDEMIOL B, V18, P13
   Wuerz T, 2012, CAN J GASTROENTEROL, V26, P729, DOI 10.1155/2012/852835
   YOUNG KH, 1979, J CLIN MICROBIOL, V10, P852, DOI 10.1128/JCM.10.6.852-853.1979
NR 33
TC 17
Z9 17
U1 0
U2 4
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD FEB
PY 2016
VL 111
IS 2
BP 114
EP 119
DI 10.1590/0074-02760150383
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DE3IW
UT WOS:000370522900005
PM 26841049
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU do Nascimento, JAA
   Guimaraes, LM
   Carvalho-Costa, FA
AF Alves do Nascimento, Joyce Anny
   Guimaraes, Lucas Melo
   Carvalho-Costa, Filipe Anibal
TI Malaria epidemiology in the State of Piaui, Northeastern Brazil: a
   retrospective study with secondary data
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Epidemiology; Malaria; health surveillance
ID MARANHAO
AB Introduction: Malaria is not considered endemic in State of Piaui. Methods: Malaria epidemiology was examined using surveillance data. Results: During 2002-2013, of the 484 cases of malaria, 217 were classified as probably acquired in Piaui, most frequently in the Campo Largo, Buriti dos Lopes, and Luzilandia municipalities, and 267 were considered probably imported, from the States of Para, Maranhao, Amazonas, Roraima, and Rondonia. Probably-imported cases occurred throughout the year, while 80.2% of the probably-acquired cases occurred in April-August, peaking at the end of the rainy season. Conclusions: Malaria surveillance should be intensified. Further ecoepidemiological and entomological studies are needed.
C1 [Alves do Nascimento, Joyce Anny; Guimaraes, Lucas Melo; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, RJ, Brazil.
   [Alves do Nascimento, Joyce Anny; Guimaraes, Lucas Melo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Programa Posgrad Med Trop, Rio De Janeiro, RJ, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Escritorio Tecn Reg, Teresina, Piaui, Brazil.
RP Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, RJ, Brazil.
EM guaratiba@ioc.fiocruz.br
FU FIOCRUZ, Brazilian Ministry of Health
FX This study comprises the work towards a Master's Degree in Tropical
   Medicine at the Oswaldo Cruz Foundation (FIOCRUZ)/Brazilian Ministry of
   Health for J.A.A. do Nascimento. Funding was provided by FIOCRUZ,
   Brazilian Ministry of Health. We thank Dr. Lindsay Carpp (Center for
   Infectious Disease Research, Seattle, WA) for English editing and
   critical revision of the manuscript.
CR Raposo CCBS, 2013, REV SOC BRAS MED TRO, V46, P67, DOI 10.1590/0037-868212382013
   Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364
   Cabral AC, 2010, T ROY SOC TROP MED H, V104, P556, DOI 10.1016/j.trstmh.2010.03.008
   Chagas MFB, 2005, REV SOC BRAS MED S1, V38, P329
   Costa AD, 2010, REV SOC BRAS MED TRO, V43, P571, DOI 10.1590/S0037-86822010000500020
   da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001
   de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228
   Hahn MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085725
   Maselli LMF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-224
   Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115
   Parise EV, 2011, REV INST MED TROP SP, V53, P141, DOI 10.1590/S0036-46652011000300005
   Pedro RS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-245
   Peiter PC, 2013, CAD SAUDE PUBLICA, V29, P2497, DOI 10.1590/0102-311X00042213
   Portal da Saude do SUS, 2015, SIT EP DAD
   Rebelo JMM, 2007, CAD SAUDE PUBLICA, V23, P2959, DOI 10.1590/S0102-311X2007001200017
NR 15
TC 2
Z9 2
U1 0
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JAN-FEB
PY 2016
VL 49
IS 1
BP 99
EP 103
DI 10.1590/0037-8682-0153-2015
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DH5RA
UT WOS:000372848300015
PM 27163571
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Guimaraes, LM
   Carneiro, ELND
   Carvalho-Costa, FA
AF Guimaraes, Lucas Melo
   Neves da Costa Carneiro, Eduilson Livio
   Carvalho-Costa, Filipe Anibal
TI Increasing incidence of pertussis in Brazil: a retrospective study using
   surveillance data
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Pertussis; Bordetella pertussis; Epidemiology; Vaccination; Brazil
ID BORDETELLA-PERTUSSIS; UNITED-STATES; EPIDEMIOLOGY; CHILDREN;
   IMMUNIZATION; VACCINATION; CALIFORNIA; STILL; AGE
AB Background: Many countries have reported an increase in the incidence of pertussis, which has become a global public health concern.
   Methods: In this study, the epidemiology of pertussis in Brazil was assessed retrospectively using surveillance data gathered from case notification forms from 2007 to 2014.
   Results: From 2007 to 2014, 80,068 suspected cases of pertussis were reported in Brazil. Of these, 24,612 (32 %) were confirmed by various criteria. The annual distribution of confirmed cases demonstrated a significant increase in incidence rate since 2012. A seasonal pattern in which cases occur most frequently between the end of spring and midsummer has been identified. Among the confirmed cases, 34.5 % occurred in infants aged 0-2 months, 22.4 % occurred in infants aged 3-6 months, 21 % occurred in children aged 7 months to 4 years, and 8 % were reported in adults >21 years. Of the confirmed cases, 47.2 % met only clinical criteria, 15.5 % met clinical and epidemiological criteria, and 36.6 % were confirmed in a laboratory. The overall case fatality rate was 2.1 %, reaching 4.7 % among infants aged 0-2 months. The complications most commonly reported in the notification forms were pneumonia, encephalitis, dehydration, otitis, and malnutrition. Of the confirmed cases, 23.1 % occurred in subjects who received at least 3 doses of the pertussis vaccine. Within this group, there were 1098 infants aged 7 to 15 months and 2079 children aged 16 months to 4 years. In 2012, 18 states did not achieve 95 % immunization coverage, a number that dropped to 10 and 6 in 2013 and 2014, respectively.
   Conclusions: Brazil's main challenges in facing pertussis resurgence will be to offer the best quality medical attention to reduce mortality, to improve the infrastructure for laboratory diagnosis and to increase vaccination coverage. Additional studies to assess the effectiveness of the current vaccination schedule and basic research on the genetics and evolution of circulating B. pertussis strains are also needed.
C1 [Guimaraes, Lucas Melo; Carvalho-Costa, Filipe Anibal] Oswaldo Cruz Fdn Fiocruz, Reg Off, Teresina, Piaui, Brazil.
   [Guimaraes, Lucas Melo; Carvalho-Costa, Filipe Anibal] Fiocruz MS, Inst Oswaldo Cruz, Lab Epidemiol & Mol Systemat, BR-21045900 Rio De Janeiro, Brazil.
   [Neves da Costa Carneiro, Eduilson Livio] Fed Inst Educ Sci & Technol Piaui IFPI, Teresina, Piaui, Brazil.
RP Carvalho-Costa, FA (corresponding author), Oswaldo Cruz Fdn Fiocruz, Reg Off, Teresina, Piaui, Brazil.
EM guaratiba@ioc.fiocruz.br
FU Fiocruz; Brazilian Federal Agency; Brazilian National Council for
   Scientific and Technological Development (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX We thank the Ministry of Health of Brazil for providing secondary data
   used in this study. The study was conducted with funding from Fiocruz
   and the Brazilian Federal Agency for Support and Evaluation of Graduate
   Education (CAPES). FACC is recipient of a research productivity grant
   level 2 of the Brazilian National Council for Scientific and
   Technological Development (CNPq).
CR Berti E, 2014, ACTA PAEDIATR, V103, P846, DOI 10.1111/apa.12655
   Borisova O, 2007, CLIN VACCINE IMMUNOL, V14, P234, DOI 10.1128/CVI.00294-06
   Centers for Disease Control and Prevention, 2013 FIN PERT SURV R
   Centers for Disease Control and Prevention, PERT WHOPP COUGH PER
   Chiappini E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-151
   Carvalho Aroldo P. de, 2006, J. Pediatr. (Rio J.), V82, ps15, DOI [10.1590/S0021-75572006000400003, 10.2223/JPED.1491]
   DeBolt Chas, 2012, Morbidity and Mortality Weekly Report, V61, P517
   deMelker HE, 1997, EMERG INFECT DIS, V3, P175, DOI 10.3201/eid0302.970211
   Edwards KM, 2005, PEDIATR INFECT DIS J, V24, pS104, DOI 10.1097/01.inf.0000166154.47013.47
   European Centre for Disease Prevention and Control, 2015, ANN EP REP 2014 VACC
   EUVAC. NET, PERT SURV REP 2009
   EUVAC.NET, PERT SURV REP 2003 2
   Faulkner A, MANUAL SURVEILLANCE
   Ferrer A, 2000, Enferm Infecc Microbiol Clin, V18, P433
   Gabutti G, 2012, INT J ENV RES PUB HE, V9, P4626, DOI 10.3390/ijerph9124626
   Galindo BM, 2012, MEDICC REV, V14, P38
   Halperin SA, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.4.e42
   Halperin SA, 1999, CLIN INFECT DIS, V28, P1238, DOI 10.1086/514792
   Hay JW, 2005, PEDIATR INFECT DIS J, V24, pS127, DOI 10.1097/01.inf.0000166160.23976.35
   Jakinovich A, 2014, CURR OPIN PEDIATR, V26, P597, DOI 10.1097/MOP.0000000000000139
   Pardo-Serrano FJ, 2014, ENFERM INFEC MICR CL, V32, P270, DOI 10.1016/j.eimc.2013.09.024
   Klein NP, 2014, HUM VACC IMMUNOTHER, V10, P2684, DOI 10.4161/hv.29576
   Lambert LC, 2014, J INFECT DIS, V209, pS4, DOI 10.1093/infdis/jit592
   Leber AL, 2014, CLIN LAB MED, V34, P237, DOI 10.1016/j.cll.2014.02.003
   Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005
   Perez-Perez Gabriela Fidela, 2015, Rev Med Inst Mex Seguro Soc, V53, P164
   Quinn HE, 2007, COMMUN DIS INTELL, V31, P205
   Salomao JB, 2011, J PEDIAT-BRAZIL, V87, P219, DOI [10.1590/S0021-75572011000300007, 10.2223/JPED.2085]
   Schellekens Joop, 2005, Pediatr Infect Dis J, V24, pS19, DOI 10.1097/01.inf.0000160909.24879.e6
   Shaikh R, 1998, PEDIATRICS, V101, P323, DOI 10.1542/peds.101.2.323
   Spokes Paula J, 2010, N S W Public Health Bull, V21, P167, DOI 10.1071/NB10031
   SUTTER RW, 1992, JAMA-J AM MED ASSOC, V267, P386, DOI 10.1001/jama.267.3.386
   Tizolova A, 2014, DIAGN MICR INFEC DIS, V78, P347, DOI 10.1016/j.diagmicrobio.2013.12.020
   Torres RSLA, 2015, J PEDIAT-BRAZIL, V91, P333, DOI [10.1016/j.jped.2014.09.004, 10.1016/j.jpedp.2015.04.006]
   van Hoek AJ, 2013, EURO SURVEILL, V18
   Winter K, 2014, MMWR-MORBID MORTAL W, V63, P1129
   Winter K, 2012, J PEDIATR-US, V161, P1091, DOI 10.1016/j.jpeds.2012.05.041
   Zhang LJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001478.pub6
NR 38
TC 24
Z9 26
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD OCT 23
PY 2015
VL 15
AR 442
DI 10.1186/s12879-015-1222-3
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA CV6HN
UT WOS:000364371400001
PM 26498058
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Brito-Santos, F
   Trilles, L
   Wanke, B
   Santos, DV
   Carvalho-Costa, FA
   Lazera, MS
AF Brito-Santos, F.
   Trilles, L.
   Wanke, B.
   Santos, D. V.
   Carvalho-Costa, F. A.
   Lazera, M. S.
TI Environmental isolation of Cryptococcus gattii molecular type VGII and
   Cryptococcus neoformans molecular type VNI from wooden poles located in
   the deep Amazon Rio Negro basin
SO MYCOSES
LA English
DT Meeting Abstract
C1 [Brito-Santos, F.; Trilles, L.; Wanke, B.; Santos, D. V.; Lazera, M. S.] Fiocruz MS, Natl Inst Infectol, BR-21045900 Rio De Janeiro, Brazil.
   [Carvalho-Costa, F. A.] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0933-7407
EI 1439-0507
J9 MYCOSES
JI Mycoses
PD OCT
PY 2015
VL 58
SU 4
SI SI
MA P384
BP 190
EP 190
PG 1
WC Dermatology; Mycology
SC Dermatology; Mycology
GA CT4SF
UT WOS:000362796800416
DA 2020-12-08
ER

PT J
AU Ganime, AC
   Leite, JPG
   Correa, ADA
   Melgaco, FG
   Carvalho-Costa, FA
   Miagostovich, MP
AF Ganime, A. C.
   Leite, J. P. G.
   de Abreu Correa, A.
   Melgaco, F. G.
   Carvalho-Costa, F. A.
   Miagostovich, M. P.
TI Evaluation of the swab sampling method to recover viruses from fomites
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Fomites; Swab; MNV-1; Bacteriophage PP7; Internal control process
ID REVERSE TRANSCRIPTION-PCR; PRIMARY IMMUNODEFICIENCY UNIT; MURINE
   NOROVIRUS; ENVIRONMENTAL SURFACES; GASTROENTERIC VIRUSES; HUMAN
   ADENOVIRUS; INTERNAL CONTROL; ENTERIC VIRUSES; POTENTIAL ROLE; RT-PCR
AB The monitoring of virus contamination on fomites, especially at hospitals has been used for a more effective evaluation of the microbiological quality of surfaces. Swab sampling is the method used currently, although the use of an internal control process (ICP) has not yet been assessed. The aim of this study is to determine the recovery rate of murine norovirus 1 (MNV-1) and bacteriophage PP7 on different surfaces in order to assess their potential use as an ICP. For this purpose both viruses were spiked experimentally both on porous and non-porous formic as well as on rubberized surfaces. Quantitative PCR (qPCR) showed a variable efficiency with a percentage recovery ranging from 0.6 to 77% according to viruses and surfaces. A global analysis suggested that MNV-1 could be used as a potential ICP for the swab sampling method. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Ganime, A. C.; Leite, J. P. G.; Melgaco, F. G.; Carvalho-Costa, F. A.; Miagostovich, M. P.] Fiocruz MS, Oswaldo Cruz Fdn, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [de Abreu Correa, A.] Univ Fed Fluminense, Inst Biomed, Dept Microbiol & Parasitol, Virol Lab, Niteroi, RJ, Brazil.
RP Ganime, AC (corresponding author), Ave Brasil,4365 Pay Helio & Peggy Pereira, BR-21040360 Manguinho, RJ, Brazil.
EM acganime@ioc.fiocruz.br
RI LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020
FU Oswaldo Cruz Institute (IOC-Fiocruz); Program of Research Excellence
   (PROEP); Carlos Chagas Filho Foundation; State of Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ);  [Brazilian National Council for Scientific
   and Technological Development (CNPq)]
FX This work was supported by Brazilian National Council for Scientific and
   Technological Development (CNPq), Oswaldo Cruz Institute (IOC-Fiocruz),
   Program of Research Excellence (PROEP) and Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ).
   The author is a PhD student in the graduate program of Cell and
   Molecular Biology, Oswaldo Cruz Institute.
CR ABAD FX, 1994, APPL ENVIRON MICROB, V60, P3704, DOI 10.1128/AEM.60.10.3704-3710.1994
   Abad FX, 2001, APPL ENVIRON MICROB, V67, P3904, DOI 10.1128/AEM.67.9.3904-3907.2001
   ANSARI SA, 1988, J CLIN MICROBIOL, V26, P1513, DOI 10.1128/JCM.26.8.1513-1518.1988
   ANSARI SA, 1991, J CLIN MICROBIOL, V29, P2115, DOI 10.1128/JCM.29.10.2115-2119.1991
   Baert L, 2008, J FOOD PROTECT, V71, P1590, DOI 10.4315/0362-028X-71.8.1590
   Baert L, 2008, APPL ENVIRON MICROB, V74, P543, DOI 10.1128/AEM.01039-07
   BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Boone SA, 2007, APPL ENVIRON MICROB, V73, P1687, DOI 10.1128/AEM.02051-06
   Boxman ILA, 2009, J FOOD PROTECT, V72, P111, DOI 10.4315/0362-028X-72.1.111
   Brandao MLL, 2014, J FOOD SCI, V79, pM961, DOI 10.1111/1750-3841.12459
   Bustin SA, 2005, CLIN SCI, V109, P365, DOI 10.1042/CS20050086
   Bustin Stephen A, 2004, J Biomol Tech, V15, P155
   Carducci A, 2011, J HOSP INFECT, V77, P242, DOI 10.1016/j.jhin.2010.10.010
   Carducci A, 2002, LETT APPL MICROBIOL, V34, P189, DOI 10.1046/j.1472-765x.2002.01066.x
   Correa AD, 2012, APPL ENVIRON MICROB, V78, P6450, DOI 10.1128/AEM.01059-12
   Dreier J, 2005, J CLIN MICROBIOL, V43, P4551, DOI 10.1128/JCM.43.9.4551-4557.2005
   Fumian TM, 2010, J VIROL METHODS, V170, P42, DOI 10.1016/j.jviromet.2010.08.017
   Gallimore CI, 2008, J CLIN MICROBIOL, V46, P3112, DOI 10.1128/JCM.00400-08
   Gallimore CI, 2006, J CLIN MICROBIOL, V44, P395, DOI 10.1128/JCM.44.2.395-399.2006
   Gallimore CI, 2005, J CLIN MICROBIOL, V43, P3890, DOI 10.1128/JCM.43.8.3890-3894.2005
   Gallimore CI, 2004, J CLIN MICROBIOL, V42, P2271, DOI 10.1128/JCM.42.5.2271-2274.2004
   Ganime AC, 2014, J MED VIROL, V86, P2065, DOI 10.1002/jmv.23907
   Ganime AC, 2012, AM J INFECT CONTROL, V40, P544, DOI 10.1016/j.ajic.2011.07.017
   Herzog AB, 2012, APPL ENVIRON MICROB, V78, P7915, DOI 10.1128/AEM.01370-12
   Kingsley DH, 2007, APPL ENVIRON MICROB, V73, P581, DOI 10.1128/AEM.02117-06
   Mattison K, 2009, INT J FOOD MICROBIOL, V132, P73, DOI 10.1016/j.ijfoodmicro.2009.04.002
   Prado T, 2013, MEM I OSWALDO CRUZ, V108, P77, DOI 10.1590/S0074-02762013000100013
   Rajal VB, 2007, WATER RES, V41, P1411, DOI 10.1016/j.watres.2006.12.034
   Poma HR, 2013, ENVIRON MONIT ASSESS, V185, P2565, DOI 10.1007/s10661-012-2731-9
   Rodriguez-Lazaro D, 2012, FEMS MICROBIOL REV, V36, P786, DOI 10.1111/j.1574-6976.2011.00306.x
   Scherer K, 2009, FOOD ENVIRON VIROL, V1, P42, DOI 10.1007/s12560-008-9007-0
   Scherer K, 2010, J VIROL METHODS, V169, P22, DOI 10.1016/j.jviromet.2010.06.008
   Stals A, 2011, J FOOD PROTECT, V74, P425, DOI 10.4315/0362-028X.JFP-10-209
   Stals A, 2011, INT J FOOD MICROBIOL, V145, P420, DOI 10.1016/j.ijfoodmicro.2011.01.013
   Stals A, 2011, FOOD MICROBIOL, V28, P52, DOI 10.1016/j.fm.2010.08.004
   Stals A, 2009, J VIROL METHODS, V161, P247, DOI 10.1016/j.jviromet.2009.06.019
   Stevenson J, 2008, J VIROL METHODS, V150, P73, DOI 10.1016/j.jviromet.2008.02.007
   Uhrbrand K, 2010, J VIROL METHODS, V169, P70, DOI 10.1016/j.jviromet.2010.06.019
   Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05
   Wu HM, 2005, INFECT CONT HOSP EP, V26, P802, DOI 10.1086/502497
NR 41
TC 7
Z9 7
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD JUN 1
PY 2015
VL 217
BP 24
EP 27
DI 10.1016/j.jviromet.2015.02.009
PG 4
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA CG2FV
UT WOS:000353091200005
PM 25704597
DA 2020-12-08
ER

PT J
AU Cabral, AC
   Iniguez, AM
   Moreno, T
   Boia, MN
   Carvalho-Costa, FA
AF Cabral, Anna Caryna
   Iniguez, Alena Mayo
   Moreno, Taiza
   Boia, Marcio Neves
   Carvalho-Costa, Filipe Anibal
TI Clinical conditions associated with intestinal strongyloidiasis in Rio
   de Janeiro, Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Strongyloides stercoralis; Co-infection; Risk factors
ID STERCORALIS INFECTION; PARASITIC INFECTIONS; PREVALENCE; CHILDREN;
   PATIENT
AB Strongyloides stercoralis is a soil-transmitted helminth that produces an infection that can persist for decades. The relationships between certain clinical conditions and strongyloidiasis remains controversial. This study aims to identify the clinical conditions associated with intestinal strongyloidiasis at a reference center for infectious diseases in Rio de Janeiro, Brazil. Methods: The clinical conditions that were assessed included HIV/AIDS, HTLV infection, cardiovascular diseases, diabetes, obstructive respiratory diseases, viral hepatitis, tuberculosis, cancer, chronic renal disease, nutritional/metabolic disorders, psychiatric conditions, rheumatic diseases and dermatologic diseases. We compared 167 S. stercoralis-positive and 133 S. stercoralis-negative patients. Results: After controlling for sex (male/female OR = 2.29; 95% (CI): (1.42 - 3.70), rheumatic diseases remained significantly associated with intestinal strongyloidiasis (OR: 4.96; 95% CI: 1.34-18.37) in a multiple logistic regression model. With respect to leukocyte counts, patients with strongyloidiasis presented with significantly higher relative eosinophil (10.32% +/- 7.2 vs. 4.23% +/- 2.92) and monocyte (8.49% +/- 7.25 vs. 5.39% +/- 4.31) counts and lower segmented neutrophil (52.85% +/- 15.31 vs. 61.32% +/- 11.4) and lymphocyte counts (28.11% +/- 9.72 vs. 30.90% +/- 9.51) than S. stercoralis-negative patients. Conclusions: Strongyloidiasis should be routinely investigated in hospitalized patients with complex conditions facilitate the treatment of patients who will undergo immunosuppressive therapy. Diagnoses should be determined through the use of appropriate parasitological methods, such as the Baermann-Moraes technique.
C1 [Cabral, Anna Caryna; Moreno, Taiza; Boia, Marcio Neves] Univ Estado Rio de Janeiro, Disciplina Doencas Infecciosas & Parasitarias, Hosp Univ Pedro Ernesto, BR-20550011 Rio De Janeiro, Brazil.
   [Cabral, Anna Caryna; Moreno, Taiza; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Epidemiol & Sistemat Mol, Rio De Janeiro, Brazil.
   [Iniguez, Alena Mayo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Tripanosomatideos, Rio De Janeiro, Brazil.
   [Boia, Marcio Neves] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Escritorio Reg, Teresina, Piaui, Brazil.
RP Cabral, AC (corresponding author), DIP HUPE UERJ, Av 28 Setembro 77-2 Andar, BR-20551030 Rio De Janeiro, Brazil.
EM caryna.cabral@hotmail.com
OI INIGUEZ, ALENA/0000-0002-9788-9533
CR Andrade E.C., 2010, REV APS, V13, P231
   Bona S, 2008, REV BRAS ANAL CLIN, V40, P247
   Caramaschi P, 2010, LUPUS, V19, P872, DOI 10.1177/0961203309356290
   Carvalho-Costa Filipe Anibal, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P147, DOI 10.1590/S0036-46652007000300003
   de Paula F M, 2000, Rev Inst Med Trop Sao Paulo, V42, P51, DOI 10.1590/S0036-46652000000100009
   Gonzalez-Ibarra F, 2014, CASE REP MED, DOI 10.1155/2014/278390
   Hirata T, 2006, AM J TROP MED HYG, V74, P246, DOI 10.4269/ajtmh.2006.74.246
   Jongwutiwes U, 2014, PATHOG GLOB HEALTH, V108, P137, DOI 10.1179/2047773214Y.0000000134
   Khan WA, 2013, BMJ CASE REPORTS
   Mohamad N, 2012, TROP BIOMED, V29, P479
   Montes M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000456
   Naidu P, 2013, CAN J INFECT DIS MED, V24, P93, DOI 10.1155/2013/290814
   Neumann I, 2012, J AM BOARD FAM MED, V25, P390, DOI 10.3122/jabfm.2012.03.110101
   Paboriboune P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091452
   Parana R, 2000, EUR J GASTROEN HEPAT, V12, P245, DOI 10.1097/00042737-200012020-00019
   Paula FM, 2011, PARASITOLOGY, V138, P1331, DOI 10.1017/S003118201100120X
   Rajadhyaksha A, 2012, INT J RHEUM DIS, V15, pE159, DOI 10.1111/j.1756-185X.2012.01741.x
   Ribeiro LC, 2005, REV SOC BRAS MED TRO, V38, P255, DOI 10.1590/S0037-86822005000300010
   Bachur TPR, 2008, BRAZ J INFECT DIS, V12, P115, DOI 10.1590/S1413-86702008000200004
   Sadjadi SA, 2013, AM J CASE REP, V14, P205, DOI 10.12659/AJCR.889341
   Salim N, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0644-7
   Satoh M, 2002, CLIN EXP IMMUNOL, V127, P354, DOI 10.1046/j.1365-2249.2002.01733.x
   Schar F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002288
   Setoyama M, 1997, SCAND J RHEUMATOL, V26, P389, DOI 10.3109/03009749709065706
   Shorman M, 2009, INT J INFECT DIS, V13, pE288, DOI 10.1016/j.ijid.2008.11.019
   Valverde JG, 2011, ANN TROP MED PARASIT, V105, P413, DOI 10.1179/1364859411Y.0000000034
   Furtado KCYO, 2013, REV SOC BRAS MED TRO, V46, P241, DOI 10.1590/0037-8682-981-2013
   Yung EE, 2014, AM J TROP MED HYG, V91, P806, DOI 10.4269/ajtmh.14-0228
   Zago-Gomes Maria P., 2002, Rev. Soc. Bras. Med. Trop., V35, P571, DOI 10.1590/S0037-86822002000600004
NR 29
TC 5
Z9 8
U1 0
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAY-JUN
PY 2015
VL 48
IS 3
BP 321
EP 325
DI 10.1590/0037-8682-0019-2015
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA CL3RO
UT WOS:000356868300014
PM 26108011
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Lima, MM
   Carvalho-Costa, FA
   Toma, HK
   Borges-Pereira, J
   de Oliveira, TG
   Sarquis, O
AF Lima, Marli M.
   Carvalho-Costa, Filipe A.
   Toma, Helena K.
   Borges-Pereira, Jos
   de Oliveira, Tiago Guedes
   Sarquis, Otilia
TI Chagas disease and housing improvement in northeastern Brazil: a
   cross-sectional survey
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE Triatomines; Trypanosoma cruzi; Housing improvement; Chagas disease;
   Northeastern Brazil
ID TRYPANOSOMA-CRUZI INFECTION; TRIATOMA-BRASILIENSIS; RHODNIUS-NASUTUS;
   EPIDEMIOLOGY; TRANSMISSION; AREAS; PSEUDOMACULATA; SHERLOCKI; VECTORS;
   ECOLOGY
AB Chagas disease was investigated in two new settlements of landless rural workers inhabiting prefabricated, triatomine-proof houses and in four neighboring older communities where mud huts were still well suitable for vectors. Through a cross-sectional survey and entomological assessment, we surveyed 148 houses/families in the two new settlements and in 47 houses/families in the four older localities. We determined seroprevalence of Chagas disease through IFI and Elisa (eluates) assays and searched for vectors in the domestic and peridomestic environments. Seroprevalence reached 0.6 % (3/466) in the new settlements and 0.8 % (1/115) in the older communities. Triatomines were not found in the new settlements, while 7 Triatoma brasiliensis, 4 T. pseudomaculata, 1 Panstrongylus lutzi, and 145 Rhodnius nasutus were collected in the older localities. In addition, a colony of T. brasiliensis (n = 55) was encountered inside a school attended by children of the region. Parasite strains isolated from the insects were characterized as T. cruzi I. Despite the low prevalence of Chagas disease in both scenarios, entomological surveillance must be strengthened and housing improvement reinforced in order to control vector transmission. The risk of infection by the vectors was lower in the settlements of improved homes, where conditions for colonization of the peridomestic environment by transmitting insects were not observed.
C1 [Lima, Marli M.; de Oliveira, Tiago Guedes; Sarquis, Otilia] Fiocruz MS, Inst Oswaldo Cruz, Lab Ecoepidemiol Doenca Chagas, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Carvalho-Costa, Filipe A.] Fiocruz MS, Lab Epidemiol & Sistemat Mol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Carvalho-Costa, Filipe A.] Escritorio Tecn Reg Fiocruz Piaui, Teresina, PI, Brazil.
   [Toma, Helena K.] Univ Fed Rio de Janeiro, Lab Diagnost Mol & Hematol, BR-21941901 Rio De Janeiro, RJ, Brazil.
   [Borges-Pereira, Jos] Inst Oswaldo Cruz, Lab Doencas Parasitarias, BR-20001 Rio De Janeiro, RJ, Brazil.
RP Lima, MM (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Ecoepidemiol Doenca Chagas, Ave Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM mmlima@ioc.fiocruz.br
CR Alencar JE, 1987, HIST NATURAL DOENCA
   Alkmim-Oliveira SM, 2013, PARASITOL RES, V112, P671, DOI 10.1007/s00436-012-3184-3
   Almeida CE, 2009, MED VET ENTOMOL, V23, P410, DOI 10.1111/j.1365-2915.2009.00822.x
   Almeida CE, 2012, ACTA TROP, V122, P71, DOI 10.1016/j.actatropica.2011.12.001
   Bastos CJC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000711
   Bezerra CM, 2014, MEM I OSWALDO CRUZ, V109, P887, DOI 10.1590/0074-0276140048
   Carvalho-Costa FA, 2010, J VECTOR ECOL, V35, P295, DOI 10.1111/j.1948-7134.2010.00085.x
   Coutinho CFS, 2012, ACTA TROP, V121, P30, DOI 10.1016/j.actatropica.2011.10.005
   Valente SADS, 2009, T ROY SOC TROP MED H, V103, P291, DOI 10.1016/j.trstmh.2008.10.047
   Coutinho CFD, 2014, CAD SAUDE PUBLICA, V30, P785, DOI 10.1590/0102-311X00176512
   DIAS E, 1968, MEM I OSWALDO CRUZ, V66, P207
   Fernandes O, 2001, T ROY SOC TROP MED H, V95, P97, DOI 10.1016/S0035-9203(01)90350-5
   Freitas Simone Patrícia Carneiro, 2004, Cad. Saúde Pública, V20, P333, DOI 10.1590/S0102-311X2004000100052
   Guhl F, 2009, MEM I OSWALDO CRUZ, V104, P71, DOI 10.1590/S0074-02762009000900012
   Lima MM, 2008, AM J TROP MED HYG, V79, P750, DOI 10.4269/ajtmh.2008.79.750
   Lima MM, 2012, T ROY SOC TROP MED H, V106, P143, DOI 10.1016/j.trstmh.2011.10.013
   Noireau F, 2002, MEM I OSWALDO CRUZ, V97, P61, DOI 10.1590/S0074-02762002000100009
   Dias JCP, 2009, MEM I OSWALDO CRUZ, V104, P41, DOI 10.1590/S0074-02762009000900007
   Ramos A N Jr, 2001, Cad Saude Publica, V17, P1403, DOI 10.1590/S0102-311X2001000600024
   Ribeiro D, 1979, AM LATINA EXISTE, P116
   Sales-Campos H, 2014, PARASITOL RES, V113, P375, DOI 10.1007/s00436-013-3665-z
   Santana KDO, 2011, GEOSPATIAL HEALTH, V5, P199
   Sarquis O, 2006, MEM I OSWALDO CRUZ, V101, P143, DOI 10.1590/S0074-02762006000200005
   Sarquis O, 2004, MEM I OSWALDO CRUZ, V99, P263, DOI 10.1590/S0074-02762004000300004
   Sarquis O, 2012, PARASITOL RES, V110, P1481, DOI 10.1007/s00436-011-2651-6
   Sarquis O, 2010, J VECTOR ECOL, V35, P385, DOI 10.1111/j.1948-7134.2010.00097.x
   Silveira AC, 2001, CONTROLE TRIATOMA BR, P86
   *WHO, 1991, TECHN REP SER, V811
   Zingales B, 1998, INT J PARASITOL, V28, P105, DOI 10.1016/S0020-7519(97)00178-1
NR 29
TC 7
Z9 8
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD MAY
PY 2015
VL 114
IS 5
BP 1687
EP 1692
DI 10.1007/s00436-015-4350-1
PG 6
WC Parasitology
SC Parasitology
GA CF7GB
UT WOS:000352723200005
PM 25673077
DA 2020-12-08
ER

PT J
AU da Silva, MFM
   Rose, TL
   Gomez, MM
   Carvalho-Costa, FA
   Fialho, AM
   de Assis, RMS
   de Andrade, JDR
   Volotao, EDM
   Leite, JPG
AF Marques da Silva, Marcelle Figueira
   Rose, Tatiana Lundgren
   Gomez, Mariela Martinez
   Carvalho-Costa, Filipe Anibal
   Fialho, Alexandre Madi
   Santos de Assis, Rosane Maria
   Ribeiro de Andrade, Juliana da Silva
   Volotao, Eduardo de Mello
   Gagliardi Leite, Jose Paulo
TI G1P[8] species A rotavirus over 27 years - Pre- and post-vaccination
   eras - in Brazil: Full genomic constellation analysis and no evidence
   for selection pressure by Rotarix (R) vaccine
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Acute gastroenteritis; Species A rotavirus; G1P[8] genomic
   constellation; Rotarix (R) vaccine; Reassortment
ID GROUP-A ROTAVIRUS; RIO-DE-JANEIRO; HUMAN WA-LIKE; PHYLOGENETIC ANALYSIS;
   DEVELOPING-COUNTRIES; GENETIC DIVERSITY; STRAINS; GENOTYPE; CHILDREN;
   EVOLUTION
AB Epidemiological data on species A rotavirus (RVA) infections have demonstrated the genetic diversity of strains circulating worldwide. Many G and P genotype combinations have been described over the years, varying regionally and temporally, especially in developing countries. However, the most common G and P genotype combinations identified in RVA human strains worldwide are G1P[8], G2P[4], G3P[8], G4P[8] and G9P[8]. RVA genotype G1P[8] strains are responsible for more than 50% of child infections worldwide and component of the two vaccines (Rotarix (R) [RV1] and RotaTeq (R) [RV5]) licensed globally. For a better understanding of the evolutionary mechanisms of this genotype in Brazil, phylogenetic analyses based on the 11 RVA genome segments (genomic constellation) from 90 GIP[8] RVA strains collected in two eras - (i) pre-vaccination with RV1 (1996-February 2006); (ii) post-vaccination (March 2006-2013) in different Brazilian states were performed. The results showed the Wa-like genomic constellation of the Brazilian G1P[8] strains with a I1-R1-C1-M1-A1-N1-T1-E1-H1 specificity, except for two strains (rj14055-07 and ba19030-10) that belong to a I1-R1-C1-M1-A1-N1-T3-E1-H1 genomic constellation, evidencing the occurrence of reassortment (Wa-like x AU-I-like) of the NSP3 gene. Reassortment events were also demonstrated between Brazilian GIP[8] strains and the RV1 vaccine strain in some genes in vaccinated and unvaccinated children. VP7 and VP8* antigenic site analysis showed that the amino acid substitutions observed in samples collected after the introduction of RV1 in Brazil were already detected in samples collected in the 19805 and 1990s, suggesting that mass Brazilian RV1 vaccination had no impact on the diversity observed inside antigenic sites for these two proteins. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Marques da Silva, Marcelle Figueira; Rose, Tatiana Lundgren; Gomez, Mariela Martinez; Carvalho-Costa, Filipe Anibal; Fialho, Alexandre Madi; Santos de Assis, Rosane Maria; Ribeiro de Andrade, Juliana da Silva; Volotao, Eduardo de Mello; Gagliardi Leite, Jose Paulo] Fundacao Oswaldo Cruz, FIOCRUZ, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Rio De Janeiro, RJ, Brazil.
RP da Silva, MFM (corresponding author), Inst Oswaldo Cruz, Lab Virol Comparada & Ambiental, Av Brasil 4365,Pavilhao Helio & Peggy Pereira, BR-21040360 Rio De Janeiro, RJ, Brazil.
EM marcelle.figueira@gmail.com
RI LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020; Silva-Sales,
   Marcelle/D-9809-2015
OI Silva-Sales, Marcelle/0000-0002-4275-9627
FU Oswaldo Cruz Institute (IOC. - Fiocruz); National Council for Scientific
   and Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq); Program of Excellence in Research
   (PROEP - IOC/Fiocruz/CNPq); PAPES VI/Fiocruz - CNPqNational Council for
   Scientific and Technological Development (CNPq); Brazilian Federal
   Agency for Support and Evaluation of Graduate Education (CAPES) -
   project CAPES-MERCOSUL [PCPP 023/2011]; General Coordination of Public
   Health Laboratories - Secretary of Health Surveillance (CGLAB/SVS/M of
   H); Carlos Chagas Filho Foundation for Research Support of Rio de
   Janeiro State (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); CAPESCAPES
FX This research was supported by funds from the Oswaldo Cruz Institute
   (IOC. - Fiocruz); the National Council for Scientific and Technological
   Development (CNPq); the Program of Excellence in Research (PROEP -
   IOC/Fiocruz/CNPq); PAPES VI/Fiocruz - CNPq; Brazilian Federal Agency for
   Support and Evaluation of Graduate Education (CAPES) - project
   CAPES-MERCOSUL PCPP 023/2011, the General Coordination of Public Health
   Laboratories - Secretary of Health Surveillance (CGLAB/SVS/M of H), and
   the Carlos Chagas Filho Foundation for Research Support of Rio de
   Janeiro State (FAPERJ). The authors would like to thank Erik Vaz da
   Silva Leocadio from National Immunization Program, Ministry of Health,
   for providing information about the vaccination coverage in Brazil and
   the Secretary of Public Health of the different Brazilian states
   involved in the present study. Marcelle Figueira Marques da Silva is a
   PhD student of the Parasite Biology Post-Graduation Program at the
   Oswaldo Cruz Institute, FIOCRUZ, supported by CAPES.
CR Anderson EJ, 2008, LANCET INFECT DIS, V8, P642, DOI 10.1016/S1473-3099(08)70231-7
   Arora R, 2011, INFECT GENET EVOL, V11, P504, DOI 10.1016/j.meegid.2011.01.005
   Assis ASF, 2013, J PEDIAT-BRAZIL, V89, P470, DOI 10.1016/j.jped.2013.02.019
   Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111
   Barril P, 2013, J MED VIROL, V85, P363, DOI 10.1002/jmv.23462
   Benati FJ, 2010, J MED VIROL, V82, P1797, DOI 10.1002/jmv.21816
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Carvalho-Costa FA, 2011, PEDIATR INFECT DIS J, V30, pS35, DOI 10.1097/INF.0b013e3181fefd5f
   Carvalho-Costa FA, 2009, EMERG INFECT DIS, V15, P95, DOI 10.3201/eid1501.071136
   Cherian T, 2012, VACCINE, V30, pA3, DOI 10.1016/j.vaccine.2011.10.007
   Cotes-Cantillo K, 2014, VACCINE, V32, P3035, DOI 10.1016/j.vaccine.2014.03.064
   De Oliveira LH, 2013, VACCINE, V31, pC99, DOI 10.1016/j.vaccine.2013.05.065
   Estes MK, 2013, ROTAVIRUSES FIELDS V
   Leite JPG, 2008, MEM I OSWALDO CRUZ, V103, P745, DOI 10.1590/S0074-02762008000800001
   Giammanco GM, 2014, J GEN VIROL, V95, P91, DOI 10.1099/vir.0.056788-0
   Gomez M.M., 2014, INFECT GENET EVOL
   Gomez MM, 2013, INFECT GENET EVOL, V19, P395, DOI 10.1016/j.meegid.2013.03.028
   Gomez MM, 2011, J MED VIROL, V83, P1093, DOI 10.1002/jmv.22071
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Heiman EM, 2008, J VIROL, V82, P11106, DOI 10.1128/JVI.01402-08
   Hemming M, 2013, INFECT GENET EVOL, V19, P51, DOI 10.1016/j.meegid.2013.06.026
   Ichihara MYT, 2014, VACCINE, V32, P2740, DOI 10.1016/j.vaccine.2014.01.007
   do Carmo GMI, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001024
   Imbert-Marcille BM, 2014, J INFECT DIS, V209, P1227, DOI 10.1093/infdis/jit655
   Iturriza-Gomara M, 2009, J INFECT DIS, V200, pS215, DOI 10.1086/605052
   Kang G, 2009, J INFECT DIS, V200, pS147, DOI 10.1086/605031
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Laszlo B, 2012, J CLIN VIROL, V55, P140, DOI 10.1016/j.jcv.2012.06.016
   Le VP, 2010, J MED VIROL, V82, P886, DOI 10.1002/jmv.21653
   Leite JPG, 1996, ARCH VIROL, V141, P2365, DOI 10.1007/BF01718637
   Linhares AC, 2014, EXPERT REV VACCINES, V13, P43, DOI 10.1586/14760584.2014.861746
   Tort LFL, 2010, J CLIN VIROL, V47, P345, DOI 10.1016/j.jcv.2009.12.018
   Luchs A, 2014, J CLIN VIROL, V59, P74, DOI 10.1016/j.jcv.2013.11.001
   Maranhao AG, 2012, INFECT GENET EVOL, V12, P1397, DOI 10.1016/j.meegid.2012.04.018
   da Silva MFM, 2013, INFECT GENET EVOL, V16, P200, DOI 10.1016/j.meegid.2013.01.004
   da Silva MFM, 2011, VIRUS RES, V160, P381, DOI 10.1016/j.virusres.2011.07.015
   Mascarenhas JDP, 2002, MEM I OSWALDO CRUZ, V97, P113, DOI 10.1590/S0074-02762002000100020
   Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07
   Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007
   McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634
   Trang NV, 2012, VIRUS RES, V165, P190, DOI 10.1016/j.virusres.2012.02.015
   Nordgren J., 2014, CLIN INFECT DIS
   O'Ryan M, 2011, EXPERT REV VACCINES, V10, P1645, DOI [10.1586/erv.11.152, 10.1586/ERV.11.152]
   Patel MM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3726
   Patel MM, 2012, LANCET INFECT DIS, V12, P561, DOI 10.1016/S1473-3099(12)70029-4
   Patton JT, 2012, DISCOV MED, V13, P85
   Pereira H G, 1983, Mem Inst Oswaldo Cruz, V78, P483
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Rahman M, 2010, INFECT GENET EVOL, V10, P746, DOI 10.1016/j.meegid.2010.04.011
   Rivera L, 2011, VACCINE, V29, P9508, DOI 10.1016/j.vaccine.2011.10.015
   Rongsen-Chandola T, 2014, VACCINE, V32, pA134, DOI 10.1016/j.vaccine.2014.04.078
   Rose TL, 2013, EMERG INFECT DIS, V19, P1843, DOI 10.3201/eid1911.121407
   Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448
   Shintani T, 2012, VIRUSES-BASEL, V4, P1289, DOI 10.3390/v4081289
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Tate JE, 2010, EXPERT REV VACCINES, V9, P395, DOI 10.1586/ERV.10.17
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0
   Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6
   Wazny K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001446
   World Health Otganization, 2013, ROT VACC WHO POS PAP
NR 62
TC 21
Z9 21
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD MAR
PY 2015
VL 30
BP 206
EP 218
DI 10.1016/j.meegid.2014.12.030
PG 13
WC Infectious Diseases
SC Infectious Diseases
GA CC7CN
UT WOS:000350525400028
PM 25562122
OA Bronze
DA 2020-12-08
ER

PT J
AU Brito-Santos, F
   Barbosa, GG
   Trilles, L
   Nishikawa, MM
   Wanke, B
   Meyer, W
   Carvalho-Costa, FA
   Lazera, MD
AF Brito-Santos, Fabio
   Barbosa, Glaucia Goncalves
   Trilles, Luciana
   Nishikawa, Marilia Martins
   Wanke, Bodo
   Meyer, Wieland
   Carvalho-Costa, Filipe Anibal
   Lazera, Marcia dos Santos
TI Environmental Isolation of Cryptococcus gattii VGII from Indoor Dust
   from Typical Wooden Houses in the Deep Amazonas of the Rio Negro Basin
SO PLOS ONE
LA English
DT Article
ID NEOFORMANS VAR. GATTII; AIDS-ASSOCIATED CRYPTOCOCCOSIS;
   VANCOUVER-ISLAND; FUNGAL PATHOGENS; NATURAL HABITAT; DECAYING WOOD;
   BUJUMBURA; OUTBREAK; TREE
AB Cryptococcosis is a human fungal infection of significant mortality and morbidity, especially in the meningoencephalitis form. Cryptococcosis is distributed worldwide and its agents, C. neoformans and C. gattii, present eight major molecular types-VNI-VNIV and VGI-VGIV respectively. The primary cryptococcosis caused by molecular type VGII (serotype B, MAT alpha) prevails in immunocompetent patients in the North and Northeast of Brazil, revealing an endemic regional pattern to this molecular type. Since 1999, C. gattii VGII has been involved in an ongoing outbreak in Canada, and is expanding to the Northwest of the United States, two temperate regions. Exposure to propagules dispersed in the environment, related to various organic substrates, mainly decomposing wood in and around dwellings, initiates the infection process. The present study investigated the presence of the agents of cryptococcosis in dust from dwellings in the upper Rio Negro, municipality of Santa Isabel do Rio Negro in Amazonas state. Indoor dust was collected from 51 houses, diluted and plated on bird seed agar. Dark brown colonies were identified phenotypically, and genotypically by URA5 restriction fragment length polymorphism analysis and multilocus sequence typing (MLST). The mating type was identified using pheromone-specific primers. Three of the 51 houses were positive for C. gattii molecular type VGII, MAT alpha and MATa, showing a high prevalence of this agent. MLST studies identified eight subtypes, VGIIb (ST7), VGIIa (ST20), (ST5) and 5 new subtypes unique to the region. For the first time in the state of Amazonas, C. gattii VGII MAT alpha and MATa were isolated from the environment and correlates with endemic cryptococcosis in this state. This is the first description of MLST subtypes on environmental isolates in the Brazilian Amazon, indicating domiciliary dust as a potential source for human infection with different subtypes of C. gattii VGII MAT alpha and MATa.
C1 [Brito-Santos, Fabio; Barbosa, Glaucia Goncalves; Trilles, Luciana; Wanke, Bodo; Meyer, Wieland; Lazera, Marcia dos Santos] Fiocruz MS, Evandro Chagas Clin Res Inst, Mycol Lab, BR-21045900 Rio De Janeiro, Brazil.
   [Meyer, Wieland] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Ctr Infect Dis & Microbiol, Mol Mycol Res Lab,Sydney Med Sch,Westmead Hosp,We, Sydney, NSW 2006, Australia.
   [Carvalho-Costa, Filipe Anibal] Fiocruz MS, Inst Oswaldo Cruz, Lab Mol Epidemiol & Systemat, BR-21045900 Rio De Janeiro, Brazil.
   [Nishikawa, Marilia Martins] INCQS FIOCRUZ, Natl Inst Qual Control Hlth, Rio De Janeiro, Brazil.
RP Lazera, MD (corresponding author), Fiocruz MS, Evandro Chagas Clin Res Inst, Mycol Lab, BR-21045900 Rio De Janeiro, Brazil.
EM marcia.lazera@ipec.fiocruz.br
RI Meyer, Wieland/G-1204-2015
OI Meyer, Wieland/0000-0001-9933-8340
FU "Coordenaao de Aperfeicoamento de Pessoal de Nivel Superior" (CAPES),
   Brazil [098/2012]
FX The work was supported by the "Coordenaao de Aperfeicoamento de Pessoal
   de Nivel Superior" (CAPES), Brazil, grant # 098/2012 to BW. The funder
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Bovers M, 2008, EMERG INFECT DIS, V14, P1105, DOI 10.3201/eid1407.080122
   Bovers M, 2006, FEMS YEAST RES, V6, P599, DOI 10.1111/j.1567-1364.2006.00082.x
   Byrnes Edmond J, 2009, F1000 Biol Rep, V1, DOI 10.3410/B1-62
   Carriconde F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016936
   CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946
   Cogliati M, 2013, MED MYCOL, V51, P499, DOI 10.3109/13693786.2012.751642
   Correa MP, 1999, BRAZIL REV SOC BRAS, V32, P505, DOI DOI 10.1590/S0037-86821999000500006.(IN
   Costa SDSE, 2009, MEM I OSWALDO CRUZ, V104, P662, DOI 10.1590/S0074-02762009000400023
   dos Santos WRA, 2008, MEM I OSWALDO CRUZ, V103, P813, DOI 10.1590/S0074-02762008000800012
   Ferrer C, 2001, J CLIN MICROBIOL, V39, P2873, DOI 10.1128/JCM.39.8.2873-2879.2001
   Fortes ST, 2001, MYCOSES, V44, P137, DOI 10.1046/j.1439-0507.2001.00651.x
   Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220
   Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003
   Gomes FS, 2010, REV PAN AMAZ SAUDE, V4, P43, DOI [10.1016/j.rbr.2014.04.003, DOI 10.1016/J.RBR.2014.04.003]
   Hagen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071148
   Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101
   Klein KR, 2009, J CLIN MICROBIOL, V47, P3669, DOI 10.1128/JCM.01072-09
   KWONCHUNG KJ, 1992, MED MYCOL, P397
   Lazera MS, 2000, MED MYCOL, V38, P379, DOI 10.1080/714030957
   Lazera MS, 1998, MED MYCOL, V36, P119, DOI 10.1080/02681219880000191
   Lazera MS, 1996, J MED VET MYCOL, V34, P127
   Freire AKL, 2012, MYCOSES, V55, pe145, DOI 10.1111/j.1439-0507.2012.02173.x
   Lockhart SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074737
   Meyer W, 2003, EMERG INFECT DIS, V9, P189
   Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886
   Mitchell TG, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P237
   Passoni LFC, 1998, MED MYCOL, V36, P305, DOI 10.1080/02681219880000481
   Perfect JR, 2006, FEMS YEAST RES, V6, P463, DOI 10.1111/j.1567-1364.2006.00051.x
   Martins LMS, 2011, MEM I OSWALDO CRUZ, V106, P725, DOI 10.1590/S0074-02762011000600012
   STAIB F, 1966, ANN I PASTEUR PARIS, V110, P792
   SWINNE D, 1991, J MED VET MYCOL, V29, P25
   SWINNE D, 1989, AIDS, V3, P389, DOI 10.1097/00002030-198906000-00009
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Trilles L, 2008, MEM I OSWALDO CRUZ, V103, P455, DOI 10.1590/S0074-02762008000500008
NR 34
TC 26
Z9 26
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 17
PY 2015
VL 10
IS 2
AR e0115866
DI 10.1371/journal.pone.0115866
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC4KQ
UT WOS:000350322700007
PM 25688971
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Sangenis, LHC
   Saraiva, RM
   Georg, I
   de Castro, L
   Lima, VD
   Roque, ALR
   Xavier, SCD
   Santos, LC
   Fernandes, FA
   Sarquis, O
   Lima, MM
   Carvalho-Costa, FA
   Boia, MN
AF Conde Sangenis, Luiz Henrique
   Saraiva, Roberto Magalhaes
   Georg, Ingebourg
   de Castro, Liane
   Lima, Valdirene dos Santos
   Roque, Andre Luiz R.
   das Chagas Xavier, Samanta Cristina
   Santos, Laura Cristina
   Fernandes, Fabiano A.
   Sarquis, Otilia
   Lima, Marli Maria
   Carvalho-Costa, Filipe Anibal
   Boia, Marcio Neves
TI Autochthonous transmission of Chagas disease in Rio de Janeiro State,
   Brazil: a clinical and eco-epidemiological study
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Chagas disease; Trypanosoma cruzi; Epidemiology; Clinical; Transmission;
   Genotypes; Triatoma vitticeps; Rio de Janeiro
ID POLYMERASE-CHAIN-REACTION; TRYPANOSOMA-CRUZI-I; ORAL-TRANSMISSION;
   INFECTION; DNA; AMPLIFICATION; SURVEILLANCE; CONSENSUS; CYCLES; SPACER
AB Background: After the control of the main modes of Chagas disease (CD) transmission in most endemic countries, it is important to identify the participation of native sylvatic vectors in CD transmission. Although CD is not considered endemic in Rio de Janeiro State (RJ), Brazil, we identified patients with CD born in RJ and investigated the possible autochthonous transmission in the state.
   Methods: Patients born in RJ and followed in our institution between 1986 and 2011 were retrospectively analyzed. The cases identified as autochthonous transmission were submitted to epidemiological, clinical, serological, parasitological and molecular studies. Sectional field study with serological survey, research of sylvatic reservoirs and vectors was conducted in rural areas where patients were born.
   Results: Among 1963 patients, 69 (3.5%) were born in RJ. From these, 15 (21.7%) were considered to have acquired the infection by autochthonous transmission. Cardiac form was the commonest form of presentation (60%). In rural areas in RJ northern region, sylvatic cycles of Trypanosoma cruzi and domestic invasion by Triatoma vitticeps were identified, and CD prevalence among inhabitants was 0.74%. TcI genotype was identified in sylvatic reservoirs and vectors. The genotype (mixed infection Tcl/TcVI) could be identified in one of the autochthonous cases.
   Conclusions: The autochthonous vectorial transmission of CD occurs in RJ, probably due to wild cycles of T. cruzi and sylvatic vectors, such as T. vitticeps. Therefore, the health authorities should evaluate if RJ should be included in the original endemic area of CD and CD should be included in the diagnostic work out of cardiomyopathy of patients born in RJ. Moreover, control and educational measures should be put into place in the risk areas.
C1 [Conde Sangenis, Luiz Henrique; Saraiva, Roberto Magalhaes] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doenca Chagas, Rio De Janeiro, RJ, Brazil.
   [Georg, Ingebourg] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Imunodiagnost, Rio De Janeiro, RJ, Brazil.
   [de Castro, Liane] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Farmacocinet, Rio De Janeiro, RJ, Brazil.
   [Lima, Valdirene dos Santos; Roque, Andre Luiz R.; das Chagas Xavier, Samanta Cristina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Tripanossomatideos, Rio De Janeiro, RJ, Brazil.
   [Santos, Laura Cristina] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Doencas Parasitarias, Rio De Janeiro, RJ, Brazil.
   [Fernandes, Fabiano A.; Sarquis, Otilia; Lima, Marli Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Ecoepidemiol Doenca Chagas, Rio De Janeiro, RJ, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Sistemat & Bioquim, Rio De Janeiro, RJ, Brazil.
   [Boia, Marcio Neves] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamfferos Silvestres Reserva, Rio De Janeiro, RJ, Brazil.
RP Sangenis, LHC (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doenca Chagas, Rio De Janeiro, RJ, Brazil.
EM luiz.sangenis@ini.fiocruz.br
RI Roque, Andre Luiz Rodrigues/W-7528-2019; Saraiva, Roberto/AAV-4946-2020;
   Saraiva, Roberto/A-7387-2014
OI Saraiva, Roberto/0000-0002-2263-4261; Saraiva,
   Roberto/0000-0002-2263-4261; Roque, Andre/0000-0002-8740-052X; Xavier,
   Samanta Cristina/0000-0002-3475-0075
CR Abad-Franch Fernando, 2014, Mem Inst Oswaldo Cruz, V109, P125
   Abad-Franch F, 2013, MEM I OSWALDO CRUZ, V108, P251, DOI 10.1590/0074-0276108022013022
   Alentejano PRR, 2005, GEOGRAPHIA-UFF, V7, P49
   Andrade SG, 2011, MEM I OSWALDO CRUZ, V106, P948, DOI 10.1590/S0074-02762011000800009
   Apt W, 2013, T ROY SOC TROP MED H, V107, P98, DOI 10.1093/trstmh/trs013
   AVILA HA, 1991, MOL BIOCHEM PARASIT, V48, P211, DOI 10.1016/0166-6851(91)90116-N
   AZOGUE E, 1985, T ROY SOC TROP MED H, V79, P176, DOI 10.1016/0035-9203(85)90328-1
   Barros G, 1975, Rev Inst Med Trop Sao Paulo, V17, P319
   BENCHIMOL AB, 1954, MED CIR FARM, V213, P5
   Bern C, 2011, CLIN MICROBIOL REV, V24, P655, DOI 10.1128/CMR.00005-11
   Bonvicino C. R., 2005, Braz. J. Biol., V65, P395, DOI 10.1590/S1519-69842005000300004
   Borges-Pereira J, 2008, REV SOC BRAS MED TRO, V41, P345, DOI 10.1590/S0037-86822008000400005
   Brito Fausto, 2006, Estud. av., V20, P221, DOI 10.1590/S0103-40142006000200017
   Britto C, 1995, EXP PARASITOL, V81, P462, DOI 10.1006/expr.1995.1139
   Bustamante FM, 1953, REV BRAS MALARIOL, V5, P23
   Coura J. R., 1966, Revista Brasileira de Malariologia e Doencas Tropicais, V18, P9
   Coura J R, 1983, Mem Inst Oswaldo Cruz, V78, P363, DOI 10.1590/S0074-02761983000300012
   COURA J. R., 1971, Revista da Sociedade Brasileira de Medicina Tropical, V5, P123, DOI 10.1590/S0037-86821971000300002
   Coura JR, 2012, REV SOC BRAS MED TRO, V45, P286, DOI 10.1590/S0037-86822012000300002
   Coura JR, 2010, NATURE, V465, pS6, DOI 10.1038/nature09221
   Coura Jose Rodrigues, 1994, Revista da Sociedade Brasileira de Medicina Tropical, V27, P251, DOI 10.1590/S0037-86821994000400009
   Cura CI, 2010, INT J PARASITOL, V40, P1599, DOI 10.1016/j.ijpara.2010.06.006
   Silva EODE, 2011, REV SOC BRAS MED TRO, V44, P74, DOI 10.1590/S0037-86822011000800012
   DA SILVA N. N., 1968, Revista do Instituto de Medicina Tropical de Sao Paulo, V10, P265
   Deane M.P., 1984, Memorias do Instituto Oswaldo Cruz, V79, P513, DOI 10.1590/S0074-02761984000400021
   Dias JCP, 1989, MEM I OSWALDO CRU S4, V84, P165
   Dias JCP, 1998, REV SOC BRAS MED TRO, V31, P582
   Dias JCP, 2011, REV SOC BRAS MED S2, V44, P67
   dos Santos CB, 2006, REV SOC BRAS MED TRO, V39, P89, DOI 10.1590/S0037-86822006000100019
   dos Santos CB, 2005, MEM I OSWALDO CRUZ, V100, P471, DOI 10.1590/S0074-02762005000500004
   Fernandes O, 2001, T ROY SOC TROP MED H, V95, P97, DOI 10.1016/S0035-9203(01)90350-5
   Fernandes O, 1999, PARASITOLOGY, V118, P161, DOI 10.1017/S0031182098003709
   Ferreira E., 1986, Revista Brasileira de Malariologia e Doencas Tropicais, V38, P11
   Forattini O P, 1980, Rev Saude Publica, V14, P265
   Goncalves TCM, 1998, MEM I OSWALDO CRUZ, V93, P711, DOI 10.1590/S0074-02761998000600002
   Guhl F, 2009, MEM I OSWALDO CRUZ, V104, P71, DOI 10.1590/S0074-02762009000900012
   Guimaraes FN, 1943, M I OSWALDO CRUZ, V39, P405
   da Camara ACJ, 2013, PARASITOL RES, V112, P1543, DOI 10.1007/s00436-013-3301-y
   Lent H, 1942, REV FLUM MED, V6, P7
   Lisboa CV, 2006, PARASITOLOGY, V133, P603, DOI 10.1017/S0031182006000722
   Lorosa ES, 2008, REV SOC BRAS MED TRO, V41, P419, DOI 10.1590/S0037-86822008000400020
   Lorosa ES, 2003, MEM I OSWALDO CRUZ, V98, P885, DOI 10.1590/S0074-02762003000700004
   Ministerio da Saude. Secretaria de Vigilancia em Saude, 2005, Rev Soc Bras Med Trop, V38 Suppl 3, P7
   Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005
   Negrette OS, 2005, PEDIATRICS, V115, pE668, DOI 10.1542/peds.2004-1732
   Neiva A., 1923, Brazil Medico, V37, P45
   Oliveira MT., 2012, THESIS U FEDERAL OUR
   Pereira KS, 2009, J FOOD PROTECT, V72, P441, DOI 10.4315/0362-028X-72.2.441
   Roque ALR, 2013, VET PARASITOL, V193, P71, DOI 10.1016/j.vetpar.2012.11.028
   Rozas M, 2007, J INFECT DIS, V195, P1381, DOI 10.1086/513440
   Santos UM, 1969, REV SOC BRAS MED TRO, V3, P52
   Schijman AG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000931
   Schmunis GA, 1999, MEM I OSWALDO CRUZ, V94, P93, DOI 10.1590/S0074-02761999000700010
   Sessa Paulo Augusto, 2002, Cad. Saúde Pública, V18, P1765, DOI 10.1590/S0102-311X2002000600031
   SHIKANAIYASUDA MA, 1991, REV I MED TROP, V33, P351, DOI 10.1590/S0036-46651991000500003
   Silva M. A. da, 2006, Revista de Patologia Tropical, V35, P213
   Silveira A C, 1984, Rev Bras Malariol Doencas Trop, V36, P15
   Silveira AC, 2011, REV SOC BRAS MED TRO, V44, P52, DOI 10.1590/S0037-86822011000800009
   Souza RCM, 2010, INFECT GENET EVOL, V10, P720
   TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4
   Valente SAD, 1999, MEM I OSWALDO CRUZ, V94, P395, DOI 10.1590/S0074-02761999000700077
   Viñas Albajar Pedro, 2003, Rev. Soc. Bras. Med. Trop., V36, P401, DOI 10.1590/S0037-86822003000300013
   Vinhaes MC, 2014, ACTA TROP, V137, P105, DOI 10.1016/j.actatropica.2014.05.007
   Westenberger SJ, 2005, GENETICS, V171, P527, DOI 10.1534/genetics.104.038745
   Xavier SS, 2006, REV SOC BRAS MED TRO, V39, P211, DOI 10.1590/S0037-86822006000200015
   Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021
   Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009
NR 67
TC 11
Z9 12
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JAN 8
PY 2015
VL 15
AR 4
DI 10.1186/s12879-014-0732-8
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA AZ7IR
UT WOS:000348393300001
PM 25566786
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Portes, SAR
   Volotao, ED
   Rose, TL
   Rocha, MS
   Xavier, MDTP
   de Assis, RM
   Fialho, AM
   Rocha, MS
   Miagostovich, MP
   Leite, JPG
   Carvalho-Costa, FA
AF Rodrigues Portes, Silvana Augusta
   Volotao, Eduardo de Mello
   Rose, Tatiana Lundgren
   Rocha, Monica Simoes
   Trindade Pinheiro Xavier, Maria da Penha
   de Assis, Rosane Maria
   Fialho, Alexandre Madi
   Rocha, Myrna Santos
   Miagostovich, Marize Pereira
   Gagliardi Leite, Jose Paulo
   Carvalho-Costa, Filipe Anibal
TI Aichi Virus Positivity in HIV-1 Seropositive Children Hospitalized with
   Diarrheal Disease
SO CURRENT HIV RESEARCH
LA English
DT Article
DE Aichi virus; AIDS; children; diarrheal disease; HIV-1; oportunistic
   agent
ID MOLECULAR CHARACTERIZATION; ENTERIC VIRUSES; GASTROENTERITIS;
   CALICIVIRUS; PREVALENCE; INFECTION; PCR
AB Aichi viruses (AiV) have been detected in patients with diarrheal diseases (DD). The aim of this study was to assess AiV infection rates in hospitalized children with DD, including 123 HIV-1 seropositive and 125 HIV-1 seronegative patients, in two public pediatric hospitals in Rio de Janeiro, Brazil. AiV was investigated by nested RT-PCR. The AiV-positive samples were also tested for specie A rotavirus, norovirus, astrovirus, enteric adenovirus and bocavirus in order to assess co-infections. AiV parcial genome sequencing and phylogenetic analyses were performed. AiV were detected in 9/123 (7.32%) of the HIV-1 seropositive subjects and 1/125 (0.8%) of the HIV seronegative patients with DD (p = 0.019). The phylogenetic analysis of positive samples disclosed that: i) 13 samples were characterized as genotype A, with one of them being from the HIV-1 seronegative patient; ii) one sample from a HIV-1 seropositive patient was characterized as genotype B. AiV genotype A was grouped into 3 genetic clusters. Data suggest that AiV may be an opportunistic pathogen infecting children with AIDS and DD.
C1 [Rodrigues Portes, Silvana Augusta; Volotao, Eduardo de Mello; Rose, Tatiana Lundgren; Rocha, Monica Simoes; Trindade Pinheiro Xavier, Maria da Penha; de Assis, Rosane Maria; Fialho, Alexandre Madi; Miagostovich, Marize Pereira; Gagliardi Leite, Jose Paulo; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Rocha, Myrna Santos] Hosp Municipal Jesus, Rio De Janeiro, Brazil.
RP Portes, SAR (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Pav Helio & Peggy Pereira,Av Brazil 4-365, BR-21040360 Rio De Janeiro, RJ, Brazil.
EM sil@ioc.fiocruz.br
RI LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020
OI Fialho, Alexandre Madi/0000-0002-5412-3896
FU Oswaldo Cruz Institute/Fiocruz; National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq); PAPES/Fiocruz-CNPqNational Council for
   Scientific and Technological Development (CNPq); PROEP/Fiocruz-CNPq;
   Coordination for Improvement of Higher Level Personnel (CAPES)CAPES;
   Carlos Chagas Filho Foundation for Research Support of the State of Rio
   de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support
   of the State of Rio de Janeiro (FAPERJ)
FX We would like to thank Juliana da Silva Andrade for technical
   assistance. The authors thank the staff at Jesus Municipal Hospital,
   Salles Netto Municipal Hospital, and Genomic Platform of DNA sequencing
   PDTIS/Fiocruz. This study was sponsored by Oswaldo Cruz
   Institute/Fiocruz, National Council for Scientific and Technological
   Development (CNPq), PAPES/Fiocruz-CNPq, PROEP/Fiocruz-CNPq, Coordination
   for Improvement of Higher Level Personnel (CAPES) and Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ).
CR Alcala A, 2010, APPL ENVIRON MICROB, V76, P4113, DOI 10.1128/AEM.00501-10
   Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001
   Arvelo W, 2010, INT J INFECT DIS, V14, pE1002, DOI 10.1016/j.ijid.2010.06.014
   Rossit ARB, 2009, REV INST MED TROP SP, V51, P59, DOI 10.1590/S0036-46652009000200001
   Drexler JF, 2011, EMERG INFECT DIS, V17, P1544, DOI 10.3201/eid1708.101556
   Giordano MO, 1999, AIDS RES HUM RETROV, V15, P1427, DOI 10.1089/088922299309937
   Goncalves ACM, 2009, AM J TROP MED HYG, V81, P463, DOI 10.4269/ajtmh.2009.81.463
   Gonzalez GG, 1998, J MED VIROL, V55, P288, DOI 10.1002/(SICI)1096-9071(199808)55:4&lt;288::AID-JMV6&gt;3.0.CO;2-X
   GROHMANN GS, 1993, NEW ENGL J MED, V329, P14, DOI 10.1056/NEJM199307013290103
   Groome MJ, 2012, VACCINE, V30, pA173, DOI 10.1016/j.vaccine.2011.08.004
   Hamada Y, 2012, AIDS, V26, P400, DOI 10.1097/QAD.0b013e32834f411b
   Han TH, 2014, ARCH VIROL, V159, P1835, DOI 10.1007/s00705-014-2006-6
   Jonsson N, 2012, ARCH VIROL, V157, P1365, DOI 10.1007/s00705-012-1296-9
   Kaikkonen S, 2010, EPIDEMIOL INFECT, V138, P1166, DOI 10.1017/S0950268809991300
   Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416
   Liste MB, 2000, J CLIN MICROBIOL, V38, P2873, DOI 10.1128/JCM.38.8.2873-2877.2000
   Ministry of Health, 2011, EP B AIDS STD YEAR
   Moyo SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097562
   Munnink BBO, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-22
   Oh DY, 2006, ARCH VIROL, V151, P1199, DOI 10.1007/s00705-005-0706-7
   Pham NTK, 2007, J CLIN MICROBIOL, V45, P2287, DOI 10.1128/JCM.00525-07
   Pollok RCG, 2008, NOVARTIS FDN S, V238
   Ferreira MSR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033754
   Rodriguez-Guillen L, 2005, J CLIN VIROL, V33, P104, DOI 10.1016/j.jcv.2004.09.031
   Sdiri-Loulizi K, 2009, J CLIN MICROBIOL, V47, P2275, DOI 10.1128/JCM.00913-09
   Silva RC, 2010, BRAZ J INFECT DIS, V14, P549, DOI [10.1590/S1413-86702010000600012, 10.1590/S1413-86702010000600001]
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Thomas P D, 1999, HIV Med, V1, P19, DOI 10.1046/j.1468-1293.1999.00004.x
   Verma H, 2011, EPIDEMIOL INFECT, V139, P1687, DOI 10.1017/S0950268810002979
   Yamashita T, 2000, J CLIN MICROBIOL, V38, P2955, DOI 10.1128/JCM.38.8.2955-2961.2000
   Yang SX, 2009, EMERG INFECT DIS, V15, P1703, DOI 10.3201/eid1510.090522
NR 31
TC 4
Z9 4
U1 0
U2 4
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-162X
EI 1873-4251
J9 CURR HIV RES
JI Curr. HIV Res.
PY 2015
VL 13
IS 4
BP 325
EP 331
PG 7
WC Immunology; Infectious Diseases; Virology
SC Immunology; Infectious Diseases; Virology
GA CK6MH
UT WOS:000356341700010
PM 26081831
DA 2020-12-08
ER

PT J
AU Gomez, MM
   Carvalho-Costa, FA
   Volotao, ED
   Rose, TL
   da Silva, MFM
   Fialho, AM
   de Assis, RMS
   Matthijnssens, J
   Leite, JPG
AF Gomez, Mariela Martinez
   Carvalho-Costa, Filipe Anibal
   Volotao, Eduardo de Mello
   Rose, Tatiana Lundgren
   Marques da Silva, Marcelle Figueira
   Fialho, Alexandre Madi
   Santos de Assis, Rosane Maria
   Matthijnssens, Jelle
   Gagliardi Leite, Jose Paulo
TI A decade of G3P[8] and G9P[8] rotaviruses in Brazil: Epidemiology and
   evolutionary analyses
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Diarrheal disease; Group A rotaviruses; Genotypes G3 and G9;
   Phylogenetic analysis; Monovalent vaccine
ID GROUP-A ROTAVIRUS; RIO-DE-JANEIRO; YOUNG-CHILDREN; HOSPITALIZED
   CHILDREN; PHYLOGENETIC ANALYSIS; GENOMIC ANALYSIS; UNITED-STATES; P
   GENOTYPES; STRAINS; VACCINE
AB This study aims to estimate the frequency of group A rotaviruses (RVA) infection with genotypes G3P[8] and G9P[8] in children that suffered from diarrheal disease (DD) between 2001 and 2011 in different Brazilian regions. In addition, the genetic diversity of G3P[8] and G9P[8] RVA strains recovered from vaccinated and non-vaccinated children was assessed. Laboratory-based RVA surveillance included 15,115 cases of DD, and RVA was detected by enzyme immune-assay and/or polyacrylamide gel electrophoresis in 3357 (22%) samples. RVA was genotyped by the semi-nested RT-PCR and among RVA-positive samples, 100 (2.9%) were G3 (63 G3P[8], 32 G3P not typed [NT], and 5 G3P[6]) and 378 (16.2%) were G9 (318 G9P[8], 59 G9P[NT], and 1 G9P[6]). From the G3 and G9 positive samples, 16 and 12, respectively, were obtained from children aged 4-48 months vaccinated with the monovalent vaccine (Rotarix(R), RV1). Phylogenetic analyses of the VP7 and VP8* encoding genes were performed for 26 G3P[8] and 48 G9P[8] strains. VP8* phylogenetic analysis revealed that all strains analyzed belonged to P[8] lineage III, whereas RV1 belongs to P[8]-I lineage. VP7 analysis revealed that all G3 and G9 strains belonged to G3-lineage III and G9-lineage III. The comparison of the VP7 and VP8* antigenic epitopes regions of Brazilian strains with RV1 strain revealed several amino acid changes. However, no particular differences among Brazilian strains detected before and after vaccine introduction were observed, or among strains detected from vaccinated and non-vaccinated children. Complete genome characterization of four G3P[8] and seven G9P[8] strains revealed a typical conserved human Wa-like genomic constellation. Changes in the genetic diversity of G3P[8] and G9P[8] RVA detected from 2001 to 2011 in Brazil seemed not be related to RV1 introduction in Brazil. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Gomez, Mariela Martinez; Carvalho-Costa, Filipe Anibal; Volotao, Eduardo de Mello; Rose, Tatiana Lundgren; Marques da Silva, Marcelle Figueira; Fialho, Alexandre Madi; Santos de Assis, Rosane Maria; Gagliardi Leite, Jose Paulo] Inst Oswaldo Cruz, FIOCRUZ, Lab Comparat & Environm Virol, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Matthijnssens, Jelle] Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Clin & Epidemiol Virol, Leuven, Belgium.
RP Gomez, MM (corresponding author), Inst Oswaldo Cruz, Lab Virol Comparada & Ambiental, Ave Brazil,4365 Pavilhao Helio & Peggy Pereira, BR-21040360 Rio De Janeiro, RJ, Brazil.
EM marielamartinezgomez@gmail.com
RI LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020; Silva-Sales,
   Marcelle/D-9809-2015; Matthijnssens, Jelle/O-7069-2019; Matthijnssens,
   Jelle/A-6770-2015; Matthijnssens, Jelle/B-8634-2016
OI Silva-Sales, Marcelle/0000-0002-4275-9627; Matthijnssens,
   Jelle/0000-0003-1188-9733; Matthijnssens, Jelle/0000-0003-1188-9733;
   Fialho, Alexandre Madi/0000-0002-5412-3896
FU Oswaldo Cruz Institute (IOC - Fiocruz); National Council for Scientific
   and Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq); Program of Excellence in Research
   (PROEP - IOC/Fiocruz/CNPq); project PAPES VI/Fiocruz - CNPqNational
   Council for Scientific and Technological Development (CNPq); Brazilian
   Federal Agency for Support and Evaluation of Graduate Education (CAPES)
   - project CAPES-MERCOSUL PCPP [023/2011]; General Coordination of Public
   Health Laboratories - Secretary of Health Surveillance (CGLAB/SVS/M of
   H); Carlos Chagas Filho Foundation for Research Support of Rio de
   Janeiro State (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); CNPqNational Council
   for Scientific and Technological Development (CNPq)
FX This research was supported by funds from the Oswaldo Cruz Institute
   (IOC - Fiocruz); National Council for Scientific and Technological
   Development (CNPq); Program of Excellence in Research (PROEP -
   IOC/Fiocruz/CNPq); the project PAPES VI/Fiocruz - CNPq; Brazilian
   Federal Agency for Support and Evaluation of Graduate Education (CAPES)
   - project CAPES-MERCOSUL PCPP 023/2011, the General Coordination of
   Public Health Laboratories - Secretary of Health Surveillance
   (CGLAB/SVS/M of H), and Carlos Chagas Filho Foundation for Research
   Support of Rio de Janeiro State (FAPERJ). The authors would like to
   thank the Secretary of Public Health of the different Brazilian states
   involved in the present study. Mariela Martinez Gomez has a
   Post-Doctoral position at IOC/Fiocruz, supported by a PDJ scholarship
   from the CNPq.
CR [Anonymous], 2013, VACCINE, V31, P6170, DOI 10.1016/j.vaccine.2013.05.037
   Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111
   Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Braeckman T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4752
   Carvalho-Costa FA, 2006, MEM I OSWALDO CRUZ, V101, P291, DOI 10.1590/S0074-02762006000300012
   Carvalho-Costa FA, 2011, PEDIATR INFECT DIS J, V30, pS35, DOI 10.1097/INF.0b013e3181fefd5f
   Carvalho-Costa FA, 2009, EMERG INFECT DIS, V15, P95, DOI 10.3201/eid1501.071136
   Castilla J, 2012, VACCINE, V30, P539, DOI 10.1016/j.vaccine.2011.11.071
   Cortese MM, 2013, PEDIATRICS, V132, pE25, DOI 10.1542/peds.2012-3804
   De Grazia S, 2010, EMERG INFECT DIS, V16, P859, DOI 10.3201/eid1605.091826
   De Vos B, 2009, PEDIATR INFECT DIS J, V28, P261, DOI 10.1097/INF.0b013e3181907177
   Endara P, 2007, EMERG INFECT DIS, V13, P574, DOI 10.3201/eid1304.061285
   Esona MD, 2013, INFECT GENET EVOL, V18, P315, DOI 10.1016/j.meegid.2013.06.005
   Estes M. K. A. G., 2013, FIELDS VIROLOGY, P1347
   Leite JPG, 2008, MEM I OSWALDO CRUZ, V103, P745, DOI 10.1590/S0074-02762008000800001
   Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499
   Gomez MM, 2013, INFECT GENET EVOL, V19, P395, DOI 10.1016/j.meegid.2013.03.028
   Gomez MM, 2011, J MED VIROL, V83, P1093, DOI 10.1002/jmv.22071
   Guo DC, 2012, INFECT GENET EVOL, V12, P1567, DOI 10.1016/j.meegid.2012.06.010
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   He B, 2013, J VIROL, V87, P12357, DOI 10.1128/JVI.02013-13
   Hoshino Y, 2000, J HEALTH POPUL NUTR, V18, P5
   Hull JJ, 2011, PEDIATR INFECT DIS J, V30, pS42, DOI 10.1097/INF.0b013e3181fefd78
   Iturriza-Gomara M, 2009, J INFECT DIS, V200, pS215, DOI 10.1086/605052
   Justino MCA, 2011, PEDIATR INFECT DIS J, V30, P396, DOI 10.1097/INF.0b013e3182055cc2
   Kirkwood CD, 2011, PEDIATR INFECT DIS J, V30, pS48, DOI 10.1097/INF.0b013e3181fefd90
   Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2
   Laird AR, 2003, J CLIN MICROBIOL, V41, P3100, DOI 10.1128/JCM.41.7.3100-3111.2003
   Leite JPG, 1996, ARCH VIROL, V141, P2365, DOI 10.1007/BF01718637
   Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3
   Linhares AC, 2014, EXPERT REV VACCINES, V13, P43, DOI 10.1586/14760584.2014.861746
   Linhares AC, 2011, REV MED VIROL, V21, P89, DOI 10.1002/rmv.682
   Tort LFL, 2010, J CLIN VIROL, V47, P345, DOI 10.1016/j.jcv.2009.12.018
   Malik YS, 2012, J VET SCI, V13, P271, DOI 10.4142/jvs.2012.13.3.271
   da Silva MFM, 2011, VIRUS RES, V160, P381, DOI 10.1016/j.virusres.2011.07.015
   Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07
   Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007
   Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137
   Matthijnssens J, 2010, J VIROL, V84, P2013, DOI 10.1128/JVI.02081-09
   McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634
   McDonald SM, 2009, J VIROL, V83, P6135, DOI 10.1128/JVI.00409-09
   Mitui MT, 2011, J CLIN VIROL, V50, P325, DOI 10.1016/j.jcv.2011.01.008
   Moon SS, 2013, PEDIATR INFECT DIS J, V32, P863, DOI 10.1097/INF.0b013e318290646d
   Nemoto M, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-63
   Ngo TC, 2009, VACCINE, V27, pF75, DOI 10.1016/j.vaccine.2009.08.074
   Nyaga MM, 2013, INFECT GENET EVOL, V16, P62, DOI 10.1016/j.meegid.2013.01.005
   O'Ryan M, 2009, EXPERT REV VACCINES, V8, P1627, DOI [10.1586/erv.09.136, 10.1586/ERV.09.136]
   Okitsu S, 2013, INFECT GENET EVOL, V18, P74, DOI 10.1016/j.meegid.2013.05.005
   Page N, 2010, J INFECT DIS, V202, pS55, DOI 10.1086/653551
   Patel M, 2013, J INFECT DIS, V208, P284, DOI 10.1093/infdis/jit166
   Payne DC, 2013, CLIN INFECT DIS, V57, P13, DOI 10.1093/cid/cit164
   PEREIRA HG, 1983, J HYG-CAMBRIDGE, V90, P117, DOI 10.1017/S0022172400063919
   Rahman M, 2005, J CLIN VIROL, V33, P1, DOI 10.1016/j.jcv.2004.09.020
   Rahman M, 2008, VIRUS RES, V137, P157, DOI 10.1016/j.virusres.2008.07.004
   Rose TL, 2013, EMERG INFECT DIS, V19, P1843, DOI 10.3201/eid1911.121407
   Sanchez-Fauquier A, 2006, EMERG INFECT DIS, V12, P1536, DOI 10.3201/eid1210.060384
   Santos SMR, 2013, J PEDIAT-BRAZIL, V89, P510, DOI 10.1016/j.jped.2013.02.017
   Siqueira AA, 2010, INT J INFECT DIS, V14, pE898, DOI 10.1016/j.ijid.2010.03.024
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Tate JE, 2012, EXPERT REV VACCINES, V11, P211, DOI [10.1586/ERV.11.184, 10.1586/erv.11.184]
   Theamboonlers A, 2014, INFECT GENET EVOL, V21, P295, DOI 10.1016/j.meegid.2013.11.020
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0
   Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6
   Wazny K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001446
NR 66
TC 7
Z9 7
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD DEC
PY 2014
VL 28
BP 389
EP 397
DI 10.1016/j.meegid.2014.05.016
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA AX1YI
UT WOS:000346739500059
PM 24861814
OA Green Published
DA 2020-12-08
ER

PT J
AU Gomez, MM
   Carvalho-Costa, FA
   Volotao, ED
   Rose, TL
   da Silva, MFM
   Fialho, AM
   Assis, RMS
   de Andrade, JDR
   Sa, ACC
   Zeller, M
   Heylen, E
   Matthijnssens, J
   Leite, JPG
AF Gomez, Mariela Martinez
   Carvalho-Costa, Filipe Anibal
   Volotao, Eduardo de Mello
   Rose, Tatiana Lundgren
   Marques da Silva, Marcelle Figueira
   Fialho, Alexandre Madi
   Assis, Rosane Maria S.
   Ribeiro de Andrade, Juliana da Silva
   Costa Sa, Ana Caroline
   Zeller, Mark
   Heylen, Elisabeth
   Matthijnssens, Jelle
   Gagliardi Leite, Jose Paulo
TI Prevalence and genomic characterization of G2P[4] group A rotavirus
   strains during monovalent vaccine introduction in Brazil
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Acute gastroenteritis; Group A rotaviruses; G2P[4]; Genomic background;
   Monovalent vaccine
ID RIO-DE-JANEIRO; GENOTYPE; POPULATION; EVOLUTION; GENE; VP7;
   EPIDEMIOLOGY; DS-1-LIKE; CHILDREN; ROTARIX
AB This study aims to: estimate the prevalence of G2P[4] rotaviruses in Brazil between 2001-2011 from patients with acute gastroenteritis; perform phylogenetic analyses of G2P[4] Brazilian strains (from vaccinated and non-vaccinated children) based on VP7 and VP8/encoding genes and analyze the antigenic regions of these proteins comparing with RV1; and assess the full genetic background of eleven selected Brazilian strains. The G2P[4] detection rate among RVA positive samples was 0/157 in 2001, 3/226 (1.3%) in 2002, 0/514 in 2003, 0/651 in 2004, 31/344 (9%)/2005, 112/227 (49%)/2006, 139/211 (66%)/2007, 240/284 (85%)/2008, 66/176 (37.5%)/2009, 367/422 (87%)/2010 and 75/149 (50%)/2011. For the VP7 and VP8/encoding genes, 52 sequences were analyzed and shared up to 99% nucleotide identity with other contemporary G2P[4] strains detected worldwide, grouping into different clusters. Most differences inside antigenic epitopes of VP7 and VP8/have been maintained in the G2P[4] Brazilian strains along the years, and all were present before RV1 introduction. Eleven G2P[4] strains (4-vaccinated/7-non-vaccinated) were completely characterized and possessed the typical DS-1-like genotype constellation (G2-P[4]-I2-R2-C2-M2-A2-N2-T2-E2-H2) sharing up to 99% of nucleotide identity with contemporary worldwide strains. Reassortments between Brazilian G2P[4] human strains were observed. In conclusion, the data obtained in the current study suggests that implementation of RV1 vaccination might not influence the genetic diversity observed in G2P[4] analyzed strains. Several factors might have contributed to the increased prevalence of this genotype in Brazil since 2005: the introduction of RV1 into the Brazilian National Immunization Program has resulted in a decrease in the relative prevalence of predominant Wa-like RVA strains facilitating the increase of the heterotypic (DS-1-like) RVA strain G2P[4] in the Brazilian population; the genetic diversity found in different geographical regions throughout the years before, and after the introduction of RV1; the long period of low or no circulation of this genotype in Brazil previous to RV1 introduction could have created favorable conditions for the accumulation of immunological susceptible individuals. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Gomez, Mariela Martinez; Carvalho-Costa, Filipe Anibal; Volotao, Eduardo de Mello; Rose, Tatiana Lundgren; Marques da Silva, Marcelle Figueira; Fialho, Alexandre Madi; Assis, Rosane Maria S.; Ribeiro de Andrade, Juliana da Silva; Costa Sa, Ana Caroline; Gagliardi Leite, Jose Paulo] Oswaldo Cruz Inst Fiocruz, Lab Comparat & Environm Virol, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Zeller, Mark; Heylen, Elisabeth; Matthijnssens, Jelle] Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Clin & Epidemiol Virol, Leuven, Belgium.
RP Gomez, MM (corresponding author), Oswaldo Cruz Inst Fiocruz, Lab Comparat & Environm Virol, Av Brasil 4365,Pavilhao Helio & Peggy Pereira, BR-21040360 Rio De Janeiro, RJ, Brazil.
EM marielamartinezgomez@gmail.com
RI Matthijnssens, Jelle/O-7069-2019; Matthijnssens, Jelle/B-8634-2016;
   Heylen, Elisabeth/AAR-5254-2020; LEITE, JOSE PAULO
   GAGLIARDI/AAY-1230-2020; Silva-Sales, Marcelle/D-9809-2015;
   Matthijnssens, Jelle/A-6770-2015
OI Matthijnssens, Jelle/0000-0003-1188-9733; Matthijnssens,
   Jelle/0000-0003-1188-9733; Heylen, Elisabeth/0000-0003-4359-7225;
   Silva-Sales, Marcelle/0000-0002-4275-9627; Fialho, Alexandre
   Madi/0000-0002-5412-3896; GOMEZ, MARIELA/0000-0002-5740-9005
FU Program of Research Excellence (PROEP - IOC/Fiocruz/CNPq); National
   Council for Scientific and Technological Development (CNPq)National
   Council for Scientific and Technological Development (CNPq); project
   PAPES VI/FIOCRUZ - CNPqNational Council for Scientific and Technological
   Development (CNPq); Oswaldo Cruz Institute (IOC/FIOCRUZ); Brazilian
   Federal Agency for Support and Evaluation of Graduate Education (CAPES)
   - project CAPES-MERCOSUL PPCP [023/2011]; General Coordination of Public
   Health Laboratories - Secretary of Health Surveillance (CGLAB/SVS);
   Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro
   State (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ); Institute for the Promotion of
   Innovation through Science and Technology in Flanders (IWT
   Vlaanderen)Institute for the Promotion of Innovation by Science and
   Technology in Flanders (IWT); CNPqNational Council for Scientific and
   Technological Development (CNPq)
FX This research was supported by funds from the Program of Research
   Excellence (PROEP - IOC/Fiocruz/CNPq), the National Council for
   Scientific and Technological Development (CNPq), project PAPES
   VI/FIOCRUZ - CNPq, Oswaldo Cruz Institute (IOC/FIOCRUZ), Brazilian
   Federal Agency for Support and Evaluation of Graduate Education (CAPES)
   - project CAPES-MERCOSUL PPCP 023/2011, the General Coordination of
   Public Health Laboratories - Secretary of Health Surveillance
   (CGLAB/SVS), and Carlos Chagas Filho Foundation for Research Support of
   Rio de Janeiro State (FAPERJ). M.Z. was supported by the Institute for
   the Promotion of Innovation through Science and Technology in Flanders
   (IWT Vlaanderen). The authors would like to thank the Secretary of
   Public Health of all Brazilian States involved in the study. Mariela M
   Gomez has a Postdoc position at the Oswaldo Cruz Institute, Fiocruz, Rio
   de Janeiro, Brazil, and was supported by the CNPq.
CR Amarilla A, 2007, MED SCI MONITOR, V13, pCR333
   [Anonymous], 2008, WHOIVB0817
   Assis ASF, 2013, J PEDIAT-BRAZIL, V89, P470, DOI 10.1016/j.jped.2013.02.019
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Carvalho-Costa FA, 2011, PEDIATR INFECT DIS J, V30, pS35, DOI 10.1097/INF.0b013e3181fefd5f
   Carvalho-Costa FA, 2009, EMERG INFECT DIS, V15, P95, DOI 10.3201/eid1501.071136
   Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843
   de Oliveira A.S.L., 2008, 8 ROT INT S IST TURK, P60
   Dennis AF, 2014, J VIROL, V88, P3789, DOI 10.1128/JVI.03516-13
   Do LP, 2014, ARCH VIROL, V159, P315, DOI 10.1007/s00705-013-1804-6
   Doan YH, 2011, ARCH VIROL, V156, P1969, DOI 10.1007/s00705-011-1083-z
   Donato C.M., 2014, INFECT GENET EVOL
   Dulgheroff ACB, 2012, J CLIN VIROL, V55, P67, DOI 10.1016/j.jcv.2012.06.003
   FERRERA A, 2007, 17 EUR C CLIN MICR I
   Fredj MB, 2013, INFECT GENET EVOL, V18, P132, DOI 10.1016/j.meegid.2013.05.008
   Leite JPG, 2008, MEM I OSWALDO CRUZ, V103, P745, DOI 10.1590/S0074-02762008000800001
   Giammanco GM, 2014, J GEN VIROL, V95, P91, DOI 10.1099/vir.0.056788-0
   Gomez MM, 2013, INFECT GENET EVOL, V19, P395, DOI 10.1016/j.meegid.2013.03.028
   Gomez MM, 2011, J MED VIROL, V83, P1093, DOI 10.1002/jmv.22071
   Gurgel RG, 2009, GASTROENTEROLOGY, V137, P1970, DOI 10.1053/j.gastro.2009.07.046
   Gurgel RQ, 2007, EMERG INFECT DIS, V13, P1571, DOI 10.3201/eid1310.070412
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Heiman EM, 2008, J VIROL, V82, P11106, DOI 10.1128/JVI.01402-08
   Kirkwood CD, 2011, PEDIATR INFECT DIS J, V30, pS48, DOI 10.1097/INF.0b013e3181fefd90
   Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07
   Matthijnssens J, 2012, EXPERT REV VACCINES, V11, P1347, DOI [10.1586/erv.12.105, 10.1586/ERV.12.105]
   Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007
   Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z
   Matthijnssens J, 2009, FUTURE MICROBIOL, V4, P1303, DOI 10.2217/FMB.09.96
   McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634
   Nakagomi T, 2008, ARCH VIROL, V153, P591, DOI 10.1007/s00705-007-0028-z
   Patel MM, 2008, EMERG INFECT DIS, V14, P863, DOI 10.3201/eid1405.071440
   PEREIRA HG, 1983, J HYG-CAMBRIDGE, V90, P117, DOI 10.1017/S0022172400063919
   Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448
   Soares LD, 2014, J MED VIROL, V86, P1065, DOI 10.1002/jmv.23797
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Tate JE, 2012, EXPERT REV VACCINES, V11, P211, DOI [10.1586/ERV.11.184, 10.1586/erv.11.184]
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0
   World Health Otganization, 2013, ROT VACC WHO POS PAP
   Zeller M, 2012, J CLIN MICROBIOL, V50, P966, DOI 10.1128/JCM.05590-11
NR 41
TC 20
Z9 20
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD DEC
PY 2014
VL 28
BP 486
EP 494
DI 10.1016/j.meegid.2014.09.012
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA AX1YI
UT WOS:000346739500069
PM 25239525
OA Green Published
DA 2020-12-08
ER

PT J
AU Ganime, AC
   Carvalho-Costa, FA
   Santos, M
   Costa, R
   Leite, JPG
   Miagostovich, MP
AF Ganime, Ana Carolina
   Carvalho-Costa, Filipe A.
   Santos, Marisa
   Costa Filho, Rubens
   Leite, Jose Paulo G.
   Miagostovich, Marize P.
TI Viability of Human Adenovirus from Hospital Fomites
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE adenovirus; viability; fomites; hospital; biomarker
ID ENTERIC VIRUSES; GASTROENTERIC VIRUSES; NESTED-PCR; SURFACES; SURVIVAL;
   CONTAMINATION; ENVIRONMENT; WATER; ENTEROVIRUSES; NOROVIRUSES
AB The monitoring of environmental microbial contamination in healthcare facilities may be a valuable tool to determine pathogens transmission in those settings; however, such procedure is limited to bacterial indicators. Viruses are found commonly in those environments and are rarely used for these procedures. The aim of this study was to assess distribution and viability of a human DNA virus on fomites in an Adult Intensive Care Unit of a private hospital in Rio de Janeiro, Brazil. Human adenoviruses (HAdV) were investigated in 141 fomites by scraping the surface area and screening by quantitative PCR (qPCR) using TaqMan (R) System (Carlsbad, CA). Ten positive samples were selected for virus isolation in A549 and/or HEp2c cell lines. A total of 63 samples (44.7%) were positive and presented viral load ranging from 2.48x10(1) to 2.1x10(3) genomic copies per millilitre (gc/ml). The viability was demonstrated by integrated cell culture/nested-PCR in 5 out of 10 samples. Nucleotide sequencing confirmed all samples as HAdV and characterized one of them as specie B, serotype 3 (HAdV-3). The results indicate the risk of nosocomial transmission via contaminated fomites and point out the use of HAdV as biomarkers of environmental contamination. J. Med. Virol. 86:2065-2069, 2014. (c) 2014 Wiley Periodicals, Inc.
C1 [Ganime, Ana Carolina; Carvalho-Costa, Filipe A.; Leite, Jose Paulo G.; Miagostovich, Marize P.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Rio De Janeiro, Brazil.
   [Santos, Marisa] Natl Inst Cardiol, Rio De Janeiro, Brazil.
   [Costa Filho, Rubens] Procardiaco Hosp, Rio De Janeiro, Brazil.
RP Ganime, AC (corresponding author), Ave Brasil,4365 Pav Helio & Peggy Pereira, BR-21040360 Rio De Janeiro, Brazil.
EM acganime@ioc.fiocruz.br
RI LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020; da Silva Santos,
   Marisa/ABA-3418-2020
OI da Silva Santos, Marisa/0000-0002-2174-6800
FU Brazilian National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Oswaldo Cruz Institute (IOC-Fiocruz); Program of Research
   Excellence (PROEP); Carlos Chagas Filho Foundation for Research Support
   of the state of Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ); Instituto
   Oswaldo Cruz-IOC, Cellular and Molecular Biology Program
FX Grant sponsor: Brazilian National Council for Scientific and
   Technological Development (CNPq); Grant sponsor: Oswaldo Cruz Institute
   (IOC-Fiocruz); Grant sponsor: Program of Research Excellence (PROEP);
   Grant sponsor: Carlos Chagas Filho Foundation for Research Support of
   the state of Rio de Janeiro (FAPERJ); Grant sponsor: Instituto Oswaldo
   Cruz-IOC, Cellular and Molecular Biology Program
CR ABAD FX, 1994, APPL ENVIRON MICROB, V60, P3704, DOI 10.1128/AEM.60.10.3704-3710.1994
   Aitken C, 2001, CLIN MICROBIOL REV, V14, P528, DOI 10.1128/CMR.14.3.528-546.2001
   Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001
   ANSARI SA, 1988, J CLIN MICROBIOL, V26, P1513, DOI 10.1128/JCM.26.8.1513-1518.1988
   Bofill-Mas S, 2000, APPL ENVIRON MICROB, V66, P238, DOI 10.1128/AEM.66.1.238-245.2000
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Carducci A, 2011, J HOSP INFECT, V77, P242, DOI 10.1016/j.jhin.2010.10.010
   Creamer E, 2008, J HOSP INFECT, V69, P8, DOI 10.1016/j.jhin.2008.01.014
   Cromeans TL, 2008, J VIROL METHODS, V151, P140, DOI 10.1016/j.jviromet.2008.03.007
   Davanzo E, 2008, AM J INFECT CONTROL, V36, P753, DOI 10.1016/j.ajic.2008.04.254
   Gallimore CI, 2008, J CLIN MICROBIOL, V46, P3112, DOI 10.1128/JCM.00400-08
   Gallimore CI, 2006, J CLIN MICROBIOL, V44, P395, DOI 10.1128/JCM.44.2.395-399.2006
   Gallimore CI, 2005, J CLIN MICROBIOL, V43, P3890, DOI 10.1128/JCM.43.8.3890-3894.2005
   Gallimore CI, 2004, J CLIN MICROBIOL, V42, P2271, DOI 10.1128/JCM.42.5.2271-2274.2004
   Ganime AC, 2012, AM J INFECT CONTROL, V40, P544, DOI 10.1016/j.ajic.2011.07.017
   Goodman ER, 2008, INFECT CONT HOSP EP, V29, P593, DOI 10.1086/588566
   Greening GE, 2006, FOOD MICROBIOL FOOD, P5
   Haramoto E, 2007, J APPL MICROBIOL, V103, P2153, DOI 10.1111/j.1365-2672.2007.03453.x
   Haramoto E, 2007, J VIROL METHODS, V142, P169, DOI 10.1016/j.jviromet.2007.01.024
   Henquell C, 2009, J CLIN VIROL, V45, P345, DOI 10.1016/j.jcv.2009.04.019
   Hernroth BE, 2002, APPL ENVIRON MICROB, V68, P4523, DOI 10.1128/AEM.68.9.4523-4533.2002
   HORWITZ MS, 1996, FIELDS VIROLOGY, P2149
   Kapikian A. Z., 2001, FIELDS VIROLOGY, V2, P1787
   Katayama H, 2008, WATER RES, V42, P1441, DOI 10.1016/j.watres.2007.10.029
   Kelley CJ, 2010, NEONATAL NETW, V29, P297, DOI 10.1891/0730-0832.29.5.297
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130
   LEITE JPG, 1985, J MED VIROL, V15, P203, DOI 10.1002/jmv.1890150213
   Lopman BA, 2004, EMERG INFECT DIS, V10, P1827, DOI 10.3201/eid1010.030941
   Matsushima Y, 2012, EMERG INFECT DIS, V18, P846, DOI 10.3201/eid1805.111584
   Myrmel M., 2006, Journal of Water and Health, V4, P197, DOI 10.2166/wh.2006.0016
   Parashar UD, 1998, EMERG INFECT DIS, V4, P561, DOI 10.3201/eid0404.980406
   Pereira E, 2007, J MED MICROBIOL, V56, P313, DOI 10.1099/jmm.0.46685-0
   Pham TTN, 2003, AM J CLIN PATHOL, V120, P575, DOI 10.1309/AWXDGNC5D70EN7YT
   Pina S, 1998, APPL ENVIRON MICROB, V64, P3376
   PUIG M, 1994, APPL ENVIRON MICROB, V60, P2963, DOI 10.1128/AEM.60.8.2963-2970.1994
   Rigotto C, 2005, WATER RES, V39, P297, DOI 10.1016/j.watres.2004.10.005
   Rigotto C, 2011, ENVIRON SCI TECHNOL, V45, P4145, DOI 10.1021/es103922r
   Rodriguez-Lazaro D, 2012, FEMS MICROBIOL REV, V36, P786, DOI 10.1111/j.1574-6976.2011.00306.x
   Rutala WA, 2006, ANTIMICROB AGENTS CH, V50, P1419, DOI 10.1128/AAC.50.4.1419-1424.2006
   Rzezutka A, 2004, FEMS MICROBIOL REV, V28, P441, DOI 10.1016/j.femsre.2004.02.001
   Sattar SA, 2004, J HOSP INFECT, V56, pS64, DOI 10.1016/j.jhin.2003.12.033
   Soule H, 1999, INFECT CONT HOSP EP, V20, P432, DOI 10.1086/501648
   Thurston-Enriquez JA, 2003, APPL ENVIRON MICROB, V69, P577, DOI 10.1128/AEM.69.1.577-582.2003
   Tian XG, 2011, VIRUS RES, V160, P214, DOI 10.1016/j.virusres.2011.06.017
   Tuladhar E, 2012, APPL ENVIRON MICROB, V78, P7769, DOI 10.1128/AEM.02144-12
   Wilhelmi I, 2003, CLIN MICROBIOL INFEC, V9, P247, DOI 10.1046/j.1469-0691.2003.00560.x
NR 46
TC 8
Z9 9
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD DEC
PY 2014
VL 86
IS 12
BP 2065
EP 2069
DI 10.1002/jmv.23907
PG 5
WC Virology
SC Virology
GA AS3LN
UT WOS:000344179400010
PM 25042068
OA Green Published
DA 2020-12-08
ER

PT J
AU Casmo, V
   Augusto, G
   Nala, R
   Sabonete, A
   Carvalho-Costa, FA
AF Casmo, Veronica
   Augusto, Gerito
   Nala, Rassul
   Sabonete, Acacio
   Carvalho-Costa, Filipe Anibal
TI THE EFFECT OF HOOKWORM INFECTION AND URINARY SCHISTOSOMIASIS ON BLOOD
   HEMOGLOBIN CONCENTRATION OF SCHOOLCHILDREN LIVING IN NORTHERN MOZAMBIQUE
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Hookworms; Schistosoma haematobium; Anemia; Hemoglobin; Mozambique
ID HAEMATOBIUM INFECTION; HELMINTH INFECTIONS; NUTRITIONAL-STATUS;
   PREGNANT-WOMEN; ANEMIA; CHILDREN; MALARIA; PRAZIQUANTEL; COMMUNITY;
   PATTERNS
AB This study aims to assess the association between schistosomiasis and hookworm infection with hemoglobin levels of schoolchildren in northern Mozambique. Through a cross-sectional survey, 1,015 children from five to 12 years old in the provinces of Nampula, Cabo Delgado and Niassa were studied. Hookworm infection and urinary schistosomiasis were diagnosed, through Ritchie and filtration methods, with a prevalence of 31.3% and 59.1%, respectively. Hemoglobin levels were obtained with a portable photometer (Hemocue (R)). The average hemoglobin concentration was 10.8 +/- 1.42 g/dL, and 62.1% of the children presented levels below 11.5 g/dL, of which 11.8% of the total number of children had hemoglobin levels below 9 g/dL. A multiple linear regression analysis demonstrated negative interactions between hemoglobin levels and ancylostomiasis, this being restricted to the province of Cabo Delgado (beta = -0.55; p < 0.001) where an independent interaction between hemoglobin levels and urinary schistosomiasis was also observed (beta = -0.35; p = 0.016). The logistical regression model indicated that hookworm infection represents a predictor of mild (OR = 1.87; 95% CI = 1.17-3.00) and moderate/severe anemia (OR = 2.71; 95% CI = 1.50 - 4.89). We concluded that, in the province of Cabo Delgado, hookworm and Schistosoma haematobium infections negatively influence hemoglobin levels in schoolchildren. Periodical deworming should be considered in the region. Health education and improvements in sanitary infrastructure could achieve long-term and sustainable reductions in soil-transmitted helminthiases and schistosomiasis prevalence rates.
C1 [Casmo, Veronica; Augusto, Gerito; Nala, Rassul; Sabonete, Acacio] Inst Nacl Saude Mocambique, Lab Parasitol Intestinal & Vesical, Cidade Maputo, Mocambique, Mozambique.
   [Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Virol Comparada Ambiental, Lab Epidemiol Sistemat Mol, BR-21045900 Rio De Janeiro, Brazil.
RP Carvalho-Costa, FA (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Virol Comparada Ambiental, Lab Epidemiol Sistemat Mol, Av Brasil 4365,Pav Leonidas Deane, BR-21045900 Rio De Janeiro, Brazil.
EM guaratiba@ioc.fiocruz.br
FU Ministry of Health of Mozambique; Schistosomiasis Control Initiative
FX This study was supported by the Ministry of Health of Mozambique and
   Schistosomiasis Control Initiative. Part of this study comprises the
   work towards a Master's Degree in Health Sciences in the Oswaldo Cruz
   Foundation (Fiocruz) for Veronica Casmo.
CR Augusto G, 2009, AM J TROP MED HYG, V81, P799, DOI 10.4269/ajtmh.2009.08-0344
   BEFIDIMENGUE RN, 1993, J TROP MED HYG, V96, P225
   Bungiro R, 2004, CURR OPIN INFECT DIS, V17, P421, DOI 10.1097/00001432-200410000-00006
   Carvalho-Costa Filipe Anibal, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P147, DOI 10.1590/S0036-46652007000300003
   Degarege Abraham, 2010, BMC Res Notes, V3, P143, DOI 10.1186/1756-0500-3-143
   Dreyfuss ML, 2000, J NUTR, V130, P2527
   Heckman J, 2010, SAMJ S AFR MED J, V100, P445, DOI 10.7196/SAMJ.3579
   Hotez P, 2007, TRENDS PARASITOL, V23, P511, DOI 10.1016/j.pt.2007.08.015
   Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261
   Instituto Nacional de Estatistica, 2008, MOC INQ IND MULT 200
   Jardim-Botelho A, 2008, TROP MED INT HEALTH, V13, P458, DOI 10.1111/j.1365-3156.2008.02022.x
   Knopp S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000681
   Koukounari A, 2007, J INFECT DIS, V196, P659, DOI 10.1086/520515
   Kung'u JK, 2009, AM J TROP MED HYG, V81, P1062, DOI 10.4269/ajtmh.2009.09-0091
   Maina RN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-S3-S4
   Midzi N, 2010, ACTA TROP, V115, P103, DOI 10.1016/j.actatropica.2010.02.010
   Montresor A, 1998, GUIDELINES EVALUATIO
   Ndibazza J, 2010, CLIN INFECT DIS, V50, P531, DOI 10.1086/649924
   Osei A, 2010, FOOD NUTR BULL, V31, P221, DOI 10.1177/156482651003100205
   PRUAL A, 1992, AM J TROP MED HYG, V47, P291, DOI 10.4269/ajtmh.1992.47.291
   Rohner F, 2010, J NUTR, V140, P635, DOI 10.3945/jn.109.114256
   Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7
   STEPHENSON LS, 1985, AM J TROP MED HYG, V34, P519, DOI 10.4269/ajtmh.1985.34.519
   Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867
   Tatala S R, 2008, Tanzan J Health Res, V10, P189
   UNICEF, 1998, STAT WORLDS CHILDR
   van Eijk AM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000370
   van Hensbroek MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012589
   World Health Organization, 2002, WHO TECHN REP SER, V912
   World Health Organization (WHO), PAR DIS
   World Health Organization (WHO), 1999, PREV CONTR IR DEF AN, P22
NR 31
TC 7
Z9 8
U1 0
U2 10
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PD MAY-JUN
PY 2014
VL 56
IS 3
BP 219
EP 224
DI 10.1590/S0036-46652014000300007
PG 6
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA AL7LO
UT WOS:000339315500007
PM 24879000
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Brito-Santos, F
   Barbosa, GB
   Trilles, L
   Wanke, B
   Wieland, WM
   Carvalho-Costa, FA
   Lazera, MS
AF Brito-Santos, F.
   Barbosa, G. B.
   Trilles, L.
   Wanke, B.
   Wieland, W. M.
   Carvalho-Costa, F. A.
   Lazera, M. S.
TI Isolation of Cryptococcus gattii VGII from indoor dust in the deep
   Amazon of the Rio Negro basin
SO MYCOSES
LA English
DT Meeting Abstract
C1 [Brito-Santos, F.] Fiocruz MS, IPEC, BR-21045900 Rio De Janeiro, Brazil.
   [Barbosa, G. B.; Trilles, L.; Wanke, B.; Lazera, M. S.] Fiocruz MS, Evandro Chagas Clin Res Inst, BR-21045900 Rio De Janeiro, Brazil.
   [Wieland, W. M.] Sydney Med School Westmead, Ctr Infect Dis & Microbiol, Sydney, NSW, Australia.
   [Carvalho-Costa, F. A.] Fiocruz MS, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0933-7407
EI 1439-0507
J9 MYCOSES
JI Mycoses
PD MAY
PY 2014
VL 57
SU 1
SI SI
BP 59
EP 60
PG 2
WC Dermatology; Mycology
SC Dermatology; Mycology
GA AG0FL
UT WOS:000335090600128
DA 2020-12-08
ER

PT J
AU da Silva, MFM
   Gomez, MM
   Rose, TL
   Volotao, ED
   Carvalho-Costa, FA
   Bello, G
   Leite, JPG
AF Marques da Silva, Marcelle Figueira
   Gomez, Mariela Martinez
   Rose, Tatiana Lundgren
   Volotao, Eduardo de Mello
   Carvalho-Costa, Filipe Anibal
   Bello, Gonzalo
   Gagliardi Leite, Jose Paulo
TI VP8*P[8] lineages of group A rotaviruses circulating over 20 years in
   Brazil: Proposal of six different sub-lineages for P[8]-3 clade
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Gastroenteritis; Group A rotavirus; Phylogenetic analysis; P[8]lineages;
   P[8]-3 sub-lineages
ID STRAINS; DIVERSITY; EVOLUTION; SEQUENCE; HUMANS; GENE; PCR
AB Group A rotaviruses (RVA) is the most important cause of severe gastroenteritis among children worldwide. Vaccination is considered the best alternative among public health measures to reduce and prevent the global burden caused by RVA infections. Rotarix (TM), a monovalent vaccine based on a human strain with a G1P[8]-1 specificity, was introduced in the National Brazilian Immunization Programs (NIP) in March, 2006. RVA P[8] is the most prevalent P genotype worldwide and four distinct phylogenetic lineages: P[8]-1, -2, -3, and -4 have been described. In the current study phylogenetic analysis of the VP8* gene of 135 RVA P[8] Brazilian strains, in combination with G1, G3, G5 or G9 VP7 genotype, collected from 1986 to 2011 were carried out for a better understanding of the evolution of this viral genotype in Brazil. Lineages P[8]-1, P[8]-2, and P[8]-3 were observed circulating in Brazil. In 2001 these three P[8] lineages co-circulated simultaneously and this is the first report in South America to date. Considering the P[8] lineage and the G genotype, all G3 strains were related to lineage P[8]-3, whereas the G9 strains were related to P[8]-2 and P[8]-3 and G1 and G5 were related to P[8]-1, P[8]-2, and P[8]-3. In addition, the phylogenetic analysis based on estimate of genetic distances between P[8]-3 strains and the definition of a 1.5% cutoff value (with relevant statistical support) it was possible to propose a new classification for the P[8]-3 lineage into six different sub-lineages: P[8]-3.1 to P[8]-3.6. These findings reinforce the notion of the existence of constraints within specific RVA strains populations. The results obtained in this study reinforce the importance of a continuous RVA surveillance of circulating strains in order to predict the possible variants that will circulate in a country, assess the effects of vaccination on RVA circulating strains, and ultimately help in the design, challenges, and prospects of RVA vaccines. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Marques da Silva, Marcelle Figueira; Gomez, Mariela Martinez; Rose, Tatiana Lundgren; Volotao, Eduardo de Mello; Carvalho-Costa, Filipe Anibal; Gagliardi Leite, Jose Paulo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Minist Hlth, BR-21040360 Rio De Janeiro, Brazil.
   [Bello, Gonzalo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab AIDS & Mol Immunol, Minist Hlth, BR-21040360 Rio De Janeiro, Brazil.
RP da Silva, MFM (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Virol Comparada & Ambiental, Ave Brasil 4365, BR-21040360 Rio De Janeiro, Brazil.
EM marcelle@ioc.fiocruz.br
RI Silva-Sales, Marcelle/D-9809-2015; Bentancor, Gonzalo Jose
   Bello/N-7377-2019; Bello, Gonzalo/E-6842-2013; LEITE, JOSE PAULO
   GAGLIARDI/AAY-1230-2020
OI Silva-Sales, Marcelle/0000-0002-4275-9627; Bentancor, Gonzalo Jose
   Bello/0000-0002-2724-2793; 
FU Oswaldo Cruz Institute/Fiocruz; National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq); PAPES VI FIOCRUZ - CNPq; General
   Coordination of Public Health Laboratories, Secretary of Health
   Surveillance - Ministry of Health (CGLAB/SVS); Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CAPESCAPES
FX We would like to thank Rosane Maria Santos de Assis and Alexandre Madri
   Fialho for technical assistance. This study was supported/sponsored by
   Oswaldo Cruz Institute/Fiocruz, National Council for Scientific and
   Technological Development (CNPq), PAPES VI FIOCRUZ - CNPq, General
   Coordination of Public Health Laboratories, Secretary of Health
   Surveillance - Ministry of Health (CGLAB/SVS), Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   and CAPES.
CR Araujo IT, 2007, J MED VIROL, V79, P995, DOI 10.1002/jmv.20918
   Arista S, 2006, J VIROL, V80, P10724, DOI 10.1128/JVI.00340-06
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Cunliffe NA, 2001, J CLIN MICROBIOL, V39, P836, DOI 10.1128/JCM.39.3.836-843.2001
   Desselberger U, 1996, ARCH VIROL, P37
   Estes MK, 2007, FIELDS VIROLOGY, V5, P1917, DOI DOI 10.1007/978-3-642-69159-1_3
   Leite JPG, 2008, MEM I OSWALDO CRUZ, V103, P745, DOI 10.1590/S0074-02762008000800001
   GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992
   Heiman EM, 2008, J VIROL, V82, P11106, DOI 10.1128/JVI.01402-08
   Iturriza-Gomara M, 2000, J CLIN MICROBIOL, V38, P898
   Iturriza-Gomara M, 2001, J VIROL, V75, P3696, DOI 10.1128/JVI.75.8.3696-3705.2001
   Kirkwood CD, 1996, ARCH VIROL, V141, P587, DOI 10.1007/BF01718319
   Leite JPG, 1996, ARCH VIROL, V141, P2365, DOI 10.1007/BF01718637
   Tort LFL, 2010, J CLIN VIROL, V47, P345, DOI 10.1016/j.jcv.2009.12.018
   da Silva MFM, 2011, J MED VIROL, V83, P357, DOI 10.1002/jmv.21968
   Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007
   Stupka JA, 2012, J CLIN VIROL, V54, P162, DOI 10.1016/j.jcv.2012.02.011
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI [10.1093/molbev/msr121, 10.1093/molbev/mst197]
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Tate JE, 2010, EXPERT REV VACCINES, V9, P395, DOI 10.1586/ERV.10.17
NR 20
TC 16
Z9 16
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUN
PY 2013
VL 16
BP 200
EP 205
DI 10.1016/j.meegid.2013.01.004
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA 166PM
UT WOS:000320569500026
PM 23352888
DA 2020-12-08
ER

PT J
AU Iniguez, AM
   Leles, D
   Jaeger, LH
   Carvalho-Costa, FA
   Araujo, A
AF Iniguez, Alena M.
   Leles, Daniela
   Jaeger, Lauren H.
   Carvalho-Costa, Filipe A.
   Araujo, Adauto
CA Amazonas Res Grp
TI Genetic characterisation and molecular epidemiology of Ascaris spp. from
   humans and pigs in Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Ascaris; Cytochrome c oxidase subunit 1; NADH dehydrogenase subunit 1;
   Molecular epidemiology; Brazil
ID RIBOSOMAL DNA; MITOCHONDRIAL-DNA; POPULATIONS; CHINA; LUMBRICOIDES;
   VARIABILITY; PARASITES; REGIONS; MARKERS
AB The molecular epidemiology of Ascaris spp. of human and pig origin has been studied as a means to assess the potential of pigs as reservoirs for human ascariasis. In this study, human (H) and pig (P) Ascaris spp. haplotypes from two Brazilian regions were characterised based on two mitochondrial genes, nad1 and cox1. The results show six haplotypes of the coxl gene, with two haplotypes (H9P9 and P3) corresponding to haplotypes previously characterised in China. Because P3 was found in humans in this study, it was designated as H14P3. Furthermore, five new Ascaris spp. nad1 haplotypes from humans (H12-H16) and five from pigs (P16-P20) were observed, with one being highly frequent and present in both hosts, here designated as H12P17. Phylogenetic and network analysis demonstrated that the molecular epidemiology of Ascaris spp. in Brazil is driven by the globally distributed haplotypes cox1 H14P3 and nad1 H12P17. In conclusion, in this study genetic characterisation of Ascaris spp. showed that humans and pigs share common haplotypes that are also present in two widely separatedigeographical regions of Brazil. (c) 2012 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
C1 [Iniguez, Alena M.; Jaeger, Lauren H.; Carvalho-Costa, Filipe A.; Amazonas Res Grp] Inst Oswaldo Cruz Fundacao Oswaldo Cruz IOC FIOCR, Lab Genet Mol Microorg, Rio De Janeiro, Brazil.
   [Leles, Daniela; Araujo, Adauto] Escola Nacl Saude Publ Sergio Arouca Fundacao Osw, Rio De Janeiro, Brazil.
RP Iniguez, AM (corresponding author), Av Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM alena@ioc.fiocruz.br
RI Valverde, Joanna G/C-1284-2014; INIGUEZ, ALENA M/B-7613-2013
OI Valverde, Joanna G/0000-0001-8064-6255; INIGUEZ, ALENA
   M/0000-0002-9788-9533
FU LGMM/IOC/FIOCRUZ fellowship; FAPERJ fellowshipCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   CNPq fellowshipNational Council for Scientific and Technological
   Development (CNPq)
FX Project support was provided by LGMM/IOC/FIOCRUZ, FAPERJ and CNPq
   fellowships.
CR Anderson TJC, 1997, PARASITOLOGY, V115, P325, DOI 10.1017/S0031182097001339
   ANDERSON TJC, 1995, PARASITOLOGY, V110, P215, DOI 10.1017/S0031182000063988
   ANDERSON TJC, 1993, PARASITOLOGY, V107, P319, DOI 10.1017/S0031182000079294
   Anderson TJC, 2001, TRENDS PARASITOL, V17, P183, DOI 10.1016/S1471-4922(00)01944-9
   Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036
   Betson M, 2011, T ROY SOC TROP MED H, V105, P370, DOI 10.1016/j.trstmh.2011.04.009
   Brandao ML, 2007, THESIS ENSP FIOCRUZ
   Coles GC, 2006, VET PARASITOL, V136, P167, DOI 10.1016/j.vetpar.2005.11.019
   Costa-Macedo L M, 1999, Cad Saude Publica, V15, P173
   Criscione CD, 2007, P ROY SOC B-BIOL SCI, V274, P2669, DOI 10.1098/rspb.2007.0877
   Criscione CD, 2007, J PARASITOL, V93, P704, DOI 10.1645/GE-1058R.1
   Crompton DWT, 1999, J PARASITOL, V85, P397, DOI 10.2307/3285768
   Ishiwata K, 2004, PARASITOL RES, V92, P50, DOI 10.1007/s00436-003-1010-7
   KATO K, 1960, JAP J MED SCI BIOL, V19, P59
   Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397
   Leles D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-42
   Leles D, 2010, PARASITOL INT, V59, P93, DOI 10.1016/j.parint.2009.10.001
   Leles D, 2009, VET PARASITOL, V163, P167, DOI 10.1016/j.vetpar.2009.03.050
   Loreille O, 2003, MEM I OSWALDO CRUZ, V98, P39, DOI 10.1590/S0074-02762003000900008
   LUTZ Adolpho, 1919, Memorias do Instituto Oswaldo Cruz, V11, P121, DOI 10.1590/S0074-02761919000100006
   Nejsum P, 2005, J CLIN MICROBIOL, V43, P1142, DOI 10.1128/JCM.43.3.1142-1148.2005
   O'Lorcain P, 2000, PARASITOLOGY, V121, pS51, DOI 10.1017/S0031182000006442
   Peng W, 2007, PARASITOLOGY, V134, P325, DOI 10.1017/S0031182006001521
   Peng WD, 2005, ELECTROPHORESIS, V26, P4317, DOI 10.1002/elps.200500276
   Peng WD, 1998, PARASITOLOGY, V117, P355, DOI 10.1017/S0031182098003102
   Peng WD, 2003, ELECTROPHORESIS, V24, P2308, DOI 10.1002/elps.200305455
   Peng W, 2012, INFECT GENET EVOL, V12, P227, DOI 10.1016/j.meegid.2012.01.012
   Roepstorff A, 2011, VET PARASITOL, V180, P72, DOI 10.1016/j.vetpar.2011.05.029
   SATIOU N, 1987, MOL BIOL EVOL, V4, P406
   Sato H, 2005, J PARASITOL, V91, P716, DOI 10.1645/GE-3374RN
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Valverde JG, 2011, ANN TROP MED PARASIT, V105, P413, DOI 10.1179/1364859411Y.0000000034
   Vilas R, 2005, PARASITOLOGY, V131, P839, DOI 10.1017/S0031182005008437
   Zhou CH, 2011, PARASITOL RES, V109, P329, DOI 10.1007/s00436-011-2260-4
   Zhu XQ, 1999, INT J PARASITOL, V29, P469, DOI 10.1016/S0020-7519(98)00226-4
NR 35
TC 18
Z9 19
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0035-9203
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD OCT
PY 2012
VL 106
IS 10
BP 604
EP 612
DI 10.1016/j.trstmh.2012.06.009
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 023NN
UT WOS:000310041800004
PM 22944771
DA 2020-12-08
ER

PT J
AU Ganime, AC
   Carvalho-Costa, FA
   Mendonca, MCL
   Vieira, CB
   Santos, M
   Costa, R
   Miagostovich, MP
   Leite, JPG
AF Ganime, Ana Carolina
   Carvalho-Costa, Filipe A.
   Mendonca, Marcos Cesar L.
   Vieira, Carmen B.
   Santos, Marisa
   Costa Filho, Rubens
   Miagostovich, Marize P.
   Leite, Jose Paulo G.
TI Group A rotavirus detection on environmental surfaces in a hospital
   intensive care unit
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
DE Fomites; Virus biomarker; Hospital infection; Adult ward
ID PRIMARY IMMUNODEFICIENCY UNIT; REVERSE-TRANSCRIPTASE PCR; GASTROENTERIC
   VIRUSES; ENTERIC VIRUSES; INFECTIONS; WATER; CONTAMINATION;
   TRANSMISSION; NOROVIRUSES; EXCRETION
AB Background: Environmental surfaces can play a role in the spread of pathogens, such as enteric viruses, within a hospital. This study assessed the level of contamination of group A rotavirus (RV-A) on environmental surfaces samples from an adult intensive care unit in a hospital in Rio de Janeiro, Brazil.
   Methods: A total of 504 environmental surface samples were obtained from multiple sites in the intensive care unit, including flushing buttons, telephones, and alcohol gel supports. Nested and quantitative reverse-transcriptase polymerase chain reaction (RT-PCR) were used to detect and quantify RV-A levels through partial amplification of VP6 and NSP3 genes, respectively, and the viability of the viruses detected was assessed by MA-104 cell integrated cell culture/RT-PCR.
   Results: RV-A was detected by nested RT-PCR in 14% of the samples (73 of 504), with viral loads ranging from 3.4 genomic copies/mL to 2.9 x 10(3) genomic copies/mL. The nucleotide sequence of the amplicons obtained from nested RT-PCR confirmed that the positive samples were RV-A. Moreover, 3 of 10 strains investigated demonstrated viability by integrated cell culture/RT-PCR.
   Conclusion: The detection of RV-A on environmental surface samples indicates a need for improvements to hospital cleaning procedures to reduce viral contamination, and suggests, as reported previously, that RV-A can be used as a biomarker to assess contamination in hospitals. Copyright (C) 2012 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
C1 [Ganime, Ana Carolina; Mendonca, Marcos Cesar L.; Vieira, Carmen B.; Miagostovich, Marize P.; Leite, Jose Paulo G.] Minist Hlth, Oswaldo Cruz Fdn, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Carvalho-Costa, Filipe A.] Minist Hlth, Oswaldo Cruz Fdn, Inst Oswaldo Cruz, Lab Systemat & Biochem, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Santos, Marisa] Natl Cardiol Laranjeiras, Rio De Janeiro, Brazil.
   [Costa Filho, Rubens] Pro Cardiaco Hosp, Rio De Janeiro, Brazil.
RP Leite, JPG (corresponding author), Minist Hlth, Oswaldo Cruz Fdn, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Ave Brazil 4365, BR-21040360 Rio De Janeiro, RJ, Brazil.
EM jpgleite@ioc.fiocruz.br
RI da Silva Santos, Marisa/ABA-3418-2020; LEITE, JOSE PAULO
   GAGLIARDI/AAY-1230-2020
OI da Silva Santos, Marisa/0000-0002-2174-6800; Vieira,
   Carmen/0000-0001-8804-4347; COSTA FILHO, RUBENS/0000-0002-9725-3762
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq); Oswaldo Cruz Institute; Programa Estrategico de Pesquisa em Sa
   de (PAPES V); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPER J)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
FX This work was supported by the Brazilian National Council for Scientific
   and Technological Development, Oswaldo Cruz Institute and Programa
   Estrategico de Pesquisa em Sa de (PAPES V) and Fundacao Carlos Chagas
   Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPER J).
CR Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) Working Group for Hygiene in Hospital and Practice, 2005, KRANK HYG HOSP PRACT, P157
   Arnold M, 2009, CURR PROTOC MICROBIO, V15
   Ayliffe G., 2000, CONTROL HOSP INFECT
   Barnes GL, 2003, J PEDIATR-US, V142, P722, DOI 10.1067/mpd.2003.240
   Bisset Juan A., 2002, Rev Cubana Med Trop, V54, P202
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Creamer E, 2008, J HOSP INFECT, V69, P8, DOI 10.1016/j.jhin.2008.01.014
   Ferreira MSR, 2008, J MED VIROL, V80, P338, DOI 10.1002/jmv.21059
   Fong TT, 2005, MICROBIOL MOL BIOL R, V69, P357, DOI 10.1128/MMBR.69.2.357-371.2005
   Gallimore CI, 2008, J CLIN MICROBIOL, V46, P3112, DOI 10.1128/JCM.00400-08
   Gallimore CI, 2006, J CLIN MICROBIOL, V44, P395, DOI 10.1128/JCM.44.2.395-399.2006
   Gallimore CI, 2005, J CLIN MICROBIOL, V43, P3890, DOI 10.1128/JCM.43.8.3890-3894.2005
   Gallimore CI, 2004, J CLIN MICROBIOL, V42, P2271, DOI 10.1128/JCM.42.5.2271-2274.2004
   Gomara MI, 2002, J VIROL, V76, P6596, DOI 10.1128/JVI.76.13.6596-6601.2002
   Haramoto E, 2007, J VIROL METHODS, V142, P169, DOI 10.1016/j.jviromet.2007.01.024
   HORST H, 1986, INFECTION, V14, P163, DOI 10.1007/BF01645255
   Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130
   Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562
   Parashar UD, 1998, EMERG INFECT DIS, V4, P561, DOI 10.3201/eid0404.980406
   Phillips G, 2010, AM J EPIDEMIOL, V171, P1023, DOI 10.1093/aje/kwq050
   Ramani S, 2008, J MED VIROL, V80, P1099, DOI 10.1002/jmv.21177
   Rzezutka A, 2004, FEMS MICROBIOL REV, V28, P441, DOI 10.1016/j.femsre.2004.02.001
   SATTAR SA, 1986, J HYG-CAMBRIDGE, V96, P277, DOI 10.1017/S0022172400066055
   Sattar SA, 2004, J HOSP INFECT, V56, pS64, DOI 10.1016/j.jhin.2003.12.033
   Soule H, 1999, INFECT CONT HOSP EP, V20, P432, DOI 10.1086/501648
   TSAI YL, 1994, APPL ENVIRON MICROB, V60, P2400, DOI 10.1128/AEM.60.7.2400-2407.1994
   Zeng SQ, 2008, J VIROL METHODS, V153, P238, DOI 10.1016/j.jviromet.2008.08.004
NR 27
TC 22
Z9 24
U1 0
U2 8
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD AUG
PY 2012
VL 40
IS 6
BP 544
EP 547
DI 10.1016/j.ajic.2011.07.017
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA 981SV
UT WOS:000306991800016
PM 22018841
DA 2020-12-08
ER

PT J
AU Carvalho-Costa, FA
   Tedesqui, VL
   Monteiro, MDN
   Boia, MN
AF Carvalho-Costa, F. A.
   Tedesqui, V. L.
   Nascimento Monteiro, M. de Jesus
   Boia, M. N.
TI Outbreaks of Attacks by Hematophagous Bats in Isolated Riverine
   Communities in the Brazilian Amazon: A Challenge to Rabies Control
SO ZOONOSES AND PUBLIC HEALTH
LA English
DT Article
DE Vampire bats; Amazon; human rabies
ID VAMPIRE BATS; EPIDEMIOLOGY; REGION; HUMANS
AB Human rabies has re-emerged in Latin America due to bat associated transmission. We present data related to attacks by hematophagous bats in three riverine communities in the Rio Negro basin, Brazilian Amazon. A cross-sectional survey was carried out to obtain demographic and epidemiological data through interviews with 201 inhabitants. A total of 721 bat attacks with bites took place from 2004 to 2006, 238 (33%) reported by residents in Campinas do Rio Preto, 329 (46%) in Aguas Vivas and 154 (21%) in the community of Malalaha. Incidence density among surveyed inhabitants was 84 attacks/100 persons-years in Campinas do Rio Preto, 249 attacks/100 persons-years in Aguas Vivas and 81 attacks/100 persons-years in Malalaha. The proportion of surveyed inhabitants bled by bats at least once was 67% (63/94) in Campinas do Rio Preto, 96% (42/44) in Aguas Vivas and 62% (39/63) in Malalaha. Among subjects bled by bats, the average number of bites was 4.6 +/- 4.2 standard deviations (SD) in Campinas do Rio Preto, 8 +/- 6 SD in Aguas Vivas and 4.1 +/- 3.9 SD in Malalaha. Regarding houses, 67% (26/39) had animals in the peridomestic environment (chickens and/or dogs) and all were vulnerable to bats due to gaps in the walls and/or in the windows and doors. In 13 dwellings, rudimentary protection against bats through the fixation of fishing nets and/or straw nets to the windows and other openings was observed. Among dwellers reporting attacks, 48% (68/144) received the full post-exposure anti-rabies vaccination protocol with five doses of diploid human cell vaccine, 28% (39/144) received an incomplete schedule (14 doses), and 26% (37/144) did not receive any dose. No cases of rabies were reported during the study; however, regular pre-exposure vaccination in the studied populations must be considered.
C1 [Carvalho-Costa, F. A.] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, Lab Sistemat Bioquim, BR-20001 Rio De Janeiro, Brazil.
   [Carvalho-Costa, F. A.; Tedesqui, V. L.] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, Curso Posgrad Med Trop, BR-20001 Rio De Janeiro, Brazil.
   [Boia, M. N.] Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, BR-20001 Rio De Janeiro, Brazil.
   [Boia, M. N.] Univ Estado Rio de Janeiro, Disciplina Doencas Infecciosas & Parasitarias, BR-20550011 Rio De Janeiro, Brazil.
RP Carvalho-Costa, FA (corresponding author), Av Brasil 4-365,Pav Leonidas Deane,Sala 308, BR-21045900 Rio De Janeiro, Brazil.
EM guaratiba@ioc.fiocruz.br
CR Albas A, 2011, REV SOC BRAS MED TRO, V44, P201, DOI [10.1590/S0037-86822011005000001, 10.1590/s0037-86822011005000001]
   Arai YT, 2003, EMERG INFECT DIS, V9, P333, DOI 10.3201/eid0903.020252
   Banyard AC, 2011, ADV VIRUS RES, V79, P239, DOI 10.1016/B978-0-12-387040-7.00012-3
   Barbosa TFS, 2008, VIROLOGY, V370, P228, DOI 10.1016/j.virol.2007.10.005
   BATISTADOCOSTA M, 1993, TROP MED PARASITOL, V44, P219
   Brasil. Ministerio da Saude, 2002, NORM TECN TRAT PROF
   Caraballo AJ, 1996, REV SAUDE PUBL, V30, P483, DOI 10.1590/S0034-89101996000500012
   Carneiro AJB, 2010, EMERG INFECT DIS, V16, P2004, DOI 10.3201/eid1612.100726
   CARNEIRO V, 1954, Bull World Health Organ, V10, P775
   Castilho JG, 2010, VIRUS RES, V153, P100, DOI 10.1016/j.virusres.2010.07.012
   Constantine DG, 2003, EMERG INFECT DIS, V9, P17
   da Rosa EST, 2006, EMERG INFECT DIS, V12, P1197, DOI 10.3201/eid1708.050929
   de Almeida MF, 2011, REV SOC BRAS MED TRO, V44, P140, DOI [10.1590/S0037-86822011005000011, 10.1590/s0037-86822011005000011]
   Delpietro HA, 1996, REV SCI TECH OIE, V15, P971, DOI 10.20506/rst.15.3.964
   Gardner A. L., 1977, Special Publ Mus Texas Tech Univ, VNo. 13, P293
   Gomes MN, 2010, PREV VET MED, V93, P139, DOI 10.1016/j.prevetmed.2009.10.006
   Gonçalves Marcio A.S., 2002, Rev. Soc. Bras. Med. Trop., V35, P461, DOI 10.1590/S0037-86822002000500006
   LOPEZ A, 1992, LANCET, V339, P408, DOI 10.1016/0140-6736(92)90088-K
   Mendes Wellington da Silva, 2009, Rev. Saúde Pública, V43, P1075, DOI 10.1590/s0034-89102009005000073
   Messenger SL, 2002, CLIN INFECT DIS, V35, P738, DOI 10.1086/342387
   Ministerio da Saude, 1998, MORC AR URB RUR MAN
   Schneider M C, 2001, Cad Saude Publica, V17, P1531, DOI 10.1590/S0102-311X2001000600038
   Schneider MC, 2009, REV PANAM SALUD PUBL, V25, P260, DOI 10.1590/S1020-49892009000300010
   Valderrama Jessika, 2006, Biomédica, V26, P387
   Warner CK, 1999, AM J TROP MED HYG, V60, P502, DOI 10.4269/ajtmh.1999.60.502
   WHO, 2010, RAB
NR 26
TC 5
Z9 6
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1863-1959
EI 1863-2378
J9 ZOONOSES PUBLIC HLTH
JI Zoonoses Public Health
PD JUN
PY 2012
VL 59
IS 4
BP 272
EP 277
DI 10.1111/j.1863-2378.2011.01444.x
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Veterinary Sciences
SC Public, Environmental & Occupational Health; Infectious Diseases;
   Veterinary Sciences
GA 932XG
UT WOS:000303323200007
PM 22171969
DA 2020-12-08
ER

PT J
AU Sarquis, O
   Carvalho-Costa, FA
   Toma, HK
   Georg, I
   Burgoa, MR
   Lima, MM
AF Sarquis, Otilia
   Carvalho-Costa, Filipe Anibal
   Toma, Helena Keiko
   Georg, Ingebourg
   Burgoa, Marcelo R.
   Lima, Marli Maria
TI Eco-epidemiology of Chagas disease in northeastern Brazil: Triatoma
   brasiliensis, T. pseudomaculata and Rhodnius nasutus in the sylvatic,
   peridomestic and domestic environments
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE Triatomines; Ecology; Habitat - chagas disease
ID TRYPANOSOMA-CRUZI; PALM TREES; TRANSMISSION; REDUVIIDAE; HEMIPTERA;
   RISK; POPULATIONS; INFESTATION; LOCALITIES; JAGUARUANA
AB An entomological survey was carried out in four rural localities situated in the state of Ceara, assessing Chagas disease seroprevalence in man, focusing on the presence of vectors in natural foci contiguous to the domestic and peridomestic environments. Fifty-three Triatoma brasiliensis, nine T. pseudomaculata and 71 Rhodnius nasutus were collected in their natural habitats as far as 10 m from the houses, and 663, 59 and 8 respectively were captured in peridomestic artificial structures, adjacent to the houses, including henhouses, pigpens, corrals, perches and piles of bricks, tiles and wood. Within the households, 37T. brasiliensis, one specimen of T. pseudomaculata and one of R. nasutus were captured. Overall, Trypanosoma cruzi infection rates were 2.3% for T. brasiliensis and 11.3% for R. nasutus. Despite that the seroprevalence survey in man did not reveal positive results using two serological techniques, natural triatomine habitats are juxtaposed to man-made artificial ecotopes, resulting in overlapping habitats. The contiguity between natural ecotopes and human dwellings increases the interaction between vectors and humans, challenging continuous surveillance and vector control efforts.
C1 [Sarquis, Otilia; Lima, Marli Maria] Fiocruz MS, Inst Oswaldo Cruz, Lab Ecoepidemiol Doenca Chagas, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fiocruz MS, Inst Oswaldo Cruz, Lab Sistemat Bioquim, Curso Posgrad Med Trop, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Georg, Ingebourg] Fiocruz MS, Inst Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, BR-21045900 Rio De Janeiro, RJ, Brazil.
   [Burgoa, Marcelo R.] Secretaria Municipal Saude, Morada Nova, Ceara, Brazil.
   [Toma, Helena Keiko] Univ Fed Rio de Janeiro, Lab Diagnost Mol & Hematol, BR-21941901 Rio De Janeiro, RJ, Brazil.
   [Toma, Helena Keiko] Fiocruz MS, IOC Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, BR-21045900 Rio De Janeiro, RJ, Brazil.
RP Sarquis, O (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Ecoepidemiol Doenca Chagas, Av Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM otiliasarquis@ioc.fiocruz.br
CR Abad-Franch F, 2005, TROP MED INT HEALTH, V10, P1258, DOI 10.1111/j.1365-3156.2005.01511.x
   Alencar JE, 1987, HIST NATURAL DOENCA
   Borges EC, 2005, ACTA TROP, V93, P119, DOI 10.1016/j.actatropica.2004.10.002
   Borges-Pereira J, 2008, REV SOC BRAS MED TRO, V41, P345, DOI 10.1590/S0037-86822008000400005
   de la Fuente ALC, 2007, ACTA TROP, V101, P115, DOI 10.1016/j.actatropica.2006.12.007
   de la Fuente ALC, 2008, J MED ENTOMOL, V45, P14, DOI 10.1603/0022-2585(2008)45[14:BPOTRT]2.0.CO;2
   Dias FB, 2011, INFECT GENE IN PRESS
   Diotaiuti L., 1984, Revista Brasileira de Malariologia e Doencas Tropicais, V36, P11
   Emperaire L, 2006, PARASITE, V13, P171, DOI 10.1051/parasite/2006132171
   Freitas Simone Patrícia Carneiro, 2004, Cad. Saúde Pública, V20, P333, DOI 10.1590/S0102-311X2004000100052
   Guhl F, 2009, MEM I OSWALDO CRUZ, V104, P71, DOI 10.1590/S0074-02762009000900012
   Lima MM, 2008, PARASITOL RES, V102, P797, DOI 10.1007/s00436-007-0823-1
   Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005
   Noireau F, 2002, MEM I OSWALDO CRUZ, V97, P61, DOI 10.1590/S0074-02762002000100009
   Oliveira Filho A M, 2000, Cad Saude Publica, V16 Suppl 2, P105, DOI 10.1590/S0102-311X2000000800014
   Dias JCP, 2009, MEM I OSWALDO CRUZ, V104, P41, DOI 10.1590/S0074-02762009000900007
   Romana CA, 1999, T ROY SOC TROP MED H, V93, P594, DOI 10.1016/S0035-9203(99)90059-7
   Sarquis O, 2006, MEM I OSWALDO CRUZ, V101, P143, DOI 10.1590/S0074-02762006000200005
   Sarquis O, 2004, MEM I OSWALDO CRUZ, V99, P263, DOI 10.1590/S0074-02762004000300004
   Silveira AC, 2001, CONTROLE TRIATOMA BR
   Silveira AC, 2011, REV SOC BRAS MED TRO, V44, P52, DOI 10.1590/S0037-86822011000800009
   Teixeira ARL, 2001, EMERG INFECT DIS, V7, P100, DOI 10.3201/eid0701.010115
NR 22
TC 25
Z9 27
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD APR
PY 2012
VL 110
IS 4
BP 1481
EP 1485
DI 10.1007/s00436-011-2651-6
PG 5
WC Parasitology
SC Parasitology
GA 926EQ
UT WOS:000302814500020
PM 21979785
DA 2020-12-08
ER

PT J
AU Lima, MM
   Sarquis, O
   de Oliveira, TG
   Gomes, TF
   Coutinho, C
   Daflon-Teixeira, NF
   Toma, HK
   Britto, C
   Teixeira, BR
   D'Andrea, PS
   Jansen, AM
   Boia, MN
   Carvalho-Costa, FA
AF Lima, Marli M.
   Sarquis, Otilia
   de Oliveira, Tiago Guedes
   Gomes, Tais F.
   Coutinho, Carolina
   Daflon-Teixeira, Natalia F.
   Toma, Helena K.
   Britto, Constanca
   Teixeira, Bernardo R.
   D'Andrea, Paulo S.
   Jansen, Ana M.
   Boia, Marcio N.
   Carvalho-Costa, Filipe A.
TI Investigation of Chagas disease in four periurban areas in northeastern
   Brazil: epidemiologic survey in man, vectors, non-human hosts and
   reservoirs
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Chagas disease; Brazil; Trypanosoma cruzi; Epidemiology; Hosts; Vectors
ID TRYPANOSOMA-CRUZI INFECTION; RHODNIUS-NASUTUS HEMIPTERA; MINI-EXON GENE;
   TRIATOMA-PSEUDOMACULATA; ENDEMIC AREA; PALM TREES; TRANSMISSION;
   REDUVIIDAE; AMAZON; HABITAT
AB Chagas disease was investigated in four periurban areas of Ceara state, northeastern Brazil, through serological, parasitological and molecular methods in humans, reservoirs and vectors. A cross-sectional survey revealed a seroprevalence rate of 1.2% (13/1076 residents, six also proving positive through PCR). Trypanosoma cruzi infection was not detected in children under 10 years old. Triatoma pseudomaculata prevailed in the peridomiciles: 63 specimens, 69% (34/49) infected with trypanosomatids. Rhodnius nasutus was captured in Copernicia prunifera palm trees (n = 280; 25.0% infected with trypanosomatids) and inside dwellings (n = 8, all uninfected). Trypanosoma cruzi seropositive reservoirs, represented by Didelphis albiventris (n = 27), Rattus rattus (n = 24), Thrichomys laurentius (n = 2), Mus musculus (n = 1) and Monodelphis domestica (n = 1), were identified. Among domestic dogs (n = 96) seroprevalence reached 21.9%. Miniexon multiplex PCR assays characterized TcI in triatomines. Both TcI and TcII were detected in wild mammal hosts. We conclude that Trypanosoma cruzi circulates within a domestic zoonotic cycle, requiring continuous surveillance. Insecticide application to domiciles does not appear to prevent continuous reintroduction of wild triatomine specimens, presenting a challenge to authorities involved in Chagas disease control. (C) 2011 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
C1 [Lima, Marli M.; Sarquis, Otilia; de Oliveira, Tiago Guedes; Gomes, Tais F.; Coutinho, Carolina; Daflon-Teixeira, Natalia F.] Fiocruz MS, Lab Ecoepidemiol Doenca Chagas IOC, BR-21045900 Rio De Janeiro, Brazil.
   [Toma, Helena K.] Fiocruz MS, Lab Interdisciplinar Pesquisas Med IOC, BR-21045900 Rio De Janeiro, Brazil.
   [Toma, Helena K.] Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil.
   [Britto, Constanca] Fiocruz MS, Lab Biol Mol & Doencas Endem IOC, BR-21045900 Rio De Janeiro, Brazil.
   [Teixeira, Bernardo R.; D'Andrea, Paulo S.; Boia, Marcio N.] Fiocruz MS, Lab Biol & Parasitol Mamiferos Silvestres Reserva, Posgrad Biol Parasitaria IOC, BR-21045900 Rio De Janeiro, Brazil.
   [Jansen, Ana M.] Fiocruz MS, Lab Biol Tripanossomatideos IOC, BR-21045900 Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe A.] Fiocruz MS, Lab Sistemat & Bioquim IOC, BR-21045900 Rio De Janeiro, Brazil.
RP Lima, MM (corresponding author), Fiocruz MS, Lab Ecoepidemiol Doenca Chagas IOC, BR-21045900 Rio De Janeiro, Brazil.
EM mmlima@ioc.fiocruz.br
RI Teixeira, Bernardo R/D-7664-2013; D'Andrea, Paulo S./G-6820-2011; de
   Souza Coutinho, Carolina Fausto/AAR-6069-2020; Britto,
   Constanca/L-7658-2016
OI Teixeira, Bernardo R/0000-0001-9013-9492; de Souza Coutinho, Carolina
   Fausto/0000-0002-9005-8171; Britto, Constanca/0000-0003-0788-7030;
   D'Andrea, Paulo Sergio/0000-0001-7880-8761; Jansen, Ana
   Maria/0000-0001-5804-6210
FU FaperjCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); CNPqNational Council for Scientific and
   Technological Development (CNPq); Fiocruz
FX This study was supported by Faperj, CNPq and Fiocruz.
CR Agapova M, 2010, TRANSFUSION, V50, P2220, DOI 10.1111/j.1537-2995.2010.02686.x
   [Anonymous], 2007, WHO CONS INT BIOL RE
   Borges-Pereira J, 2008, REV SOC BRAS MED TRO, V41, P345, DOI 10.1590/S0037-86822008000400005
   CAMARGO MARIO E., 1966, REV INST MED TROP SAO PAULO, V8, P227
   de la Fuente ALC, 2007, ACTA TROP, V101, P115, DOI 10.1016/j.actatropica.2006.12.007
   Carvalho-Costa FA, 2010, J VECTOR ECOL, V35, P295, DOI 10.1111/j.1948-7134.2010.00085.x
   Chagas C., 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008
   Coura JR, 2010, NATURE, V465, pS6, DOI 10.1038/nature09221
   Coura Jose Rodrigues, 1994, Revista da Sociedade Brasileira de Medicina Tropical, V27, P251, DOI 10.1590/S0037-86821994000400009
   Coura JR, 1999, MEM I OSWALDO CRUZ, V94, P379, DOI 10.1590/S0074-02761999000700074
   de la Fuente ALC, 2008, J MED ENTOMOL, V45, P14, DOI 10.1603/0022-2585(2008)45[14:BPOTRT]2.0.CO;2
   Estrada-Franco JG, 2006, EMERG INFECT DIS, V12, P624
   Fe NF, 2009, MEM I OSWALDO CRUZ, V104, P121, DOI 10.1590/S0074-02762009000100019
   Fernandes O, 2001, T ROY SOC TROP MED H, V95, P97, DOI 10.1016/S0035-9203(01)90350-5
   Fernandes O, 1999, PARASITOLOGY, V118, P161, DOI 10.1017/S0031182098003709
   Ferreira MS, 2002, COMPENDIUM INFECTOLO, P1195
   Freitas Simone Patrícia Carneiro, 2004, Cad. Saúde Pública, V20, P333, DOI 10.1590/S0102-311X2004000100052
   Galuppo S, 2009, ACTA TROP, V111, P90, DOI 10.1016/j.actatropica.2009.02.010
   Guhl F, 2009, MEM I OSWALDO CRUZ, V104, P71, DOI 10.1590/S0074-02762009000900012
   Jackson Y, 2009, EMERG INFECT DIS, V15, P601, DOI 10.3201/eid1504.080438
   JANSEN AM, 1985, T ROY SOC TROP MED H, V79, P474, DOI 10.1016/0035-9203(85)90069-0
   Lent H., 1979, Bulletin of the American Museum of Natural History, V163, P125
   Lima MM, 2008, PARASITOL RES, V102, P797, DOI 10.1007/s00436-007-0823-1
   Lima MM, 2008, AM J TROP MED HYG, V79, P750, DOI 10.4269/ajtmh.2008.79.750
   Mascola L., 2006, Morbidity and Mortality Weekly Report, V55, P798
   MERCOSUR, 1991, M HLTH MIN MERCOSUR
   Mills JN, 1995, METHODS TRAPPING SAM
   Moncayo A, 2009, MEM I OSWALDO CRUZ, V104, P17, DOI 10.1590/S0074-02762009000900005
   Noireau F, 2002, MEM I OSWALDO CRUZ, V97, P61, DOI 10.1590/S0074-02762002000100009
   Noireau F, 2009, VET RES, V40, DOI 10.1051/vetres/2009009
   Oliveira TG, 2009, AM J TROP MED HYG, V81, P651, DOI 10.4269/ajtmh.2009.08-0590
   Pereira KS, 2009, J FOOD PROTECT, V72, P441, DOI 10.4315/0362-028X-72.2.441
   Pinto Ana Yecê das Neves, 2004, Braz J Infect Dis, V8, P454, DOI 10.1590/S1413-86702004000600010
   Dias JCP, 2009, MEM I OSWALDO CRUZ, V104, P41, DOI 10.1590/S0074-02762009000900007
   Rodriguez-Guardado A, 2009, SCAND J INFECT DIS, V41, P774, DOI 10.1080/00365540903161523
   Sarquis O, 2006, MEM I OSWALDO CRUZ, V101, P143, DOI 10.1590/S0074-02762006000200005
   Sarquis O, 2004, MEM I OSWALDO CRUZ, V99, P263, DOI 10.1590/S0074-02762004000300004
   Silveira AC, 2001, CONTROL TRIATOMA BRA
   Dias FBS, 2011, INFECT GENET EVOL, V11, P869, DOI 10.1016/j.meegid.2011.02.008
   Teixeira ARL, 2001, EMERG INFECT DIS, V7, P100, DOI 10.3201/eid0701.010115
   Zingales B, 1998, INT J PARASITOL, V28, P105, DOI 10.1016/S0020-7519(97)00178-1
   Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021
NR 42
TC 33
Z9 37
U1 0
U2 11
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAR
PY 2012
VL 106
IS 3
BP 143
EP 149
DI 10.1016/j.trstmh.2011.10.013
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 910HD
UT WOS:000301626900002
PM 22136953
DA 2020-12-08
ER

PT J
AU Tedesqui, VL
   Calleja, GNC
   Parra, R
   Pabon, JP
   Boia, MN
   Carvalho-Costa, FA
AF Tedesqui, Vladimir Luna
   Chuquimia Calleja, Guido Noel
   Parra, Rolando
   Pabon, Javier Palacios
   Boia, Marcio Neves
   Carvalho-Costa, Filipe Anibal
TI Active surveillance of American tegumentary leishmaniasis in endemic
   areas in rural Bolivia
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE American tegumentary leishmaniasis; Surveillance; Bolivia; Treatment;
   Diagnosis
ID SUB ANDEAN REGION; MUCOCUTANEOUS LEISHMANIASIS; CUTANEOUS LEISHMANIASIS;
   VIANNIA LAINSONI; VECTOR; TRANSMISSION; BRAZILIENSIS; EPIDEMIOLOGY;
   AMAZONENSIS; YUNGAS
AB Introduction: American tegumentary leishmaniasis (ATL), including mucocutaneous leishmaniasis (MCL) and localized cutaneous leishmaniasis (LCL), is endemic in Bolivia. We describe the results of active surveillance of ATL from 2001 to 2006 and assess demographic data related to ATL epidemiology in the Yungas valleys. Methods: Community-based active ATL surveillance was performed by the institutions SERVIR, CARITAS, and the Health Services Department of La Paz, whose files were reviewed retrospectively. A cross-sectional survey was carried out to assess demographic data in two communities. Results: Two thousand nine hundred nine cases of ATL were detected from 2001 to 2006: 2,488 (85.5%) corresponded to LCL and 421 (14.5%) to MCL. A reduction in the proportion of mucosal cases was observed between 2001 and 2006. The proportion of MCL cases increased with age and was higher among males (15.5% versus 12.1%, p=0.018). The rate of positivity via direct observation of the parasite in dermal scrapings and in parasite cultivation was significantly higher for LCL than for MCL (p<0.001 and p=0.009, respectively). The rate of reactivity in the leishmanin skin test was higher in the group with mucosal lesions (p=0.012). The cross-sectional survey showed that 40% of the families had emigrated from the Altiplano. Conclusions: It is necessary to undertake continuous case detection of ATL in the area, where the disease presents a high rate of mucosal cases. Increasing incidence seems to be associated with immigration and continuous deforestation to expand the crop-growing areas.
C1 [Tedesqui, Vladimir Luna; Boia, Marcio Neves; Carvalho-Costa, Filipe Anibal] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil.
   [Chuquimia Calleja, Guido Noel] Dept Salud La Paz, La Paz, Bolivia.
   [Parra, Rolando] Proyecto Obras Sociales Caminos Acceso Rural, La Paz, Bolivia.
   [Pabon, Javier Palacios] Serv Educ, La Paz, Bolivia.
RP Carvalho-Costa, FA (corresponding author), Lab Sistemat Bioquim IOC FIOCRUZ, Av Brasil 4365,Sala 308, BR-21040900 Rio De Janeiro, RJ, Brazil.
EM guaratiba@ioc.fiocruz.br
CR Altamirano-Enciso Alfredo J., 2003, Hist. cienc. saude-Manguinhos, V10, P853, DOI 10.1590/S0104-59702003000300004
   Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003
   Bastrenta B, 2002, ACTA TROP, V83, P249, DOI 10.1016/S0001-706X(02)00129-8
   DAVID C, 1993, T ROY SOC TROP MED H, V87, P7, DOI 10.1016/0035-9203(93)90398-A
   Davies C R, 2000, Cad Saude Publica, V16, P925, DOI 10.1590/S0102-311X2000000400013
   DEDET JP, 1995, B WORLD HEALTH ORGAN, V73, P339
   DIMIERDAVID L, 1993, B SOC PATHOL EXOT, V86, P106
   ESPEJO JMT, 1989, MEM I OSWALDO CRUZ, V84, P583
   ESPEJO JMT, 1989, ANN SOC BELG MED TR, V69, P297
   Garcia AL, 2009, AM J TROP MED HYG, V80, P704, DOI 10.4269/ajtmh.2009.80.704
   Instituto Nacional de Estatistica Portugal, 2002, EST PROYECC POBL PER, P1
   Kawa Helia, 2002, Cad. Saúde Pública, V18, P853, DOI 10.1590/S0102-311X2002000300029
   le Pont F., 1986, Memorias do Instituto Oswaldo Cruz, V81, P311, DOI 10.1590/S0074-02761986000300007
   LEPONT F, 1989, ANN SOC BELG MED TR, V69, P307
   LEPONT F, 1985, T ROY SOC TROP MED H, V79, P227, DOI 10.1016/0035-9203(85)90341-4
   Martinez E, 1999, AM J TROP MED HYG, V61, P846, DOI 10.4269/ajtmh.1999.61.846
   Martinez E, 1998, ACTA TROP, V71, P97, DOI 10.1016/S0001-706X(98)00049-7
   Martinez E, 2001, T ROY SOC TROP MED H, V95, P375, DOI 10.1016/S0035-9203(01)90185-3
   Rojas E, 2009, EMERG INFECT DIS, V15, P678, DOI 10.3201/eid1504.081257
   Torrez M, 1998, ACTA TROP, V71, P311, DOI 10.1016/S0001-706X(98)00068-0
NR 20
TC 6
Z9 8
U1 0
U2 5
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JAN-FEB
PY 2012
VL 45
IS 1
BP 30
EP 34
DI 10.1590/S0037-86822012000100007
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 899PT
UT WOS:000300829000007
PM 22370825
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Valverde, JG
   Gomes-Silva, A
   Moreira, CJD
   De Souza, DL
   Jaeger, LH
   Martins, PP
   Meneses, VF
   Boia, MN
   Carvalho-Costa, FA
AF Valverde, J. G.
   Gomes-Silva, A.
   De Carvalho Moreira, C. J.
   Leles De Souza, D.
   Jaeger, L. H.
   Martins, P. P.
   Meneses, V. F.
   Boia, M. N.
   Carvalho-Costa, F. A.
TI Prevalence and epidemiology of intestinal parasitism, as revealed by
   three distinct techniques in an endemic area in the Brazilian Amazon
SO ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY
LA English
DT Article
ID NUTRITIONAL-STATUS; CHILDREN; INFECTIONS; STATE; SCHOOL; ENTEROBIASIS;
   ASCARIASIS; FREQUENCY; MORBIDITY; HELMINTHS
AB This survey aims to estimate the prevalence of intestinal parasitic infections in Santa Isabel do Rio Negro, Amazonian Brazil, through three distinct techniques, correlating the prevalence rates with family income and age groups as well as assessing the household clustering of infections. Prevalence rates were assessed through Graham (n=113), Baermann-Moraes (n=232) and Ritchie (n=463) methods. The Graham method was adopted only for children under 5 years old, 15% of whom were positive for Enterobius vermicularis. By the Baermann-Moraes technique, 5.6% of the samples were positive for Strongyloides stercoralis larvae. The Ritchie technique disclosed the following results: Ascaris lumbricoides (26%), Trichuris trichiura (22.5%), hookworms (9.5%), Entamoeba histolytica/Entamoeba dispar (25.3%), Giardia lamblia (12.5%) and E. vermicularis (0.6%). Children aged 5-14 years presented the highest prevalence for pathogenic parasites. Giardiasis and hookworm infection rates were inversely related to family income. The presence of positive contacts in the same household substantially increased the risk of infection by enteric parasites: odds ratio (OR)=2.70, 95% confidence interval (CI)=1.69-4.29 for ascariasis; OR=2.17, 95% CI=1.34-3.51 for trichuriasis; OR=2.13, 95% CI=1.08-4.17 for hookworm disease; OR=3.42, 95% CI=1.86-6.30 for giardiasis; and OR=2.16, 95% CI=1.35-3.47 for amoebiasis, supporting infection clustering in the home. Intestinal parasitoses are extremely frequent in the studied area, and routine methods for diagnosis may underestimate the prevalence of enterobiasis and strongyloidiasis.
C1 [Valverde, J. G.; Gomes-Silva, A.; De Carvalho Moreira, C. J.; Jaeger, L. H.; Martins, P. P.; Meneses, V. F.; Boia, M. N.; Carvalho-Costa, F. A.] Inst Oswaldo Cruz Fiocruz, Programa Posgrad Med Trop, BR-21045900 Rio De Janeiro, Brazil.
   [Valverde, J. G.; Gomes-Silva, A.; Jaeger, L. H.] Inst Oswaldo Cruz Fiocruz, Lab Interdisciplinar Pesquisas Med, BR-21045900 Rio De Janeiro, Brazil.
   [De Carvalho Moreira, C. J.] Inst Oswaldo Cruz Fiocruz, Lab Doencas Parasitarias, BR-21045900 Rio De Janeiro, Brazil.
   [Leles De Souza, D.; Boia, M. N.] Univ Fed Fluminense, Dept Microbiol & Parasitol, Inst Biomed, Macae E Santos, RJ, Brazil.
   [Leles De Souza, D.] Lab Paleoparasitol Escola Nacl Saude Publ, BR-21045900 Rio De Janeiro, Brazil.
   [Martins, P. P.; Meneses, V. F.] Inst Oswaldo Cruz Fiocruz, Lab Hepatites Virais, BR-21045900 Rio De Janeiro, Brazil.
   [Boia, M. N.] Inst Oswaldo Cruz Fiocruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, BR-21045900 Rio De Janeiro, Brazil.
   Inst Oswaldo Cruz Fiocruz, Lab Sistemat Bioquim, BR-21045900 Rio De Janeiro, Brazil.
RP Carvalho-Costa, FA (corresponding author), Av Brasil 4365,Sala 308, BR-21045900 Rio De Janeiro, Brazil.
EM guaratiba@ioc.fiocruz.br
RI Valverde, Joanna G/C-1284-2014
OI Valverde, Joanna G/0000-0001-8064-6255
FU Brazilian Federal Agency; Evaluation of Graduate Education (CAPES)CAPES;
   National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX The study on which this report is based was supported with federal funds
   from the Brazilian Federal Agency for Support and Evaluation of Graduate
   Education (CAPES) and the National Council for Scientific and
   Technological Development (CNPq). DLS, JGV, AGS, LHJ, VFM and PPM are
   recipients of scholarships from these institutions.
CR Agudelo-Lopez Sonia, 2008, Rev. salud pública, V10, P633, DOI 10.1590/S0124-00642008000400013
   Albonico M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000126
   Matos SMA, 2008, CAD SAUDE PUBLICA, V24, P1527, DOI 10.1590/S0102-311X2008000700007
   Boia MN, 2009, REV SAUDE PUBL, V43, P176, DOI 10.1590/s0034-89102009000100023
   Bóia Márcio Neves, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P189, DOI 10.1590/S0036-46652006000400003
   Botero-Garces JH, 2009, REV INST MED TROP SP, V51, P155, DOI 10.1590/S0036-46652009000300006
   Burkhart CN, 2005, INT J DERMATOL, V44, P837, DOI 10.1111/j.1365-4632.2004.02332.x
   Carvalho-Costa FA, 2009, T ROY SOC TROP MED H, V103, P1071, DOI 10.1016/j.trstmh.2009.04.015
   Carvalho-Costa Filipe Anibal, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P147, DOI 10.1590/S0036-46652007000300003
   COLLINS RF, 1981, T ROY SOC TROP MED H, V75, P549, DOI 10.1016/0035-9203(81)90196-6
   CROMPTON DWT, 1988, PARASITOL TODAY, V4, P162, DOI 10.1016/0169-4758(88)90152-4
   deSilva NR, 1997, T ROY SOC TROP MED H, V91, P31, DOI 10.1016/S0035-9203(97)90384-9
   GRAHAM CLARENCE F., 1941, AMER JOUR TROP MED, V21, P159
   GUYATT HL, 1991, T ROY SOC TROP MED H, V85, P778, DOI 10.1016/0035-9203(91)90453-6
   Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261
   Fonseca EOL, 2010, CAD SAUDE PUBLICA, V26, P143, DOI 10.1590/S0102-311X2010000100015
   Machado ER, 2008, REV SOC BRAS MED TRO, V41, P581, DOI 10.1590/S0037-86822008000600007
   Mine JC, 2008, REV SOC BRAS MED TRO, V41, P565, DOI 10.1590/S0037-86822008000600004
   Miranda R A, 1998, Cad Saude Publica, V14, P507, DOI 10.1590/S0102-311X1998000300007
   Montresor A, 2002, HELMINTH CONTROL SCH
   Moraes RG, 1948, REV SERV ESP SAUDE P, V1, P507
   Nematian J, 2008, ANN TROP MED PARASIT, V102, P209, DOI 10.1179/136485908X267876
   Olsen A, 2009, T ROY SOC TROP MED H, V103, P967, DOI 10.1016/j.trstmh.2009.02.013
   Parija SC, 2010, INDIAN J GASTROENTER, V29, P140, DOI 10.1007/s12664-010-0033-0
   Quihui L, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-225
   RITCHIE LAWRENCE S., 1948, BULL U S ARMY MED DEPT, V8, P326
   Rossignol JF, 2010, EXP PARASITOL, V124, P45, DOI 10.1016/j.exppara.2009.07.005
   Sato Megumi, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P213
   Schuster H, 2001, CURR OPIN INFECT DIS, V14, P587, DOI 10.1097/00001432-200110000-00013
   Sowemimo O. A., 2010, J HELMINTHOL, V2, P1
   Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491
   Ugbomoiko US, 2009, T ROY SOC TROP MED H, V103, P223, DOI 10.1016/j.trstmh.2008.12.014
   World Health Organisation, 1981, INSTR DET SUSC RES M, P1
   Ximenez C, 2010, INT J ENV RES PUB HE, V7, P1105, DOI 10.3390/ijerph7031105
   Yori PP, 2006, AM J TROP MED HYG, V74, P97, DOI 10.4269/ajtmh.2006.74.97
NR 35
TC 17
Z9 18
U1 0
U2 13
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0003-4983
EI 1364-8594
J9 ANN TROP MED PARASIT
JI Ann. Trop. Med. Parasitol.
PD SEP
PY 2011
VL 105
IS 6
BP 413
EP 424
DI 10.1179/1364859411Y.0000000034
PG 12
WC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
SC Public, Environmental & Occupational Health; Parasitology; Tropical
   Medicine
GA 862AL
UT WOS:000298062100001
PM 22117850
OA Green Published
DA 2020-12-08
ER

PT J
AU Carvalho-Costa, FA
   Volotao, ED
   de Assis, RMS
   Fialho, AM
   de Andrade, JDR
   Rocha, LN
   Tort, LFL
   da Silva, MFM
   Gomez, MM
   de Souza, PM
   Leite, JPG
AF Carvalho-Costa, Filipe Anibal
   Volotao, Eduardo de Mello
   Santos de Assis, Rosane Maria
   Fialho, Alexandre Madi
   Ribeiro de Andrade, Juliana da Silva
   Rocha, Ludmila Nascimento
   Lopez Tort, Luis Fernando
   Marques da Silva, Marcelle Figueira
   Gomez, Mariela Martinez
   de Souza, Pamella Macedo
   Gagliardi Leite, Jose Paulo
TI Laboratory-based Rotavirus Surveillance During the Introduction of a
   Vaccination Program, Brazil, 2005-2009
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE rotavirus A; genotypes; Rotarix vaccine; Brazil
ID RIO-DE-JANEIRO; 1ST 2 YEARS; DOUBLE-BLIND; STRAINS; GASTROENTERITIS;
   POPULATION; CHILDREN; EFFICACY; DIARRHEA; CLASSIFICATION
AB Background: Brazil introduced universal antirotavirus vaccination in March 2006. This article reports the results of rotavirus A (RV-A) surveillance from January 2005 to December 2009.
   Methods: A total of 6109 fecal samples were collected in 18 Brazilian states. RV-A was detected by enzyme immunoassay and/or polyacrylamide gel electrophoresis, and genotyped through seminested reverse transcription-polymerase chain reaction.
   Results: RV-A was detected in 20.3% (n = 1242) of the samples. Among children less than 2 years old, regardless the antirotavirus vaccination status, the rates of RV-A detection were 33.8% in 2005, 23.7% in 2006, 16.8% in 2007, 22.9% in 2008, and 18.3% in 2009 (P < 0.001; chi(2) test for linear trend). Among RV-A-positive samples, genotype G1P[8] or G1P[not typed(NT)] was detected in 14% in 2005, 12.3% in 2006, 9.5% in 2007, 0.7% in 2008, and 20.4% in 2009; G2P[4]/G2P[NT] was characterized in 9% in 2005, 49% in 2006, 66% in 2007, 85% in 2008, and 37.5% in 2009; G3P[8]/G3P[NT] was observed in 8.7% in 2005, 3.5% in 2006, and 5.7% in 2009; G9P[8]/G9P[NT] was observed in 52% in 2005, 22% in 2006, 12.3% in 2007, 3.2% in 2008, and 3.4% in 2009.
   Conclusions: Our data demonstrate the reemergence of RV-A genotype G2P[4] in Brazil from 2005 to 2008, and that the rate of G2P[4] detection decreased in 2009, probably reflecting natural oscillations of RV-A genotypes.
C1 [Carvalho-Costa, Filipe Anibal; Volotao, Eduardo de Mello; Santos de Assis, Rosane Maria; Fialho, Alexandre Madi; Ribeiro de Andrade, Juliana da Silva; Rocha, Ludmila Nascimento; Lopez Tort, Luis Fernando; Marques da Silva, Marcelle Figueira; Gomez, Mariela Martinez; de Souza, Pamella Macedo; Gagliardi Leite, Jose Paulo] Fiocruz MS, Inst Oswaldo Cruz, Lab Virol Comparada & Ambiental, BR-21045900 Rio De Janeiro, Brazil.
RP Leite, JPG (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Virol Comparada & Ambiental, Ave Brasil,CEF 21040-360,4365 Manguinhos, BR-21045900 Rio De Janeiro, Brazil.
EM jpgleite@ioc.fiocruz.br
RI Silva-Sales, Marcelle/D-9809-2015; LEITE, JOSE PAULO
   GAGLIARDI/AAY-1230-2020
OI Silva-Sales, Marcelle/0000-0002-4275-9627; Lopez Tort, Luis
   Fernando/0000-0001-9252-5135; GOMEZ, MARIELA/0000-0002-5740-9005;
   Fialho, Alexandre Madi/0000-0002-5412-3896
FU Oswaldo Cruz Institute/Fiocruz; General Coordination of Public Health
   Laboratories Secretary of Health Surveillance (CGLAB/SVS); Ministry of
   HealthMinistry of Health - Turkey; National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq); Brazilian Federal Agency for Support
   and Evaluation of Graduate Education (Capes)CAPES; Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ)
FX Supported with federal funds from the Oswaldo Cruz Institute/Fiocruz
   through Project PAPES V/FIOCRUZ-CNPq, General Coordination of Public
   Health Laboratories Secretary of Health Surveillance (CGLAB/SVS),
   Ministry of Health, National Council for Scientific and Technological
   Development (CNPq), Brazilian Federal Agency for Support and Evaluation
   of Graduate Education (Capes), and Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ).
CR Amarilla A, 2007, MED SCI MONITOR, V13, pCR333
   Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1255
   [Anonymous], 2009, COMMUNICABLE DIS SUR
   Barnes GL, 1998, J CLIN MICROBIOL, V36, P133, DOI 10.1128/JCM.36.1.133-138.1998
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   BOSCHIPINTO C, 2008, ESTIMATING CHILD MOR
   Carvalho-Costa FA, 2009, EMERG INFECT DIS, V15, P95, DOI 10.3201/eid1501.071136
   Castello Alejandro A, 2004, Pediatr Infect Dis J, V23, pS168, DOI 10.1097/01.inf.0000142466.57262.2a
   Ciarlet M, 2008, VIRUS GENES, V37, P250, DOI 10.1007/s11262-008-0257-6
   Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843
   DAS BK, 1994, J CLIN MICROBIOL, V32, P1820, DOI 10.1128/JCM.32.7.1820-1822.1994
   Dennehy PH, 2008, CLIN MICROBIOL REV, V21, P198, DOI 10.1128/CMR.00029-07
   Estes M.K., 2001, FIELDS VIROLOGY, V4, P1747
   FERRERA A, 2007, 17 EUR C CLIN MICR I
   Leite JPG, 2008, MEM I OSWALDO CRUZ, V103, P745, DOI 10.1590/S0074-02762008000800001
   Gentsch JR, 2009, FUTURE MICROBIOL, V4, P1231, DOI 10.2217/FMB.09.105
   Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499
   GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992
   GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990
   Grimwood K, 2008, LANCET, V371, P1144, DOI 10.1016/S0140-6736(08)60501-2
   Gurgel RG, 2009, GASTROENTEROLOGY, V137, P1970, DOI 10.1053/j.gastro.2009.07.046
   Gurgel RQ, 2008, J CLIN VIROL, V43, P1, DOI 10.1016/j.jcv.2008.04.010
   Gurgel RQ, 2007, EMERG INFECT DIS, V13, P1571, DOI 10.3201/eid1310.070412
   Kale PL, 2004, J HEALTH POPUL NUTR, V22, P27
   Kamel AH, 2009, J CLIN MICROBIOL, V47, P1037, DOI 10.1128/JCM.01381-08
   Kane EM, 2004, REV PANAM SALUD PUBL, V16, P371, DOI 10.1590/S1020-49892004001200002
   Leite JPG, 1996, ARCH VIROL, V141, P2365, DOI 10.1007/BF01718637
   Linhares AC, 2010, EUR SOC PAED INF DIS
   Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3
   Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1
   Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07
   Matthijnssens J, 2009, FUTURE MICROBIOL, V4, P1303, DOI 10.2217/FMB.09.96
   Nakagomi T, 2008, ARCH VIROL, V153, P591, DOI 10.1007/s00705-007-0028-z
   Parashar UD, 2006, EMERG INFECT DIS, V12, P304
   Patel MM, 2008, EMERG INFECT DIS, V14, P863, DOI 10.3201/eid1405.071440
   PEREIRA HG, 1983, J HYG-CAMBRIDGE, V90, P117, DOI 10.1017/S0022172400063919
   PEREIRA HG, 1985, J VIROL METHODS, V10, P21, DOI 10.1016/0166-0934(85)90084-9
   Rahman M, 2007, EMERG INFECT DIS, V13, P18, DOI 10.3201/eid1301.060910
   Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434
   Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448
   Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9
   World Health Organisation, 2002, GEN PROT HOSP BAS SU
   World Health Organization, 2007, Wkly Epidemiol Rec, V82, P285
NR 43
TC 68
Z9 69
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD JAN
PY 2011
VL 30
IS 1
SU S
BP S35
EP S41
DI 10.1097/INF.0b013e3181fefd5f
PG 7
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA 701EA
UT WOS:000285795900008
PM 21048523
DA 2020-12-08
ER

PT J
AU Carvalho-Costa, FA
   Dos Santos, SM
   Pires, MQ
   Lopes, CM
   Noireau, F
   Pacheco, RS
AF Carvalho-Costa, Filipe Anibal
   Dos Santos, Silvia M.
   Pires, Marize Quinhones
   Lopes, Catarina Macedo
   Noireau, Francois
   Pacheco, Raquel S.
TI Sylvatic and peridomestic populations of Triatoma pseudomaculata are not
   significantly structured by habitat, as revealed by two genetic markers
SO JOURNAL OF VECTOR ECOLOGY
LA English
DT Article
DE Chagas disease; Triatoma pseudomaculata; RAPD; isoenzymes
ID CHAGAS-DISEASE VECTORS; DOMESTIC POPULATIONS; NORTHEASTERN BRAZIL;
   RUBROVARIA REDUVIIDAE; SORDIDA HEMIPTERA; INFESTANS; BRASILIENSIS;
   BOLIVIA; STATE; CEARA
AB Chagas disease remains a public health concern in Brazil and other Latin American countries, mainly due to the potential domiciliation of native triatomine species. We analyzed the genetic variability of Triatoma pseudomaculata in sylvatic and peridomestic ecotopes throughout three localities in the northeastern state of Bahia, Brazil. We studied polymorphisms generated by random amplified polymorphic DNA (RAPD) and isoenzyme electrophoresis analyses. Based on RAPD analysis, each specimen was assigned to one of three genetic clusters. Although all sylvatic specimens from one locality were grouped into the same cluster, sylvatic and peridomestic specimens from the other two localities were broadly distributed between the remaining two clusters, suggesting that geographic population structuring was not occurring. Furthermore, isoenzyme analysis suggested that distinct populations were in Hardy-Weinberg equilibrium. Low statistical values for Wright's Fst index also supported the absence of population structuring and suggested the occurrence of panmixia. We conclude that genetic flow occurs between sylvatic and peridomestic T. pseudomaculata populations, probably as a consequence of passive and active dispersion of the insects, associated with deforestation and anthropic transformations.
C1 [Carvalho-Costa, Filipe Anibal; Dos Santos, Silvia M.; Pires, Marize Quinhones; Lopes, Catarina Macedo; Pacheco, Raquel S.] Fiocruz MS, Inst Oswaldo Cruz, BR-21040900 Rio De Janeiro, Brazil.
   [Noireau, Francois] IRD, Montpellier, France.
   [Noireau, Francois] Univ Mayor San Simon, Fac Med, Cochabamba, Bolivia.
RP Pacheco, RS (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Av Brasil 4365, BR-21040900 Rio De Janeiro, Brazil.
CR Alencar J. E., 1962, B SOC CEARENSE AGRON, V3, P49
   Borges EC, 2005, ACTA TROP, V93, P119, DOI 10.1016/j.actatropica.2004.10.002
   de la Fuente ALC, 2007, ACTA TROP, V101, P115, DOI 10.1016/j.actatropica.2006.12.007
   Carcavallo R.U., 1998, ATLAS CHAGAS DIS VEC, VIII, P747
   Costa J, 2009, MEM I OSWALDO CRUZ, V104, P46, DOI 10.1590/S0074-02762009000900008
   de la Fuente ALC, 2008, J MED ENTOMOL, V45, P14, DOI 10.1603/0022-2585(2008)45[14:BPOTRT]2.0.CO;2
   Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092
   Dujardin JP, 1998, MED VET ENTOMOL, V12, P20, DOI 10.1046/j.1365-2915.1998.00076.x
   Dujardin JP, 1997, J MED ENTOMOL, V34, P544, DOI 10.1093/jmedent/34.5.544
   Fe NF, 2009, MEM I OSWALDO CRUZ, V104, P121, DOI 10.1590/S0074-02762009000100019
   Freitas Simone Patrícia Carneiro, 2004, Cad. Saúde Pública, V20, P333, DOI 10.1590/S0102-311X2004000100052
   Guhl F, 2009, MEM I OSWALDO CRUZ, V104, P71, DOI 10.1590/S0074-02762009000900012
   de Assisi GFM, 2007, REV SOC BRAS MED TRO, V40, P391, DOI 10.1590/S0037-86822007000400003
   NEI M, 1978, GENETICS, V89, P583
   Noireau F, 1999, T ROY SOC TROP MED H, V93, P13, DOI 10.1016/S0035-9203(99)90161-X
   Noireau F, 1998, TROP MED INT HEALTH, V3, P364
   Noireau F, 1999, MEM I OSWALDO CRUZ, V94, P347, DOI 10.1590/S0074-02761999000300011
   Oliveira Filho A M, 2000, Cad Saude Publica, V16 Suppl 2, P105, DOI 10.1590/S0102-311X2000000800014
   Pacheco RS, 2007, PARASITE, V14, P231, DOI 10.1051/parasite/2007143231
   Pacheco RS, 2003, ANN TROP MED PARASIT, V97, P757, DOI 10.1179/000349803225002372
   Sarquis O, 2006, MEM I OSWALDO CRUZ, V101, P143, DOI 10.1590/S0074-02762006000200005
   Sarquis O, 2004, MEM I OSWALDO CRUZ, V99, P263, DOI 10.1590/S0074-02762004000300004
   Silveira A. C., 2001, CONTROLE TRIATOMA BR
   Sneath PHA, 1973, NUMERICAL TAXONOMY P
   Wright S., 1978, EVOLUTION GENETICS P, V4
NR 25
TC 6
Z9 6
U1 0
U2 1
PU SOC VECTOR ECOLOGY
PI CORONA
PA 1966 COMPTON AVE, CORONA, CA 92881 USA
EI 1948-7134
J9 J VECTOR ECOL
JI J. Vector Ecol.
PD DEC
PY 2010
VL 35
IS 2
BP 295
EP 300
DI 10.1111/j.1948-7134.2010.00085.x
PG 6
WC Entomology
SC Entomology
GA 700QC
UT WOS:000285758200005
PM 21175934
DA 2020-12-08
ER

PT J
AU Sarquis, O
   Carvalho-Costa, FA
   Oliveira, LS
   Duarte, R
   D'Andrea, PS
   de Oliveira, TG
   Lima, MM
AF Sarquis, Otilia
   Carvalho-Costa, Filipe A.
   Oliveira, Livia Silva
   Duarte, Rosemere
   D'Andrea, Paulo Sergio
   de Oliveira, Tiago Guedes
   Lima, Marli Maria
TI Ecology of Triatoma brasiliensis in northeastern Brazil: seasonal
   distribution, feeding resources, and Trypanosoma cruzi infection in a
   sylvatic population
SO JOURNAL OF VECTOR ECOLOGY
LA English
DT Article
DE Chagas disease; Triatoma brasiliensis; sylvatic population; ecology;
   Trypanosoma cruzi
ID RURAL NORTHWESTERN ARGENTINA; CHAGAS-DISEASE; NUTRITIONAL-STATUS;
   PERIDOMESTIC POPULATIONS; DOMESTIC POPULATIONS; 1911 HEMIPTERA;
   INFESTANS; REDUVIIDAE; VECTOR; TRANSMISSION
AB We assessed some ecological parameters of Triatoma brasiliensis in rock piles in the state of Ceara during the rainy and dry seasons. The greatest density was in April (median = 12.5 triatomines/site). The greatest abundance was in December, when the insects were more dispersed and the density per site was lower (6 triatomines/site). The nutritional status of females and 5th instar nymphs was increased in July. The rate of T. cruzi infection reached its highest peak in July (10.9%). ELISA revealed that the principal food sources were birds (33.1%), followed by armadillos (18.8%). Food sources were more frequently identified during the rainy season. T. brasiliensis specimens collected in the drought tended to: i) present lower rates of T. cruzi infection and gut content reactivity to tested antisera, ii) have a poorer nutritional status, iii) exhibit lower fecundity, iv) be more dispersed among the studied collection sites, and v) be more abundant and easily collected in the surface of the rocks, possibly reflecting an increased searching for blood meals. Such findings underscore epidemiological concerns and allow inferences about the season when triatomines can more frequently invade the peridomestic environment in search of food and recolonize artificial structures.
C1 [Sarquis, Otilia; Oliveira, Livia Silva; de Oliveira, Tiago Guedes; Lima, Marli Maria] Fiocruz MS, Inst Oswaldo Cruz, Lab Ecoepidemiol Doenca Chagas, BR-21045900 Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe A.] Fiocruz MS, Inst Oswaldo Cruz, Lab Sistemat Bioquim, BR-21045900 Rio De Janeiro, Brazil.
   [Duarte, Rosemere] Fiocruz MS, ENSP, Dept Ciencias Biol, BR-21031210 Rio De Janeiro, Brazil.
   [D'Andrea, Paulo Sergio] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, BR-21045900 Rio De Janeiro, Brazil.
RP Sarquis, O (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Ecoepidemiol Doenca Chagas, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
RI D'Andrea, Paulo S./G-6820-2011; Habe, Neusa K/D-6316-2011
OI D'Andrea, Paulo Sergio/0000-0001-7880-8761
FU Fiocruz; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (Faperj)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ)
FX Thanks to the Secretary of Health of the State of Ceara, the City Hall
   of Jaguaruana, Ceara, and Ana Luisa Barbosa, for technical assistance,
   transportation, and physical facilities; Marcos Eduardo Melo and Cleber
   Cesar Ramos, for assistance with the field work. We thank three
   anonymous reviewers who gave invaluable suggestions that improved
   substantially the paper. This study received financial support from
   Fiocruz and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (Faperj).
CR Abad-Franch F, 2005, TROP MED INT HEALTH, V10, P1258, DOI 10.1111/j.1365-3156.2005.01511.x
   Alencar JE, 1987, HIST NATURAL DOENCA
   Almeida CE, 2008, AM J TROP MED HYG, V78, P791, DOI 10.4269/ajtmh.2008.78.791
   Almeida CE, 2000, MEM I OSWALDO CRUZ, V95, P761, DOI 10.1590/S0074-02762000000600003
   Borges EC, 2005, ACTA TROP, V93, P119, DOI 10.1016/j.actatropica.2004.10.002
   BURKOT TR, 1981, AM J TROP MED HYG, V30, P1336, DOI 10.4269/ajtmh.1981.30.1336
   Camara A. C., 2010, ACTA TROP IN PRESS
   Carcavallo U. R., 1999, ATLAS CHAGAS DIS VEC, VII , P561
   CATALA S, 1991, MED VET ENTOMOL, V5, P325, DOI 10.1111/j.1365-2915.1991.tb00558.x
   Ceballos LA, 2005, ACTA TROP, V95, P149, DOI 10.1016/j.actatropica.2005.05.010
   Chagas C., 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008
   Cortez MR, 2007, ACTA TROP, V102, P47, DOI 10.1016/j.actatropica.2007.02.014
   Cortez MR, 2006, EXP PARASITOL, V114, P305, DOI 10.1016/j.exppara.2006.04.010
   Costa J, 2003, MEM I OSWALDO CRUZ, V98, P443, DOI 10.1590/S0074-02762003000400002
   Costa J, 1999, MEM I OSWALDO CRUZ, V94, P239, DOI 10.1590/S0074-02761999000700038
   Diotaiuti L ., 2007, DOENCA CHAGAS EVOLUC, P204
   Duarte R., 1997, MEM I OSWALDO CRUZ, V92, P273
   Fe NF, 2009, MEM I OSWALDO CRUZ, V104, P121, DOI 10.1590/S0074-02762009000100019
   FORATTINI O P, 1971, Revista de Saude Publica, V5, P163, DOI 10.1590/S0034-89101971000200001
   Guhl F, 2009, MEM I OSWALDO CRUZ, V104, P71, DOI 10.1590/S0074-02762009000900012
   LAZZARI CR, 1992, J INSECT PHYSIOL, V38, P895, DOI 10.1016/0022-1910(92)90101-I
   Leal IR, 2005, CONSERV BIOL, V19, P701, DOI 10.1111/j.1523-1739.2005.00703.x
   Lent H., 1979, Bulletin of the American Museum of Natural History, V163, P125
   Lima MM, 2008, PARASITOL RES, V102, P797, DOI 10.1007/s00436-007-0823-1
   Lopez A, 1999, ACTA TROP, V73, P275, DOI 10.1016/S0001-706X(99)00039-X
   Lorenzo M G, 2000, Cad Saude Publica, V16 Suppl 2, P69
   Lorenzo MG, 1999, ACTA TROP, V72, P241, DOI 10.1016/S0001-706X(98)00094-1
   Noireau F, 2005, AN ACAD BRAS CIENC, V77, P431, DOI 10.1590/S0001-37652005000300006
   Noireau F, 2000, T ROY SOC TROP MED H, V94, P23, DOI 10.1016/S0035-9203(00)90426-7
   Noireau F, 2001, MEM I OSWALDO CRUZ, V96, P385, DOI 10.1590/S0074-02762001000300018
   Noireau F, 2009, MEM I OSWALDO CRUZ, V104, P60, DOI 10.1590/S0074-02762009000900010
   Oliveira-Lima J W, 2000, Cad Saude Publica, V16 Suppl 2, P75
   Sarquis O, 2006, MEM I OSWALDO CRUZ, V101, P143, DOI 10.1590/S0074-02762006000200005
   Sarquis O, 2004, MEM I OSWALDO CRUZ, V99, P263, DOI 10.1590/S0074-02762004000300004
   SCHOFIELD CJ, 1980, T ROY SOC TROP MED H, V74, P770, DOI 10.1016/0035-9203(80)90197-2
   Silveira A C, 1998, Rev Soc Bras Med Trop, V31 Suppl 2, P15
   Silveira AC, 1999, MEM I OSWALDO CRUZ, V94, P405, DOI 10.1590/S0074-02761999000700080
   Soares RPP, 2000, MEM I OSWALDO CRUZ, V95, P151, DOI 10.1590/S0074-02762000000200003
   Vazquez-Prokopec GM, 2004, J MED ENTOMOL, V41, P614, DOI 10.1603/0022-2585-41.4.614
   (WHO) World Health Organization, 2002, WHO TECHN REP SER, V905
   Yeo M, 2005, INT J PARASITOL, V35, P225, DOI 10.1016/j.ijpara.2004.10.024
NR 41
TC 20
Z9 20
U1 0
U2 3
PU SOC VECTOR ECOLOGY
PI CORONA
PA 1966 COMPTON AVE, CORONA, CA 92881 USA
EI 1948-7134
J9 J VECTOR ECOL
JI J. Vector Ecol.
PD DEC
PY 2010
VL 35
IS 2
BP 385
EP 394
DI 10.1111/j.1948-7134.2010.00097.x
PG 10
WC Entomology
SC Entomology
GA 700QC
UT WOS:000285758200017
PM 21175946
DA 2020-12-08
ER

PT J
AU Oliveira, TG
   Carvalho-Costa, FA
   Gomes, TF
   Sarquis, O
   Sposina, R
   Lima, MM
AF Oliveira, Tiago G.
   Carvalho-Costa, Filipe A.
   Gomes, Tais F.
   Sarquis, Otilia
   Sposina, Ricardo
   Lima, Marli M.
TI Developmental and reproductive patterns of Triatoma brasiliensis
   infected with Trypanosoma cruzi under laboratory conditions
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Triatoma brasiliensis; Trypanosoma cruzi; Chagas disease
ID CHAGAS-DISEASE; NORTHEASTERN BRAZIL; VECTORS; HEMIPTERA; INFESTANS;
   EPIDEMIOLOGY; STRAINS
AB The aim of this work was to study the interaction between Trypanosoma cruzi-1 and Triatoma brasiliensis. A group of 1st instar nymphs was initially fed on T. cruzi-infected mice and a control group was fed on uninfected mice. From the second feeding onwards, both groups were otherwise fed on non-infected mice. The resulting adults were grouped in pairs: infected male/uninfected female, uninfected male/infected female, infected male and female and uninfected male/uninfected female. The infection affected only the 1st instar nymphs, which took significantly more time to reach the 2nd instar than uninfected nymphs. The differences in the molting time between the infected and uninfected nymphs from the 2nd to the 5th instars were not statistically significant. Both groups presented similar rates of nymphal mortality and reproductive performance was not significantly affected by infection in any of the treatments.
C1 [Oliveira, Tiago G.; Gomes, Tais F.; Sarquis, Otilia; Sposina, Ricardo; Lima, Marli M.] Inst Oswaldo Cruz Fiocruz, Lab Ecoepidemiol Doenca Chagas, BR-21045900 Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe A.] Inst Oswaldo Cruz Fiocruz, Lab Sistemat & Bioquim, BR-21045900 Rio De Janeiro, Brazil.
   [Sposina, Ricardo] Univ Fed Rio de Janeiro, Inst Quim, Lab Tecnol Enzimat, Rio De Janeiro, Brazil.
RP Lima, MM (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Ecoepidemiol Doenca Chagas, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM mmlima@ioc.fiocruz.br
RI Teixeira, Ricardo Sposina Sobral/A-2128-2013
OI Teixeira, Ricardo Sposina Sobral/0000-0002-9839-0013
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ)
FX FAPERJ, CNPq
CR ANEZ N, 1984, Memorias do Instituto Oswaldo Cruz, V79, P249, DOI 10.1590/S0074-02761984000200012
   ANEZ N, 1987, Memorias do Instituto Oswaldo Cruz, V82, P1, DOI 10.1590/S0074-02761987000100001
   Brecher G., 1944, PARASITOLOGY, V35, P220, DOI 10.1017/S0031182000021648
   Costa J, 2009, MEM I OSWALDO CRUZ, V104, P46, DOI 10.1590/S0074-02762009000900008
   Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006
   DOSSANTOS JR, 1985, AN ACAD BRAS CIENC, V57, P127
   Eichler S, 2002, EXP PARASITOL, V100, P17, DOI 10.1006/expr.2001.4653
   Fe NF, 2009, MEM I OSWALDO CRUZ, V104, P121, DOI 10.1590/S0074-02762009000100019
   GREWAL MANOHAR SINGH, 1957, EXPTL PARASITOL, V6, P123, DOI 10.1016/0014-4894(57)90010-3
   Guhl F, 2009, MEM I OSWALDO CRUZ, V104, P71, DOI 10.1590/S0074-02762009000900012
   Lima MM, 2008, PARASITOL RES, V102, P797, DOI 10.1007/s00436-007-0823-1
   LIMA MM, 1992, ANN ENTOMOL SOC AM, V85, P458, DOI 10.1093/aesa/85.4.458
   NEVES D P, 1975, Revista Brasileira de Biologia, V35, P317
   Pacheco RS, 2005, BIOCHEM GENET, V43, P519, DOI 10.1007/s10528-005-8168-x
   Sarquis O, 2006, MEM I OSWALDO CRUZ, V101, P143, DOI 10.1590/S0074-02762006000200005
   Sarquis O, 2004, MEM I OSWALDO CRUZ, V99, P263, DOI 10.1590/S0074-02762004000300004
   SCHAUB GA, 1989, PARASITOL TODAY, V5, P185, DOI 10.1016/0169-4758(89)90142-7
   SCHAUB GA, 1992, ADV PARASIT, V31, P255, DOI 10.1016/S0065-308X(08)60023-8
   SCHAUB GA, 1987, PARASITOL RES, V73, P417, DOI 10.1007/BF00538198
   SCHAUB GA, 1994, PARASITOL TODAY, V10, P463, DOI 10.1016/0169-4758(94)90155-4
   SCHAUB GA, 1988, PARASITOL RES, V74, P593, DOI 10.1007/BF00531641
   SCHAUB GA, 1989, EXP PARASITOL, V68, P260, DOI 10.1016/0014-4894(89)90108-2
NR 22
TC 8
Z9 8
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD DEC
PY 2010
VL 105
IS 8
BP 1057
EP 1060
DI 10.1590/S0074-02762010000800018
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 705CV
UT WOS:000286107400018
PM 21225206
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Ferreira, MSR
   Victoria, M
   Carvalho-Costa, FA
   Vieira, CB
   Xavier, MPTP
   Fioretti, JM
   Andrade, J
   Volotao, EM
   Rocha, M
   Leite, JPG
   Miagostovich, MP
AF Ferreira, M. S. R.
   Victoria, M.
   Carvalho-Costa, F. A.
   Vieira, C. B.
   Xavier, M. P. T. P.
   Fioretti, J. M.
   Andrade, J.
   Volotao, E. M.
   Rocha, M.
   Leite, J. P. G.
   Miagostovich, M. P.
TI Surveillance of Norovirus Infections in the State of Rio De Janeiro,
   Brazil 2005-2008
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE norovirus; gastroenteritis; prevalence; genetic diversity; outbreaks;
   Rio de Janeiro
ID ACUTE GASTROENTERITIS; MOLECULAR EPIDEMIOLOGY; HOSPITALIZED CHILDREN;
   HUMAN CALICIVIRUSES; CLINICAL-FEATURES; GENETIC DIVERSITY; SAO-PAULO;
   OUTBREAKS; ROTAVIRUS; PREVALENCE
AB A 4-year (2005-2008) norovirus (NoV) surveillance study was conducted in the state of Rio Janeiro, Brazil, to demonstrate the role of these viruses in outbreaks and sporadic cases of acute gastroenteritis. A cohort of 1,687 fecal samples was obtained from patients with gastroenteritis; 324 were rotavirus-positive. Of the remainder 1,363 rotavirus-negative samples, 1,087 samples were tested for NoV RNA in this study. The study enrolled 267 outpatients from Municipal Public Health Centers and 820 inpatients, whose samples were obtained by active surveillance in Public Hospitals. Fecal samples were tested by reverse transcription (RT) followed by polymerase chain reaction (PCR) using the MON 431 434 set of degenerate primers for NoV GI and GII detection, and there were 35.1% (381/1,087) positive samples for NoV, consisting of 30.2% (248/820) and 49.8% (133/267) from inpatient and outpatient, respectively. Children infected by NoV had significantly more frequent mucus in feces, vomiting and fever. No seasonal pattern in NoV infections was observed in patients admitted to hospital; however, two peaks of NoV infections were observed from ambulatory cases, suggesting that there was an occurrence of outbreaks in those time periods. Molecular characterization revealed GII to be the most prevalent genogroup, totaling 96.3% (104/108) of all sequences analyzed, and GII.4 was the genotype detected most frequently (80.7%), followed by GII.6, 3, 14, 7, and 8. Two GI strains, GI.2 and GI.3, were also observed. The number of outbreaks and sporadic cases described in this study highlights the need to implement diagnosis of NoV in surveillance laboratories. J. Med. Virol. 82:1442-1448, 2010. (C) 2010 Wiley-Liss, Inc.
C1 [Carvalho-Costa, F. A.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biochem Systemt, BR-21045900 Rio De Janeiro, Brazil.
   [Rocha, M.] Hosp Municipal Jesus, Rio De Janeiro, Brazil.
   [Ferreira, M. S. R.; Victoria, M.; Vieira, C. B.; Xavier, M. P. T. P.; Fioretti, J. M.; Andrade, J.; Volotao, E. M.; Leite, J. P. G.; Miagostovich, M. P.] Fiocruz MS, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, BR-21045900 Rio De Janeiro, Brazil.
RP Miagostovich, MP (corresponding author), Av Brasil 4-365, BR-21045900 Rio De Janeiro, Brazil.
EM marizepm@ioc.fiocruz.br
RI Victoria, Matias/ABE-1729-2020; LEITE, JOSE PAULO
   GAGLIARDI/AAY-1230-2020
OI Vieira, Carmen/0000-0001-8804-4347
FU Oswaldo Cruz Institute (IOC)/FIOCRUZ; General Coordination of Public
   Health Laboratories/Ministry of Health, Brazil
FX Grant sponsor: Oswaldo Cruz Institute (IOC)/FIOCRUZ; Grant sponsor:
   General Coordination of Public Health Laboratories/Ministry of Health,
   Brazil.
CR Ambert-Balay K, 2005, J CLIN MICROBIOL, V43, P5179, DOI 10.1128/JCM.43.10.5179-5186.2005
   Ando T, 2000, J INFECT DIS, V181, pS336, DOI 10.1086/315589
   Arias C, 2010, CLIN MICROBIOL INFEC, V16, P39, DOI 10.1111/j.1469-0691.2009.02831.x
   Beuret C, 2002, APPL ENVIRON MICROB, V68, P1925, DOI 10.1128/AEM.68.4.1925-1931.2002
   Bon F, 2005, J CLIN MICROBIOL, V43, P4659, DOI 10.1128/JCM.43.9.4659-4664.2005
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8
   Campos GS, 2008, ARCH VIROL, V153, P1125, DOI 10.1007/s00705-008-0078-x
   Cardoso DDP, 2002, MED SCI MONITOR, V8, P624
   Carvalho-Costa FA, 2009, EMERG INFECT DIS, V15, P95, DOI 10.3201/eid1501.071136
   Castilho JG, 2006, J CLIN MICROBIOL, V44, P3947, DOI 10.1128/JCM.00279-06
   Colomba C, 2007, EMERG INFECT DIS, V13, P1389, DOI 10.3201/eid1309.061408
   DUIZER E, 2008, EUROSURVEILLANCE, V8, P13
   Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085
   Ferreira MSR, 2008, J MED VIROL, V80, P338, DOI 10.1002/jmv.21059
   Leite JPG, 2008, MEM I OSWALDO CRUZ, V103, P745, DOI 10.1590/S0074-02762008000800001
   Gallimore CI, 2004, BRAZ J MED BIOL RES, V37, P321, DOI 10.1590/S0100-879X2004000300005
   Goodgame Richard, 2007, Curr Infect Dis Rep, V9, P102, DOI 10.1007/s11908-007-0004-5
   Junquera CG, 2009, PEDIATR INFECT DIS J, V28, P604, DOI 10.1097/INF.0b013e318197c3ca
   Hall T. A, 1999, NUCL ACIDS S SER, DOI DOI 10.1021/BK-1999-0734.CH008
   Hansman GS, 2004, ARCH VIROL, V149, P1673, DOI 10.1007/s00705-004-0345-4
   Hardy ME, 2005, FEMS MICROBIOL LETT, V253, P1, DOI 10.1016/j.femsle.2005.08.031
   Ike AC, 2006, J CLIN MICROBIOL, V44, P1262, DOI 10.1128/JCM.44.4.1262-1267.2006
   JIANG X, 1990, Science (Washington D C), V250, P1580
   Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9
   Kroneman A., 2006, EUROSURVEILLANCE, V11
   Gutierrez-Escolano AL, 2010, J MED VIROL, V82, P632, DOI 10.1002/jmv.21743
   Marshall JA, 2003, J MED VIROL, V69, P568, DOI 10.1002/jmv.10346
   Mattison K, 2009, J CLIN MICROBIOL, V47, P3927, DOI 10.1128/JCM.00497-09
   Monroe SS, 2000, J INFECT DIS, V181, pS249, DOI 10.1086/315594
   Noel JS, 1997, J MED VIROL, V53, P372, DOI 10.1002/(SICI)1096-9071(199712)53:4&lt;372::AID-JMV10&gt;3.0.CO;2-H
   Okada M, 2005, J CLIN MICROBIOL, V43, P4391, DOI 10.1128/JCM.43.9.4391-4401.2005
   Otto TD, 2008, GENET MOL RES, V7, P861, DOI 10.4238/vol7-3X-Meeting04
   Parashar UD, 2004, J INFECT DIS, V190, P1088, DOI 10.1086/423324
   Parks CG, 1999, J MED VIROL, V58, P426, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;426::AID-JMV17&gt;3.0.CO;2-K
   Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114
   PEREIRA HG, 1983, J HYG-CAMBRIDGE, V90, P117, DOI 10.1017/S0022172400063919
   Phan TG, 2004, J MED VIROL, V73, P256, DOI 10.1002/jmv.20084
   Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287
   Ribeiro LR, 2008, MEM I OSWALDO CRUZ, V103, P201, DOI 10.1590/S0074-02762008000200013
   Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07
   Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127
   Soares CC, 2007, EMERG INFECT DIS, V13, P1244, DOI 10.3201/eid1308.070300
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Tsugawa T, 2006, J CLIN MICROBIOL, V44, P177, DOI 10.1128/JCM.44.1.177-182.2006
   Vennema H, 2002, J CLIN VIROL, V25, P233, DOI 10.1016/S1386-6532(02)00126-9
   Victoria M, 2007, PEDIATR INFECT DIS J, V26, P602, DOI 10.1097/INF.0b013e3180618bea
   Vinje J, 2004, J VIROL METHODS, V116, P109, DOI 10.1016/j.jviromet.2003.11.001
   Xavier MPTP, 2009, BRAZ J MED BIOL RES, V42, P438, DOI 10.1590/S0100-879X2009000500007
   Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015
NR 50
TC 49
Z9 49
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD AUG
PY 2010
VL 82
IS 8
BP 1442
EP 1448
DI 10.1002/jmv.21831
PG 7
WC Virology
SC Virology
GA 617IH
UT WOS:000279273700023
PM 20572088
DA 2020-12-08
ER

PT J
AU Cabral, AC
   Fe, NF
   Suarez-Mutis, MC
   Boia, MN
   Carvalho-Costa, FA
AF Cabral, A. C.
   Fe, N. F.
   Suarez-Mutis, M. C.
   Boia, M. N.
   Carvalho-Costa, F. A.
TI Increasing incidence of malaria in the Negro River basin, Brazilian
   Amazon
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Malaria; Amazon; Anopheles darlingi; Yanomami Indians; Plasmodium vivax;
   Plasmodium falciparum
ID ASYMPTOMATIC PLASMODIUM-VIVAX; NINO SOUTHERN-OSCILLATION; EL-NINO;
   YANOMAMI COMMUNITIES; HIGH PREVALENCE; RIO-NEGRO; POPULATIONS;
   INFECTION; URBAN; AREA
AB Malaria in Brazil is virtually restricted to the Amazon Region, where it has a heterogeneous geographic distribution. We reviewed secondary data in order to describe the regional and temporal distribution of 8018 malaria cases seen between 2003 and 2007 in Santa Isabel do Rio Negro, a municipality in the northwest Brazilian Amazon. A significant rise in malaria incidence, mainly in the Yanomami Indian reservation, was observed during this time. Anopheline breeding sites were also mapped and entomological data were obtained through the capture of larval and adult mosquitoes. Thirty-three potential breeding sites were identified in the urban and periurban areas, 28 of which were positive for anopheline larvae. Anopheles darlingi specimens were captured in both intra- and peridomicile locations in the urban areas. Demographic data were also assessed via a sectional survey, revealing that the majority of dwellings were vulnerable to mosquitoes. This study suggests that urban and periurban areas of this municipality are highly susceptible to epidemic malaria, which is endemic in the Yanomami Indian reservation near the city. In addition, transmission can be perpetuated autochthonously in the urban area, drawing attention to the continuous need for preventative measures such as controlling adult and aquatic stages of mosquitoes and improving housing. (C) 2010 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
C1 [Cabral, A. C.; Suarez-Mutis, M. C.; Boia, M. N.; Carvalho-Costa, F. A.] Minist Hlth, Oswaldo Cruz Fdn, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Fe, N. F.] Amazonas Fdn Trop Med, Amazonas, Brazil.
   [Boia, M. N.] Univ Estado Rio De Janeiro, Fac Med Sci, Rio De Janeiro, Brazil.
RP Carvalho-Costa, FA (corresponding author), Av Brasil 4365,Pav Leonidas Deane,Sala 308, BR-21045900 Rio De Janeiro, Brazil.
EM guaratiba@ioc.fiocruz.br
RI Su\\xc3\\xa1rez-Mutis, Martha/T-9260-2019; Suarez-Mutis,
   Martha/B-9189-2015
OI Suarez-Mutis, Martha/0000-0003-2809-6799
FU CAPESCAPES; National Council for Scientific and Technological
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq)
FX The study on which this report is based was supported with federal funds
   from the Brazilian Federal Agency for Support and Evaluation of Graduate
   Education (CAPES) and the National Council for Scientific and
   Technological Development (CNPq).
CR Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641
   Barata R C, 1995, Cad Saude Publica, V11, P128
   Bouma MJ, 1997, TROP MED INT HEALTH, V2, P1122, DOI 10.1046/j.1365-3156.1997.d01-210.x
   Consoli R.A.G.B, 1994, PRINCIPAIS MOSQUITOS
   Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001
   Daniel-Ribeiro C T, 2008, Bull Soc Pathol Exot, V101, P243
   de Castro MC, 2007, HEALTH PLACE, V13, P368, DOI 10.1016/j.healthplace.2006.03.006
   DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002
   DEARRUDA M, 1986, AM J TROP MED HYG, V35, P873, DOI 10.4269/ajtmh.1986.35.873
   Gagnon AS, 2002, INT J BIOMETEOROL, V46, P81, DOI 10.1007/s00484-001-0119-6
   Grenfell P, 2008, T ROY SOC TROP MED H, V102, P645, DOI 10.1016/j.trstmh.2008.02.021
   Ladeia-Andrade S, 2009, AM J TROP MED HYG, V80, P452, DOI 10.4269/ajtmh.2009.80.452
   Lindsay SW, 2000, LANCET, V355, P989, DOI 10.1016/S0140-6736(00)90022-9
   Loiola Carlos Catão Prates, 2002, Rev Panam Salud Publica, V11, P235, DOI 10.1590/S1020-49892002000400005
   Macauley C, 2005, SOC SCI MED, V60, P563, DOI 10.1016/j.socscimed.2004.05.025
   Marcano TJ, 2004, MEM I OSWALDO CRUZ, V99, P369, DOI 10.1590/S0074-02762004000400005
   *MIN SAUD, 2007, SIT EP MAL BRAS 2006
   Pithan O A, 1991, Cad Saude Publica, V7, P563, DOI 10.1590/S0102-311X1991000400007
   Gil LHS, 2007, MEM I OSWALDO CRUZ, V102, P271, DOI 10.1590/S0074-02762007005000013
   Souza-Santos R, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-55
   Suárez-Mutis Martha C., 2007, Rev. Inst. Med. trop. S. Paulo, V49, P159, DOI 10.1590/S0036-46652007000300005
   Suarez-Mutis MC, 2007, CAD SAUDE PUBLICA, V23, P795, DOI 10.1590/S0102-311X2007000400007
   Tada MS, 2007, MEM I OSWALDO CRUZ, V102, P263, DOI 10.1590/S0074-02762007005000012
   Tadei Wanderli Pedro, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P87, DOI 10.1590/S0036-46652000000200005
   Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325
   *UR, 2006, REL TECN MAL DISTR S
   VEEKEN H, 1993, BRIT MED J, V14, P433
NR 27
TC 20
Z9 20
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD AUG
PY 2010
VL 104
IS 8
BP 556
EP 562
DI 10.1016/j.trstmh.2010.03.008
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 639DX
UT WOS:000280952100009
PM 20462621
DA 2020-12-08
ER

PT J
AU Daflon-Teixeira, NF
   Carvalho-Costa, FA
   Chiang, RG
   Lima, MM
AF Daflon-Teixeira, Natalia Faria
   Carvalho-Costa, Filipe Anibal
   Chiang, Ralem Gary
   Lima, Marli Maria
TI Influence of blood meal and mating in reproduction patterns of Triatoma
   brasiliensis females (Hemiptera: Reduviidae) under laboratory conditions
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Triatoma brasiliensis; triatomine; fecundity; fertility
ID EGG-PRODUCTION; HETEROPTERA; INFESTANS; COPULATION; BEHAVIOR; INSECT;
   STAL
AB The influence of blood meal and mating on Triatoma brasiliensis (Neiva) female fecundity, fertility, life-span and the preoviposition period were investigated under laboratory conditions. Nourishment increased fecundity, fertility and adult lifespan, whereas mating increased fecundity, fertility and decreased the preoviposition period. Females also required more than one mating to reach their full reproductive potential. Results indicate that both nourishment and mating are important in T. brasiliensis proliferation. Such information will help towards developing effective control strategies of this vector of Chagas disease.
C1 [Daflon-Teixeira, Natalia Faria; Lima, Marli Maria] Fiocruz MS, Lab Ecoepidemiol Doenca Chagas, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fiocruz MS, Lab Sistemat & Bioquim, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Chiang, Ralem Gary] Redeemer Univ Coll, Dept Biol, Ancaster, ON, Canada.
RP Lima, MM (corresponding author), Fiocruz MS, Lab Ecoepidemiol Doenca Chagas, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
EM mmlima@ioc.fiocruz.br
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); Fiocruz
FX CNPq, Fiocruz
CR ASIN S, 1992, MEM I OSWALDO CRUZ, V87, P369, DOI 10.1590/S0074-02761992000300006
   BRASILEIRO V L F, 1982, Revista Brasileira de Biologia, V42, P1
   CABELLO DR, 2001, MEM I O CRUZ, V96, P1
   Chiang RG, 1998, ARCH INSECT BIOCHEM, V39, P126, DOI 10.1002/(SICI)1520-6327(1998)39:3&lt;126::AID-ARCH5&gt;3.0.CO;2-2
   Costa M J, 1973, Rev Saude Publica, V7, P207, DOI 10.1590/S0034-89101973000300003
   DAVEY KG, 1986, CAN J ZOOL, V64, P2654, DOI 10.1139/z86-385
   DAVEY KG, 1989, INVERTEBR REPROD DEV, V16, P131, DOI 10.1080/07924259.1989.9672068
   DAVEY KG, 1974, J MED ENTOMOL, V11, P40, DOI 10.1093/jmedent/11.1.40
   DIAS JCP, 1995, REV SOC BRAS MED TRO, V28, P23
   Dias JCP, 2007, MEM I OSWALDO CRUZ, V102, P11, DOI 10.1590/S0074-02762007005000092
   ESPINOLA H. N., 1966, REV BRASIL BIOL, V26, P263
   Garcia-Zapata M.T., 1985, REV SOC BRAS MED TRO, V18, P199
   Gomes J. E. P. L., 1990, Memorias do Instituto Oswaldo Cruz, V85, P299, DOI 10.1590/S0074-02761990000300006
   Guarneri AA, 2000, J MED ENTOMOL, V37, P373, DOI 10.1603/0022-2585(2000)037[0373:IOTBMS]2.0.CO;2
   JURBERG J, 1989, MEM I OSWALDO CRUZ, V84, P393, DOI 10.1590/S0074-02761989000300016
   LIMA M M, 1987, Memorias do Instituto Oswaldo Cruz, V82, P501, DOI 10.1590/S0074-02761987000400007
   LIMA M M, 1987, Memorias do Instituto Oswaldo Cruz, V82, P37
   Martinez-Ibarra JA, 1999, MEM I OSWALDO CRUZ, V94, P837, DOI 10.1590/S0074-02761999000600023
   Micholitsch T, 2000, EUR J ENTOMOL, V97, P13, DOI 10.14411/eje.2000.003
   Neiva A., 1910, Memorias do Instituto Oswaldo Cruz, V2
   Pires HHR, 2004, MEM I OSWALDO CRUZ, V99, P295, DOI 10.1590/S0074-02762004000300010
   VALLE D, 1987, J INSECT PHYSIOL, V33, P249, DOI 10.1016/0022-1910(87)90045-X
   Vitta ACR, 2009, J MED ENTOMOL, V46, P789, DOI 10.1603/033.046.0409
   Wang Q, 2008, J INSECT BEHAV, V21, P89, DOI 10.1007/s10905-007-9110-3
   Wigglesworth V.B., 1972, PRINCIPLES INSECT PH
   Wigglesworth V. B., 1959, CONTROL GROWTH FORM
   Wolff M, 2004, J MED ENTOMOL, V41, P1010, DOI 10.1603/0022-2585-41.6.1010
   WOOD SF, 1964, B WORLD HEALTH ORGAN, V31, P579
NR 28
TC 11
Z9 11
U1 0
U2 6
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD NOV
PY 2009
VL 104
IS 7
BP 1031
EP 1034
DI 10.1590/S0074-02762009000700016
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 534WS
UT WOS:000272928800016
PM 20027473
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Oliveira, TG
   Carvalho-Costa, FA
   Sarquis, O
   Lima, MM
AF Oliveira, Tiago G.
   Carvalho-Costa, Filipe A.
   Sarquis, Otilia
   Lima, Marli M.
TI Feeding and Defecation Patterns of Rhodnius nasutus (Hemiptera;
   Reduviidae), A Triatomine Native to an Area Endemic for Chagas Disease
   in the State of Ceara, Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID TRYPANOSOMA-CRUZI; LABORATORY CONDITIONS; NORTHEASTERN BRAZIL; PROLIXUS
   HEMIPTERA; PALM TREES; BEHAVIOR; VECTORS; BLOOD; EPIDEMIOLOGY;
   LOCALITIES
AB The importance of Rhodnius nasutus ill the transmission of Chagas disease in northeastern Brazil was investigated regarding feeding and defecation patterns of this triatomine under laboratory conditions. All average of 30 samples were studied for each instar, from fourth-instar nymphs onward. Oil average, 86.4% started feeding after less than 10 minutes. In terms of the duration of feeding, 53.3% of fourth instar nymphs, 81.9% of fifth-instar nymphs, 21.9% of males, and 36.7% of females fed for more than 15 minutes. In all groups, there were insects that defecated and urinated during feeding; adult males defecated the most and fourth instar nymphs defecated the (cast. The results demonstrate that R. nasutus may be considered all efficient T. Cruzi vector because it avidly searches for a food source, has a lengthy feeding time with low probability of interruption during feeding, and achieves a high percentage of engorgement.
C1 [Lima, Marli M.] Fiocruz MS, Lab Ecoepidemiol Doenca Chagas, Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe A.] Fundacao Oswaldo Cruz, Lab Sistemat Bioquim, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
RP Lima, MM (corresponding author), Fiocruz MS, Lab Ecoepidemiol Doenca Chagas, Inst Oswaldo Cruz, Fundacao Oswaldo Cruz, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM tiago@ioc.fiocruz.br; guaratiba@ioc.fiocruz.br;
   otiliasarquis@ioc.fiocruz.br; mmlima@ioc.fiocruz.br
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ)
FX This study was supported by the Fundacao de Amparo a Pesquisa do Estado
   do Rio de Janeiro.
CR Aldana E, 2001, REV BIOL TROP, V49, P693
   Alencar JE, 1987, HIST NATURAL DOENCA
   Arevalo A, 2007, BIOMEDICA, V27, P101, DOI 10.7705/biomedica.v27i1.253
   Bar María E., 2003, Rev. Soc. Entomol. Argent., V62, P107
   Borges-Pereira J, 2008, REV SOC BRAS MED TRO, V41, P345, DOI 10.1590/S0037-86822008000400005
   Braga MV, 1999, MEM I OSWALDO CRUZ, V94, P127, DOI 10.1590/S0074-02761999000100025
   Brito CMM, 2008, PARASITOL RES, V103, P1111, DOI 10.1007/s00436-008-1102-5
   Carcavallo R.U., 1998, ATLAS CHAGAS DIS VEC, VIII, P747
   Carcavallo U. R., 1999, ATLAS CHAGAS DIS VEC, VII , P561
   DIAS EMMANUEL, 1956, MEM INST OSWALDO CRUZ, V54, P115
   Dias J C, 2000, Cad Saude Publica, V16 Suppl 2, P13, DOI 10.1590/S0102-311X2000000800003
   Fe NF, 2009, MEM I OSWALDO CRUZ, V104, P121, DOI 10.1590/S0074-02762009000100019
   Galvao Cleber, 2001, Revista Brasileira de Zoologia, V18, P233, DOI 10.1590/S0101-81752001000500019
   Guarneri AA, 2000, J INSECT PHYSIOL, V46, P1121, DOI 10.1016/S0022-1910(99)00222-X
   Hecht MM, 2006, AM J TROP MED HYG, V75, P893, DOI 10.4269/ajtmh.2006.75.893
   KRINSKY WL, 1985, J MED ENTOMOL, V22, P670, DOI 10.1093/jmedent/22.6.670
   LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123
   Lima MM, 2008, PARASITOL RES, V102, P797, DOI 10.1007/s00436-007-0823-1
   Lima MM, 2008, AM J TROP MED HYG, V79, P750, DOI 10.4269/ajtmh.2008.79.750
   Mac Cord J.R., 1983, Memorias do Instituto Oswaldo Cruz, V78, P473, DOI 10.1590/S0074-02761983000400010
   MADDRELL SH, 1964, J EXP BIOL, V41, P163
   Nattero J, 2002, MEM I OSWALDO CRUZ, V97, P1063, DOI 10.1590/S0074-02762002000700022
   Pacheco RS, 2005, BIOCHEM GENET, V43, P519, DOI 10.1007/s10528-005-8168-x
   PIESMAN J, 1983, ACTA TROP, V40, P351
   Pinto Dias J. C., 1979, Ciencia e Cultura, V31, P105
   RABINOVICH JE, 1979, T ROY SOC TROP MED H, V73, P272, DOI 10.1016/0035-9203(79)90082-8
   Rocha DD, 2004, MEM I OSWALDO CRUZ, V99, P591, DOI 10.1590/S0074-02762004000600010
   ROCHA DD, 1994, MEM I OSWALDO CRUZ, V89, P265
   Romana CA, 1999, T ROY SOC TROP MED H, V93, P594, DOI 10.1016/S0035-9203(99)90059-7
   Sant'Anna MRV, 2001, J INSECT PHYSIOL, V47, P1459, DOI 10.1016/S0022-1910(01)00136-6
   Sarquis O, 2006, MEM I OSWALDO CRUZ, V101, P143, DOI 10.1590/S0074-02762006000200005
   Sarquis O, 2004, MEM I OSWALDO CRUZ, V99, P263, DOI 10.1590/S0074-02762004000300004
   SARQUIS O, 2003, THESIS FIOCRUZ RIO D
   Silveira A C, 1984, Rev Bras Malariol Doencas Trop, V36, P15
   Dias FBS, 2007, MEM I OSWALDO CRUZ, V102, P643, DOI 10.1590/S0074-02762007005000057
   ZARATE LG, 1984, J MED ENTOMOL, V21, P548, DOI 10.1093/jmedent/21.5.548
   ZELEDON R, 1981, ANNU REV ENTOMOL, V26, P101, DOI 10.1146/annurev.en.26.010181.000533
   Zeledon R., 1977, Acta Tropica, V34, P65
NR 38
TC 5
Z9 5
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2009
VL 81
IS 4
BP 651
EP 655
DI 10.4269/ajtmh.2009.08-0590
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 502QC
UT WOS:000270474000021
PM 19815881
OA Bronze
DA 2020-12-08
ER

PT J
AU Carvalho-Costa, FA
   Silva, AG
   de Souza, AH
   Moreira, CJD
   de Souza, DL
   Valverde, JG
   Jaeger, LH
   Martins, PP
   de Meneses, VF
   Araujo, A
   Boia, MN
AF Carvalho-Costa, Filipe A.
   Silva, Adriano Gomes
   de Souza, Alberto H.
   Moreira, Carlos J. de C.
   de Souza, Daniela L.
   Valverde, Joanna G.
   Jaeger, Lauren H.
   Martins, Patricia P.
   de Meneses, Viviane F.
   Araujo, Adauto
   Boia, Marcio N.
TI Pseudoparasitism by Calodium hepaticum (syn. Capillaria hepatica;
   Hepaticola hepatica) in the Negro River, Brazilian Amazon
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Calodium hepaticum; Capillaria hepatica; Intestinal parasites; Stool;
   Indians; Brazil
AB We report the finding of eggs of Calodium spp. (syn. Capillaria spp.; Hepaticola spp.) in a fecal sample from an old woman living in a riverine community in the Negro River Basin and describe the associated epidemiological investigation. The case probably does not represent true parasitism; the eggs, which were compatible with the species Calodium hepaticum, were most likely ingested upon consumption of infected tapir (Tapirus terrestris) liver, subsequently passing through the gut and being eliminated. The evolution of these eggs to infective stages in the environment, given the poor sanitation background, could provide the risk of occurrence of hepatic disease in humans. (c) 2009 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights reserved.
C1 [Carvalho-Costa, Filipe A.; Silva, Adriano Gomes; Moreira, Carlos J. de C.; de Souza, Daniela L.; Valverde, Joanna G.; Jaeger, Lauren H.; Martins, Patricia P.; de Meneses, Viviane F.; Boia, Marcio N.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [de Souza, Alberto H.] Secretary Hlth, Santa Isabel Rio Negro, Amazonas, Brazil.
   [de Souza, Daniela L.; Araujo, Adauto] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, Brazil.
   [Boia, Marcio N.] Univ Estado Rio De Janeiro, Fac Med Sci, Rio De Janeiro, Brazil.
RP Carvalho-Costa, FA (corresponding author), Av Brasil 4365,Pav Leonidas Deane,Sala 308, BR-21045900 Rio De Janeiro, Brazil.
EM guaratiba@ioc.fiocruz.br
RI Valverde, Joanna G/C-1284-2014
OI Valverde, Joanna G/0000-0001-8064-6255
FU Brazilian Federal Agency for Support and Evaluation of Graduate
   Education (CAPES)CAPES; National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq)
FX The study on which this report is based was supported with federal funds
   from the Brazilian Federal Agency for Support and Evaluation of Graduate
   Education (CAPES) and the National Council for Scientific and
   Technological Development (CNPq).
CR COIMBRA C E A JR, 1981, Memorias do Instituto Oswaldo Cruz, V76, P299
   Costa Carlos Alberto Fagonde, 1994, Revista Brasileira de Biologia, V54, P39
   LAWRENCE DN, 1980, AM J TROP MED HYG, V29, P530, DOI 10.4269/ajtmh.1980.29.530
   Mangini Paulo Rogerio, 2002, Arquivos de Ciencias Veterinarias e Zoologia da UNIPAR, V5, P93
   MATAMOROS Y, 1991, REV BIOL TROP, V39, P173
   Sawamura R, 1999, AM J TROP MED HYG, V61, P642, DOI 10.4269/ajtmh.1999.61.642
NR 6
TC 20
Z9 22
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD OCT
PY 2009
VL 103
IS 10
BP 1071
EP 1073
DI 10.1016/j.trstmh.2009.04.015
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 540CV
UT WOS:000273309300018
PM 19477475
DA 2020-12-08
ER

PT J
AU Fe, NF
   Franca, MS
   Carvalho-Costa, FA
AF Fe, Nelson Ferreira
   Franca, Menabarreto Segadilha
   Carvalho-Costa, Filipe Anibal
TI Reassessing the entomological investigation around the first
   autochthonous case of Chagas disease in Western Brazilian Amazon
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Chagas disease; triatomines; Amazon
ID RHODNIUS-PROLIXUS; TRYPANOSOMA-CRUZI; REDUVIIDAE; HEMIPTERA; ROBUSTUS;
   TRANSMISSION; HOUSES; BASIN
AB In 1979, the first autochthonous case of Chagas disease in the Western Brazilian Amazon was reported and an entomological survey was carried out around it. Specimens of Rhodnius pictipes and Rhodnius robustus were collected in intradomicile and sylvatic ecotopes. Adult bugs were infected with trypanosomatids. Invasion of houses by triatomines was demonstrated and the presence of infected bugs inside dwellings was associated with the possibility of vector-borne Chagas disease. Continuous entomological surveillance employing additional taxonomic tools is needed in the Brazilian Amazon in order to better understand the dynamics of house invasion by sylvatic triatomines and the risk of Trypanosoma cruzi infection transmission.
C1 [Carvalho-Costa, Filipe Anibal] Fiocruz MS, Inst Oswaldo Cruz, Lab Sistemat Bioquim, BR-21045900 Rio De Janeiro, Brazil.
   [Fe, Nelson Ferreira] Fundacao Med Trop Amazonas, Manaus, Amazonas, Brazil.
   [Franca, Menabarreto Segadilha] Univ Fed Amazonas, Fac Med, Manaus, Amazonas, Brazil.
RP Carvalho-Costa, FA (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Sistemat Bioquim, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM guaratiba@ioc.fiocruz.br
RI Oliveira, Claudia DL/G-8618-2011
CR Abad-Franch F, 2007, MEM I OSWALDO CRUZ, V102, P57, DOI 10.1590/S0074-02762007005000108
   Aguilar HM, 1999, MEM I OSWALDO CRUZ, V94, P387, DOI 10.1590/S0074-02761999000700076
   Aguilar HM, 2007, MEM I OSWALDO CRUZ, V102, P47, DOI 10.1590/S0074-02762007005000098
   Carcavallo R.U., 1998, ATLAS CHAGAS DIS VEC, VIII, P747
   Coura Jose Rodrigues, 1994, Revista da Sociedade Brasileira de Medicina Tropical, V27, P251, DOI 10.1590/S0037-86821994000400009
   Coura JR, 1999, MEM I OSWALDO CRUZ, V94, P379, DOI 10.1590/S0074-02761999000700074
   Feliciangeli MD, 2002, TROP MED INT HEALTH, V7, P280, DOI 10.1046/j.1365-3156.2002.00853.x
   Fitzpatrick S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000210
   FRANCA M S, 1980, Acta Amazonica, V10, P759
   Harry M, 2008, INFECT GENET EVOL, V8, P381, DOI 10.1016/j.meegid.2008.01.006
   LAINSON R, 1979, T ROY SOC TROP MED H, V73, P193, DOI 10.1016/0035-9203(79)90211-6
   MILES M A, 1983, Memorias do Instituto Oswaldo Cruz, V78, P391, DOI 10.1590/S0074-02761983000400002
   Monteiro FA, 2003, MOL ECOL, V12, P997, DOI 10.1046/j.1365-294X.2003.01802.x
   *PAHO, 2005, IMPL INT IN SURV CON
   *PAHO, 2006, INF CONS TECN EP PRE
   Pavan MG, 2007, TROP MED INT HEALTH, V12, P751, DOI 10.1111/j.1365-3156.2007.01845.x
   SHAW J, 1969, Revista de Saude Publica, V3, P153, DOI 10.1590/S0034-89101969000200005
   Silveira FT, 1979, HILEIA MED BELEM, V1, P61
   Teixeira ARL, 2001, EMERG INFECT DIS, V7, P100, DOI 10.3201/eid0701.010115
   Valente VC, 1998, J MED ENTOMOL, V35, P99, DOI 10.1093/jmedent/35.2.99
   Villegas J, 2002, INFECT GENET EVOL, V2, P121, DOI 10.1016/S1567-1348(02)00095-3
NR 21
TC 10
Z9 12
U1 0
U2 1
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD FEB
PY 2009
VL 104
IS 1
BP 121
EP 123
DI 10.1590/S0074-02762009000100019
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 416ZB
UT WOS:000264042900019
PM 19274387
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Boia, MN
   Carvalho-Costa, FA
   Sodre, FC
   Porras-Pedroza, BE
   Faria, EC
   Magalhaes, GAP
   da Silva, IM
AF Boia, Marcio Neves
   Carvalho-Costa, Filipe Anibal
   Sodre, Fernando Campos
   Porras-Pedroza, Beatriz Elena
   Faria, Eduardo Cesar
   Pinto Magalhaes, Gustavo Albino
   da Silva, Iran Mendonca
TI Tuberculosis and intestinal parasitism among indigenous people in the
   Brazilian Amazon region
SO REVISTA DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Indigenous Population; Tuberculosis, epidemiology; Parasitic Diseases,
   epidemiology; Cross-Sectional Studies; Brazil
AB The objective of the survey was to estimate the frequencies of tuberculosis and intestinal parasitosis in indigenous communities at the locality of Iauarete, Northern Brazil, in 2001. This was a cross-sectional survey (n=333) aimed at obtaining demographic data and biological samples for sputum and feces examinations. Among the 43 individuals with respiratory symptoms, six presented alcohol/acid-fast bacilli in sputum. Intestinal parasitosis was significantly more frequent among the Hupdpopulatio than among the Indians living in other districts (37.5% vs. 19.3% for Ascaris lumbricoides, 32.4% vs. 16.3% for Trichuris trichiura, 75% vs. 19.3% for hookworms, 75% vs. 35.4% for Entamoeba histolytica/dispar and 33.3% vs. 10.7% for Giardia lamblia). It is concluded that tuberculosis and intestinal parasitism are frequent in these communities, thus requiring control measures and better medical care.
C1 [Boia, Marcio Neves] Fundacao Oswaldo Cruz Fiocruz, IOC, Lab Doencas Parasitarias, Rio De Janeiro, RJ, Brazil.
   [Boia, Marcio Neves; Pinto Magalhaes, Gustavo Albino] Univ Estado Rio de Janeiro, Fac Ciencias Med, Dept Med Interna, Rio De Janeiro, RJ, Brazil.
   [Carvalho-Costa, Filipe Anibal] IOC Fiocruz, Lab Sistemat Bioquim, Rio De Janeiro, RJ, Brazil.
   [Sodre, Fernando Campos] Univ Fed Fluminense, Dept Patol, Rio De Janeiro, RJ, Brazil.
   [Porras-Pedroza, Beatriz Elena; Faria, Eduardo Cesar; Pinto Magalhaes, Gustavo Albino; da Silva, Iran Mendonca] Fiocruz MS, Curso Posgrad Med Trop, Rio De Janeiro, RJ, Brazil.
RP Carvalho-Costa, FA (corresponding author), Av Brasil 4-365,Sala 308, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM guaratiba@ioc.fiocruz.br
CR Buchillet D, 1998, CAD SAUDE PUBLICA, V14, P181, DOI DOI 10.1590/S0102-311X1998000100026
   Carme B, 2002, PARASITE, V9, P167, DOI 10.1051/parasite/2002092167
   Coimbra CEA, 2007, T ROY SOC TROP MED H, V101, P635, DOI 10.1016/j.trstmh.2007.03.013
   Ribeiro D, 1956, SOCIOLOGIA, V18, P3
   Santos RV, 1995, REV INST MED TROP SP, V37, P15, DOI [10.1590/S0036-46651995000200009, DOI 10.1590/S0036-46651995000200009]
NR 5
TC 22
Z9 28
U1 0
U2 1
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD FEB
PY 2009
VL 43
IS 1
BP 176
EP 178
DI 10.1590/S0034-89102009000100023
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA V45KQ
UT WOS:000209815900024
PM 19169591
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Carvalho-Costa, FA
   Araujo, IT
   de Assis, RMS
   Fialho, AM
   Martins, CMMD
   Boia, MN
   Leite, JPG
AF Carvalho-Costa, Filipe Anibal
   Araujo, Irene Trigueiros
   Santos de Assis, Rosane Maria
   Fialho, Alexandre Madi
   Miranda de Assis Martins, Carolina Maria
   Boia, Marcio Neves
   Gagliardi Leite, Jose Paulo
TI Rotavirus Genotype Distribution after Vaccine Introduction, Rio de
   Janeiro, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID HOSPITALIZED CHILDREN; STRAINS; GASTROENTERITIS; SURVEILLANCE;
   POPULATION
AB Brazil introduced rotavirus vaccination in March 2006. We studied 133 rotavirus-positive fecal samples collected from February 2005 through December 2007. Genotype G2P[4] was found in 1.4% of samples in 2005, in 44% in 2006, and in 96% in 2007. Rotavirus detection rate decreased from 38% in 2005 to 24% in 2007 (p = 0.012).
C1 [Gagliardi Leite, Jose Paulo] Fiocruz MS, Inst Oswaldo Cruz, Lab Virol Comparada, BR-21040900 Rio De Janeiro, Brazil.
   [Miranda de Assis Martins, Carolina Maria] Salles Netto Municipal Hosp, Rio De Janeiro, Brazil.
   [Boia, Marcio Neves] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil.
RP Leite, JPG (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Virol Comparada, Av Brasil,4365 Pavilhao Helio & Peggy Pereira, BR-21040900 Rio De Janeiro, Brazil.
EM jpgleite@ioc.fiocruz.br
RI LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020
OI Fialho, Alexandre Madi/0000-0002-5412-3896
FU Brazilian Federal Agency; Systematic Biochemistry in the Oswaldo Cruz
   Foundation, Brazil; Evaluation of Graduate Education; National Council
   for Scientific and Technological Development (CNP(q)National Council for
   Scientific and Technological Development (CNPq) [303539/2004-6,
   303475/2005-6]; Oswaldo Cruz Institute-F1-OCRUZ; General Coordination of
   Public Health Laboratories-Secretary of Health Surveillance (CGLAB/SVS),
   Ministry of Health
FX We thank the direction and pediatric staff of Salles Netto Municipal
   Hospital for supporting the inclusion of children in the study, Gilmar
   Alcantara de Matos for technical assistance with laboratory procedures,
   and Enilza Marcela do Nascimento for Support regarding the collection of
   stool samples. The Study on which this report was based was Supported
   with federal funds from the Brazilian Federal Agency for Support and Dr
   Carvallio-Costa is a research scientist in the Laboratory of Systematic
   Biochemistry in the Oswaldo Cruz Foundation, Brazil. His research
   interest is focused on the detection, molecular characterization. and
   epidemiology of the pathogens and vectors of Infectious diseases.
   Evaluation of Graduate Education, the National Council for Scientific
   and Technological Development (CNP(q) (CNPq grants: 303539/2004-6;
   303475/2005-6), Oswaldo Cruz Institute-F1-OCRUZ, and General
   Coordination of Public Health Laboratories-Secretary of Health
   Surveillance (CGLAB/SVS), Ministry of Health. This work was performed at
   the Laboratory of Comparative Virology. Oswaldo Cruz Institute, Oswaldo
   Cruz Foundation, Rio de Janeiro. and at the Salles Netto Municipal
   Hospital. Rio de Janeiro.; Dr Carvallio-Costa is a research scientist in
   the Laboratory of Systematic Biochemistry in the Oswaldo Cruz
   Foundation, Brazil. His research interest is focused on the detection,
   molecular characterization. and epidemiology of the pathogens and
   vectors of Infectious diseases.
CR Araujo IT, 2002, J TROP PEDIATRICS, V48, P214, DOI 10.1093/tropej/48.4.214
   Araujo IT, 2001, J CLIN MICROBIOL, V39, P1999, DOI 10.1128/JCM.39.5.1999-2001.2001
   Arnado JM, 2007, ASIAN J WOMEN STUD, V13, P7
   Carvalho-Costa FA, 2006, MEM I OSWALDO CRUZ, V101, P291, DOI 10.1590/S0074-02762006000300012
   FERRERA A, 2007, 17 EUR C CLIN MICR I
   Gurgel RQ, 2008, LANCET, V371, P301, DOI 10.1016/S0140-6736(08)60164-6
   Gurgel RQ, 2007, EMERG INFECT DIS, V13, P1571, DOI 10.3201/eid1310.070412
   Leite JPG, 1996, ARCH VIROL, V141, P2365, DOI 10.1007/BF01718637
   Nakagomi T, 2008, ARCH VIROL, V153, P591, DOI 10.1007/s00705-007-0028-z
   Parashar UD, 2006, EMERG INFECT DIS, V12, P304
   Patel MM, 2008, EMERG INFECT DIS, V14, P863, DOI 10.3201/eid1405.071440
   Rahman M, 2007, EMERG INFECT DIS, V13, P18, DOI 10.3201/eid1301.060910
   Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434
   Santos N, 2003, J CLIN MICROBIOL, V41, P3399, DOI 10.1128/JCM.41.7.3399-3402.2003
   Volotao EM, 2006, J MED VIROL, V78, P263, DOI 10.1002/jmv.20535
NR 15
TC 61
Z9 62
U1 0
U2 3
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JAN
PY 2009
VL 15
IS 1
BP 95
EP 97
DI 10.3201/eid1501.071136
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 393AG
UT WOS:000262342700022
PM 19116062
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Leite, JPG
   Carvalho-Costa, FA
   Linhares, AC
AF Gagliardi Leite, Jose Paulo
   Carvalho-Costa, Filipe Anibal
   Linhares, Alexandre C.
TI Group A rotavirus genotypes and the ongoing Brazilian experience - A
   Review
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Review
DE rotavirus; genotypes; vaccine; Brazil
ID RIO-DE-JANEIRO; 1ST 2 YEARS; HOSPITALIZED CHILDREN; ACUTE
   GASTROENTERITIS; SAO-PAULO; MOLECULAR CHARACTERIZATION; INFANTILE
   DIARRHEA; P-TYPE; VACCINATED POPULATION; NORTHERN BRAZIL
AB Brazil was the first Latin American country to introduce universal group A rotavirus (RV-A) vaccination in March 2006, resulting in a unique epidemiological scenario. Since RV-A first identification in Brazil, 2,691 RV-A-positive stool samples, collected between 1982-2007, were typed by independent research groups throughout the country. In the pre-vaccination era, 2,492 RV-A-positive samples collected from 1982-2005 were successfully typed, while 199 samples were analyzed from 2006-2007. According to the reviewed studies, there were two important times in the pre-vaccination era: (i) the period from 1982-1995, during which the detection of G5P[8] RV-A, in addition to the classical genotypes G1-4, challenged vaccine development programs; and (ii) the period from 1996-2005, during which genotype G9P[8] emerged, following a global trend. The rate of G2P[4] RV-A detection decreased from 26% (173/653) during 1982-1995 to 2% (43/1,839) during 1996-2005. The overall detection rate of RV-A genotypes from 1982-2005 was as follows: 43% (n = 1,079) G1P[8]/G1P[not typed (NT)]; 20% (n = 488) G9P[8]/G9P[NT]; 9% (n = 216) G2P[4]/G2P[NT]; 6% (n = 151) G3P[8]/G3P[NT]; 4% (n = 103) G4P[8]/G4P[NT]; and 4% (n = 94) G5P[8]/G5P[NT]. Mixed infections accounted for 189 (7%) of the positive samples, while atypical G/P combinations or other genotypes, including G6, G8, G10 and G12, were identified in 172 (7%) samples. The initial surveillance studies carried out in several Brazilian states with RV-A-positive samples collected in 2006 and 2007 show a predominance of G2P[4] strains (148/199 or 74%). Herein, we review RV-A typing studies carried out since the 1980s in Brazil, highlighting the dynamics of RV-A strain circulation profiles before and early after universal use of RV-A vaccine in Brazil.
C1 [Gagliardi Leite, Jose Paulo] Fiocruz MS, Lab Virol Comparada, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Carvalho-Costa, Filipe Anibal] Fiocruz MS, Lab Sistemat Bioquim, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, Brazil.
   [Linhares, Alexandre C.] Secretaria Vigilancia Saude, Inst Evandro Chagas, Belem, Para, Brazil.
RP Leite, JPG (corresponding author), Fiocruz MS, Lab Virol Comparada, Inst Oswaldo Cruz, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM jpgleite@ioc.fiocruz.br
CR Amarilla A, 2007, MED SCI MONITOR, V13, pCR333
   Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1255
   Araujo IT, 2007, J MED MICROBIOL, V56, P854, DOI 10.1099/jmm.0.46787-0
   Araujo IT, 2007, J MED VIROL, V79, P995, DOI 10.1002/jmv.20918
   Araujo IT, 2002, J TROP PEDIATRICS, V48, P214, DOI 10.1093/tropej/48.4.214
   ARAUJO TME, 2007, SURTO DIARREIA ROTAV
   Arista S, 2005, J MED VIROL, V77, P587, DOI 10.1002/jmv.20496
   ARISTA S, 1990, RES VIROLOGY, V141, P435, DOI 10.1016/0923-2516(90)90044-J
   Arista S, 2006, J VIROL, V80, P10724, DOI 10.1128/JVI.00340-06
   Andreasi MSA, 2007, REV SOC BRAS MED TRO, V40, P411, DOI 10.1590/S0037-86822007000400008
   Andreasi MSA, 2008, MEM I OSWALDO CRUZ, V103, P741, DOI 10.1590/S0074-02762008000700020
   Barnes GL, 1998, J CLIN MICROBIOL, V36, P133, DOI 10.1128/JCM.36.1.133-138.1998
   BERNSTEIN DI, 1991, J INFECT DIS, V164, P277, DOI 10.1093/infdis/164.2.277
   BHAN MK, 1993, J INFECT DIS, V168, P282, DOI 10.1093/infdis/168.2.282
   BISHOP RF, 1983, NEW ENGL J MED, V309, P72, DOI 10.1056/NEJM198307143090203
   BISHOP RF, 1991, J CLIN MICROBIOL, V29, P862, DOI 10.1128/JCM.29.5.862-868.1991
   BOSCHIPINTO C, 2008, ESTIMATING CHILD MOR
   Cardoso DDP, 2000, J HEALTH POPUL NUTR, V18, P39
   Cardoso DDP, 2001, BRAZ J MED BIOL RES, V34, P471, DOI 10.1590/S0100-879X2001000400005
   Carmona RCC, 2006, EMERG INFECT DIS, V12, P963
   Carmona RCC, 2004, J MED VIROL, V74, P166, DOI 10.1002/jmv.20161
   Carvalho-Costa FA, 2006, MEM I OSWALDO CRUZ, V101, P291, DOI 10.1590/S0074-02762006000300012
   CARVALHOCOSTA FA, 2009, EMERG INFEC IN PRESS, V15
   Castello Alejandro A, 2004, Pediatr Infect Dis J, V23, pS168, DOI 10.1097/01.inf.0000142466.57262.2a
   *CDC, 1999, MMWR-MORBID MORTAL W, V48, P1007
   *CDC, 2007, MMWR-MORBID MORTAL W, V82, P285
   Ciarlet M, 2008, VIRUS GENES, V37, P250, DOI 10.1007/s11262-008-0257-6
   Costa Paulo S. S., 2004, J. Pediatr. (Rio J.), V80, P119, DOI 10.1590/S0021-75572004000200008
   de Oliveira A.S.L., 2008, 8 ROT INT S IST TURK, P60
   DECASTRO L, 1994, MEM I OSWALDO CRUZ, V89, P5, DOI 10.1590/S0074-02761994000100002
   Dennehy PH, 2008, CLIN MICROBIOL REV, V21, P198, DOI 10.1128/CMR.00029-07
   Domingues ALS, 2008, J CLIN VIROL, V43, P298, DOI 10.1016/j.jcv.2008.07.008
   Estes MK, 2001, FIELDS VIROLOGY, P1747
   FERRERA A, 2007, 17 EUR C CLIN MICR I
   FONTEYNE J, 1978, LANCET, V1, P983
   FRIEDMAN MG, 1988, J INFECT DIS, V158, P814, DOI 10.1093/infdis/158.4.814
   Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499
   GEORGESCOURBOT MC, 1988, ANN INST PASTEUR VIR, V139, P421, DOI 10.1016/S0769-2617(88)80077-7
   Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6
   Gomara MI, 2001, J CLIN MICROBIOL, V39, P3796, DOI 10.1128/JCM.39.10.3796-3798.2001
   GOUVEA V, 1994, J CLIN MICROBIOL, V32, P1408, DOI 10.1128/JCM.32.5.1408-1409.1994
   Gouvea V, 1999, VACCINE, V17, P1291
   Gouvea Vera S, 2007, Open Virol J, V1, P47, DOI 10.2174/1874357900701010047
   Grimwood K, 2008, LANCET, V371, P1144, DOI 10.1016/S0140-6736(08)60501-2
   Gurgel RQ, 2008, J CLIN VIROL, V43, P1, DOI 10.1016/j.jcv.2008.04.010
   Gurgel RQ, 2007, EMERG INFECT DIS, V13, P1571, DOI 10.3201/eid1310.070412
   GURWITH M, 1981, J INFECT DIS, V144, P218, DOI 10.1093/infdis/144.3.218
   Gusmao RHP, 1995, MEM I OSWALDO CRUZ, V90, P743, DOI 10.1590/S0074-02761995000600016
   Gusmao RHP, 1999, J TROP PEDIATRICS, V45, P81, DOI 10.1093/tropej/45.2.81
   Hoshino Y, 2004, J VIROL, V78, P7795, DOI 10.1128/JVI.78.14.7795-7802.2004
   Kale PL, 2004, J HEALTH POPUL NUTR, V22, P27
   KAPIKIAN AZ, 2003, FIELDS VIROLOGY, P1657
   Leite JPG, 1996, ARCH VIROL, V141, P2365, DOI 10.1007/BF01718637
   LINHARES AC, 1988, ANN INST PASTEUR VIR, V139, P89, DOI 10.1016/S0769-2617(88)80009-1
   LINHARES AC, 1993, J TROP PEDIATRICS, V39, P137, DOI 10.1093/tropej/39.3.137
   Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3
   LOPEZ S, 1994, VIROLOGY, V204, P153, DOI 10.1006/viro.1994.1519
   Luz Cláudia Regina N. E., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P287, DOI 10.1590/S0036-46652005000500009
   Macedo CI, 2007, REV SOC BRAS MED TRO, V40, P381, DOI 10.1590/S0037-86822007000400001
   Magalhaes GF, 2007, MEM I OSWALDO CRUZ, V102, P555, DOI 10.1590/S0074-02762007005000067
   MARTINEZLASO J, 2008, J CLIN VIRO IN PRESS
   Martini IJ, 2008, J CLIN VIROL, V43, P244, DOI 10.1016/j.jcv.2008.06.015
   Mascarenhas JDP, 2002, MEM I OSWALDO CRUZ, V97, P113, DOI 10.1590/S0074-02762002000100020
   Mascarenhas JDP, 1998, J DIARRHOEAL DIS RES, V16, P8
   Mascarenhas Joana D'Arc P., 1999, Revista do Instituto de Medicina Tropical de Sao Paulo, V41, P165, DOI 10.1590/S0036-46651999000300006
   Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1
   Miagostovich MP, 2008, APPL ENVIRON MICROB, V74, P375, DOI 10.1128/AEM.00944-07
   Miller MA, 2000, HEALTH ECON, V9, P19, DOI 10.1002/(SICI)1099-1050(200001)9:1<19::AID-HEC487>3.0.CO;2-C
   Montenegro FMU, 2007, J MED VIROL, V79, P335, DOI 10.1002/jmv.20803
   Moulton LH, 1998, J INFECT DIS, V178, P1562, DOI 10.1086/314504
   *MS, 2006, DATASUS
   Nakagomi T, 2008, ARCH VIROL, V153, P591, DOI 10.1007/s00705-007-0028-z
   Parashar UD, 2006, EMERG INFECT DIS, V12, P304
   Parra GI, 2008, VET MICROBIOL, V126, P243, DOI 10.1016/j.vetmic.2007.06.006
   Patel MM, 2008, EMERG INFECT DIS, V14, P863, DOI 10.3201/eid1405.071440
   Phan TG, 2007, INFECT GENET EVOL, V7, P656, DOI 10.1016/j.meegid.2007.05.001
   Phan TG, 2007, J VIROL, V81, P4645, DOI 10.1128/JVI.02342-06
   Pietruchinski E, 2006, J MED VIROL, V78, P1241, DOI 10.1002/jmv.20686
   Rahman M, 2007, EMERG INFECT DIS, V13, P18, DOI 10.3201/eid1301.060910
   REVES RR, 1989, AM J EPIDEMIOL, V130, P981, DOI 10.1093/oxfordjournals.aje.a115431
   Ribeiro LR, 2008, MEM I OSWALDO CRUZ, V103, P201, DOI 10.1590/S0074-02762008000200013
   Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434
   Santos N, 2005, J CLIN MICROBIOL, V43, P4064, DOI 10.1128/JCM.43.8.4064-4069.2005
   Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448
   Santos N, 1998, J CLIN MICROBIOL, V36, P2727, DOI 10.1128/JCM.36.9.2727-2729.1998
   Santos N, 2003, J CLIN MICROBIOL, V41, P3399, DOI 10.1128/JCM.41.7.3399-3402.2003
   Santos N, 2001, J CLIN MICROBIOL, V39, P1157, DOI 10.1128/JCM.39.3.1157-1160.2001
   Silva MLRE, 2002, J CLIN MICROBIOL, V40, P2837, DOI 10.1128/JCM.40.8.2837-2842.2002
   Souza MBLD, 2003, EUR J CLIN MICROBIOL, V22, P441, DOI 10.1007/s10096-003-0952-0
   STEWIEN KE, 1994, BRAZ J MED BIOL RES, V27, P1355
   Tang BZ, 1997, VIROLOGY, V237, P89, DOI 10.1006/viro.1997.8762
   Tavares TD, 2008, MEM I OSWALDO CRUZ, V103, P288, DOI 10.1590/S0074-02762008000300011
   TIMENETSKY MDST, 1994, J CLIN MICROBIOL, V32, P2622, DOI 10.1128/JCM.32.10.2622-2624.1994
   Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404
   Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9
   Victoria M, 2007, PEDIATR INFECT DIS J, V26, P602, DOI 10.1097/INF.0b013e3180618bea
   Victoria M, 2007, J MED VIROL, V79, P939, DOI 10.1002/jmv.20814
   Volotao EM, 2006, J MED VIROL, V78, P263, DOI 10.1002/jmv.20535
   WARD RL, 1994, J INFECT DIS, V169, P900, DOI 10.1093/infdis/169.4.900
   World Health Organisation, 2002, GEN PROT HOSP BAS SU
NR 100
TC 86
Z9 86
U1 0
U2 5
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD DEC
PY 2008
VL 103
IS 8
BP 745
EP 753
DI 10.1590/S0074-02762008000800001
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 396GI
UT WOS:000262579800001
PM 19148411
OA DOAJ Gold, Green Published
DA 2020-12-08
ER

PT J
AU Boia, MN
   Carvalho-Costa, FA
   Sodre, FC
   Pinto, GMT
   Amendoeira, MRR
AF Boia, Marcio Neves
   Carvalho-Costa, Filipe Anibal
   Sodre, Fernando Campos
   Trindade Pinto, Gloria Maria
   Ries Amendoeira, Marin Regina
TI Seroprevalence of Toxoplasma gondii infection among Indian people living
   in Iauarete, Sao Gabriel da Cachoeira, Amazonas, Brazil
SO REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
LA English
DT Article
DE Toxoplasma gondii; prevalence; Indians; Brazilian Amazon; Iauarete
AB The goal of this survey was to estimate the seroprevalence of Toxoplasma gondii infection in Iauarete, a multiethnic Indian community in the upper Rio Negro basin. We carried out a cross-sectional survey (n=260), in order to obtain serum samples and demographic data. The sample was randomly selected. by family conglomerate analysis. Serodiagnosis was performed by an enzyme-linked immunosorbent assay and indirect immunofluorescence. Prevalence of reactivity was 73.5% (191/260) being higher in the older-age groups, reaching 95.7% (44/46) in the group aged 50 years or more. The majority of seropositive subjects bad titers equal to or less than 1:64. Seroprevalence was greater in Indians belonging to the Hupda ethnic group (p=0.03). According to the present survey, Indian people living in Iauarete have a high prevalence of antibodies to T. gondii. Demographic concentration and urbanization within low sanitation and poor hygiene backgounds, as well as unfiltered water consumption, may be related to the high frequency of T. gondii seroprevalence observed in the studied area.
C1 [Boia, Marcio Neves; Carvalho-Costa, Filipe Anibal] Inst Oswaldo Cruz Fiocruz, Lab Doencas Parasitarias, Rio De Janeiro, Brazil.
   [Boia, Marcio Neves] Univ Estado Rio de Janeiro, Disciplina Doencas Infecc & Parasitarias, Fac Ciencias Med, BR-20550011 Rio De Janeiro, Brazil.
   [Sodre, Fernando Campos] Univ Fed Fluminense, Dept Patol, Rio De Janeiro, Brazil.
   [Trindade Pinto, Gloria Maria; Ries Amendoeira, Marin Regina] Inst Oswaldo Cruz Fiocruz, Lab Toxoplasmose, Rio De Janeiro, Brazil.
RP Carvalho-Costa, FA (corresponding author), Ave Brasil 4365,Pavilhao Arthur Neiva Sala 21B, BR-21045900 Rio De Janeiro, Brazil.
EM guaratiba@ioc.fiocruz.br
CR AMBROISETHOMAS P, 1993, PARASITOL TODAY, V9, P61, DOI 10.1016/0169-4758(93)90038-H
   BARUZZI RG, 1970, REV INST MED TROP SP, V12, P92
   CamargO M. E., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P117
   Camargo M E, 1976, Rev Inst Med Trop Sao Paulo, V18, P215
   Chacin-Bonilla L, 2001, AM J TROP MED HYG, V65, P131, DOI 10.4269/ajtmh.2001.65.131
   DESMONTS G, 1974, NEW ENGL J MED, V290, P1110, DOI 10.1056/NEJM197405162902003
   Dubey J.P., 1993, P1
   Ferraroni J J, 1982, Rev Inst Med Trop Sao Paulo, V24, P155
   *I SOC, POV IND BRAS NOR AM
   Leser P G, 1977, Rev Inst Med Trop Sao Paulo, V19, P232
   LOVELACE JK, 1978, TROP GEOGR MED, V30, P295
   MELAMED J, 1992, RECENT ADV UVEITIS, P211
   NEEL JV, 1968, AM J TROP MED HYG, V17, P486, DOI 10.4269/ajtmh.1968.17.486
   Sobral CA, 2005, AM J TROP MED HYG, V72, P37, DOI 10.4269/ajtmh.2005.72.37
   WONG SY, 1994, CLIN INFECT DIS, V18, P853, DOI 10.1093/clinids/18.6.853
NR 15
TC 26
Z9 26
U1 1
U2 5
PU INST MEDICINA TROPICAL SAO PAULO
PI SAO PAULO
PA AV DR ENEAS CARVALHO DE AGUIAR, 470, C CESAR, SAO PAULO, 05403-000,
   BRAZIL
SN 0036-4665
EI 1678-9946
J9 REV INST MED TROP SP
JI Rev. Inst. Med. Trop. Sao Paulo
PD JAN-FEB
PY 2008
VL 50
IS 1
BP 17
EP 20
DI 10.1590/S0036-46652008000100004
PG 4
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA 306UX
UT WOS:000256274400004
PM 18327482
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Victoria, M
   Carvalho-Costa, FA
   Heinemann, MB
   Leite, JPG
   Miagostovich, MP
AF Victoria, Matias
   Carvalho-Costa, Filipe Anibal
   Heinemann, Marcos Bryan
   Gagliardi Leite, Jose Paulo
   Miagostovich, Marize Pereira
TI Genotypes and molecular epidemiology of human astroviruses in
   hospitalized children with acute gastroenteritis in Rio de Janeiro,
   Brazil
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE astroviruses; gastroenteritis; genotypes; inpatients
ID ENZYME-IMMUNOASSAY; GENETIC DIVERSITY; YOUNG-CHILDREN; VIRAL AGENTS;
   SAO-PAULO; DIARRHEA; PREVALENCE; INFECTION; ROTAVIRUS; IDENTIFICATION
AB Human astrovirus (HAstV) is an important pathogen that causes acute gastroenteritis mainly in children up to 5 years old worldwide. A total of 318 fecal samples were collected from January to December of 2004 from children with acute gastroenteritis hospitalized in Rio de Janeiro (RJ), Brazil. The samples were obtained from three public hospitals and were previously investigated for the presence of rotavirus (RV) and enteric adenovirus (AdV). The aim of this study was to determine the prevalence and molecular characterization of HAstV by reverse-transcription polymerase chain reaction (RT-PCR) and partial sequencing of open reading frame 2 (ORF2). HAstV infections were detected in 43 (14%) of the samples, of which 19 (6%) were mixed infections with HAstV and RV. HAstV were identified in all age groups, with 85% of the cases occurring in children younger than 2 years old. HAstV infections were more prevalent from March to May. Diarrhea, vomiting, and fever were the main clinical manifestations observed in these infections. Partial capsid sequencing of 35 HAstV strains characterized 25 (71%) as genotype 1 (HAstV-1), 6 (17%) HAstV-2, 3 (9%) HAstV-8, and 1 (3%) HAstV-4. Based on the genetic variability, three lineages were observed between RJ HAstV-1 strains. This study demonstrated the importance of HAstV infections causing acute infantile gastroenteritis in hospitalized children in RJ, Brazil. Molecular epidemiological surveillance is helpful for designing prevention strategies of HAstV transmission.
C1 Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Virol, Rio De Janeiro, Brazil.
RP Victoria, M (corresponding author), Lab Virol Comparada, Sala 71,Pavilhao Cardoso Fontes,Av Brazil 4-365, BR-21040000 Rio De Janeiro, Brazil.
EM matias@ioc.fiocruz.br
RI Victoria, Matias/ABE-1729-2020; Heinemann, Marcos Bryan/AAI-9390-2020;
   Heinemann, Marcos B/G-2780-2015
OI Heinemann, Marcos Bryan/0000-0001-6444-9788; Heinemann, Marcos
   B/0000-0001-6444-9788
CR Bhattacharya R, 2006, INFECT GENET EVOL, V6, P425, DOI 10.1016/j.meegid.2006.02.001
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8
   Carvalho-Costa FA, 2006, MEM I OSWALDO CRUZ, V101, P291, DOI 10.1590/S0074-02762006000300012
   Dalton RM, 2002, PEDIATR INFECT DIS J, V21, P1038, DOI 10.1097/00006454-200211000-00012
   das Dores de Paula Cardoso Divina, 2002, Med Sci Monit, V8, pCR624
   De Grazia S, 2004, CLIN MICROBIOL INFEC, V10, P1025, DOI 10.1111/j.1469-0691.2004.00995.x
   Espul C, 2004, J MED VIROL, V72, P75, DOI 10.1002/jmv.10537
   Gabbay YB, 2005, MEM I OSWALDO CRUZ, V100, P709, DOI 10.1590/S0074-02762005000700004
   Gaggero A, 1998, J CLIN MICROBIOL, V36, P3691, DOI 10.1128/JCM.36.12.3691-3693.1998
   Galdiero E, 2005, MED MALADIES INFECT, V35, P213, DOI 10.1016/j.medmal.2005.03.006
   Geigenmuller U, 2002, J GEN VIROL, V83, P1691, DOI 10.1099/0022-1317-83-7-1691
   Giordano Miguel O., 2004, Rev. Inst. Med. trop. S. Paulo, V46, P93, DOI 10.1590/S0036-46652004000200007
   Gofti-Laroche L, 2003, J CLIN VIROL, V27, P74, DOI 10.1016/S1386-6532(02)00130-0
   Guix S, 2002, J CLIN MICROBIOL, V40, P133, DOI 10.1128/JCM.40.1.133-139.2002
   HALL TA, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.5598/IMAFUNGUS.2011.02.02.06
   Jakab F, 2004, J MED VIROL, V74, P71, DOI 10.1002/jmv.20148
   Jonassen CM, 2003, VIRUS RES, V91, P195, DOI 10.1016/S0168-1702(02)00269-1
   Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244
   LEITE JPG, 1991, MEM I OSWALDO CRUZ, V86, P489, DOI 10.1590/S0074-02761991000400025
   Liu CY, 2006, J CLIN VIROL, V35, P69, DOI 10.1016/j.jcv.2005.04.007
   Liu CY, 2004, CHINESE MED J-PEKING, V117, P353
   Medina SM, 2000, J CLIN MICROBIOL, V38, P3481, DOI 10.1128/JCM.38.9.3481-3483.2000
   Mendez-Toss M, 2004, J CLIN MICROBIOL, V42, P151, DOI 10.1128/JCM.42.1.151-157.2004
   Naficy AB, 2000, J INFECT DIS, V182, P685, DOI 10.1086/315763
   NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995
   Oh DY, 2003, J MED VIROL, V71, P82, DOI 10.1002/jmv.10449
   Pang XLL, 2005, J CLIN VIROL, V33, P168, DOI 10.1016/j.jcv.2004.12.014
   PEREIRA HG, 1983, J HYG-CAMBRIDGE, V90, P117, DOI 10.1017/S0022172400063919
   PEREIRA HG, 1985, J VIROL METHODS, V10, P21, DOI 10.1016/0166-0934(85)90084-9
   Phan TG, 2004, J MED VIROL, V73, P256, DOI 10.1002/jmv.20084
   Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448
   Schnagl RD, 2002, J CLIN MICROBIOL, V40, P4114, DOI 10.1128/JCM.40.11.4114-4120.2002
   Silva PA, 2006, ARCH VIROL, V151, P1405, DOI 10.1007/s00705-005-0704-9
   STEWIEN KE, 1993, J DIARRHOEAL DIS RES, V11, P148
   STEWIEN KE, 1991, REV SAUDE PUBL, V25, P157, DOI 10.1590/S0034-89101991000200011
   Timenetsky Maria Do Carmo Sampaio Tavares, 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P275
   Wilhelmi I, 2003, CLIN MICROBIOL INFEC, V9, P247, DOI 10.1046/j.1469-0691.2003.00560.x
NR 38
TC 29
Z9 32
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD JUL
PY 2007
VL 79
IS 7
BP 939
EP 944
DI 10.1002/jmv.20814
PG 6
WC Virology
SC Virology
GA 174JN
UT WOS:000246938300013
PM 17516522
DA 2020-12-08
ER

PT J
AU Victoria, M
   Carvalho-Costa, FA
   Heinemann, MB
   Leite, JP
   Miagostovich, M
AF Victoria, Matias
   Carvalho-Costa, Filipe Anibal
   Heinemann, Marcos Bryan
   Leite, Jose Paulo
   Miagostovich, Marize
TI Prevalence and molecular epidemiology of noroviruses in hospitalized
   children with acute gastroenteritis in Rio de Janeiro, Brazil, 2004
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Article
DE noroviruses; gastroenteritis; genotypes; inpatients
ID HUMAN CALICIVIRUSES; GENETIC DIVERSITY; YOUNG-CHILDREN; WINTER SEASON;
   VIRAL AGENTS; INFECTION; OUTBREAKS; DIARRHEA; ASTROVIRUS; SAMPLES
AB Background: The role of noroviruses (NoV) as a cause of gastroenteritis outbreaks is well documented; however, the importance of NoV infections in hospitalized children is not well established. The aim of this study was to determine the prevalence and the genetic diversity of NoV in hospitalized children.
   Methods: Three-hundred eighteen fecal samples were collected from January to December 2004, from children with acute gastroenteritis in 3 public hospitals in Rio de Janeiro, Brazil. The prevalence and genetic diversity of NoV was carried out by using genome amplification and sequencing of polymerase and capsid genes.
   Results: NoV infections were detected in 65 (20%) of the samples, of which 11 (4%) were mixed infections with rotavirus. Infants up to 1-year-old were the most affected and a peak of virus detection was observed in autumn and spring seasons. Dehydration and diarrhea were the inclusion criterion; coughing (51%), vomiting (33%), and fever (22%) were the main clinical manifestations. Phylogenetic analysis showed that Genogroup II and GII/4 were prevalent. Two potential recombinant strains based in the different clustering pattern were observed.
   Conclusions: This study demonstrated the importance of NoV infections causing severe acute gastroenteritis in hospitalized children in Rio de Janeiro, Brazil. Molecular epidemiology surveillance determining the circulation pattern of different genotypes and recombinant strains is helpful for designing prevention strategies of NoV transmission in children. Studies concerning the prevalence and the molecular epidemiology of gastroenteric viruses in hospitalized children are particularly important to evaluate the impact of the rotavirus vaccine in Brazil.
C1 Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Virol, Lab Comparat Virol, BR-21040000 Rio De Janeiro, Brazil.
RP Victoria, M (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Dept Virol, Lab Comparat Virol, Pavilhao Cardoso Fontes,Av Brasil 4-365, BR-21040000 Rio De Janeiro, Brazil.
EM matias@ioc.flocruz.br
RI Heinemann, Marcos Bryan/AAI-9390-2020; Heinemann, Marcos B/G-2780-2015;
   Victoria, Matias/ABE-1729-2020
OI Heinemann, Marcos Bryan/0000-0001-6444-9788; Heinemann, Marcos
   B/0000-0001-6444-9788; 
CR Beuret C, 2002, APPL ENVIRON MICROB, V68, P1925, DOI 10.1128/AEM.68.4.1925-1931.2002
   Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315
   Bon F, 2005, J CLIN MICROBIOL, V43, P4659, DOI 10.1128/JCM.43.9.4659-4664.2005
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Borges AMT, 2006, MEM I OSWALDO CRUZ, V101, P721, DOI 10.1590/S0074-02762006000700003
   Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8
   CARDOSO D, 2002, MED SCI MONITOR, V8, P264
   Carvalho-Costa FA, 2006, MEM I OSWALDO CRUZ, V101, P291, DOI 10.1590/S0074-02762006000300012
   Castilho JG, 2006, J CLIN MICROBIOL, V44, P3947, DOI 10.1128/JCM.00279-06
   Dove W, 2005, J MED VIROL, V77, P522, DOI 10.1002/jmv.20488
   Estes MK, 2006, CURR OPIN INFECT DIS, V19, P467, DOI 10.1097/01.qco.0000244053.69253.3d
   Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085
   Fretz R, 2005, EUR J CLIN MICROBIOL, V24, P214, DOI 10.1007/s10096-005-1300-3
   Froggatt PC, 2004, J MED VIROL, V72, P307, DOI 10.1002/jmv.10569
   Gabbay YB, 2005, MEM I OSWALDO CRUZ, V100, P709, DOI 10.1590/S0074-02762005000700004
   Gaggero A, 1998, J CLIN MICROBIOL, V36, P3691, DOI 10.1128/JCM.36.12.3691-3693.1998
   Gallimore CI, 2004, BRAZ J MED BIOL RES, V37, P321, DOI 10.1590/S0100-879X2004000300005
   Glass RI, 2000, J INFECT DIS, V181, pS254, DOI 10.1086/315588
   HALL TA, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.5598/IMAFUNGUS.2011.02.02.06
   Hansman GS, 2004, ARCH VIROL, V149, P1673, DOI 10.1007/s00705-004-0345-4
   Hardy ME, 2005, FEMS MICROBIOL LETT, V253, P1, DOI 10.1016/j.femsle.2005.08.031
   Ike AC, 2006, J CLIN MICROBIOL, V44, P1262, DOI 10.1128/JCM.44.4.1262-1267.2006
   Kirkwood CD, 2005, J MED VIROL, V77, P96, DOI 10.1002/jmv.20419
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Lau CS, 2004, J MED VIROL, V73, P113, DOI 10.1002/jmv.20066
   Lindell AT, 2005, J CLIN MICROBIOL, V43, P1086, DOI 10.1128/JCM.43.3.1086-1092.2005
   Liu CY, 2006, J CLIN VIROL, V35, P69, DOI 10.1016/j.jcv.2005.04.007
   Marshall JA, 2003, J MED VIROL, V69, P568, DOI 10.1002/jmv.10346
   Martinez N, 2002, J MED VIROL, V67, P289, DOI 10.1002/jmv.2220
   Oh DY, 2003, J MED VIROL, V71, P82, DOI 10.1002/jmv.10449
   Pang XL, 2000, J INFECT DIS, V181, pS288, DOI 10.1086/315590
   Parashar UD, 2004, J INFECT DIS, V190, P1088, DOI 10.1086/423324
   Phan TG, 2004, J MED VIROL, V73, P256, DOI 10.1002/jmv.20084
   Prasad BVV, 1999, SCIENCE, V286, P287, DOI 10.1126/science.286.5438.287
   Rockx B, 2002, CLIN INFECT DIS, V35, P246, DOI 10.1086/341408
   Simpson R, 2003, J MED VIROL, V70, P258, DOI 10.1002/jmv.10386
   VICTORIA M, IN PRESS J MED VIROL
   Vidal R, 2006, J CLIN MICROBIOL, V44, P2271, DOI 10.1128/JCM.01890-05
   Vinje J, 2004, J VIROL METHODS, V116, P109, DOI 10.1016/j.jviromet.2003.11.001
   Waters A, 2006, EPIDEMIOL INFECT, V134, P917, DOI 10.1017/S0950268806006121
   Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015
   Zintz Carmelann, 2005, Infection Genetics and Evolution, V5, P281, DOI 10.1016/j.meegid.2004.06.010
NR 42
TC 59
Z9 62
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD JUL
PY 2007
VL 26
IS 7
BP 602
EP 606
DI 10.1097/INF.0b013e3180618bea
PG 5
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA 185FS
UT WOS:000247697400010
PM 17596802
DA 2020-12-08
ER

PT J
AU Carvalho-Costa, FA
   Goncalves, AQ
   Lassance, SL
   de Albuquerque, CP
   Leite, JPG
   Boia, MN
AF Carvalho-Costa, Filipe Anibal
   Goncalves, Alessandra Queiroga
   Lassance, Sandra Laranjeira
   de Albuquerque, Carla Pontes
   Leite, Jose Paulo Gagliardi
   Boia, Marcio Neves
TI Defection of Cryptosporidium spp and other intesdonal parasites in
   children with acute diarrhea and severe dehydration in Rio de Janeiro
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE cryptosporidium spp; acute diarrhea; children; stool examination
ID EPIDEMIOLOGY; DISEASE
AB The objective of the present study was to estimate the frequency of infection by Cryptosporidium spp and other intestinal parasites in dehydrated children with gastroenteritis who were admitted to a pediatric hospital. Stool examinations from 218 children were performed. Cryptosporidium spp was identified in eighteen out of 193 stool samples (9.3%) subjected to safranin-methylene blue staining. Giardia lamblia was detected in ten out of 213 (4.7%) samples examined via the direct or Ritchie methods. other parasites identified were Ascaris lumbricoides (4.2%), Blastocystis hominis (1.4%), Entamoeba coli (0.9%), Entamoeba histolytica/Entamoeba dispar (0.5%), Endolimax nana (0.5%), Trichuris trichiura (0.5%) and Enterobius vermicularis (0.5%)
C1 Fiocruz MS, Dept Trop Med, Lab Doencas Parasitarias, IOC, BR-21045900 Rio De Janeiro, Brazil.
   Hosp Municipal Souza Aguiar, Rio De Janeiro, Brazil.
   Hosp Municipal Salles Netto, Rio De Janeiro, Brazil.
   Fundacao Oswaldo Cruz, Lab Virol Comparada, Dept Virol, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   Univ Estado Rio de Janeiro, Fac Ciencias Med, Disciplina Doencas Infecciosas & Parasitarias, Rio De Janeiro, Brazil.
RP Carvalho-Costa, FA (corresponding author), Fiocruz MS, Dept Trop Med, Lab Doencas Parasitarias, IOC, Av Brasil,4365, BR-21045900 Rio De Janeiro, Brazil.
EM guaratiba@ioc.fiocruz.br
RI LEITE, JOSE PAULO GAGLIARDI/AAY-1230-2020
OI Goncalves, Alessandra Queiroga/0000-0003-3272-6861
CR Amato Neto V., 2003, REV SOC BRASILEIRA M, V36, P515
   Amato Neto Vicente, 2004, Rev. Soc. Bras. Med. Trop., V37, P354, DOI 10.1590/S0037-86822004000400013
   BAXBY D, 1984, J HYG-CAMBRIDGE, V93, P317, DOI 10.1017/S0022172400064858
   BERN C, 1992, B WORLD HEALTH ORGAN, V70, P705
   Dillingham RA, 2002, MICROBES INFECT, V4, P1059, DOI 10.1016/S1286-4579(02)01630-1
   GennariCardoso ML, 1996, MEM I OSWALDO CRUZ, V91, P551, DOI 10.1590/S0074-02761996000500003
   Griffiths JK, 1998, ADV PARASIT, V40, P37, DOI 10.1016/S0065-308X(08)60117-7
   Khan WA, 2004, AM J TROP MED HYG, V71, P412, DOI 10.4269/ajtmh.2004.71.412
   Leav BA, 2003, CLIN INFECT DIS, V36, P903, DOI 10.1086/368194
   MANGINI ACS, 1992, REV I MED TROP, V34, P341, DOI 10.1590/S0036-46651992000400012
   NASICMENTO SA, 2005, REV SOC BRASILEIRA M, V47, P213
   Nimri LF, 2004, CLIN MICROBIOL INFEC, V10, P634, DOI 10.1111/j.1469-0691.2004.00891.x
   Orlandi PP, 2001, MEM I OSWALDO CRUZ, V96, P621, DOI 10.1590/S0074-02762001000500005
   RITCHIE LAWRENCE S., 1948, BULL U S ARMY MED DEPT, V8, P326
   Schnack Felice Jaqueline, 2003, Cad. Saúde Pública, V19, P1205, DOI 10.1590/S0102-311X2003000400042
   Tzipori S, 2002, MICROBES INFECT, V4, P1047, DOI 10.1016/S1286-4579(02)01629-5
   Vargas M, 2004, AM J TROP MED HYG, V70, P536, DOI 10.4269/ajtmh.2004.70.536
NR 17
TC 12
Z9 13
U1 0
U2 1
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD MAY-JUN
PY 2007
VL 40
IS 3
BP 346
EP 348
DI 10.1590/S0037-86822007000300020
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 190BN
UT WOS:000248032900020
PM 17653475
OA DOAJ Gold
DA 2020-12-08
ER

PT J
AU Carvalho-Costa, FA
   Assis, RM
   Fialho, AM
   Boia, MN
   Alves, DPD
   Martins, CMMD
   Leite, JPG
AF Carvalho-Costa, Filipe Anibal
   Assis, Rosane Maria
   Fialho, Alexandre Madi
   Boia, Marcio Neves
   Alves, Daniele Pires Dias
   Miranda de Assis Martins, Carolina Maria
   Leite, Jose Paulo Gagliardi
TI Detection and molecular characterization of group A rotavirus from
   hospitalized children in Rio de Janeiro, Brazil, 2004
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE gastroenteritis; hospitalization; rotavirus A; genotypes; Rio de
   Janeiro; Brazil
ID POLYMERASE CHAIN-REACTION; GENOTYPE G9; DIARRHEA; STRAINS; VACCINE;
   EPIDEMIOLOGY; INFECTIONS; WINTER
AB Rotavirus is a major cause of infantile acute diarrhea, causing about 440, 000 deaths per year mainly in developing countries. The World Health Organization has been recommending the assessment of rotavirus burden and strain characterization as part of the strategies of immunization programs against this pathogen. In this context, a prospective study was made on a sample of 134 children with acute diarrhea and severe dehydration admitted to venous fluid therapy in two state hospitals in Rio de Janeiro, Brazil, from February to September 2004. Rotavirus where detected by polyacrylamide gel electrophoresis (PAGE) and by an enzyme-linked immunoassay to rotavirus and adenovirus (EIARA) in 48% of the children. Positive samples for group A rotavirus (n = 65) were analyzed by reverse transcription/heminested multiplex polymerase chain reaction to determine the frequency of G and [P] genotypes and, from these, 64 samples could be typed The most frequent G genotype was G1 (58%) followed by G9 (40%). One mixed infection (G1/G9) was detected. The only [P] genotype identified was P[8]. In order to estimate the rotavirus infection frequency in children who acquired diarrhea as hospital infection in those hospitals, we studied 24 patients, detecting the pathogen in 41% of them. This data suggest that genotype G9 is an important genotype in Rio de Janeiro, with implications to the future strategies of vaccination against rotavirus, reinforcing the need of continuous monitoring of circulating strains of the pathogen, in a surveillance context.
C1 Fiocruz MS, Inst Oswaldo Cruz, Dept Virol, Lab Virol Comparada, BR-21045900 Rio De Janeiro, Brazil.
   Fiocruz MS, Inst Oswaldo Cruz, Dept Virol, Lab Virol Comparada, BR-21045900 Rio De Janeiro, Brazil.
   Fiocruz MS, Inst Oswaldo Cruz, Dept Trop Med, Lab Doencas Parasitarias, BR-21045900 Rio De Janeiro, Brazil.
   Hosp Municipal Salles Netto, Rio De Janeiro, Brazil.
   Hosp Municipal Souza Aguiar, Rio De Janeiro, Brazil.
RP Leite, JPG (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Dept Virol, Lab Virol Comparada, Av Brasil 4365, BR-21045900 Rio De Janeiro, Brazil.
EM jpgleite@ioc.fiocruz.br
OI Fialho, Alexandre Madi/0000-0002-5412-3896
CR Araujo IT, 2001, J CLIN MICROBIOL, V39, P1999, DOI 10.1128/JCM.39.5.1999-2001.2001
   Arista S, 2004, EPIDEMIOL INFECT, V132, P343, DOI 10.1017/S0950268803001602
   Armah GE, 2003, J CLIN MICROBIOL, V41, P2317, DOI 10.1128/JCM.41.6.2317-2322.2003
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Chen KT, 2005, J INFECT DIS, V192, pS44, DOI 10.1086/431495
   Clark HF, 2004, J PEDIATR-US, V144, P184, DOI 10.1016/j.jpeds.2003.10.054
   Costa Paulo S. S., 2004, J. Pediatr. (Rio J.), V80, P119, DOI 10.1590/S0021-75572004000200008
   DAS BK, 1994, J CLIN MICROBIOL, V32, P1820, DOI 10.1128/JCM.32.7.1820-1822.1994
   DEVOS B, 2004, PEDIATR INFECT DIS J, V23, P179
   Fischer TK, 2004, VACCINE, V22, pS49, DOI 10.1016/j.vaccine.2004.08.017
   GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365, DOI 10.1128/JCM.30.6.1365-1373.1992
   GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990
   Gouvea V, 1999, VACCINE, V17, P1291
   Hoshino Y, 2000, J HEALTH POPUL NUTR, V18, P5
   Jiraphongsa C, 2005, J INFECT DIS, V192, pS87, DOI 10.1086/431508
   Kapikian AZ, 1996, J INFECT DIS, V174, pS65, DOI 10.1093/infdis/174.Supplement_1.S65
   Kebaabetswe L P, 2005, East Afr Med J, V82, P203
   Kirkwood Carl D, 2003, Commun Dis Intell Q Rep, V27, P492
   Le Roux P, 2004, ARCH PEDIATRIE, V11, P908, DOI 10.1016/j.arcped.2004.04.022
   Leite JPG, 1996, ARCH VIROL, V141, P2365, DOI 10.1007/BF01718637
   Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562
   PEREIRA HG, 1983, J HYG-CAMBRIDGE, V90, P117, DOI 10.1017/S0022172400063919
   PEREIRA HG, 1985, J VIROL METHODS, V10, P21, DOI 10.1016/0166-0934(85)90084-9
   Salinas M, 2005, PEDIATR INFECT DIS J, V24, P807, DOI 10.1097/01.inf.0000178294.13954.a1
   Santos N, 2005, J CLIN MICROBIOL, V43, P4064, DOI 10.1128/JCM.43.8.4064-4069.2005
   Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448
   Santos N, 2001, J CLIN MICROBIOL, V39, P1157, DOI 10.1128/JCM.39.3.1157-1160.2001
   Sung Yuk-Lan, 2004, Journal of Microbiology Immunology and Infection, V37, P322
   Thuret A, 2004, PATHOL BIOL, V52, P131, DOI 10.1016/j.patbio.2003.06.005
   Urbina D, 2004, INT MICROBIOL, V7, P113
   Van der Donck I, 2003, ACTA CLIN BELG, V58, P12, DOI 10.1179/acb.2003.58.1.002
   Volotao EM, 2006, J MED VIROL, V78, P263, DOI 10.1002/jmv.20535
   Zhou Y, 2003, MICROBIOL IMMUNOL, V47, P591, DOI 10.1111/j.1348-0421.2003.tb03422.x
NR 33
TC 27
Z9 27
U1 0
U2 0
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD MAY
PY 2006
VL 101
IS 3
BP 291
EP 294
DI 10.1590/S0074-02762006000300012
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 050VJ
UT WOS:000238116700012
PM 16862325
OA DOAJ Gold
DA 2020-12-08
ER

EF